data_2eyd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2eyd _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.492 ' HB ' HG13 ' A' ' 35' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 120.881 0.372 . . . . 0.0 110.344 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.6 m -95.99 109.52 21.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.958 0.408 . . . . 0.0 109.929 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 64.3 m -123.49 168.33 12.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -173.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 9' ' ' ALA . 5.6 t -160.24 136.74 6.44 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.1 11.71 3.24 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.506 2.137 . . . . 0.0 114.847 -170.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 p -164.34 149.58 10.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.218 0.463 . . . . 0.0 110.639 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.637 HD13 ' H ' ' A' ' 7' ' ' ILE . 4.1 mp -66.95 -34.5 70.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.05 -46.71 95.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.265 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.451 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . . . -66.85 -52.37 44.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.21 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -46.28 -44.47 16.56 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.969 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 15' ' ' VAL . 63.3 m -60.27 -58.2 9.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.454 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 9.4 p30 -70.51 -23.56 62.68 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.681 -175.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.551 ' HB2' HG21 ' A' ' 30' ' ' THR . 44.6 t80 -60.48 -52.17 66.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.551 173.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -68.58 -28.34 66.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.336 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 11' ' ' SER . 77.6 t -67.12 -25.85 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.554 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 28.5 t -80.9 -12.78 59.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 110.26 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.727 ' HD3' ' HG3' ' A' ' 23' ' ' GLU . 38.1 mmm-85 -74.85 -44.14 50.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.092 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.829 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -53.83 -39.39 72.87 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -175.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.829 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 13.7 Cg_exo -72.18 4.39 3.34 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 121.925 1.75 . . . . 0.0 113.145 176.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.23 37.13 12.91 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.22 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.454 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -103.29 138.32 19.51 Favored Pre-proline 0 N--CA 1.436 -1.168 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.423 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 30.1 Cg_endo -66.72 129.72 21.68 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.887 2.392 . . . . 0.0 110.441 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.727 ' HG3' ' HD3' ' A' ' 17' ' ' ARG . 1.5 mp0 -42.55 -35.38 1.06 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.614 172.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.74 -47.4 64.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.15 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.73 -46.72 62.51 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.948 0.404 . . . . 0.0 110.145 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 11.6 m -66.06 -43.95 85.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.502 -174.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.71 89.75 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.421 0.629 . . . . 0.0 111.661 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.3 m -68.39 -24.77 64.81 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.604 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -100.04 -46.48 5.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.502 0.668 . . . . 0.0 109.792 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.551 HG21 ' HB2' ' A' ' 13' ' ' PHE . 48.8 m -60.91 -44.91 96.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.552 -1.203 . . . . 0.0 112.124 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.53 -16.12 7.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.169 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 37.7 m -66.09 164.94 14.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.5 pt -130.06 143.55 40.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 121.937 -0.477 . . . . 0.0 111.857 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.3 mt -117.15 101.8 12.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.881 HD12 ' HB2' ' A' ' 38' ' ' ALA . 6.6 pt -114.45 136.79 22.39 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.949 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.6 -39.43 88.33 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.155 2.57 . . . . 0.0 112.534 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.92 -138.14 4.33 Favored Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.881 ' HB2' HD12 ' A' ' 35' ' ' ILE . . . 65.45 88.75 0.1 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.456 0.646 . . . . 0.0 111.086 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.79 95.8 0.12 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.538 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.475 ' SG ' HD13 ' A' ' 35' ' ' ILE . 60.2 m -56.02 131.17 73.98 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.999 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 32.3 Cg_endo -67.25 178.32 3.14 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 123.012 2.475 . . . . 0.0 112.539 173.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.15 4.51 11.07 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -113.82 -5.69 13.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.666 0.733 . . . . 0.0 110.266 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.531 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 21.4 m-85 -115.88 -14.27 11.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.891 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.4 30.56 3.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.787 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.42 HD21 ' C ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.3 -177.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.823 0.344 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 m -103.24 129.68 50.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.182 -175.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.2 m -122.2 98.47 5.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.854 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.0 m -106.03 113.64 63.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 28.2 Cg_exo -64.37 10.44 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.518 2.812 . . . . 0.0 115.068 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.4 p -165.37 148.39 8.02 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.66 0.664 . . . . 0.0 111.131 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.862 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 53.1 mt -64.11 -30.16 49.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.55 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.99 -55.37 19.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.251 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.1 67.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.487 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.862 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -68.05 -31.63 71.41 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.503 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 27.4 m -69.79 -47.76 61.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.957 175.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -51.52 -44.45 62.61 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.262 0.553 . . . . 0.0 110.631 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 75.8 t80 -54.91 -59.02 5.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.381 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -63.65 -31.18 72.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.544 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 11' ' ' SER . 54.0 t -67.86 -37.53 78.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.223 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.527 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 8.5 t -76.34 -33.95 58.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.284 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.443 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -83.31 2.0 38.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.933 0.397 . . . . 0.0 111.376 -178.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 mt -76.12 -49.47 3.23 Favored Pre-proline 0 N--CA 1.444 -0.74 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 74.1 Cg_endo -75.59 19.08 0.56 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.146 1.897 . . . . 0.0 113.368 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.17 35.22 7.67 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.966 177.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 m -105.0 134.74 19.48 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.785 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 11.5 Cg_endo -59.16 121.11 9.38 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.703 2.269 . . . . 0.0 110.877 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 36.7 mt-10 -40.11 -38.94 0.81 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.125 170.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.97 -48.74 75.27 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.873 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.785 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.5 tt -64.68 -42.9 95.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 110.035 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.7 m -68.96 -30.96 69.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.937 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.61 -33.79 76.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.949 0.88 . . . . 0.0 110.503 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 m -74.68 -17.01 60.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.765 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -101.16 -42.91 6.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.735 0.779 . . . . 0.0 109.924 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.8 m -71.88 -47.91 49.47 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.852 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.15 -18.66 15.86 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 41.2 t -66.42 143.37 57.16 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.7 pt -103.34 149.8 7.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 111.871 -173.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.401 HD11 ' CE1' ' A' ' 13' ' ' PHE . 65.6 mt -125.59 124.98 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.037 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.5 pt -122.25 158.55 55.34 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.926 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.0 23.03 0.86 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.229 2.619 . . . . 0.0 112.584 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.03 -154.33 6.85 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.32 60.43 1.7 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.414 0.626 . . . . 0.0 110.218 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 m -85.36 -6.64 59.21 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.87 0.843 . . . . 0.0 110.917 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.9 m -85.22 122.22 73.87 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.504 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.525 ' HD2' ' CZ ' ' A' ' 44' ' ' TYR . 55.9 Cg_endo -72.03 172.31 14.95 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.602 2.202 . . . . 0.0 110.905 169.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.69 38.1 3.26 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.185 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.509 ' OD1' ' HG2' ' A' ' 41' ' ' PRO . 12.6 p-10 -111.84 -31.63 6.88 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CZ ' ' HD2' ' A' ' 41' ' ' PRO . 2.4 p90 -122.77 18.6 10.26 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.7 0.762 . . . . 0.0 110.23 175.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.0 24.31 13.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.559 170.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.7 t30 . . . . . 0 C--O 1.245 0.838 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.305 -172.755 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.496 HG22 HD12 ' A' ' 35' ' ' ILE . 10.2 m . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.799 0.333 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.652 HG21 ' SG ' ' A' ' 32' ' ' CYS . 80.8 m -132.71 136.49 46.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.701 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.603 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 26.9 m -127.49 138.33 52.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.498 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 52.6 m -106.16 160.31 26.62 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.19 -171.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.407 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 92.8 Cg_endo -89.78 24.99 0.6 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.613 2.209 . . . . 0.0 113.009 174.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.5 t -172.49 136.05 0.75 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -64.0 -29.27 46.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.563 0.697 . . . . 0.0 109.833 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -71.02 -33.82 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.43 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.459 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -71.7 -45.35 62.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.057 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -53.96 -39.14 65.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.135 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.447 ' O ' HG22 ' A' ' 15' ' ' VAL . 36.6 t -63.04 -52.7 61.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.408 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 10.7 p30 -74.72 -23.83 58.65 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.551 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 2' ' ' THR . 25.9 t80 -55.1 -50.5 69.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.2 170.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -59.54 -38.53 81.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.424 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 11' ' ' SER . 87.2 t -63.29 -39.33 84.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.532 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.552 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 11.5 t -76.73 -31.59 57.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.956 0.408 . . . . 0.0 110.485 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -78.49 -13.67 59.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.189 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.555 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 13.6 mt -63.6 -54.49 42.44 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 7.5 Cg_exo -74.56 18.36 0.5 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.684 2.256 . . . . 0.0 113.282 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.89 33.71 12.11 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.082 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.7 m -99.53 133.36 21.94 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.768 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -57.69 122.71 12.22 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.562 2.175 . . . . 0.0 110.695 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -43.67 -33.27 1.17 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.764 170.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.538 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -56.17 -53.23 59.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 173.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.768 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.6 tt -61.47 -46.68 89.03 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.881 0.372 . . . . 0.0 110.227 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.6 m -65.6 -38.32 89.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.325 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 32' ' ' CYS . . . -61.77 -33.67 74.5 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.627 0.727 . . . . 0.0 111.133 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.9 m -74.35 -18.96 60.61 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.947 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -100.64 -40.11 7.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.768 0.794 . . . . 0.0 109.634 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.6 m -74.74 -31.37 61.8 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.196 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.64 14.66 42.94 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -172.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.652 ' SG ' HG21 ' A' ' 2' ' ' THR . 6.1 t -87.97 167.6 13.57 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.4 pt -133.48 138.03 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 118.559 0.618 . . . . 0.0 112.272 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 24' ' ' ALA . 4.3 mp -81.76 142.57 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.678 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.496 HD12 HG22 ' A' ' 1' ' ' THR . 0.2 OUTLIER -122.93 148.15 53.21 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 176.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.8 -40.12 47.41 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.959 2.439 . . . . 0.0 112.79 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -113.61 -138.78 7.08 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.076 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.68 9.92 15.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.29 0.567 . . . . 0.0 110.034 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -96.29 107.61 19.99 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.95 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.4 m -104.16 134.15 19.85 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.953 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.667 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 10.0 Cg_endo -52.99 145.88 39.5 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.873 2.382 . . . . 0.0 111.495 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.2 -34.94 63.38 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 114.347 0.499 . . . . 0.0 114.347 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.71 -20.25 39.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.43 0.633 . . . . 0.0 109.901 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.667 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 9.6 m-85 -119.21 26.18 9.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.892 -173.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.91 22.07 6.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.247 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 45.9 m-80 . . . . . 0 C--O 1.243 0.729 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.56 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.902 0.382 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.45 ' OG1' HG12 ' A' ' 34' ' ' ILE . 44.1 m -86.49 97.29 10.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.308 0.575 . . . . 0.0 110.742 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 84.2 m -89.86 100.09 12.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.575 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.588 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 20.5 t -105.75 135.63 19.37 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.879 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.455 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 72.7 Cg_endo -76.83 23.49 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.711 2.274 . . . . 0.0 114.004 -174.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 31.2 t -162.47 145.83 11.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.513 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 58.2 mt -76.11 -26.39 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.65 -46.3 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.722 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 6' ' ' SER . . . -62.11 -41.51 98.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.816 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.588 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 7.1 ptp180 -72.47 -24.3 61.17 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.254 0.55 . . . . 0.0 110.182 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.485 ' O ' HG23 ' A' ' 15' ' ' VAL . 32.7 t -68.41 -47.3 67.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.725 173.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.37 -33.03 71.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.066 0.46 . . . . 0.0 110.163 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.542 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 38.9 t80 -54.99 -53.19 58.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.37 172.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -61.65 -39.99 93.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.029 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 11' ' ' SER . 90.1 t -59.72 -42.22 87.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.209 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.546 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.1 t -74.35 -34.44 63.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.292 0.567 . . . . 0.0 110.577 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.481 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 16.2 tpt180 -60.35 -44.44 95.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.982 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.562 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 60.8 mt -52.94 -53.53 54.02 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 33.5 Cg_exo -60.78 -16.83 46.56 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.582 2.188 . . . . 0.0 113.808 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.32 30.66 2.61 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.285 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.56 HG21 ' HD2' ' A' ' 22' ' ' PRO . 0.5 OUTLIER -97.85 139.17 21.15 Favored Pre-proline 0 N--CA 1.431 -1.39 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.703 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -56.89 118.05 4.84 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.045 2.497 . . . . 0.0 111.113 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.481 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 15.1 pt-20 -44.79 -32.55 1.58 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.951 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.8 -48.3 82.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.925 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.703 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -64.96 -47.4 77.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.003 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.422 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 20.8 m -60.93 -39.62 90.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.108 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.15 -55.46 28.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.817 0.817 . . . . 0.0 110.832 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 m -62.56 -25.72 68.21 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.843 -1.526 . . . . 0.0 112.57 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -90.84 -20.03 22.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.844 0.83 . . . . 0.0 109.816 -172.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 m -102.76 -27.77 12.49 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.463 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.18 2.1 13.84 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.132 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.5 m -88.12 154.39 20.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.7 pt -128.62 144.36 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.986 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.45 HG12 ' OG1' ' A' ' 2' ' ' THR . 63.3 mt -106.38 121.57 59.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.571 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.801 HG23 ' H ' ' A' ' 37' ' ' GLY . 5.0 mp -106.42 131.28 21.85 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.645 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.97 -15.88 52.66 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.82 2.346 . . . . 0.0 112.248 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.801 ' H ' HG23 ' A' ' 35' ' ' ILE . . . -99.37 -142.57 13.38 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.96 15.27 1.53 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.051 0.453 . . . . 0.0 110.803 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -103.13 106.53 17.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.391 0.615 . . . . 0.0 110.781 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.2 p -143.96 146.0 32.51 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.389 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.86 166.7 13.45 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.743 2.295 . . . . 0.0 112.56 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.97 2.96 39.78 Favored Glycine 0 CA--C 1.518 0.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.257 -170.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 11.9 p-10 -97.69 -12.67 22.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.631 0.715 . . . . 0.0 109.334 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 21.0 m-85 -105.82 -14.07 15.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.078 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.11 19.75 5.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.278 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.526 -178.589 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.951 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 17.7 m . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.811 0.338 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.2 m -126.34 126.67 44.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 73.8 m -128.05 130.44 48.26 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -171.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.66 ' HB2' ' HB2' ' A' ' 10' ' ' ARG . 63.3 m -136.0 140.88 34.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 171.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 10.6 Cg_exo -72.0 15.36 0.39 Allowed 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.087 2.525 . . . . 0.0 114.398 -173.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.2 m -159.27 145.16 16.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.733 HD13 ' H ' ' A' ' 7' ' ' ILE . 3.8 mp -58.11 -38.75 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.54 0.686 . . . . 0.0 109.688 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.34 -42.24 65.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.223 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.38 -33.75 76.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.799 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.66 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -76.38 -27.85 56.52 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.395 0.617 . . . . 0.0 110.003 -179.367 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.45 ' O ' HG23 ' A' ' 15' ' ' VAL . 36.2 m -72.78 -38.01 67.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.958 172.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -59.21 -30.11 67.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.965 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 65.7 t80 -53.41 -53.88 44.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.343 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -65.57 -29.2 69.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.949 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 11' ' ' SER . 76.8 t -65.46 -31.19 52.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.829 0.347 . . . . 0.0 110.524 177.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 42.8 t -92.2 -0.95 57.4 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.066 0.936 . . . . 0.0 109.822 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -92.43 -29.63 16.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.885 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.51 ' HG ' ' CD ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -61.08 -47.31 95.47 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.661 178.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.51 ' CD ' ' HG ' ' A' ' 18' ' ' LEU . 14.5 Cg_exo -70.73 -3.11 11.99 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.15 1.9 . . . . 0.0 112.807 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.05 33.51 14.82 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.955 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.602 HG23 ' HD2' ' A' ' 22' ' ' PRO . 1.7 m -95.37 143.78 26.69 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.649 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 12.4 Cg_endo -61.9 121.29 9.29 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.786 2.324 . . . . 0.0 110.96 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 1.7 mp0 -39.5 -36.93 0.42 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.068 171.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.87 -49.18 76.28 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.399 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.649 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.2 tt -68.08 -38.84 82.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.354 0.597 . . . . 0.0 109.737 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.524 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 13.0 m -76.14 4.01 9.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.326 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -101.33 -21.47 14.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.592 0.711 . . . . 0.0 110.315 173.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 m -76.98 -42.3 39.48 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.921 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -86.55 -23.15 25.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.746 0.784 . . . . 0.0 110.535 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.572 ' HB ' ' SG ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -99.9 1.8 43.14 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.798 -174.368 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.48 33.6 86.86 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.126 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.576 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 75.0 m -102.13 165.13 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.95 0.405 . . . . 0.0 110.744 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 3' ' ' CYS . 12.6 pt -139.12 147.98 24.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.396 177.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.77 127.37 56.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.582 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.951 ' HB ' ' HB ' ' A' ' 1' ' ' THR . 8.6 mm -115.69 113.16 42.64 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.627 -175.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -71.17 -16.73 31.72 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.176 2.584 . . . . 0.0 111.541 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' H ' HG21 ' A' ' 35' ' ' ILE . . . -124.35 -139.8 5.4 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.114 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -124.04 25.47 7.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.4 0.619 . . . . 0.0 110.329 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 m -81.81 42.0 0.68 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.877 0.846 . . . . 0.0 110.866 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.543 ' HB2' HG13 ' A' ' 35' ' ' ILE . 53.3 t -134.56 120.09 14.39 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.203 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.4 169.97 20.22 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.741 2.294 . . . . 0.0 112.168 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.66 16.32 4.18 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.078 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -100.31 -17.08 17.46 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.523 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 15.9 m-85 -113.96 -14.18 12.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.45 176.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.73 29.09 5.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.37 0.605 . . . . 0.0 110.047 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.404 ' C ' HH21 ' A' ' 10' ' ' ARG . 2.4 t-20 . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.109 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.456 ' OG1' ' HA ' ' A' ' 38' ' ' ALA . 23.6 m . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.047 0.451 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.717 HG21 HG12 ' A' ' 34' ' ' ILE . 9.8 m -89.35 110.22 21.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.423 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 87.5 m -127.72 167.53 16.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.042 -177.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.718 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 9.8 t -138.93 149.42 61.63 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.718 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 6.1 Cg_exo -41.06 -37.91 2.84 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.23 3.287 . . . . 0.0 115.31 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 p -169.36 173.02 6.82 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.309 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.709 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 60.3 mt -61.63 -40.15 85.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.53 177.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.89 -53.2 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.434 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.02 88.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.471 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.709 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -69.7 -25.91 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 0.0 110.949 -177.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.5 m -75.13 -12.78 60.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.013 0.435 . . . . 0.0 110.914 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -94.1 -8.2 40.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.8 0.81 . . . . 0.0 109.452 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.641 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 65.0 t80 -88.34 -58.06 2.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.625 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -61.22 -37.99 85.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.179 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.92 -18.85 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.062 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.0 t -78.72 -26.14 44.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.876 -0.515 . . . . 0.0 110.19 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.564 ' CD ' ' HB3' ' A' ' 23' ' ' GLU . 51.5 mtm180 -74.18 -29.12 61.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.974 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.8 mt -51.15 -53.07 52.63 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -175.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.87 -6.27 16.53 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.974 1.783 . . . . 0.0 113.719 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.03 30.93 3.49 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.475 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -101.8 133.26 20.86 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.848 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.5 Cg_endo -63.58 127.72 20.52 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.576 2.184 . . . . 0.0 110.282 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.641 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 9.8 pt-20 -51.6 -27.54 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.422 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.3 85.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.953 0.406 . . . . 0.0 110.137 172.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.848 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -66.07 -42.64 89.15 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.169 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.481 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 37.5 m -69.24 -31.74 70.49 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.663 -176.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.27 -36.31 83.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.127 0.965 . . . . 0.0 110.123 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 m -77.75 -18.41 56.52 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.207 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -104.33 -54.82 2.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.636 0.731 . . . . 0.0 109.765 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.2 m -63.01 -52.88 61.23 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.608 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.51 1.43 4.27 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.968 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 13' ' ' PHE . 27.1 m -74.36 164.31 26.75 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.448 HD13 ' HB2' ' A' ' 3' ' ' CYS . 2.8 pp -124.58 149.14 28.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.372 0.606 . . . . 0.0 112.412 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.717 HG12 HG21 ' A' ' 2' ' ' THR . 74.2 mt -127.13 112.16 27.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.113 174.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.526 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.5 pp -122.14 135.44 25.42 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -68.7 79.43 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.436 2.757 . . . . 0.0 111.659 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.46 -149.59 6.23 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.456 ' HA ' ' OG1' ' A' ' 1' ' ' THR . . . -142.98 10.34 1.75 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.94 0.4 . . . . 0.0 111.4 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.8 m -146.85 103.61 3.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.614 0.721 . . . . 0.0 110.412 176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 5.8 p -78.77 152.57 77.67 Favored Pre-proline 0 C--N 1.308 -1.227 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.337 175.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.654 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 18.6 Cg_endo -60.26 153.12 61.66 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.142 2.561 . . . . 0.0 112.7 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.45 6.2 39.46 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 114.514 0.566 . . . . 0.0 114.514 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -113.05 -3.06 14.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 15.7 m-30 -134.25 21.85 3.74 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.097 -1.411 . . . . 0.0 109.773 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.7 20.96 5.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -170.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.41 ' C ' HH21 ' A' ' 10' ' ' ARG . 20.4 m120 . . . . . 0 C--O 1.253 1.245 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.55 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.2 t -105.12 124.53 49.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.459 0.647 . . . . 0.0 110.357 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.1 m -112.87 117.49 32.26 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 5.8 t -146.9 105.27 3.91 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.7 ' HG3' ' HA ' ' A' ' 44' ' ' TYR . 44.9 Cg_endo -92.3 38.57 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.985 2.456 . . . . 0.0 114.259 -171.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.742 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 3.6 m -142.28 119.42 11.42 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.923 -174.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.7 mt -50.63 -37.88 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 123.815 0.697 . . . . 0.0 110.885 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.57 -42.71 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.198 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 6' ' ' SER . . . -61.12 -48.62 80.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.287 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.742 ' HG3' ' O ' ' A' ' 6' ' ' SER . 28.5 mtt180 -55.96 -32.73 64.12 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.271 0.558 . . . . 0.0 110.134 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.42 ' O ' HG21 ' A' ' 15' ' ' VAL . 50.5 m -72.69 -57.87 3.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.523 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -73.59 -20.75 60.53 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.328 -173.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -51.94 -57.16 10.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.498 173.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.403 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 92.0 m-20 -61.87 -37.36 84.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.525 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 11' ' ' SER . 82.0 t -64.74 -26.01 39.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.265 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.591 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 3.6 t -82.68 -36.31 26.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.1 0.476 . . . . 0.0 110.163 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 21' ' ' THR . 62.3 ttt180 -68.95 -45.26 71.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.69 -174.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.524 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 84.6 mt -53.36 -47.82 94.8 Favored Pre-proline 0 N--CA 1.444 -0.734 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 13.2 Cg_exo -71.04 21.59 0.22 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.488 2.125 . . . . 0.0 113.752 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.16 35.52 8.07 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.089 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 1.7 m -114.14 134.69 22.16 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.742 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.6 Cg_endo -60.74 124.7 15.54 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.452 2.102 . . . . 0.0 110.817 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -44.31 -32.06 1.2 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.867 170.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.67 -50.47 73.74 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.811 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.742 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.9 tt -62.41 -47.1 85.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.4 m -64.63 -34.09 77.46 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.309 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.0 94.65 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.92 0.867 . . . . 0.0 110.528 176.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -72.81 -20.67 61.11 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.121 -1.4 . . . . 0.0 111.147 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -101.38 -37.45 8.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.785 0.802 . . . . 0.0 109.875 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.5 m -80.85 -42.87 20.86 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.987 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.74 -6.67 9.63 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.8 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 4' ' ' CYS . 3.9 m -74.96 157.94 34.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.3 pt -120.39 138.7 50.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.727 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -111.65 112.91 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.178 0.513 . . . . 0.0 110.594 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.5 pt -115.96 150.76 45.59 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.732 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.18 -51.0 8.48 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.297 2.664 . . . . 0.0 112.488 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.63 -139.77 10.52 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.337 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.74 70.8 1.25 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.543 0.687 . . . . 0.0 109.449 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 m -130.63 43.84 3.05 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.595 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 45' ' ' ALA . 7.4 p -96.12 127.57 40.15 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.478 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.592 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 11.7 Cg_endo -53.61 157.37 9.81 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.476 2.784 . . . . 0.0 113.186 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.61 -23.86 55.72 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.446 -0.797 . . . . 0.0 114.682 -172.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -93.09 0.01 57.17 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 117.852 0.826 . . . . 0.0 109.514 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.7 ' HA ' ' HG3' ' A' ' 5' ' ' PRO . 21.0 m-85 -121.57 0.55 9.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.552 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.499 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -126.66 54.64 1.58 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.575 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.628 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 10.0 t30 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.022 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 38.1 m . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.013 0.435 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.429 HG23 ' CD2' ' A' ' 13' ' ' PHE . 10.4 t -133.86 158.65 42.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.203 -176.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.569 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 93.3 m -137.84 138.97 39.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.214 174.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -134.62 153.29 78.9 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.25 3.86 3.76 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.903 2.402 . . . . 0.0 114.324 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.456 ' HA ' ' OD1' ' A' ' 46' ' ' ASN . 33.1 p -164.17 142.66 7.31 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.358 0.526 . . . . 0.0 111.218 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.59 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 61.8 mt -57.27 -32.3 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.32 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.71 -54.19 30.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.182 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.48 ' HB2' HG23 ' A' ' 30' ' ' THR . . . -68.51 -36.8 79.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.475 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.59 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 13.1 ptm180 -69.11 -24.02 64.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.219 0.533 . . . . 0.0 110.636 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.468 ' O ' HG21 ' A' ' 15' ' ' VAL . 49.2 m -76.86 -40.63 46.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.923 172.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -55.87 -34.31 65.38 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.826 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.578 ' CE1' ' HB2' ' A' ' 23' ' ' GLU . 79.6 t80 -53.57 -57.87 9.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.728 0.775 . . . . 0.0 110.546 174.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -62.04 -34.47 76.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.376 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.626 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 92.7 t -63.51 -34.47 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.355 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.72 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 48.4 t -62.56 -31.78 72.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.293 0.568 . . . . 0.0 111.734 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.969 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 12.0 mmm180 -80.11 -10.97 59.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.13 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.568 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 54.6 mt -71.24 -56.87 5.05 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.626 ' HD3' ' O ' ' A' ' 15' ' ' VAL . 10.4 Cg_endo -90.01 24.17 0.64 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.474 2.116 . . . . 0.0 113.135 -173.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.81 45.75 26.33 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.781 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.72 ' HB ' ' SG ' ' A' ' 16' ' ' CYS . 1.3 m -114.96 132.85 22.79 Favored Pre-proline 0 N--CA 1.44 -0.934 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.874 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 19.0 Cg_endo -61.05 120.9 8.85 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.132 2.555 . . . . 0.0 111.598 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.969 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -52.38 -29.49 24.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.978 170.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.27 -45.53 87.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.571 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.874 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 2.2 tt -62.55 -51.18 68.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.187 0.517 . . . . 0.0 109.832 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 96.1 m -71.58 -16.06 62.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.79 -15.72 61.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.981 0.896 . . . . 0.0 110.037 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.3 m -101.69 -20.4 15.01 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.189 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.53 ' HB3' ' HA ' ' A' ' 26' ' ' CYS . 26.2 t80 -101.53 -41.96 6.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.885 0.85 . . . . 0.0 110.001 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 9' ' ' ALA . 21.8 m -89.76 -37.96 14.16 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.557 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.98 12.75 26.95 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.308 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 55.7 m -81.38 153.45 26.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.837 0.318 . . . . 0.0 110.268 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 pt -117.22 139.79 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.681 0.276 . . . . 0.0 110.838 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mp -96.54 131.9 42.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.136 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.411 ' O ' ' HB ' ' A' ' 1' ' ' THR . 2.3 pp -141.5 155.44 67.15 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.513 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.54 -51.83 8.32 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.937 2.425 . . . . 0.0 112.384 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.05 141.56 3.36 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.733 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 59.25 17.0 5.36 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 172.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -108.92 54.24 0.66 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.83 0.824 . . . . 0.0 110.535 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.1 m -130.96 123.03 19.68 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.2 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.03 168.33 25.06 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.573 2.182 . . . . 0.0 111.787 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.67 9.5 10.75 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.382 -0.437 . . . . 0.0 113.683 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -101.13 -16.48 17.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.569 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 20.9 m-85 -122.99 14.62 9.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.145 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.12 21.32 17.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.004 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' A' ' 6' ' ' SER . 22.3 t-20 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.318 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.541 HG21 ' HA ' ' A' ' 38' ' ' ALA . 19.9 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.653 0.263 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 m -112.91 125.93 54.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.321 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 73.6 m -127.97 151.57 48.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.396 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.553 ' HB2' ' HD3' ' A' ' 10' ' ' ARG . 60.1 m -125.39 142.95 43.12 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.32 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.647 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 2.3 Cg_endo -83.99 5.56 6.27 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.081 2.521 . . . . 0.0 114.535 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 56.6 p -158.13 151.03 22.68 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.799 -0.563 . . . . 0.0 110.605 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.7 mt -67.84 -30.77 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.96 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.51 -46.87 74.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.011 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -64.08 -49.71 71.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.093 176.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.553 ' HD3' ' HB2' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -49.19 -40.45 33.4 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.462 176.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.417 ' O ' HG23 ' A' ' 15' ' ' VAL . 13.6 t -65.79 -58.43 5.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.459 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.415 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 9.9 p30 -69.74 -23.07 63.33 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.541 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.42 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 45.0 t80 -60.13 -58.63 7.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.326 174.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -65.25 -30.7 71.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.401 . . . . 0.0 110.286 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 11' ' ' SER . 61.6 t -74.42 -14.9 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.805 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.699 ' O ' ' HB ' ' A' ' 21' ' ' THR . 49.2 t -91.36 -11.37 38.06 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.861 -0.524 . . . . 0.0 110.562 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.567 ' HD2' ' HB3' ' A' ' 23' ' ' GLU . 4.6 ptm180 -112.32 -22.09 11.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.782 0.801 . . . . 0.0 109.816 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -45.26 95.89 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 114.198 -1.364 . . . . 0.0 112.121 174.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.21 -12.8 30.52 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.923 1.748 . . . . 0.0 112.814 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.53 7.78 23.76 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.803 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.699 ' HB ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -77.81 138.96 61.83 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.039 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.612 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.7 Cg_endo -58.52 115.66 2.7 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 122.859 2.373 . . . . 0.0 111.565 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.567 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 10.5 pt-20 -55.16 -22.62 17.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.643 171.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.452 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -59.74 -49.45 77.66 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.256 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.612 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.2 tt -67.72 -43.48 79.9 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 110.304 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.0 m -68.18 -25.9 65.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.823 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.24 -30.37 70.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.655 0.741 . . . . 0.0 110.731 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.7 m -74.65 -26.16 59.68 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.985 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -102.13 -50.23 3.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.532 0.682 . . . . 0.0 109.905 -173.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.3 m -63.36 -42.81 98.91 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.597 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.62 8.91 17.92 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.526 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 58.6 m -81.98 163.47 22.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.3 pt -127.26 143.48 40.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.684 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 24' ' ' ALA . 55.1 mt -106.41 118.44 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.313 177.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.577 HD12 ' SG ' ' A' ' 40' ' ' CYS . 21.3 pt -128.89 148.17 67.68 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.947 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.66 67.07 8.51 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.83 2.353 . . . . 0.0 112.46 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.68 149.12 5.18 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HA ' HG21 ' A' ' 1' ' ' THR . . . -81.94 30.19 0.39 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.144 0.497 . . . . 0.0 110.906 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 m -85.13 30.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.617 0.722 . . . . 0.0 111.192 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.577 ' SG ' HD12 ' A' ' 35' ' ' ILE . 66.7 m -69.16 119.34 69.52 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.346 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.511 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 11.6 Cg_endo -57.66 156.33 27.82 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.668 2.245 . . . . 0.0 111.805 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.98 -8.45 35.31 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 114.344 0.498 . . . . 0.0 114.344 -170.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -100.74 -21.27 15.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.562 0.681 . . . . 0.0 109.696 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.647 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 20.7 m-85 -108.37 8.28 27.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.045 -177.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.33 24.66 12.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.028 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.8 t30 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.191 -176.633 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.473 0.679 0 CA-C-O 120.84 0.352 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t -104.9 130.56 53.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.008 0.432 . . . . 0.0 110.017 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 25.1 m -118.02 132.43 56.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.984 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 5.9 t -152.43 120.16 3.18 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -90.04 35.4 0.34 Allowed 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.078 2.519 . . . . 0.0 114.209 -170.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 t -162.47 139.98 8.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.1 mt -74.72 -23.99 18.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.6 t -73.11 -44.24 56.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.086 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -44.21 74.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.227 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.13 -38.15 67.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.159 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 15' ' ' VAL . 22.7 t -61.04 -53.93 51.05 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.961 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -53.28 -35.55 60.2 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.31 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -62.97 -59.06 5.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.224 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.27 -34.12 74.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.17 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 11' ' ' SER . 77.2 t -62.83 -28.57 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.161 0.505 . . . . 0.0 110.829 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.564 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 32.2 t -89.71 -32.08 17.18 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.85 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.713 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 36.8 tpt85 -70.25 -36.2 74.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.725 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.54 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 27.7 mt -60.23 -49.37 91.03 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -175.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 20.4 Cg_exo -68.34 11.93 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.554 2.17 . . . . 0.0 113.428 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 18' ' ' LEU . . . 81.27 40.03 11.88 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.429 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.527 HG21 ' HD2' ' A' ' 22' ' ' PRO . 1.1 m -104.94 140.0 20.65 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.699 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.0 Cg_endo -56.56 118.57 5.43 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.881 2.388 . . . . 0.0 111.021 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.713 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 8.8 pt-20 -51.36 -29.4 15.26 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.104 171.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.22 -43.56 87.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.686 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.699 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -70.95 -52.41 20.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.916 0.389 . . . . 0.0 110.061 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 10.9 m -60.52 -38.12 83.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.783 -173.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.06 -58.83 5.51 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.685 0.755 . . . . 0.0 111.218 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -64.55 -21.21 66.63 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.543 -172.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -84.61 -38.34 20.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 122.14 0.971 . . . . 0.0 109.25 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.9 m -81.02 -44.08 18.62 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.881 -1.508 . . . . 0.0 111.722 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.07 -13.16 4.12 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.704 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 4' ' ' CYS . 3.3 m -75.69 157.81 33.14 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.6 pt -125.43 161.54 29.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.188 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.0 mt -128.11 125.04 63.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.273 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.95 HD11 ' HB2' ' A' ' 38' ' ' ALA . 2.7 pt -136.03 146.56 57.12 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.624 -177.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 31.5 Cg_exo -57.69 -55.78 2.17 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.082 2.521 . . . . 0.0 111.91 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.36 -138.79 6.63 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.95 ' HB2' HD11 ' A' ' 35' ' ' ILE . . . 62.55 81.06 0.21 Allowed 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.677 0.751 . . . . 0.0 110.754 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 m -68.1 97.24 0.68 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.722 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.765 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . 72.2 m -62.73 135.43 95.81 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.795 176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 19.6 Cg_endo -60.64 178.24 0.5 Allowed 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.985 2.457 . . . . 0.0 112.972 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.81 -0.91 28.74 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 114.816 0.686 . . . . 0.0 114.816 -171.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -99.69 -11.15 21.14 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 118.171 0.985 . . . . 0.0 109.306 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.765 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 18.6 m-85 -106.13 -20.69 13.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.545 173.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.53 36.11 1.18 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.783 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.4 t30 . . . . . 0 C--O 1.244 0.792 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.143 -175.995 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 94.3 m . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 121.096 0.474 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.2 m -108.6 124.71 50.91 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.82 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 65.4 m -125.7 120.56 31.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.163 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.4 m -104.93 162.82 18.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.731 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.17 -0.56 10.0 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.275 1.983 . . . . 0.0 115.526 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t -170.59 148.7 3.09 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.547 1.067 . . . . 0.0 111.948 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.746 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 29.3 mm -59.84 -35.71 62.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.466 0.65 . . . . 0.0 109.965 172.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -71.97 -42.83 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.767 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.794 ' HB2' HG22 ' A' ' 30' ' ' THR . . . -71.48 -41.15 69.7 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.901 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.746 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.6 OUTLIER -66.73 -28.98 68.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.179 0.514 . . . . 0.0 109.845 178.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.489 ' O ' HG22 ' A' ' 15' ' ' VAL . 37.8 t -64.29 -53.28 51.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.547 172.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -52.9 -41.01 63.99 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.555 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.634 ' HA ' ' SG ' ' A' ' 26' ' ' CYS . 58.8 t80 -54.93 -55.76 27.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.945 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 11' ' ' SER . 10.9 p30 -70.28 -25.78 63.5 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.439 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.574 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 47.4 t -65.09 -37.89 81.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.676 174.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.577 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 86.1 m -61.2 -26.84 68.0 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.261 0.553 . . . . 0.0 111.654 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -76.34 -29.65 57.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.622 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.889 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -61.97 -44.58 90.38 Favored Pre-proline 0 CA--C 1.549 0.916 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.298 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.889 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 4.1 Cg_exo -78.5 -30.13 3.36 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 122.101 1.868 . . . . 0.0 112.279 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.5 13.97 2.23 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.1 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 7.0 m -72.34 126.92 90.83 Favored Pre-proline 0 N--CA 1.443 -0.8 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.901 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -57.96 126.42 21.6 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 122.133 1.889 . . . . 0.0 109.932 175.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.72 -37.99 1.34 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.038 171.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.74 -46.63 88.55 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.388 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.901 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 2.3 tt -61.46 -46.52 89.69 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.94 0.4 . . . . 0.0 110.142 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.634 ' SG ' ' HA ' ' A' ' 13' ' ' PHE . 10.9 t -70.14 -26.67 64.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.948 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.06 -19.47 64.88 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.751 0.786 . . . . 0.0 110.731 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.3 m -88.16 -23.82 23.52 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.691 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -96.41 -49.41 5.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.718 0.771 . . . . 0.0 109.84 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.794 HG22 ' HB2' ' A' ' 9' ' ' ALA . 12.8 m -69.8 -29.45 66.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.721 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.77 20.47 65.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.576 -177.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.1 t -90.65 145.9 24.46 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.7 pt -111.73 135.7 50.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.598 . . . . 0.0 112.216 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.7 mt -108.88 104.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.041 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.577 HD13 ' SG ' ' A' ' 40' ' ' CYS . 27.8 pt -123.42 149.56 58.5 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.244 -173.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.0 20.18 1.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.719 2.28 . . . . 0.0 112.466 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.4 -153.05 6.0 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.706 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.9 23.22 6.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.911 0.386 . . . . 0.0 111.062 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 m -77.11 57.03 1.33 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.68 0.753 . . . . 0.0 111.032 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.577 ' SG ' HD13 ' A' ' 35' ' ' ILE . 28.4 m -110.96 104.69 56.51 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.328 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 40' ' ' CYS . 29.3 Cg_endo -64.17 166.87 15.65 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.498 2.132 . . . . 0.0 111.847 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.45 -30.69 65.33 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.38 -0.438 . . . . 0.0 114.049 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.18 -26.56 30.75 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.337 0.589 . . . . 0.0 109.855 -176.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.486 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 14.1 m-85 -113.14 21.99 14.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.765 -171.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' A' ' 3' ' ' CYS . . . -112.75 30.07 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.526 0.679 . . . . 0.0 109.47 175.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 . . . . . 0 C--O 1.247 0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.263 -176.972 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.404 ' CG2' HG13 ' A' ' 35' ' ' ILE . 3.6 t . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.436 0.636 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.556 ' HB ' ' CZ ' ' A' ' 13' ' ' PHE . 78.2 m -134.52 141.61 46.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.006 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.8 m -116.15 126.78 54.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.811 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 10' ' ' ARG . 63.7 m -118.6 117.35 34.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.904 176.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.39 25.97 0.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.727 2.284 . . . . 0.0 112.802 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -153.04 134.8 14.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.552 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 33.3 mt -60.66 -37.12 74.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.048 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.0 t -72.65 -49.05 43.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.193 0.52 . . . . 0.0 110.127 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.435 ' HB3' HG21 ' A' ' 30' ' ' THR . . . -55.72 -46.23 77.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.988 177.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -68.11 -29.75 68.74 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 -175.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 15' ' ' VAL . 58.6 m -62.38 -59.06 5.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.946 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -69.7 -25.71 64.0 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.523 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.556 ' CZ ' ' HB ' ' A' ' 2' ' ' THR . 3.9 t80 -58.96 -48.5 81.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.015 172.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.85 -39.49 90.81 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.071 0.463 . . . . 0.0 110.207 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 11' ' ' SER . 43.1 t -69.89 -20.52 23.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.977 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.808 ' O ' ' HB ' ' A' ' 21' ' ' THR . 25.4 t -91.44 -2.93 57.11 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.799 0.809 . . . . 0.0 109.693 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -109.42 -29.5 8.4 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.819 0.818 . . . . 0.0 109.281 -172.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -48.43 92.72 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.855 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.78 -18.65 58.58 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 122.225 1.95 . . . . 0.0 113.282 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.99 12.69 7.57 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.495 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.808 ' HB ' ' O ' ' A' ' 16' ' ' CYS . 3.6 m -85.64 136.31 37.21 Favored Pre-proline 0 N--CA 1.433 -1.31 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.722 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.3 Cg_endo -58.63 118.67 5.6 Favored 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 122.816 2.344 . . . . 0.0 111.389 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.42 ' HB2' ' HE1' ' A' ' 13' ' ' PHE . 10.2 pt-20 -42.36 -31.63 0.43 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.912 168.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.6 -51.49 69.59 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.847 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.722 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 3.0 tt -59.41 -44.96 92.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.223 0.535 . . . . 0.0 109.951 177.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.7 m -66.92 -42.09 85.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.897 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.43 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -57.8 -47.25 83.12 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.396 0.617 . . . . 0.0 111.823 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 m -63.0 -29.21 70.65 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.318 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -95.11 -48.11 6.09 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.614 0.721 . . . . 0.0 109.52 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.435 HG21 ' HB3' ' A' ' 9' ' ' ALA . 91.7 m -61.84 -38.33 87.81 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.751 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.66 -4.05 11.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.094 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 58.8 m -73.1 168.79 18.36 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.853 0.359 . . . . 0.0 110.196 176.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 40.0 pt -122.53 132.48 71.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.009 0.433 . . . . 0.0 110.762 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 16.5 tt -95.92 139.0 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.403 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.615 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 20.0 pt -121.56 173.01 4.33 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.615 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 73.6 Cg_endo -80.41 -24.09 5.63 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.638 1.558 . . . . 0.0 113.719 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -153.01 -138.15 2.65 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.971 -1.109 . . . . 0.0 113.856 -171.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.38 13.69 33.12 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -83.24 77.2 9.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.732 0.777 . . . . 0.0 110.319 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.55 ' HB2' HD13 ' A' ' 35' ' ' ILE . 30.7 t -155.84 129.28 4.48 Favored Pre-proline 0 C--N 1.311 -1.074 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.087 -178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.05 163.16 31.14 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.61 2.207 . . . . 0.0 112.451 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 45' ' ' ALA . . . -73.81 8.82 9.96 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.537 -176.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.31 -27.79 21.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -105.61 -7.14 18.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.658 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . . . -94.1 40.05 1.08 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.926 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--O 1.251 1.14 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.604 178.263 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 6.4 m . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 121.621 0.724 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.4 m -111.44 132.12 54.7 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.682 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.404 ' HB2' HG13 ' A' ' 33' ' ' ILE . 63.6 m -138.71 153.95 48.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.015 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.534 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 14.7 t -150.06 133.24 8.5 Favored Pre-proline 0 N--CA 1.447 -0.589 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 9.9 Cg_exo -73.1 -6.12 18.38 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.927 2.418 . . . . 0.0 114.797 -174.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.9 p -163.75 153.54 14.85 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.679 0.672 . . . . 0.0 110.836 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.3 mt -66.41 -30.47 49.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.308 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.49 -46.81 91.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.116 0.484 . . . . 0.0 110.135 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.534 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -63.24 -47.42 82.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.728 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -50.48 -41.21 52.83 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.288 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.491 ' O ' HG21 ' A' ' 15' ' ' VAL . 75.7 m -59.96 -56.47 21.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.458 0.17 . . . . 0.0 111.458 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.404 HD22 ' HA ' ' A' ' 9' ' ' ALA . 9.3 p30 -75.55 -20.52 58.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.755 -175.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.554 ' HB2' HG22 ' A' ' 30' ' ' THR . 65.0 t80 -57.12 -55.42 34.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.592 170.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.556 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 1.7 t-20 -56.32 -41.62 76.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.634 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 11' ' ' SER . 89.8 t -56.86 -30.26 32.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.619 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.508 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.1 t -81.17 -34.14 32.58 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.973 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.648 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 73.5 ttt180 -71.25 -30.65 66.57 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 14' ' ' ASN . 83.2 mt -48.22 -52.45 41.83 Favored Pre-proline 0 N--CA 1.444 -0.736 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -175.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 54.7 Cg_endo -71.0 3.19 3.52 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.007 1.805 . . . . 0.0 113.617 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.06 27.45 6.24 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.34 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.569 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 1.2 m -94.44 137.12 22.76 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.789 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.1 Cg_endo -62.36 126.4 18.42 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.905 2.404 . . . . 0.0 110.478 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.648 ' HG2' ' HD2' ' A' ' 17' ' ' ARG . 37.8 mt-10 -41.5 -38.41 1.29 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.342 173.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.38 82.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.578 0.228 . . . . 0.0 111.2 177.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.789 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.3 tt -64.55 -43.22 94.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.569 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 58.1 m -69.06 -26.2 64.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.593 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.19 -28.95 68.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.224 1.011 . . . . 0.0 110.328 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.4 m -82.39 -19.91 38.19 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.241 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -98.2 -46.09 5.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.02 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.554 HG22 ' HB2' ' A' ' 13' ' ' PHE . 15.7 m -76.16 -61.88 1.79 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.282 -1.327 . . . . 0.0 112.552 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.83 -16.55 3.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.348 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.524 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 32.7 m -65.17 152.88 42.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 3' ' ' CYS . 32.8 pt -113.78 136.71 49.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.077 -174.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 mm -98.44 135.13 34.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.439 HD12 ' SG ' ' A' ' 40' ' ' CYS . 45.3 pt -124.4 150.33 63.99 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.477 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.48 56.99 5.3 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.411 2.074 . . . . 0.0 111.639 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 1' ' ' THR . . . 172.38 -141.05 6.05 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.19 14.75 0.52 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 m -94.67 102.03 13.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.152 0.501 . . . . 0.0 111.433 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.439 ' SG ' HD12 ' A' ' 35' ' ' ILE . 67.9 m -142.18 124.05 8.92 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.654 175.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 59.0 Cg_endo -71.92 -173.94 1.2 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.886 2.39 . . . . 0.0 112.395 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.29 -19.59 66.52 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -168.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -88.23 -15.35 36.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.607 0.704 . . . . 0.0 109.677 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.413 ' HD2' ' HD2' ' A' ' 41' ' ' PRO . 17.3 m-85 -116.42 -1.6 12.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.897 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.22 32.55 4.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.049 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.718 178.045 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 33.1 m . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 120.894 0.378 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.774 ' HG1' HG12 ' A' ' 34' ' ' ILE . 17.6 m -126.77 139.97 52.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.107 0.479 . . . . 0.0 111.262 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 32' ' ' CYS . 55.8 m -111.99 96.51 6.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.066 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.585 ' HA ' ' CB ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -106.2 126.08 31.43 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.612 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 65.5 Cg_endo -88.03 31.69 0.42 Allowed 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.105 2.537 . . . . 0.0 114.8 -167.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.428 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 23.9 t -163.93 143.39 7.98 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 122.075 -0.391 . . . . 0.0 110.567 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.706 HD13 ' H ' ' A' ' 7' ' ' ILE . 3.8 mp -60.8 -36.07 68.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -73.68 -52.6 20.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.634 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.411 ' HA ' HD22 ' A' ' 12' ' ' ASN . . . -57.1 -48.05 79.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.582 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -66.38 -24.43 66.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.227 -176.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.409 ' O ' HG21 ' A' ' 15' ' ' VAL . 69.9 m -70.69 -55.27 9.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.756 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 9' ' ' ALA . 10.0 p30 -67.47 -23.13 65.47 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.289 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -60.94 -60.8 3.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.006 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -69.16 -32.7 72.21 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.776 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 11' ' ' SER . 68.8 t -67.01 -24.49 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.408 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.512 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -72.76 -33.67 66.49 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.836 0.351 . . . . 0.0 110.384 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 21' ' ' THR . 77.6 ttt180 -72.84 -27.53 61.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.348 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.0 mt -54.62 -52.41 70.16 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -175.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.512 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 72.1 Cg_endo -75.85 17.35 0.7 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.062 1.841 . . . . 0.0 113.716 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.03 28.59 7.65 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.475 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 1.3 m -103.39 138.96 19.69 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.509 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 24.8 Cg_endo -66.28 128.89 20.29 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.734 2.29 . . . . 0.0 110.532 173.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -46.09 -30.72 2.0 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.876 173.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -53.06 -54.18 39.28 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 174.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.1 tm? -61.01 -41.53 96.72 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 120.86 0.362 . . . . 0.0 110.847 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.2 m -68.57 -39.66 80.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.369 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.91 73.22 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.765 0.793 . . . . 0.0 110.608 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.8 m -76.51 -21.87 55.18 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.694 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -94.87 -52.53 4.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.103 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 90.5 m -61.2 -41.55 97.02 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.215 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.54 -8.83 13.25 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.223 175.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.585 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 6.3 p -89.42 179.95 5.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.156 0.478 . . . . 0.0 111.671 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.404 HD11 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -120.93 153.09 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -168.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.774 HG12 ' HG1' ' A' ' 2' ' ' THR . 71.2 mt -109.82 131.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.949 175.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.625 ' O ' ' HB ' ' A' ' 1' ' ' THR . 12.9 pt -135.97 161.35 63.12 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 73.5 Cg_endo -75.57 1.65 7.77 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.53 2.153 . . . . 0.0 113.623 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.32 -123.47 1.17 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.368 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.517 ' HB3' HD11 ' A' ' 35' ' ' ILE . . . 71.32 -5.8 1.5 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.734 0.814 . . . . 0.0 112.802 173.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 39' ' ' THR . 85.7 m 63.16 10.14 4.38 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.72 0.771 . . . . 0.0 111.823 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.3 m 67.02 141.98 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.642 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.449 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 39.8 Cg_endo -70.24 159.1 54.22 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.511 2.14 . . . . 0.0 111.397 171.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.65 85.92 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 114.199 0.44 . . . . 0.0 114.199 -170.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -82.51 -14.15 55.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.325 0.563 . . . . 0.0 110.58 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.612 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 13.5 m-85 -119.34 19.69 12.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.604 -174.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.15 56.56 1.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.185 0.517 . . . . 0.0 110.173 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.421 HD21 ' C ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.705 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.642 HG23 ' HA2' ' A' ' 37' ' ' GLY . 21.1 m . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 120.897 0.379 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.693 HG21 ' SG ' ' A' ' 32' ' ' CYS . 4.0 m -134.48 132.14 38.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.996 -173.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.0 m -127.03 121.08 30.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.874 0.369 . . . . 0.0 110.532 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 13' ' ' PHE . 57.9 m -109.07 121.29 43.28 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.693 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.744 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 87.7 Cg_endo -88.47 30.92 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.817 2.344 . . . . 0.0 114.779 -171.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.608 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 77.9 p -165.78 147.82 7.29 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.387 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -55.74 -37.69 47.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.679 0.612 . . . . 0.0 112.343 -170.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.67 -39.44 22.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.012 0.434 . . . . 0.0 110.029 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.418 ' HA ' ' CG2' ' A' ' 30' ' ' THR . . . -63.64 -45.67 89.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.55 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -55.67 -42.45 75.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 177.263 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.495 ' O ' HG21 ' A' ' 15' ' ' VAL . 49.1 m -64.43 -49.8 70.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.113 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.33 -41.41 84.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 110.644 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.576 ' CE1' ' HB ' ' A' ' 2' ' ' THR . 15.0 t80 -50.17 -46.92 54.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.213 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -71.4 -41.3 69.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.832 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 11' ' ' SER . 87.1 t -63.59 -37.36 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.719 -176.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.576 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 92.5 m -69.86 -28.09 65.37 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.477 ' HD2' ' CE1' ' A' ' 13' ' ' PHE . 81.1 mtp180 -84.69 -20.81 30.62 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 121.662 -0.649 . . . . 0.0 111.811 -170.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.938 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -66.49 -44.41 55.83 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.541 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.938 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 89.3 Cg_endo -85.15 -3.8 9.56 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.626 1.55 . . . . 0.0 113.183 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.22 16.8 15.35 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.397 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.419 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 3.6 m -78.82 125.32 84.31 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.551 ' HG2' ' HB3' ' A' ' 25' ' ' LEU . 10.2 Cg_endo -55.64 121.63 10.29 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.688 2.259 . . . . 0.0 111.035 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -41.8 -36.46 1.03 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.277 169.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.523 ' HA ' HG13 ' A' ' 34' ' ' ILE . . . -62.09 -45.18 94.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.876 177.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.551 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 35.9 tp -73.52 -41.3 63.21 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 120.905 0.383 . . . . 0.0 110.613 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.3 t -67.43 -35.73 79.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.484 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.559 ' HA ' ' HB3' ' A' ' 32' ' ' CYS . . . -56.28 -53.72 53.94 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.786 0.803 . . . . 0.0 111.124 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.7 m -61.36 -24.8 66.73 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.143 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.16 -41.96 11.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.448 1.118 . . . . 0.0 109.002 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.418 ' CG2' ' HA ' ' A' ' 9' ' ' ALA . 90.2 m -76.7 -32.33 57.8 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.26 -174.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.68 -5.76 24.38 Favored Glycine 0 C--O 1.229 -0.196 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -174.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.693 ' SG ' HG21 ' A' ' 2' ' ' THR . 6.4 t -73.86 164.95 25.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.609 -0.796 . . . . 0.0 109.379 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.4 pt -122.64 152.23 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.887 -175.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.523 HG13 ' HA ' ' A' ' 24' ' ' ALA . 34.5 mm -104.87 134.28 46.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.777 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.631 ' O ' ' HB ' ' A' ' 1' ' ' THR . 42.0 pt -144.88 162.68 37.13 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.51 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 14.6 Cg_endo -60.14 -43.46 35.53 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.503 2.135 . . . . 0.0 111.703 174.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.642 ' HA2' HG23 ' A' ' 1' ' ' THR . . . 131.76 136.78 3.91 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.854 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.74 -85.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.4 m -141.77 -3.69 1.12 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.939 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.523 ' SG ' HD12 ' A' ' 35' ' ' ILE . 64.8 m 66.09 139.7 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.676 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.36 149.55 29.27 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.044 2.496 . . . . 0.0 112.551 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.43 -26.25 64.03 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 114.793 0.677 . . . . 0.0 114.793 -169.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -88.35 -14.36 38.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.658 0.729 . . . . 0.0 110.093 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.672 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 16.6 m-85 -117.97 10.98 13.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.914 -175.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.14 50.89 0.86 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.232 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.744 ' HB3' ' HA ' ' A' ' 5' ' ' PRO . 39.7 t30 . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.587 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 120.977 0.418 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.1 m -106.49 114.01 27.87 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.601 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.439 ' HB2' HD11 ' A' ' 35' ' ' ILE . 81.0 m -128.15 106.43 9.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.566 0.698 . . . . 0.0 111.106 -176.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.721 ' SG ' ' HA ' ' A' ' 10' ' ' ARG . 4.1 m -117.15 157.27 47.25 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.547 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.28 -12.22 33.3 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.815 2.343 . . . . 0.0 114.495 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.2 m -143.96 153.44 42.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.923 -0.486 . . . . 0.0 110.57 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.4 -38.9 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 110.567 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.0 t -80.78 -33.75 13.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.949 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.563 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -63.42 -37.67 88.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.104 176.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.721 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 18.5 ttm-85 -69.89 -27.65 64.98 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.606 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.418 ' O ' HG23 ' A' ' 15' ' ' VAL . 22.8 t -77.8 -46.07 22.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.52 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.563 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 11.4 p30 -68.29 -21.62 64.78 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.704 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 31.2 t80 -54.37 -54.29 42.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.734 172.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.2 -34.32 77.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.781 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.528 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 73.3 t -60.65 -37.82 76.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.098 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.504 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 23.3 m -62.08 -38.47 88.95 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.899 0.381 . . . . 0.0 112.016 177.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 mtp85 -75.9 -2.59 30.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.663 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.61 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 18.2 mt -76.33 -59.83 1.01 Allowed Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.899 176.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.61 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 6.8 Cg_exo -75.45 -24.17 12.38 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.142 1.895 . . . . 0.0 112.64 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 126.83 16.06 2.51 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.874 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 1.1 m -81.39 127.56 73.11 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.82 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 11.6 Cg_endo -59.42 120.26 7.99 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 122.431 2.087 . . . . 0.0 110.685 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -53.4 -28.09 27.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.225 172.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.81 -48.92 76.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.089 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.82 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -68.92 -41.31 78.32 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.015 0.436 . . . . 0.0 110.424 -179.441 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.51 -28.23 63.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.841 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.65 -37.9 83.06 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.858 0.837 . . . . 0.0 110.42 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 m -69.68 -23.59 63.47 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.417 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -101.22 -49.11 4.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.728 0.775 . . . . 0.0 110.127 -174.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 83.7 m -66.52 -27.46 67.79 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.798 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.82 24.41 42.0 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.622 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.8 t -103.54 150.77 23.61 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.0 pt -124.29 139.76 49.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.348 0.594 . . . . 0.0 111.464 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.0 mt -93.88 115.76 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.935 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.501 HD11 ' SG ' ' A' ' 40' ' ' CYS . 39.0 mt -124.38 139.29 32.61 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.442 -171.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.52 -45.52 22.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.937 2.425 . . . . 0.0 112.405 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.79 148.09 4.68 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.955 174.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 76.46 -19.47 0.42 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.77 0.828 . . . . 0.0 112.747 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 39' ' ' THR . 18.0 m -88.24 5.67 40.53 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.006 0.908 . . . . 0.0 110.984 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.753 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 67.6 m -75.04 115.63 46.56 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.09 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.774 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 30.3 Cg_endo -65.14 150.59 87.53 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.606 2.204 . . . . 0.0 111.48 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.23 -15.27 60.72 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 114.406 0.522 . . . . 0.0 114.406 -171.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.1 -19.15 18.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.586 0.693 . . . . 0.0 109.61 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.774 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 19.8 m-85 -114.71 19.39 16.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.304 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.753 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . . . -137.95 31.18 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.245 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.429 ' C ' HH21 ' A' ' 10' ' ' ARG . 57.4 t30 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.235 -0.888 . . . . 0.0 109.933 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 6.8 m . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.826 0.346 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.8 m -120.64 108.09 13.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.282 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 78.1 m -98.17 124.83 42.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.297 -177.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 4.1 t -110.91 126.15 29.29 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.723 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 4.3 Cg_endo -85.42 22.95 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.783 2.322 . . . . 0.0 114.222 -170.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.8 m -154.83 136.66 14.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 122.07 -0.394 . . . . 0.0 110.072 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.415 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 60.4 mt -65.06 -31.05 52.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.926 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.61 -41.29 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.28 -50.31 74.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.815 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -63.19 -26.2 68.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.142 0.496 . . . . 0.0 110.485 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.489 ' O ' HG21 ' A' ' 15' ' ' VAL . 19.8 t -68.74 -54.7 14.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.619 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -75.09 -24.62 58.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.007 0.432 . . . . 0.0 110.275 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -54.8 -57.22 12.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.478 174.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.33 -27.71 67.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 110.428 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 11' ' ' SER . 93.6 t -71.41 -18.7 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.567 176.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 t -83.76 -26.92 29.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.261 0.553 . . . . 0.0 109.669 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.611 ' HG3' ' HB3' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -89.67 -37.97 14.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.557 -171.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.526 ' HG ' ' CD ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -49.64 -45.53 78.8 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 115.007 -0.997 . . . . 0.0 113.538 -179.333 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.526 ' CD ' ' HG ' ' A' ' 18' ' ' LEU . 9.8 Cg_exo -73.06 9.15 1.46 Allowed 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 122.389 2.059 . . . . 0.0 113.961 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.29 34.48 4.2 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.642 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.512 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 1.6 m -115.7 137.37 23.18 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 14.9 Cg_endo -60.55 123.5 13.17 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.484 2.123 . . . . 0.0 110.651 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.611 ' HB3' ' HG3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -47.54 -31.19 4.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.366 172.255 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.572 ' HA ' HD13 ' A' ' 34' ' ' ILE . . . -54.14 -50.94 65.81 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.475 172.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.6 tp -70.14 -38.5 75.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.826 0.346 . . . . 0.0 110.398 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -68.78 -34.43 75.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.4 89.91 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.929 0.871 . . . . 0.0 110.453 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 m -65.04 -24.78 67.58 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.625 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -100.94 -40.84 7.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.586 0.707 . . . . 0.0 110.184 -173.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.0 m -74.49 -39.05 62.7 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.579 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.49 -7.5 11.33 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.949 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.51 154.58 41.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 pt -118.75 155.9 20.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.684 -175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 24' ' ' ALA . 81.7 mt -113.51 125.12 70.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.679 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.497 ' O ' ' HB ' ' A' ' 1' ' ' THR . 13.0 pt -128.14 106.01 19.9 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.546 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.35 80.13 0.78 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 123.061 2.507 . . . . 0.0 111.687 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.92 -137.05 2.15 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.798 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.77 -37.22 0.54 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.71 100.77 6.35 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.178 0.513 . . . . 0.0 111.984 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 53.7 t -119.67 119.13 31.61 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.44 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.434 ' C ' ' H ' ' A' ' 43' ' ' ASP . 43.9 Cg_endo -67.53 148.78 79.28 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.555 2.17 . . . . 0.0 112.104 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.509 ' HA2' ' HB1' ' A' ' 45' ' ' ALA . . . -73.5 21.28 1.18 Allowed Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.22 -0.445 . . . . 0.0 113.295 -175.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 41' ' ' PRO . 6.9 m-20 -102.96 -22.65 13.79 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.723 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 8.0 m-85 -121.74 -2.73 9.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.784 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.509 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -90.32 42.29 1.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.373 -169.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.0 m120 . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.471 175.721 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.542 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 8.7 m . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 t -138.14 161.29 37.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.718 0.294 . . . . 0.0 110.604 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.0 p -143.96 149.96 37.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 3.3 t -140.6 136.08 16.25 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 26.4 Cg_exo -64.33 -19.53 65.66 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.288 2.659 . . . . 0.0 114.915 -173.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.5 p -137.55 156.29 48.27 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.867 -0.521 . . . . 0.0 111.486 -176.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.784 ' HA ' ' HD2' ' A' ' 10' ' ' ARG . 54.2 mt -69.1 -32.92 56.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.338 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.7 t -67.29 -51.49 52.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.035 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.5 ' HB3' HG23 ' A' ' 30' ' ' THR . . . -62.63 -36.49 82.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.738 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.784 ' HD2' ' HA ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -65.02 -39.66 93.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.196 0.522 . . . . 0.0 110.654 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 15' ' ' VAL . 27.9 m -65.92 -44.51 84.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.023 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -61.76 -45.17 95.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.781 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.644 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 1.3 p90 -71.58 -31.23 66.72 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.987 -176.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.45 -51.16 68.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.96 0.409 . . . . 0.0 110.685 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 11' ' ' SER . 39.8 t -68.44 -10.75 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.737 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.582 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.6 t -81.47 -26.26 35.38 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.807 -0.558 . . . . 0.0 109.874 176.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 1.101 ' HD3' ' HG3' ' A' ' 23' ' ' GLU . 40.4 mtm180 -75.35 -24.13 57.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.487 0.661 . . . . 0.0 109.992 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.558 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 64.2 tp -56.4 -52.21 74.97 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.077 -177.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.582 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 13.9 Cg_exo -71.03 -3.09 12.14 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.339 2.026 . . . . 0.0 113.397 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.54 30.09 5.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.691 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.5 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -96.07 139.33 21.74 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.545 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.5 ' HD2' HG22 ' A' ' 21' ' ' THR . 26.0 Cg_endo -66.29 132.27 29.05 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.93 2.42 . . . . 0.0 111.099 175.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 1.101 ' HG3' ' HD3' ' A' ' 17' ' ' ARG . 28.8 mp0 -39.38 -39.65 0.7 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.508 170.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.69 -52.95 20.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.216 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.09 -45.92 75.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.739 0.304 . . . . 0.0 110.203 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 21.8 m -64.68 -40.11 94.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.618 -174.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.76 -47.34 72.52 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.585 0.707 . . . . 0.0 111.173 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.4 m -65.93 -24.98 66.93 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.124 -175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -92.13 -45.48 8.25 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.009 0.909 . . . . 0.0 109.257 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.5 HG23 ' HB3' ' A' ' 9' ' ' ALA . 61.6 m -70.16 -40.04 74.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.122 -176.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.56 4.18 21.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.15 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -84.45 155.7 22.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.5 pt -118.71 153.41 20.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.321 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.41 135.99 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.01 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' A' ' 40' ' ' CYS . 13.0 pt -131.67 129.53 22.09 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.084 0.468 . . . . 0.0 110.88 -173.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.1 -29.01 65.45 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.866 2.378 . . . . 0.0 111.783 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.97 -135.6 3.13 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.011 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.61 41.01 1.09 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.361 0.6 . . . . 0.0 110.284 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -80.59 22.93 0.54 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.182 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.581 ' HB2' HD12 ' A' ' 35' ' ' ILE . 31.6 t -135.94 124.25 15.33 Favored Pre-proline 0 C--N 1.313 -1.022 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.196 -175.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.76 164.63 33.81 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.668 2.246 . . . . 0.0 112.514 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.89 -2.33 45.24 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.29 -172.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -90.03 -25.22 20.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 117.796 0.798 . . . . 0.0 109.253 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 13.3 m-85 -101.3 8.53 42.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.309 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.61 48.24 0.93 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.256 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.619 -178.415 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 3.1 m . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -138.79 143.47 38.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.843 0.354 . . . . 0.0 111.126 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 5.9 m -152.62 160.4 43.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.451 178.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 10' ' ' ARG . 8.9 t -140.01 143.81 35.65 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.5 0.87 5.55 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.087 2.525 . . . . 0.0 113.493 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.0 m -152.8 139.73 19.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.615 HG13 ' OD1' ' A' ' 46' ' ' ASN . 72.0 mt -61.29 -36.37 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.142 0.496 . . . . 0.0 110.276 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.47 -29.98 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.759 -174.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.461 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . . . -84.2 -28.68 27.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.167 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HB2' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -70.2 -35.62 74.04 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.596 -177.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.503 ' O ' HG21 ' A' ' 15' ' ' VAL . 2.9 p -68.13 -46.91 69.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.491 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.88 -30.99 71.95 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.906 0.384 . . . . 0.0 111.029 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.483 ' HZ ' ' HB2' ' A' ' 23' ' ' GLU . 36.5 t80 -54.27 -50.95 66.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.488 174.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.416 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 28.9 m-80 -65.85 -32.7 74.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.224 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.503 HG21 ' O ' ' A' ' 11' ' ' SER . 93.1 t -61.53 -32.85 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.306 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.435 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 6.4 t -78.06 -26.41 48.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.132 0.491 . . . . 0.0 110.426 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -79.28 -18.92 51.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.479 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.8 mt -55.25 -53.57 60.38 Favored Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.142 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 59.8 Cg_endo -72.97 17.03 0.4 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.081 1.854 . . . . 0.0 113.11 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.88 15.5 61.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.46 173.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.585 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 1.3 m -77.85 138.08 61.91 Favored Pre-proline 0 N--CA 1.433 -1.3 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.511 ' HD2' HG21 ' A' ' 21' ' ' THR . 15.6 Cg_endo -61.88 121.89 10.18 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.726 2.284 . . . . 0.0 110.861 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.483 ' HB2' ' HZ ' ' A' ' 13' ' ' PHE . 10.3 pt-20 -40.64 -37.43 0.73 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.939 170.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.68 77.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.317 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.475 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 32.2 tp -72.99 -39.81 65.75 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 120.609 0.242 . . . . 0.0 110.43 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.585 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 61.2 m -65.44 -34.03 77.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.467 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -65.55 -39.41 91.69 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.702 0.763 . . . . 0.0 110.496 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.4 m -71.28 -18.88 62.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.841 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -92.84 -21.43 19.88 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.235 1.017 . . . . 0.0 109.525 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 m -107.78 -49.91 3.15 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.029 -172.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.92 -17.74 5.15 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.429 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 11.5 m -67.8 167.41 13.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.077 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.9 pt -131.65 137.11 55.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.388 0.613 . . . . 0.0 112.46 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.75 128.77 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 167.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.483 ' O ' ' HB ' ' A' ' 1' ' ' THR . 4.8 tt -130.35 97.62 22.02 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-O 121.654 0.74 . . . . 0.0 110.153 -173.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.0 42.76 1.38 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.641 2.894 . . . . 0.0 113.073 -174.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.8 145.72 4.26 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.638 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 76.41 30.64 0.65 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.397 0.679 . . . . 0.0 111.006 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.461 ' HA ' HG21 ' A' ' 1' ' ' THR . 58.2 m 46.91 -95.48 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.93 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 63.0 m -151.75 152.66 30.65 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-O 120.941 0.4 . . . . 0.0 110.961 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.623 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 6.2 Cg_exo -74.82 -172.02 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.217 2.611 . . . . 0.0 111.233 171.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.63 -44.35 2.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.621 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.5 -22.06 35.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.69 0.757 . . . . 0.0 109.74 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.623 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 12.4 m-85 -101.38 20.93 14.99 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.485 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.57 63.56 1.57 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.391 0.615 . . . . 0.0 109.377 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.615 ' OD1' HG13 ' A' ' 7' ' ' ILE . 20.7 t-20 . . . . . 0 C--O 1.249 1.053 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.686 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' THR . . . . . 0.441 ' HB ' HG13 ' A' ' 35' ' ' ILE . 31.0 m . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 120.784 0.326 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.1 t -72.43 142.47 48.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.286 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.53 ' HB3' HG13 ' A' ' 33' ' ' ILE . 30.3 t -144.49 79.08 1.6 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 82.3 m -103.53 112.37 65.6 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.805 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.723 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 3.0 Cg_exo -77.25 14.29 1.39 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.171 2.581 . . . . 0.0 114.896 -173.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.0 p -160.36 156.18 25.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 118.753 0.706 . . . . 0.0 111.213 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.6 mt -62.67 -34.34 64.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.666 173.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.61 -49.66 82.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.602 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.58 -48.29 80.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.682 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 10' ' ' ARG . 23.5 tpp180 -55.05 -38.83 68.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.767 176.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.493 ' O ' HG21 ' A' ' 15' ' ' VAL . 14.3 t -66.9 -50.05 63.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -55.19 -39.41 69.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.105 0.478 . . . . 0.0 110.702 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -49.7 75.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.957 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -73.52 -23.72 60.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.902 0.382 . . . . 0.0 111.202 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 11' ' ' SER . 79.4 t -66.37 -43.58 91.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.213 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.631 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 85.1 m -69.2 -16.71 63.68 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.755 HH11 ' HG3' ' A' ' 23' ' ' GLU . 21.0 mmm180 -71.05 -27.2 63.48 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.827 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.599 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 93.6 mt -66.98 -52.69 30.16 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 1.2 Cg_endo -85.41 17.24 1.8 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.525 2.15 . . . . 0.0 112.68 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.68 30.13 68.84 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.863 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.631 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 2.1 m -85.67 128.56 58.3 Favored Pre-proline 0 N--CA 1.438 -1.057 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.862 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.4 Cg_endo -58.74 122.29 11.38 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.552 2.168 . . . . 0.0 110.672 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.755 ' HG3' HH11 ' A' ' 17' ' ' ARG . 49.3 mt-10 -48.52 -32.8 8.47 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.111 172.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.68 -51.4 69.7 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.272 173.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.862 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 4.2 tt -57.64 -50.23 73.84 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.032 0.444 . . . . 0.0 110.262 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.6 m -72.71 -21.54 61.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.256 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -66.87 -42.21 85.98 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.944 0.878 . . . . 0.0 110.067 175.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.6 m -66.99 -18.74 65.52 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.776 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -98.63 -48.2 5.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.835 0.826 . . . . 0.0 110.115 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.9 m -68.09 -38.08 81.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.339 -1.3 . . . . 0.0 112.498 -174.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.57 -12.94 32.93 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.523 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.468 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 38.9 t -73.13 143.26 47.39 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.53 HG13 ' HB3' ' A' ' 3' ' ' CYS . 22.1 pt -110.13 144.61 17.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.123 0.487 . . . . 0.0 111.472 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.5 mt -109.17 104.12 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.359 174.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.441 HG13 ' HB ' ' A' ' 1' ' ' THR . 26.1 pt -93.62 138.95 22.69 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.766 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.67 -40.71 44.16 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.055 2.504 . . . . 0.0 112.096 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.99 -139.52 5.86 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.454 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.53 21.16 2.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.585 0.231 . . . . 0.0 111.329 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -81.64 73.97 8.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.869 0.842 . . . . 0.0 110.682 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 44' ' ' TYR . 52.9 t -140.38 107.53 6.65 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.267 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 48.5 Cg_endo -71.1 171.41 15.98 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.622 2.214 . . . . 0.0 112.643 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.59 -3.98 23.08 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.85 -0.613 . . . . 0.0 114.353 -174.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -88.67 -19.9 25.58 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 117.614 0.707 . . . . 0.0 109.289 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.723 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 13.0 m-85 -112.22 -6.55 14.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.776 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.97 37.69 1.49 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.959 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.93 -177.665 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.492 ' HB ' HG13 ' A' ' 35' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 120.881 0.372 . . . . 0.0 110.344 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.6 m -95.99 109.52 21.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.958 0.408 . . . . 0.0 109.929 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 64.3 m -123.49 168.33 12.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -173.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 9' ' ' ALA . 5.6 t -160.24 136.74 6.44 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.1 11.71 3.24 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.506 2.137 . . . . 0.0 114.847 -170.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 p -164.34 149.58 10.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.218 0.463 . . . . 0.0 110.639 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.637 HD13 ' H ' ' A' ' 7' ' ' ILE . 4.1 mp -66.95 -34.5 70.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.05 -46.71 95.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.265 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.451 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . . . -66.85 -52.37 44.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.21 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -46.28 -44.47 16.56 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.969 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 15' ' ' VAL . 63.3 m -60.27 -58.2 9.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.454 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 9.4 p30 -70.51 -23.56 62.68 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.681 -175.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.551 ' HB2' HG21 ' A' ' 30' ' ' THR . 44.6 t80 -60.48 -52.17 66.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.551 173.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -68.58 -28.34 66.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.336 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 11' ' ' SER . 77.6 t -67.12 -25.85 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.554 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 28.5 t -80.9 -12.78 59.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 110.26 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.727 ' HD3' ' HG3' ' A' ' 23' ' ' GLU . 38.1 mmm-85 -74.85 -44.14 50.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.092 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.829 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -53.83 -39.39 72.87 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -175.353 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.829 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 13.7 Cg_exo -72.18 4.39 3.34 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 121.925 1.75 . . . . 0.0 113.145 176.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.23 37.13 12.91 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.22 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.454 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -103.29 138.32 19.51 Favored Pre-proline 0 N--CA 1.436 -1.168 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.423 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 30.1 Cg_endo -66.72 129.72 21.68 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.887 2.392 . . . . 0.0 110.441 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.727 ' HG3' ' HD3' ' A' ' 17' ' ' ARG . 1.5 mp0 -42.55 -35.38 1.06 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.614 172.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.74 -47.4 64.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.15 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.73 -46.72 62.51 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.948 0.404 . . . . 0.0 110.145 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 11.6 m -66.06 -43.95 85.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.502 -174.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.71 89.75 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.421 0.629 . . . . 0.0 111.661 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.3 m -68.39 -24.77 64.81 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.604 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -100.04 -46.48 5.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.502 0.668 . . . . 0.0 109.792 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.551 HG21 ' HB2' ' A' ' 13' ' ' PHE . 48.8 m -60.91 -44.91 96.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.552 -1.203 . . . . 0.0 112.124 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.53 -16.12 7.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.169 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 37.7 m -66.09 164.94 14.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.5 pt -130.06 143.55 40.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 121.937 -0.477 . . . . 0.0 111.857 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.3 mt -117.15 101.8 12.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.881 HD12 ' HB2' ' A' ' 38' ' ' ALA . 6.6 pt -114.45 136.79 22.39 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.949 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.6 -39.43 88.33 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.155 2.57 . . . . 0.0 112.534 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.92 -138.14 4.33 Favored Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.881 ' HB2' HD12 ' A' ' 35' ' ' ILE . . . 65.45 88.75 0.1 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.456 0.646 . . . . 0.0 111.086 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.79 95.8 0.12 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.538 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.475 ' SG ' HD13 ' A' ' 35' ' ' ILE . 60.2 m -56.02 131.17 73.98 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.999 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 32.3 Cg_endo -67.25 178.32 3.14 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 123.012 2.475 . . . . 0.0 112.539 173.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.15 4.51 11.07 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -113.82 -5.69 13.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.666 0.733 . . . . 0.0 110.266 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.531 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 21.4 m-85 -115.88 -14.27 11.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.891 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.4 30.56 3.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.787 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.42 HD21 ' C ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.3 -177.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.823 0.344 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 m -103.24 129.68 50.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.182 -175.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.2 m -122.2 98.47 5.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.854 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.0 m -106.03 113.64 63.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 28.2 Cg_exo -64.37 10.44 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.518 2.812 . . . . 0.0 115.068 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.4 p -165.37 148.39 8.02 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.66 0.664 . . . . 0.0 111.131 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.862 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 53.1 mt -64.11 -30.16 49.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.55 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.99 -55.37 19.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.251 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.1 67.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.487 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.862 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -68.05 -31.63 71.41 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.503 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 27.4 m -69.79 -47.76 61.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.957 175.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -51.52 -44.45 62.61 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.262 0.553 . . . . 0.0 110.631 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 75.8 t80 -54.91 -59.02 5.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.381 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -63.65 -31.18 72.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.544 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 11' ' ' SER . 54.0 t -67.86 -37.53 78.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.223 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.527 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 8.5 t -76.34 -33.95 58.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.284 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.443 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -83.31 2.0 38.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.933 0.397 . . . . 0.0 111.376 -178.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 mt -76.12 -49.47 3.23 Favored Pre-proline 0 N--CA 1.444 -0.74 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 74.1 Cg_endo -75.59 19.08 0.56 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.146 1.897 . . . . 0.0 113.368 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.17 35.22 7.67 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.966 177.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 m -105.0 134.74 19.48 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.785 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 11.5 Cg_endo -59.16 121.11 9.38 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.703 2.269 . . . . 0.0 110.877 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 13' ' ' PHE . 36.7 mt-10 -40.11 -38.94 0.81 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.125 170.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.97 -48.74 75.27 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.873 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.785 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.5 tt -64.68 -42.9 95.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 110.035 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.7 m -68.96 -30.96 69.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.937 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.61 -33.79 76.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.949 0.88 . . . . 0.0 110.503 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 m -74.68 -17.01 60.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.765 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -101.16 -42.91 6.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.735 0.779 . . . . 0.0 109.924 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.8 m -71.88 -47.91 49.47 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.852 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.15 -18.66 15.86 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 41.2 t -66.42 143.37 57.16 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.7 pt -103.34 149.8 7.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 111.871 -173.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.401 HD11 ' CE1' ' A' ' 13' ' ' PHE . 65.6 mt -125.59 124.98 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.037 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.5 pt -122.25 158.55 55.34 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.926 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.0 23.03 0.86 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.229 2.619 . . . . 0.0 112.584 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.03 -154.33 6.85 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.32 60.43 1.7 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.414 0.626 . . . . 0.0 110.218 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 m -85.36 -6.64 59.21 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.87 0.843 . . . . 0.0 110.917 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.9 m -85.22 122.22 73.87 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.504 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.525 ' HD2' ' CZ ' ' A' ' 44' ' ' TYR . 55.9 Cg_endo -72.03 172.31 14.95 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.602 2.202 . . . . 0.0 110.905 169.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.69 38.1 3.26 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.185 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.509 ' OD1' ' HG2' ' A' ' 41' ' ' PRO . 12.6 p-10 -111.84 -31.63 6.88 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CZ ' ' HD2' ' A' ' 41' ' ' PRO . 2.4 p90 -122.77 18.6 10.26 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.7 0.762 . . . . 0.0 110.23 175.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.0 24.31 13.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.559 170.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.7 t30 . . . . . 0 C--O 1.245 0.838 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.305 -172.755 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.496 HG22 HD12 ' A' ' 35' ' ' ILE . 10.2 m . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.799 0.333 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.652 HG21 ' SG ' ' A' ' 32' ' ' CYS . 80.8 m -132.71 136.49 46.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.701 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.603 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 26.9 m -127.49 138.33 52.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.498 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 52.6 m -106.16 160.31 26.62 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.19 -171.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.407 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 92.8 Cg_endo -89.78 24.99 0.6 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.613 2.209 . . . . 0.0 113.009 174.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.5 t -172.49 136.05 0.75 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -64.0 -29.27 46.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.563 0.697 . . . . 0.0 109.833 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -71.02 -33.82 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.43 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.459 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -71.7 -45.35 62.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.057 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -53.96 -39.14 65.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.135 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.447 ' O ' HG22 ' A' ' 15' ' ' VAL . 36.6 t -63.04 -52.7 61.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.408 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 10.7 p30 -74.72 -23.83 58.65 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.551 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 2' ' ' THR . 25.9 t80 -55.1 -50.5 69.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.2 170.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -59.54 -38.53 81.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.424 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 11' ' ' SER . 87.2 t -63.29 -39.33 84.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.532 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.552 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 11.5 t -76.73 -31.59 57.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.956 0.408 . . . . 0.0 110.485 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -78.49 -13.67 59.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.189 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.555 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 13.6 mt -63.6 -54.49 42.44 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 7.5 Cg_exo -74.56 18.36 0.5 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.684 2.256 . . . . 0.0 113.282 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.89 33.71 12.11 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.082 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.7 m -99.53 133.36 21.94 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.768 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -57.69 122.71 12.22 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.562 2.175 . . . . 0.0 110.695 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -43.67 -33.27 1.17 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.764 170.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.538 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -56.17 -53.23 59.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 173.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.768 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.6 tt -61.47 -46.68 89.03 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.881 0.372 . . . . 0.0 110.227 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.6 m -65.6 -38.32 89.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.325 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.404 ' HA ' ' HB3' ' A' ' 32' ' ' CYS . . . -61.77 -33.67 74.5 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.627 0.727 . . . . 0.0 111.133 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.9 m -74.35 -18.96 60.61 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.947 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -100.64 -40.11 7.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.768 0.794 . . . . 0.0 109.634 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.6 m -74.74 -31.37 61.8 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.196 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.64 14.66 42.94 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -172.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.652 ' SG ' HG21 ' A' ' 2' ' ' THR . 6.1 t -87.97 167.6 13.57 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.4 pt -133.48 138.03 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 118.559 0.618 . . . . 0.0 112.272 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 24' ' ' ALA . 4.3 mp -81.76 142.57 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.678 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.496 HD12 HG22 ' A' ' 1' ' ' THR . 0.2 OUTLIER -122.93 148.15 53.21 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 176.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.8 -40.12 47.41 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.959 2.439 . . . . 0.0 112.79 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -113.61 -138.78 7.08 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.076 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.68 9.92 15.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.29 0.567 . . . . 0.0 110.034 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -96.29 107.61 19.99 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.95 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.4 m -104.16 134.15 19.85 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.953 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.667 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 10.0 Cg_endo -52.99 145.88 39.5 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.873 2.382 . . . . 0.0 111.495 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.2 -34.94 63.38 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 114.347 0.499 . . . . 0.0 114.347 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.71 -20.25 39.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.43 0.633 . . . . 0.0 109.901 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.667 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 9.6 m-85 -119.21 26.18 9.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.892 -173.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.91 22.07 6.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.247 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 45.9 m-80 . . . . . 0 C--O 1.243 0.729 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.56 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.902 0.382 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.45 ' OG1' HG12 ' A' ' 34' ' ' ILE . 44.1 m -86.49 97.29 10.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.308 0.575 . . . . 0.0 110.742 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 84.2 m -89.86 100.09 12.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.575 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.588 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 20.5 t -105.75 135.63 19.37 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.879 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 72.7 Cg_endo -76.83 23.49 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.711 2.274 . . . . 0.0 114.004 -174.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 31.2 t -162.47 145.83 11.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.513 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 58.2 mt -76.11 -26.39 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.65 -46.3 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.722 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.527 ' HB3' ' HB3' ' A' ' 6' ' ' SER . . . -62.11 -41.51 98.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.816 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.588 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 7.1 ptp180 -72.47 -24.3 61.17 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.254 0.55 . . . . 0.0 110.182 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.485 ' O ' HG23 ' A' ' 15' ' ' VAL . 32.7 t -68.41 -47.3 67.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.725 173.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.37 -33.03 71.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.066 0.46 . . . . 0.0 110.163 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.542 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 38.9 t80 -54.99 -53.19 58.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.37 172.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -61.65 -39.99 93.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.029 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 11' ' ' SER . 90.1 t -59.72 -42.22 87.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.209 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.546 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.1 t -74.35 -34.44 63.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.292 0.567 . . . . 0.0 110.577 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.481 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 16.2 tpt180 -60.35 -44.44 95.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.982 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.562 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 60.8 mt -52.94 -53.53 54.02 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 33.5 Cg_exo -60.78 -16.83 46.56 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.582 2.188 . . . . 0.0 113.808 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.32 30.66 2.61 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.285 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.56 HG21 ' HD2' ' A' ' 22' ' ' PRO . 0.5 OUTLIER -97.85 139.17 21.15 Favored Pre-proline 0 N--CA 1.431 -1.39 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.703 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -56.89 118.05 4.84 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.045 2.497 . . . . 0.0 111.113 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.481 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 15.1 pt-20 -44.79 -32.55 1.58 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.951 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.8 -48.3 82.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.925 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.703 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -64.96 -47.4 77.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.003 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.422 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 20.8 m -60.93 -39.62 90.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.108 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.15 -55.46 28.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.817 0.817 . . . . 0.0 110.832 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 m -62.56 -25.72 68.21 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.843 -1.526 . . . . 0.0 112.57 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -90.84 -20.03 22.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.844 0.83 . . . . 0.0 109.816 -172.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 m -102.76 -27.77 12.49 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.463 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.18 2.1 13.84 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.132 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.5 m -88.12 154.39 20.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.7 pt -128.62 144.36 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.986 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.45 HG12 ' OG1' ' A' ' 2' ' ' THR . 63.3 mt -106.38 121.57 59.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.571 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.801 HG23 ' H ' ' A' ' 37' ' ' GLY . 5.0 mp -106.42 131.28 21.85 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.645 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.97 -15.88 52.66 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.82 2.346 . . . . 0.0 112.248 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.801 ' H ' HG23 ' A' ' 35' ' ' ILE . . . -99.37 -142.57 13.38 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.96 15.27 1.53 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.051 0.453 . . . . 0.0 110.803 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -103.13 106.53 17.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.391 0.615 . . . . 0.0 110.781 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.2 p -143.96 146.0 32.51 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.389 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.86 166.7 13.45 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.743 2.295 . . . . 0.0 112.56 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.97 2.96 39.78 Favored Glycine 0 CA--C 1.518 0.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.257 -170.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 11.9 p-10 -97.69 -12.67 22.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.631 0.715 . . . . 0.0 109.334 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 21.0 m-85 -105.82 -14.07 15.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.078 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.11 19.75 5.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.278 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.526 -178.589 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.951 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 17.7 m . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.811 0.338 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.2 m -126.34 126.67 44.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.523 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 73.8 m -128.05 130.44 48.26 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -171.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.66 ' HB2' ' HB2' ' A' ' 10' ' ' ARG . 63.3 m -136.0 140.88 34.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 171.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 10.6 Cg_exo -72.0 15.36 0.39 Allowed 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.087 2.525 . . . . 0.0 114.398 -173.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.2 m -159.27 145.16 16.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.733 HD13 ' H ' ' A' ' 7' ' ' ILE . 3.8 mp -58.11 -38.75 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.54 0.686 . . . . 0.0 109.688 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.34 -42.24 65.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.223 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.38 -33.75 76.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.799 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.66 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -76.38 -27.85 56.52 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.395 0.617 . . . . 0.0 110.003 -179.367 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.45 ' O ' HG23 ' A' ' 15' ' ' VAL . 36.2 m -72.78 -38.01 67.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.958 172.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -59.21 -30.11 67.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.965 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.4 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 65.7 t80 -53.41 -53.88 44.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.343 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -65.57 -29.2 69.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.949 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 11' ' ' SER . 76.8 t -65.46 -31.19 52.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.829 0.347 . . . . 0.0 110.524 177.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 42.8 t -92.2 -0.95 57.4 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.066 0.936 . . . . 0.0 109.822 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -92.43 -29.63 16.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.885 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.51 ' HG ' ' CD ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -61.08 -47.31 95.47 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.661 178.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.51 ' CD ' ' HG ' ' A' ' 18' ' ' LEU . 14.5 Cg_exo -70.73 -3.11 11.99 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.15 1.9 . . . . 0.0 112.807 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.05 33.51 14.82 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.955 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.602 HG23 ' HD2' ' A' ' 22' ' ' PRO . 1.7 m -95.37 143.78 26.69 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.649 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 12.4 Cg_endo -61.9 121.29 9.29 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.786 2.324 . . . . 0.0 110.96 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 1.7 mp0 -39.5 -36.93 0.42 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.068 171.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.87 -49.18 76.28 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.399 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.649 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.2 tt -68.08 -38.84 82.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.354 0.597 . . . . 0.0 109.737 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.524 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 13.0 m -76.14 4.01 9.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.326 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -101.33 -21.47 14.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.592 0.711 . . . . 0.0 110.315 173.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 m -76.98 -42.3 39.48 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.921 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -86.55 -23.15 25.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.746 0.784 . . . . 0.0 110.535 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.572 ' HB ' ' SG ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -99.9 1.8 43.14 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.798 -174.368 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.48 33.6 86.86 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.126 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.576 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 75.0 m -102.13 165.13 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.95 0.405 . . . . 0.0 110.744 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 3' ' ' CYS . 12.6 pt -139.12 147.98 24.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.396 177.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.77 127.37 56.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.582 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.951 ' HB ' ' HB ' ' A' ' 1' ' ' THR . 8.6 mm -115.69 113.16 42.64 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.627 -175.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -71.17 -16.73 31.72 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.176 2.584 . . . . 0.0 111.541 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' H ' HG21 ' A' ' 35' ' ' ILE . . . -124.35 -139.8 5.4 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.114 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -124.04 25.47 7.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.4 0.619 . . . . 0.0 110.329 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 m -81.81 42.0 0.68 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.877 0.846 . . . . 0.0 110.866 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.543 ' HB2' HG13 ' A' ' 35' ' ' ILE . 53.3 t -134.56 120.09 14.39 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.203 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.4 169.97 20.22 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.741 2.294 . . . . 0.0 112.168 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.66 16.32 4.18 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.078 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -100.31 -17.08 17.46 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.523 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 15.9 m-85 -113.96 -14.18 12.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.45 176.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.73 29.09 5.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.37 0.605 . . . . 0.0 110.047 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.404 ' C ' HH21 ' A' ' 10' ' ' ARG . 2.4 t-20 . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.109 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.456 ' OG1' ' HA ' ' A' ' 38' ' ' ALA . 23.6 m . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.047 0.451 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.717 HG21 HG12 ' A' ' 34' ' ' ILE . 9.8 m -89.35 110.22 21.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.423 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 87.5 m -127.72 167.53 16.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.042 -177.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.718 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 9.8 t -138.93 149.42 61.63 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.718 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 6.1 Cg_exo -41.06 -37.91 2.84 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.23 3.287 . . . . 0.0 115.31 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 p -169.36 173.02 6.82 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.309 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.709 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 60.3 mt -61.63 -40.15 85.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.53 177.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.89 -53.2 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.434 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.02 88.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.471 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.709 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -69.7 -25.91 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 0.0 110.949 -177.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.5 m -75.13 -12.78 60.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.013 0.435 . . . . 0.0 110.914 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -94.1 -8.2 40.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.8 0.81 . . . . 0.0 109.452 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.641 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 65.0 t80 -88.34 -58.06 2.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.625 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -61.22 -37.99 85.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.179 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.92 -18.85 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.062 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.0 t -78.72 -26.14 44.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.876 -0.515 . . . . 0.0 110.19 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.564 ' CD ' ' HB3' ' A' ' 23' ' ' GLU . 51.5 mtm180 -74.18 -29.12 61.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.974 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.8 mt -51.15 -53.07 52.63 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -175.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.87 -6.27 16.53 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.974 1.783 . . . . 0.0 113.719 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.03 30.93 3.49 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.475 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -101.8 133.26 20.86 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.848 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.5 Cg_endo -63.58 127.72 20.52 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.576 2.184 . . . . 0.0 110.282 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.641 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 9.8 pt-20 -51.6 -27.54 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.422 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.3 85.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.953 0.406 . . . . 0.0 110.137 172.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.848 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -66.07 -42.64 89.15 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.169 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.481 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 37.5 m -69.24 -31.74 70.49 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.663 -176.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.27 -36.31 83.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.127 0.965 . . . . 0.0 110.123 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 m -77.75 -18.41 56.52 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.207 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -104.33 -54.82 2.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.636 0.731 . . . . 0.0 109.765 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.2 m -63.01 -52.88 61.23 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.608 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.51 1.43 4.27 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.968 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 13' ' ' PHE . 27.1 m -74.36 164.31 26.75 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.448 HD13 ' HB2' ' A' ' 3' ' ' CYS . 2.8 pp -124.58 149.14 28.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.372 0.606 . . . . 0.0 112.412 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.717 HG12 HG21 ' A' ' 2' ' ' THR . 74.2 mt -127.13 112.16 27.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.113 174.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.526 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.5 pp -122.14 135.44 25.42 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -68.7 79.43 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.436 2.757 . . . . 0.0 111.659 174.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.46 -149.59 6.23 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.456 ' HA ' ' OG1' ' A' ' 1' ' ' THR . . . -142.98 10.34 1.75 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.94 0.4 . . . . 0.0 111.4 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.8 m -146.85 103.61 3.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.614 0.721 . . . . 0.0 110.412 176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 5.8 p -78.77 152.57 77.67 Favored Pre-proline 0 C--N 1.308 -1.227 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.337 175.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.654 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 18.6 Cg_endo -60.26 153.12 61.66 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.142 2.561 . . . . 0.0 112.7 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.45 6.2 39.46 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 114.514 0.566 . . . . 0.0 114.514 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -113.05 -3.06 14.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 15.7 m-30 -134.25 21.85 3.74 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.097 -1.411 . . . . 0.0 109.773 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.7 20.96 5.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -170.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.41 ' C ' HH21 ' A' ' 10' ' ' ARG . 20.4 m120 . . . . . 0 C--O 1.253 1.245 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.55 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.2 t -105.12 124.53 49.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.459 0.647 . . . . 0.0 110.357 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.1 m -112.87 117.49 32.26 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 5.8 t -146.9 105.27 3.91 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.7 ' HG3' ' HA ' ' A' ' 44' ' ' TYR . 44.9 Cg_endo -92.3 38.57 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.985 2.456 . . . . 0.0 114.259 -171.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.742 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 3.6 m -142.28 119.42 11.42 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.923 -174.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.7 mt -50.63 -37.88 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 123.815 0.697 . . . . 0.0 110.885 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.57 -42.71 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.198 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.567 ' HB1' ' HB2' ' A' ' 6' ' ' SER . . . -61.12 -48.62 80.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.287 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.742 ' HG3' ' O ' ' A' ' 6' ' ' SER . 28.5 mtt180 -55.96 -32.73 64.12 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.271 0.558 . . . . 0.0 110.134 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.42 ' O ' HG21 ' A' ' 15' ' ' VAL . 50.5 m -72.69 -57.87 3.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.523 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -73.59 -20.75 60.53 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.328 -173.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -51.94 -57.16 10.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.498 173.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 92.0 m-20 -61.87 -37.36 84.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.525 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 11' ' ' SER . 82.0 t -64.74 -26.01 39.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.265 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.591 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 3.6 t -82.68 -36.31 26.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.1 0.476 . . . . 0.0 110.163 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 21' ' ' THR . 62.3 ttt180 -68.95 -45.26 71.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.69 -174.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.524 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 84.6 mt -53.36 -47.82 94.8 Favored Pre-proline 0 N--CA 1.444 -0.734 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 13.2 Cg_exo -71.04 21.59 0.22 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.488 2.125 . . . . 0.0 113.752 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.16 35.52 8.07 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.089 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 1.7 m -114.14 134.69 22.16 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.742 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.6 Cg_endo -60.74 124.7 15.54 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.452 2.102 . . . . 0.0 110.817 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -44.31 -32.06 1.2 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.867 170.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.67 -50.47 73.74 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.811 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.742 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.9 tt -62.41 -47.1 85.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.4 m -64.63 -34.09 77.46 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.309 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.0 94.65 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.92 0.867 . . . . 0.0 110.528 176.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -72.81 -20.67 61.11 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.121 -1.4 . . . . 0.0 111.147 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -101.38 -37.45 8.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.785 0.802 . . . . 0.0 109.875 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.5 m -80.85 -42.87 20.86 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.987 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.74 -6.67 9.63 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.8 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 4' ' ' CYS . 3.9 m -74.96 157.94 34.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.3 pt -120.39 138.7 50.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.727 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -111.65 112.91 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.178 0.513 . . . . 0.0 110.594 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.5 pt -115.96 150.76 45.59 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.732 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.18 -51.0 8.48 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.297 2.664 . . . . 0.0 112.488 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.63 -139.77 10.52 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.337 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.74 70.8 1.25 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.543 0.687 . . . . 0.0 109.449 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 m -130.63 43.84 3.05 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.595 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 45' ' ' ALA . 7.4 p -96.12 127.57 40.15 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.478 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.592 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 11.7 Cg_endo -53.61 157.37 9.81 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.476 2.784 . . . . 0.0 113.186 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.61 -23.86 55.72 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.446 -0.797 . . . . 0.0 114.682 -172.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -93.09 0.01 57.17 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 117.852 0.826 . . . . 0.0 109.514 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.7 ' HA ' ' HG3' ' A' ' 5' ' ' PRO . 21.0 m-85 -121.57 0.55 9.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.552 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.499 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -126.66 54.64 1.58 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.575 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.628 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 10.0 t30 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.022 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 38.1 m . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.013 0.435 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.429 HG23 ' CD2' ' A' ' 13' ' ' PHE . 10.4 t -133.86 158.65 42.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.203 -176.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.569 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 93.3 m -137.84 138.97 39.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.214 174.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -134.62 153.29 78.9 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.598 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.25 3.86 3.76 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.903 2.402 . . . . 0.0 114.324 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.456 ' HA ' ' OD1' ' A' ' 46' ' ' ASN . 33.1 p -164.17 142.66 7.31 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.358 0.526 . . . . 0.0 111.218 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.59 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 61.8 mt -57.27 -32.3 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.32 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.71 -54.19 30.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.182 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.48 ' HB2' HG23 ' A' ' 30' ' ' THR . . . -68.51 -36.8 79.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.475 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.59 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 13.1 ptm180 -69.11 -24.02 64.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.219 0.533 . . . . 0.0 110.636 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.468 ' O ' HG21 ' A' ' 15' ' ' VAL . 49.2 m -76.86 -40.63 46.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.923 172.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -55.87 -34.31 65.38 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.826 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.578 ' CE1' ' HB2' ' A' ' 23' ' ' GLU . 79.6 t80 -53.57 -57.87 9.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.728 0.775 . . . . 0.0 110.546 174.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -62.04 -34.47 76.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.376 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.626 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 92.7 t -63.51 -34.47 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.355 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.72 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 48.4 t -62.56 -31.78 72.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.293 0.568 . . . . 0.0 111.734 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.969 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 12.0 mmm180 -80.11 -10.97 59.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.13 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.568 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 54.6 mt -71.24 -56.87 5.05 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.626 ' HD3' ' O ' ' A' ' 15' ' ' VAL . 10.4 Cg_endo -90.01 24.17 0.64 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.474 2.116 . . . . 0.0 113.135 -173.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.81 45.75 26.33 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.781 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.72 ' HB ' ' SG ' ' A' ' 16' ' ' CYS . 1.3 m -114.96 132.85 22.79 Favored Pre-proline 0 N--CA 1.44 -0.934 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.874 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 19.0 Cg_endo -61.05 120.9 8.85 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.132 2.555 . . . . 0.0 111.598 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.969 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -52.38 -29.49 24.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.978 170.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.27 -45.53 87.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.571 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.874 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 2.2 tt -62.55 -51.18 68.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.187 0.517 . . . . 0.0 109.832 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 96.1 m -71.58 -16.06 62.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.79 -15.72 61.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.981 0.896 . . . . 0.0 110.037 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.3 m -101.69 -20.4 15.01 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.189 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.53 ' HB3' ' HA ' ' A' ' 26' ' ' CYS . 26.2 t80 -101.53 -41.96 6.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.885 0.85 . . . . 0.0 110.001 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 9' ' ' ALA . 21.8 m -89.76 -37.96 14.16 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.557 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.98 12.75 26.95 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.308 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 55.7 m -81.38 153.45 26.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.837 0.318 . . . . 0.0 110.268 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 pt -117.22 139.79 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.681 0.276 . . . . 0.0 110.838 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mp -96.54 131.9 42.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.136 176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.411 ' O ' ' HB ' ' A' ' 1' ' ' THR . 2.3 pp -141.5 155.44 67.15 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.513 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.54 -51.83 8.32 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.937 2.425 . . . . 0.0 112.384 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.05 141.56 3.36 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.733 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 59.25 17.0 5.36 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 172.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -108.92 54.24 0.66 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.83 0.824 . . . . 0.0 110.535 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.1 m -130.96 123.03 19.68 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.2 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.03 168.33 25.06 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.573 2.182 . . . . 0.0 111.787 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.67 9.5 10.75 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.382 -0.437 . . . . 0.0 113.683 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -101.13 -16.48 17.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.569 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 20.9 m-85 -122.99 14.62 9.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.145 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.12 21.32 17.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.004 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' A' ' 6' ' ' SER . 22.3 t-20 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.318 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.541 HG21 ' HA ' ' A' ' 38' ' ' ALA . 19.9 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.653 0.263 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 m -112.91 125.93 54.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.321 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 73.6 m -127.97 151.57 48.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.396 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.553 ' HB2' ' HD3' ' A' ' 10' ' ' ARG . 60.1 m -125.39 142.95 43.12 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.32 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.647 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 2.3 Cg_endo -83.99 5.56 6.27 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.081 2.521 . . . . 0.0 114.535 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 56.6 p -158.13 151.03 22.68 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.799 -0.563 . . . . 0.0 110.605 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.7 mt -67.84 -30.77 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.96 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.51 -46.87 74.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.011 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -64.08 -49.71 71.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.093 176.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.553 ' HD3' ' HB2' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -49.19 -40.45 33.4 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.462 176.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.417 ' O ' HG23 ' A' ' 15' ' ' VAL . 13.6 t -65.79 -58.43 5.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.459 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.415 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 9.9 p30 -69.74 -23.07 63.33 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.541 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.42 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 45.0 t80 -60.13 -58.63 7.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.326 174.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -65.25 -30.7 71.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.401 . . . . 0.0 110.286 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 11' ' ' SER . 61.6 t -74.42 -14.9 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.805 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.699 ' O ' ' HB ' ' A' ' 21' ' ' THR . 49.2 t -91.36 -11.37 38.06 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.861 -0.524 . . . . 0.0 110.562 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.567 ' HD2' ' HB3' ' A' ' 23' ' ' GLU . 4.6 ptm180 -112.32 -22.09 11.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.782 0.801 . . . . 0.0 109.816 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -45.26 95.89 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 114.198 -1.364 . . . . 0.0 112.121 174.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.21 -12.8 30.52 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.923 1.748 . . . . 0.0 112.814 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.53 7.78 23.76 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.803 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.699 ' HB ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -77.81 138.96 61.83 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.039 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.612 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.7 Cg_endo -58.52 115.66 2.7 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 122.859 2.373 . . . . 0.0 111.565 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.567 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 10.5 pt-20 -55.16 -22.62 17.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.643 171.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -59.74 -49.45 77.66 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.256 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.612 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.2 tt -67.72 -43.48 79.9 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 110.304 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.0 m -68.18 -25.9 65.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.823 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.24 -30.37 70.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.655 0.741 . . . . 0.0 110.731 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.7 m -74.65 -26.16 59.68 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.985 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -102.13 -50.23 3.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.532 0.682 . . . . 0.0 109.905 -173.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.3 m -63.36 -42.81 98.91 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.597 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.62 8.91 17.92 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.526 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 58.6 m -81.98 163.47 22.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.3 pt -127.26 143.48 40.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.684 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 24' ' ' ALA . 55.1 mt -106.41 118.44 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.313 177.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.577 HD12 ' SG ' ' A' ' 40' ' ' CYS . 21.3 pt -128.89 148.17 67.68 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.947 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.66 67.07 8.51 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.83 2.353 . . . . 0.0 112.46 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.68 149.12 5.18 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.541 ' HA ' HG21 ' A' ' 1' ' ' THR . . . -81.94 30.19 0.39 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.144 0.497 . . . . 0.0 110.906 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 m -85.13 30.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.617 0.722 . . . . 0.0 111.192 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.577 ' SG ' HD12 ' A' ' 35' ' ' ILE . 66.7 m -69.16 119.34 69.52 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.346 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.511 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 11.6 Cg_endo -57.66 156.33 27.82 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.668 2.245 . . . . 0.0 111.805 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.98 -8.45 35.31 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 114.344 0.498 . . . . 0.0 114.344 -170.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -100.74 -21.27 15.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.562 0.681 . . . . 0.0 109.696 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.647 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 20.7 m-85 -108.37 8.28 27.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.045 -177.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.33 24.66 12.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.028 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.8 t30 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.191 -176.633 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.473 0.679 0 CA-C-O 120.84 0.352 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t -104.9 130.56 53.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.008 0.432 . . . . 0.0 110.017 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 25.1 m -118.02 132.43 56.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.984 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 5.9 t -152.43 120.16 3.18 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -90.04 35.4 0.34 Allowed 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.078 2.519 . . . . 0.0 114.209 -170.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 t -162.47 139.98 8.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.1 mt -74.72 -23.99 18.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.6 t -73.11 -44.24 56.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.086 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -44.21 74.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.227 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.13 -38.15 67.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.159 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 15' ' ' VAL . 22.7 t -61.04 -53.93 51.05 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.961 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -53.28 -35.55 60.2 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.31 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -62.97 -59.06 5.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.224 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.27 -34.12 74.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.17 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 11' ' ' SER . 77.2 t -62.83 -28.57 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.161 0.505 . . . . 0.0 110.829 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.564 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 32.2 t -89.71 -32.08 17.18 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.85 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.713 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 36.8 tpt85 -70.25 -36.2 74.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.725 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.54 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 27.7 mt -60.23 -49.37 91.03 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -175.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.564 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 20.4 Cg_exo -68.34 11.93 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.554 2.17 . . . . 0.0 113.428 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 18' ' ' LEU . . . 81.27 40.03 11.88 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.429 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.527 HG21 ' HD2' ' A' ' 22' ' ' PRO . 1.1 m -104.94 140.0 20.65 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.699 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.0 Cg_endo -56.56 118.57 5.43 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.881 2.388 . . . . 0.0 111.021 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.713 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 8.8 pt-20 -51.36 -29.4 15.26 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.104 171.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.22 -43.56 87.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.686 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.699 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -70.95 -52.41 20.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.916 0.389 . . . . 0.0 110.061 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 10.9 m -60.52 -38.12 83.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.783 -173.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.06 -58.83 5.51 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.685 0.755 . . . . 0.0 111.218 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -64.55 -21.21 66.63 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.543 -172.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -84.61 -38.34 20.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 122.14 0.971 . . . . 0.0 109.25 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.9 m -81.02 -44.08 18.62 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.881 -1.508 . . . . 0.0 111.722 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.07 -13.16 4.12 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.704 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 4' ' ' CYS . 3.3 m -75.69 157.81 33.14 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.6 pt -125.43 161.54 29.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.188 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.0 mt -128.11 125.04 63.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.273 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.95 HD11 ' HB2' ' A' ' 38' ' ' ALA . 2.7 pt -136.03 146.56 57.12 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.624 -177.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 31.5 Cg_exo -57.69 -55.78 2.17 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.082 2.521 . . . . 0.0 111.91 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.36 -138.79 6.63 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.95 ' HB2' HD11 ' A' ' 35' ' ' ILE . . . 62.55 81.06 0.21 Allowed 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.677 0.751 . . . . 0.0 110.754 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 m -68.1 97.24 0.68 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.722 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.765 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . 72.2 m -62.73 135.43 95.81 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.795 176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.424 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 19.6 Cg_endo -60.64 178.24 0.5 Allowed 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.985 2.457 . . . . 0.0 112.972 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.81 -0.91 28.74 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 114.816 0.686 . . . . 0.0 114.816 -171.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -99.69 -11.15 21.14 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 118.171 0.985 . . . . 0.0 109.306 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.765 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 18.6 m-85 -106.13 -20.69 13.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.545 173.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.53 36.11 1.18 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.783 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.4 t30 . . . . . 0 C--O 1.244 0.792 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.143 -175.995 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 94.3 m . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 121.096 0.474 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 26.2 m -108.6 124.71 50.91 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.82 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 65.4 m -125.7 120.56 31.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.163 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.4 m -104.93 162.82 18.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.731 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.17 -0.56 10.0 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.275 1.983 . . . . 0.0 115.526 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t -170.59 148.7 3.09 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.547 1.067 . . . . 0.0 111.948 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.746 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 29.3 mm -59.84 -35.71 62.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.466 0.65 . . . . 0.0 109.965 172.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -71.97 -42.83 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.767 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.794 ' HB2' HG22 ' A' ' 30' ' ' THR . . . -71.48 -41.15 69.7 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.901 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.746 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.6 OUTLIER -66.73 -28.98 68.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.179 0.514 . . . . 0.0 109.845 178.551 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.489 ' O ' HG22 ' A' ' 15' ' ' VAL . 37.8 t -64.29 -53.28 51.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.547 172.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -52.9 -41.01 63.99 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.555 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.634 ' HA ' ' SG ' ' A' ' 26' ' ' CYS . 58.8 t80 -54.93 -55.76 27.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.945 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.456 ' ND2' ' HA ' ' A' ' 11' ' ' SER . 10.9 p30 -70.28 -25.78 63.5 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.439 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.574 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 47.4 t -65.09 -37.89 81.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.676 174.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.577 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 86.1 m -61.2 -26.84 68.0 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.261 0.553 . . . . 0.0 111.654 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -76.34 -29.65 57.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.622 -176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.889 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -61.97 -44.58 90.38 Favored Pre-proline 0 CA--C 1.549 0.916 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.298 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.889 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 4.1 Cg_exo -78.5 -30.13 3.36 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 122.101 1.868 . . . . 0.0 112.279 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.5 13.97 2.23 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.1 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 7.0 m -72.34 126.92 90.83 Favored Pre-proline 0 N--CA 1.443 -0.8 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.901 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -57.96 126.42 21.6 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 122.133 1.889 . . . . 0.0 109.932 175.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.72 -37.99 1.34 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.038 171.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.74 -46.63 88.55 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.388 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.901 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 2.3 tt -61.46 -46.52 89.69 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.94 0.4 . . . . 0.0 110.142 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.634 ' SG ' ' HA ' ' A' ' 13' ' ' PHE . 10.9 t -70.14 -26.67 64.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.948 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.06 -19.47 64.88 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.751 0.786 . . . . 0.0 110.731 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.3 m -88.16 -23.82 23.52 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.691 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -96.41 -49.41 5.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.718 0.771 . . . . 0.0 109.84 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.794 HG22 ' HB2' ' A' ' 9' ' ' ALA . 12.8 m -69.8 -29.45 66.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.721 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.77 20.47 65.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.576 -177.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.1 t -90.65 145.9 24.46 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.7 pt -111.73 135.7 50.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.598 . . . . 0.0 112.216 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.7 mt -108.88 104.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.041 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.577 HD13 ' SG ' ' A' ' 40' ' ' CYS . 27.8 pt -123.42 149.56 58.5 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.244 -173.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.0 20.18 1.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.719 2.28 . . . . 0.0 112.466 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.4 -153.05 6.0 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.706 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.9 23.22 6.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.911 0.386 . . . . 0.0 111.062 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 m -77.11 57.03 1.33 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.68 0.753 . . . . 0.0 111.032 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.577 ' SG ' HD13 ' A' ' 35' ' ' ILE . 28.4 m -110.96 104.69 56.51 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.328 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 40' ' ' CYS . 29.3 Cg_endo -64.17 166.87 15.65 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.498 2.132 . . . . 0.0 111.847 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.45 -30.69 65.33 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.38 -0.438 . . . . 0.0 114.049 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.18 -26.56 30.75 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.337 0.589 . . . . 0.0 109.855 -176.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.486 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 14.1 m-85 -113.14 21.99 14.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.765 -171.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' A' ' 3' ' ' CYS . . . -112.75 30.07 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.526 0.679 . . . . 0.0 109.47 175.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 . . . . . 0 C--O 1.247 0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.263 -176.972 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.404 ' CG2' HG13 ' A' ' 35' ' ' ILE . 3.6 t . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.436 0.636 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.556 ' HB ' ' CZ ' ' A' ' 13' ' ' PHE . 78.2 m -134.52 141.61 46.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.006 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 65.8 m -116.15 126.78 54.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.811 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 10' ' ' ARG . 63.7 m -118.6 117.35 34.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.904 176.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.39 25.97 0.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.727 2.284 . . . . 0.0 112.802 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -153.04 134.8 14.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.552 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 33.3 mt -60.66 -37.12 74.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.048 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.0 t -72.65 -49.05 43.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.193 0.52 . . . . 0.0 110.127 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.435 ' HB3' HG21 ' A' ' 30' ' ' THR . . . -55.72 -46.23 77.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.988 177.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.552 ' HG3' ' O ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -68.11 -29.75 68.74 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 -175.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 15' ' ' VAL . 58.6 m -62.38 -59.06 5.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.946 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -69.7 -25.71 64.0 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.523 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.556 ' CZ ' ' HB ' ' A' ' 2' ' ' THR . 3.9 t80 -58.96 -48.5 81.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.015 172.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.85 -39.49 90.81 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.071 0.463 . . . . 0.0 110.207 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 11' ' ' SER . 43.1 t -69.89 -20.52 23.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.977 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.808 ' O ' ' HB ' ' A' ' 21' ' ' THR . 25.4 t -91.44 -2.93 57.11 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.799 0.809 . . . . 0.0 109.693 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -109.42 -29.5 8.4 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.819 0.818 . . . . 0.0 109.281 -172.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -48.43 92.72 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.855 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.78 -18.65 58.58 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 122.225 1.95 . . . . 0.0 113.282 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.99 12.69 7.57 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.495 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.808 ' HB ' ' O ' ' A' ' 16' ' ' CYS . 3.6 m -85.64 136.31 37.21 Favored Pre-proline 0 N--CA 1.433 -1.31 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.722 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.3 Cg_endo -58.63 118.67 5.6 Favored 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 122.816 2.344 . . . . 0.0 111.389 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.42 ' HB2' ' HE1' ' A' ' 13' ' ' PHE . 10.2 pt-20 -42.36 -31.63 0.43 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.912 168.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.6 -51.49 69.59 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.847 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.722 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 3.0 tt -59.41 -44.96 92.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.223 0.535 . . . . 0.0 109.951 177.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.7 m -66.92 -42.09 85.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.897 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.43 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -57.8 -47.25 83.12 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.396 0.617 . . . . 0.0 111.823 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 m -63.0 -29.21 70.65 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.318 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -95.11 -48.11 6.09 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.614 0.721 . . . . 0.0 109.52 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.435 HG21 ' HB3' ' A' ' 9' ' ' ALA . 91.7 m -61.84 -38.33 87.81 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.751 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.66 -4.05 11.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.094 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.43 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 58.8 m -73.1 168.79 18.36 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.853 0.359 . . . . 0.0 110.196 176.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 40.0 pt -122.53 132.48 71.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.009 0.433 . . . . 0.0 110.762 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 16.5 tt -95.92 139.0 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.403 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.615 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 20.0 pt -121.56 173.01 4.33 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.615 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 73.6 Cg_endo -80.41 -24.09 5.63 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.638 1.558 . . . . 0.0 113.719 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -153.01 -138.15 2.65 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.971 -1.109 . . . . 0.0 113.856 -171.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.38 13.69 33.12 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -83.24 77.2 9.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.732 0.777 . . . . 0.0 110.319 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.55 ' HB2' HD13 ' A' ' 35' ' ' ILE . 30.7 t -155.84 129.28 4.48 Favored Pre-proline 0 C--N 1.311 -1.074 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.087 -178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.05 163.16 31.14 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.61 2.207 . . . . 0.0 112.451 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 45' ' ' ALA . . . -73.81 8.82 9.96 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.537 -176.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.31 -27.79 21.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -105.61 -7.14 18.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.658 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HB2' ' HA2' ' A' ' 42' ' ' GLY . . . -94.1 40.05 1.08 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.926 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--O 1.251 1.14 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.604 178.263 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 6.4 m . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 121.621 0.724 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.4 m -111.44 132.12 54.7 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.682 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.404 ' HB2' HG13 ' A' ' 33' ' ' ILE . 63.6 m -138.71 153.95 48.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.015 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.534 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 14.7 t -150.06 133.24 8.5 Favored Pre-proline 0 N--CA 1.447 -0.589 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 9.9 Cg_exo -73.1 -6.12 18.38 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.927 2.418 . . . . 0.0 114.797 -174.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.9 p -163.75 153.54 14.85 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.679 0.672 . . . . 0.0 110.836 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.3 mt -66.41 -30.47 49.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.308 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.49 -46.81 91.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.116 0.484 . . . . 0.0 110.135 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.534 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -63.24 -47.42 82.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.728 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -50.48 -41.21 52.83 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.288 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.491 ' O ' HG21 ' A' ' 15' ' ' VAL . 75.7 m -59.96 -56.47 21.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.458 0.17 . . . . 0.0 111.458 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.404 HD22 ' HA ' ' A' ' 9' ' ' ALA . 9.3 p30 -75.55 -20.52 58.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.755 -175.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.554 ' HB2' HG22 ' A' ' 30' ' ' THR . 65.0 t80 -57.12 -55.42 34.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.592 170.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.556 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 1.7 t-20 -56.32 -41.62 76.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.634 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 11' ' ' SER . 89.8 t -56.86 -30.26 32.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.619 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.508 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.1 t -81.17 -34.14 32.58 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.973 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.648 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 73.5 ttt180 -71.25 -30.65 66.57 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 14' ' ' ASN . 83.2 mt -48.22 -52.45 41.83 Favored Pre-proline 0 N--CA 1.444 -0.736 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -175.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 54.7 Cg_endo -71.0 3.19 3.52 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.007 1.805 . . . . 0.0 113.617 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.06 27.45 6.24 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.34 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.569 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 1.2 m -94.44 137.12 22.76 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.789 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.1 Cg_endo -62.36 126.4 18.42 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.905 2.404 . . . . 0.0 110.478 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.648 ' HG2' ' HD2' ' A' ' 17' ' ' ARG . 37.8 mt-10 -41.5 -38.41 1.29 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.342 173.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.38 82.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.578 0.228 . . . . 0.0 111.2 177.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.789 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.3 tt -64.55 -43.22 94.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.569 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 58.1 m -69.06 -26.2 64.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.593 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.19 -28.95 68.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.224 1.011 . . . . 0.0 110.328 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.4 m -82.39 -19.91 38.19 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.241 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -98.2 -46.09 5.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.02 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.554 HG22 ' HB2' ' A' ' 13' ' ' PHE . 15.7 m -76.16 -61.88 1.79 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.282 -1.327 . . . . 0.0 112.552 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.83 -16.55 3.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.348 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.524 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 32.7 m -65.17 152.88 42.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 3' ' ' CYS . 32.8 pt -113.78 136.71 49.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.077 -174.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 mm -98.44 135.13 34.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.439 HD12 ' SG ' ' A' ' 40' ' ' CYS . 45.3 pt -124.4 150.33 63.99 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.477 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.48 56.99 5.3 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.411 2.074 . . . . 0.0 111.639 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.609 ' O ' ' HA ' ' A' ' 1' ' ' THR . . . 172.38 -141.05 6.05 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.19 14.75 0.52 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 m -94.67 102.03 13.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.152 0.501 . . . . 0.0 111.433 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.439 ' SG ' HD12 ' A' ' 35' ' ' ILE . 67.9 m -142.18 124.05 8.92 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.654 175.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 59.0 Cg_endo -71.92 -173.94 1.2 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.886 2.39 . . . . 0.0 112.395 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.29 -19.59 66.52 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -168.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -88.23 -15.35 36.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.607 0.704 . . . . 0.0 109.677 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.413 ' HD2' ' HD2' ' A' ' 41' ' ' PRO . 17.3 m-85 -116.42 -1.6 12.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.897 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.22 32.55 4.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.049 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.718 178.045 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 33.1 m . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 120.894 0.378 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.774 ' HG1' HG12 ' A' ' 34' ' ' ILE . 17.6 m -126.77 139.97 52.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.107 0.479 . . . . 0.0 111.262 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 32' ' ' CYS . 55.8 m -111.99 96.51 6.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.066 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.585 ' HA ' ' CB ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -106.2 126.08 31.43 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.612 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 65.5 Cg_endo -88.03 31.69 0.42 Allowed 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.105 2.537 . . . . 0.0 114.8 -167.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.428 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 23.9 t -163.93 143.39 7.98 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 122.075 -0.391 . . . . 0.0 110.567 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.706 HD13 ' H ' ' A' ' 7' ' ' ILE . 3.8 mp -60.8 -36.07 68.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -73.68 -52.6 20.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.634 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.411 ' HA ' HD22 ' A' ' 12' ' ' ASN . . . -57.1 -48.05 79.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.582 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -66.38 -24.43 66.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.227 -176.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.409 ' O ' HG21 ' A' ' 15' ' ' VAL . 69.9 m -70.69 -55.27 9.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.756 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 9' ' ' ALA . 10.0 p30 -67.47 -23.13 65.47 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.289 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -60.94 -60.8 3.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.006 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -69.16 -32.7 72.21 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.776 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 11' ' ' SER . 68.8 t -67.01 -24.49 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.408 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.512 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -72.76 -33.67 66.49 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.836 0.351 . . . . 0.0 110.384 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 21' ' ' THR . 77.6 ttt180 -72.84 -27.53 61.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.348 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.0 mt -54.62 -52.41 70.16 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -175.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.512 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 72.1 Cg_endo -75.85 17.35 0.7 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.062 1.841 . . . . 0.0 113.716 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.03 28.59 7.65 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.475 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 1.3 m -103.39 138.96 19.69 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.509 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 24.8 Cg_endo -66.28 128.89 20.29 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.734 2.29 . . . . 0.0 110.532 173.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -46.09 -30.72 2.0 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.876 173.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -53.06 -54.18 39.28 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 174.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.1 tm? -61.01 -41.53 96.72 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 120.86 0.362 . . . . 0.0 110.847 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.2 m -68.57 -39.66 80.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.369 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.91 73.22 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.765 0.793 . . . . 0.0 110.608 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.8 m -76.51 -21.87 55.18 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.694 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -94.87 -52.53 4.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.103 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 90.5 m -61.2 -41.55 97.02 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.215 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.54 -8.83 13.25 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.223 175.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.585 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 6.3 p -89.42 179.95 5.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.156 0.478 . . . . 0.0 111.671 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.404 HD11 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -120.93 153.09 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -168.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.774 HG12 ' HG1' ' A' ' 2' ' ' THR . 71.2 mt -109.82 131.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.949 175.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.625 ' O ' ' HB ' ' A' ' 1' ' ' THR . 12.9 pt -135.97 161.35 63.12 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 73.5 Cg_endo -75.57 1.65 7.77 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.53 2.153 . . . . 0.0 113.623 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.32 -123.47 1.17 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.368 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.517 ' HB3' HD11 ' A' ' 35' ' ' ILE . . . 71.32 -5.8 1.5 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.734 0.814 . . . . 0.0 112.802 173.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 39' ' ' THR . 85.7 m 63.16 10.14 4.38 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.72 0.771 . . . . 0.0 111.823 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.3 m 67.02 141.98 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.642 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.449 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 39.8 Cg_endo -70.24 159.1 54.22 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.511 2.14 . . . . 0.0 111.397 171.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.65 85.92 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 114.199 0.44 . . . . 0.0 114.199 -170.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -82.51 -14.15 55.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.325 0.563 . . . . 0.0 110.58 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.612 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 13.5 m-85 -119.34 19.69 12.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.604 -174.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.15 56.56 1.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.185 0.517 . . . . 0.0 110.173 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.421 HD21 ' C ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.705 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.642 HG23 ' HA2' ' A' ' 37' ' ' GLY . 21.1 m . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 120.897 0.379 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.693 HG21 ' SG ' ' A' ' 32' ' ' CYS . 4.0 m -134.48 132.14 38.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.996 -173.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.0 m -127.03 121.08 30.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.874 0.369 . . . . 0.0 110.532 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 13' ' ' PHE . 57.9 m -109.07 121.29 43.28 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.693 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.744 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 87.7 Cg_endo -88.47 30.92 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.817 2.344 . . . . 0.0 114.779 -171.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.608 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 77.9 p -165.78 147.82 7.29 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.387 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -55.74 -37.69 47.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.679 0.612 . . . . 0.0 112.343 -170.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.67 -39.44 22.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.012 0.434 . . . . 0.0 110.029 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.418 ' HA ' ' CG2' ' A' ' 30' ' ' THR . . . -63.64 -45.67 89.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.55 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -55.67 -42.45 75.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 177.263 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.495 ' O ' HG21 ' A' ' 15' ' ' VAL . 49.1 m -64.43 -49.8 70.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.113 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -58.33 -41.41 84.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 110.644 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.576 ' CE1' ' HB ' ' A' ' 2' ' ' THR . 15.0 t80 -50.17 -46.92 54.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.213 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -71.4 -41.3 69.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.832 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 11' ' ' SER . 87.1 t -63.59 -37.36 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.719 -176.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.576 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 92.5 m -69.86 -28.09 65.37 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.477 ' HD2' ' CE1' ' A' ' 13' ' ' PHE . 81.1 mtp180 -84.69 -20.81 30.62 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 121.662 -0.649 . . . . 0.0 111.811 -170.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.938 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -66.49 -44.41 55.83 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.541 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.938 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 89.3 Cg_endo -85.15 -3.8 9.56 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.626 1.55 . . . . 0.0 113.183 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.22 16.8 15.35 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.397 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.419 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 3.6 m -78.82 125.32 84.31 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.551 ' HG2' ' HB3' ' A' ' 25' ' ' LEU . 10.2 Cg_endo -55.64 121.63 10.29 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.688 2.259 . . . . 0.0 111.035 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -41.8 -36.46 1.03 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.277 169.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.523 ' HA ' HG13 ' A' ' 34' ' ' ILE . . . -62.09 -45.18 94.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.876 177.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.551 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 35.9 tp -73.52 -41.3 63.21 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 120.905 0.383 . . . . 0.0 110.613 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.3 t -67.43 -35.73 79.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.484 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.559 ' HA ' ' HB3' ' A' ' 32' ' ' CYS . . . -56.28 -53.72 53.94 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.786 0.803 . . . . 0.0 111.124 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.7 m -61.36 -24.8 66.73 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.143 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.16 -41.96 11.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.448 1.118 . . . . 0.0 109.002 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.418 ' CG2' ' HA ' ' A' ' 9' ' ' ALA . 90.2 m -76.7 -32.33 57.8 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.26 -174.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.68 -5.76 24.38 Favored Glycine 0 C--O 1.229 -0.196 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -174.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.693 ' SG ' HG21 ' A' ' 2' ' ' THR . 6.4 t -73.86 164.95 25.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.609 -0.796 . . . . 0.0 109.379 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.4 pt -122.64 152.23 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.887 -175.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.523 HG13 ' HA ' ' A' ' 24' ' ' ALA . 34.5 mm -104.87 134.28 46.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.777 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.631 ' O ' ' HB ' ' A' ' 1' ' ' THR . 42.0 pt -144.88 162.68 37.13 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.51 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 14.6 Cg_endo -60.14 -43.46 35.53 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.503 2.135 . . . . 0.0 111.703 174.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.642 ' HA2' HG23 ' A' ' 1' ' ' THR . . . 131.76 136.78 3.91 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.854 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.74 -85.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.4 m -141.77 -3.69 1.12 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.939 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.523 ' SG ' HD12 ' A' ' 35' ' ' ILE . 64.8 m 66.09 139.7 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.676 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.36 149.55 29.27 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.044 2.496 . . . . 0.0 112.551 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.43 -26.25 64.03 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 114.793 0.677 . . . . 0.0 114.793 -169.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -88.35 -14.36 38.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.658 0.729 . . . . 0.0 110.093 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.672 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 16.6 m-85 -117.97 10.98 13.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.914 -175.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.14 50.89 0.86 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.232 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.744 ' HB3' ' HA ' ' A' ' 5' ' ' PRO . 39.7 t30 . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.587 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 120.977 0.418 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.1 m -106.49 114.01 27.87 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.601 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.439 ' HB2' HD11 ' A' ' 35' ' ' ILE . 81.0 m -128.15 106.43 9.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.566 0.698 . . . . 0.0 111.106 -176.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.721 ' SG ' ' HA ' ' A' ' 10' ' ' ARG . 4.1 m -117.15 157.27 47.25 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.547 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.28 -12.22 33.3 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.815 2.343 . . . . 0.0 114.495 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.2 m -143.96 153.44 42.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.923 -0.486 . . . . 0.0 110.57 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.4 -38.9 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 110.567 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.0 t -80.78 -33.75 13.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.949 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.563 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -63.42 -37.67 88.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.104 176.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.721 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 18.5 ttm-85 -69.89 -27.65 64.98 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.606 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.418 ' O ' HG23 ' A' ' 15' ' ' VAL . 22.8 t -77.8 -46.07 22.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.52 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.563 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 11.4 p30 -68.29 -21.62 64.78 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.704 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 31.2 t80 -54.37 -54.29 42.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.734 172.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.2 -34.32 77.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.781 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.528 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 73.3 t -60.65 -37.82 76.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.098 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.504 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 23.3 m -62.08 -38.47 88.95 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.899 0.381 . . . . 0.0 112.016 177.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 mtp85 -75.9 -2.59 30.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.663 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.61 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 18.2 mt -76.33 -59.83 1.01 Allowed Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.899 176.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.61 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 6.8 Cg_exo -75.45 -24.17 12.38 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.142 1.895 . . . . 0.0 112.64 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 126.83 16.06 2.51 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.874 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 1.1 m -81.39 127.56 73.11 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.82 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 11.6 Cg_endo -59.42 120.26 7.99 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 122.431 2.087 . . . . 0.0 110.685 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -53.4 -28.09 27.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.225 172.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.81 -48.92 76.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.089 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.82 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -68.92 -41.31 78.32 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.015 0.436 . . . . 0.0 110.424 -179.441 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.51 -28.23 63.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.841 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.65 -37.9 83.06 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.858 0.837 . . . . 0.0 110.42 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 m -69.68 -23.59 63.47 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.417 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -101.22 -49.11 4.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.728 0.775 . . . . 0.0 110.127 -174.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 83.7 m -66.52 -27.46 67.79 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.798 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.82 24.41 42.0 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.622 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.8 t -103.54 150.77 23.61 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.0 pt -124.29 139.76 49.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.348 0.594 . . . . 0.0 111.464 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.0 mt -93.88 115.76 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.935 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.501 HD11 ' SG ' ' A' ' 40' ' ' CYS . 39.0 mt -124.38 139.29 32.61 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.442 -171.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.52 -45.52 22.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.937 2.425 . . . . 0.0 112.405 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.79 148.09 4.68 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.955 174.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 76.46 -19.47 0.42 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.77 0.828 . . . . 0.0 112.747 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 39' ' ' THR . 18.0 m -88.24 5.67 40.53 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.006 0.908 . . . . 0.0 110.984 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.753 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 67.6 m -75.04 115.63 46.56 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.09 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.774 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 30.3 Cg_endo -65.14 150.59 87.53 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.606 2.204 . . . . 0.0 111.48 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.23 -15.27 60.72 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 114.406 0.522 . . . . 0.0 114.406 -171.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.1 -19.15 18.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.586 0.693 . . . . 0.0 109.61 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.774 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 19.8 m-85 -114.71 19.39 16.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.304 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.753 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . . . -137.95 31.18 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.245 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.429 ' C ' HH21 ' A' ' 10' ' ' ARG . 57.4 t30 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.235 -0.888 . . . . 0.0 109.933 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 6.8 m . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.826 0.346 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.8 m -120.64 108.09 13.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.282 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 78.1 m -98.17 124.83 42.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.297 -177.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 4.1 t -110.91 126.15 29.29 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.723 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 4.3 Cg_endo -85.42 22.95 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.783 2.322 . . . . 0.0 114.222 -170.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.8 m -154.83 136.66 14.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 122.07 -0.394 . . . . 0.0 110.072 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.415 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 60.4 mt -65.06 -31.05 52.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.926 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.61 -41.29 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.28 -50.31 74.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.815 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -63.19 -26.2 68.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.142 0.496 . . . . 0.0 110.485 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.489 ' O ' HG21 ' A' ' 15' ' ' VAL . 19.8 t -68.74 -54.7 14.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.619 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -75.09 -24.62 58.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.007 0.432 . . . . 0.0 110.275 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -54.8 -57.22 12.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.478 174.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.33 -27.71 67.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 110.428 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 11' ' ' SER . 93.6 t -71.41 -18.7 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.567 176.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.8 t -83.76 -26.92 29.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.261 0.553 . . . . 0.0 109.669 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.611 ' HG3' ' HB3' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -89.67 -37.97 14.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.557 -171.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.526 ' HG ' ' CD ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -49.64 -45.53 78.8 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 115.007 -0.997 . . . . 0.0 113.538 -179.333 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.526 ' CD ' ' HG ' ' A' ' 18' ' ' LEU . 9.8 Cg_exo -73.06 9.15 1.46 Allowed 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 122.389 2.059 . . . . 0.0 113.961 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.29 34.48 4.2 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.642 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.512 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 1.6 m -115.7 137.37 23.18 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 14.9 Cg_endo -60.55 123.5 13.17 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.484 2.123 . . . . 0.0 110.651 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.611 ' HB3' ' HG3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -47.54 -31.19 4.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.366 172.255 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.572 ' HA ' HD13 ' A' ' 34' ' ' ILE . . . -54.14 -50.94 65.81 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.475 172.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.6 tp -70.14 -38.5 75.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.826 0.346 . . . . 0.0 110.398 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -68.78 -34.43 75.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.4 89.91 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.929 0.871 . . . . 0.0 110.453 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 m -65.04 -24.78 67.58 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.625 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -100.94 -40.84 7.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.586 0.707 . . . . 0.0 110.184 -173.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 39.0 m -74.49 -39.05 62.7 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.579 -177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.49 -7.5 11.33 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.949 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.51 154.58 41.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 pt -118.75 155.9 20.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.684 -175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 24' ' ' ALA . 81.7 mt -113.51 125.12 70.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.679 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.497 ' O ' ' HB ' ' A' ' 1' ' ' THR . 13.0 pt -128.14 106.01 19.9 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.546 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.35 80.13 0.78 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 123.061 2.507 . . . . 0.0 111.687 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.92 -137.05 2.15 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.798 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.77 -37.22 0.54 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.71 100.77 6.35 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.178 0.513 . . . . 0.0 111.984 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 53.7 t -119.67 119.13 31.61 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.44 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.434 ' C ' ' H ' ' A' ' 43' ' ' ASP . 43.9 Cg_endo -67.53 148.78 79.28 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.555 2.17 . . . . 0.0 112.104 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.509 ' HA2' ' HB1' ' A' ' 45' ' ' ALA . . . -73.5 21.28 1.18 Allowed Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.22 -0.445 . . . . 0.0 113.295 -175.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 41' ' ' PRO . 6.9 m-20 -102.96 -22.65 13.79 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.723 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 8.0 m-85 -121.74 -2.73 9.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.784 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.509 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -90.32 42.29 1.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.373 -169.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.0 m120 . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.471 175.721 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.542 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 8.7 m . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 t -138.14 161.29 37.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.718 0.294 . . . . 0.0 110.604 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.0 p -143.96 149.96 37.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 3.3 t -140.6 136.08 16.25 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 26.4 Cg_exo -64.33 -19.53 65.66 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.288 2.659 . . . . 0.0 114.915 -173.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.5 p -137.55 156.29 48.27 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.867 -0.521 . . . . 0.0 111.486 -176.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.784 ' HA ' ' HD2' ' A' ' 10' ' ' ARG . 54.2 mt -69.1 -32.92 56.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.338 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.7 t -67.29 -51.49 52.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.035 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.5 ' HB3' HG23 ' A' ' 30' ' ' THR . . . -62.63 -36.49 82.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.738 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.784 ' HD2' ' HA ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -65.02 -39.66 93.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.196 0.522 . . . . 0.0 110.654 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 15' ' ' VAL . 27.9 m -65.92 -44.51 84.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.023 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -61.76 -45.17 95.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.781 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.644 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 1.3 p90 -71.58 -31.23 66.72 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.987 -176.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.45 -51.16 68.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.96 0.409 . . . . 0.0 110.685 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 11' ' ' SER . 39.8 t -68.44 -10.75 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.737 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.582 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.6 t -81.47 -26.26 35.38 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.807 -0.558 . . . . 0.0 109.874 176.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 1.101 ' HD3' ' HG3' ' A' ' 23' ' ' GLU . 40.4 mtm180 -75.35 -24.13 57.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.487 0.661 . . . . 0.0 109.992 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.558 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 64.2 tp -56.4 -52.21 74.97 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.077 -177.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.582 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 13.9 Cg_exo -71.03 -3.09 12.14 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.339 2.026 . . . . 0.0 113.397 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.54 30.09 5.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.691 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.5 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -96.07 139.33 21.74 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.545 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.5 ' HD2' HG22 ' A' ' 21' ' ' THR . 26.0 Cg_endo -66.29 132.27 29.05 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.93 2.42 . . . . 0.0 111.099 175.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 1.101 ' HG3' ' HD3' ' A' ' 17' ' ' ARG . 28.8 mp0 -39.38 -39.65 0.7 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.508 170.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.69 -52.95 20.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.216 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.09 -45.92 75.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.739 0.304 . . . . 0.0 110.203 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 21.8 m -64.68 -40.11 94.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.618 -174.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.76 -47.34 72.52 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.585 0.707 . . . . 0.0 111.173 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.4 m -65.93 -24.98 66.93 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.124 -175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -92.13 -45.48 8.25 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.009 0.909 . . . . 0.0 109.257 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.5 HG23 ' HB3' ' A' ' 9' ' ' ALA . 61.6 m -70.16 -40.04 74.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.122 -176.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.56 4.18 21.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.15 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -84.45 155.7 22.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.5 pt -118.71 153.41 20.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.321 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.41 135.99 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.01 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' A' ' 40' ' ' CYS . 13.0 pt -131.67 129.53 22.09 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.084 0.468 . . . . 0.0 110.88 -173.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.1 -29.01 65.45 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.866 2.378 . . . . 0.0 111.783 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.97 -135.6 3.13 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.011 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.61 41.01 1.09 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.361 0.6 . . . . 0.0 110.284 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -80.59 22.93 0.54 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.182 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.581 ' HB2' HD12 ' A' ' 35' ' ' ILE . 31.6 t -135.94 124.25 15.33 Favored Pre-proline 0 C--N 1.313 -1.022 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.196 -175.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.76 164.63 33.81 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.668 2.246 . . . . 0.0 112.514 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.89 -2.33 45.24 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.29 -172.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -90.03 -25.22 20.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 117.796 0.798 . . . . 0.0 109.253 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 13.3 m-85 -101.3 8.53 42.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.309 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.61 48.24 0.93 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.256 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.619 -178.415 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 3.1 m . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -138.79 143.47 38.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.843 0.354 . . . . 0.0 111.126 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 5.9 m -152.62 160.4 43.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.451 178.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 10' ' ' ARG . 8.9 t -140.01 143.81 35.65 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.5 0.87 5.55 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.087 2.525 . . . . 0.0 113.493 -178.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.0 m -152.8 139.73 19.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.615 HG13 ' OD1' ' A' ' 46' ' ' ASN . 72.0 mt -61.29 -36.37 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.142 0.496 . . . . 0.0 110.276 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.47 -29.98 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.759 -174.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.461 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . . . -84.2 -28.68 27.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.167 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HB2' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -70.2 -35.62 74.04 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.596 -177.961 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.503 ' O ' HG21 ' A' ' 15' ' ' VAL . 2.9 p -68.13 -46.91 69.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.491 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.88 -30.99 71.95 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.906 0.384 . . . . 0.0 111.029 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.483 ' HZ ' ' HB2' ' A' ' 23' ' ' GLU . 36.5 t80 -54.27 -50.95 66.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.488 174.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.416 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 28.9 m-80 -65.85 -32.7 74.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.224 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.503 HG21 ' O ' ' A' ' 11' ' ' SER . 93.1 t -61.53 -32.85 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.306 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.435 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 6.4 t -78.06 -26.41 48.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.132 0.491 . . . . 0.0 110.426 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -79.28 -18.92 51.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.479 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.8 mt -55.25 -53.57 60.38 Favored Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.142 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 59.8 Cg_endo -72.97 17.03 0.4 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.081 1.854 . . . . 0.0 113.11 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.88 15.5 61.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.46 173.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.585 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 1.3 m -77.85 138.08 61.91 Favored Pre-proline 0 N--CA 1.433 -1.3 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.511 ' HD2' HG21 ' A' ' 21' ' ' THR . 15.6 Cg_endo -61.88 121.89 10.18 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.726 2.284 . . . . 0.0 110.861 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.483 ' HB2' ' HZ ' ' A' ' 13' ' ' PHE . 10.3 pt-20 -40.64 -37.43 0.73 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.939 170.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.68 77.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.317 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.475 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 32.2 tp -72.99 -39.81 65.75 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 120.609 0.242 . . . . 0.0 110.43 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.585 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 61.2 m -65.44 -34.03 77.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.467 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -65.55 -39.41 91.69 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.702 0.763 . . . . 0.0 110.496 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.4 m -71.28 -18.88 62.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.841 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -92.84 -21.43 19.88 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.235 1.017 . . . . 0.0 109.525 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 m -107.78 -49.91 3.15 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.029 -172.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.92 -17.74 5.15 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.429 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 11.5 m -67.8 167.41 13.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.077 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.9 pt -131.65 137.11 55.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.388 0.613 . . . . 0.0 112.46 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.75 128.77 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 167.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.483 ' O ' ' HB ' ' A' ' 1' ' ' THR . 4.8 tt -130.35 97.62 22.02 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-O 121.654 0.74 . . . . 0.0 110.153 -173.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.0 42.76 1.38 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.641 2.894 . . . . 0.0 113.073 -174.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.8 145.72 4.26 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.638 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 76.41 30.64 0.65 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.397 0.679 . . . . 0.0 111.006 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.461 ' HA ' HG21 ' A' ' 1' ' ' THR . 58.2 m 46.91 -95.48 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.93 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 63.0 m -151.75 152.66 30.65 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-O 120.941 0.4 . . . . 0.0 110.961 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.623 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 6.2 Cg_exo -74.82 -172.02 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.217 2.611 . . . . 0.0 111.233 171.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.63 -44.35 2.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.621 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.5 -22.06 35.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.69 0.757 . . . . 0.0 109.74 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.623 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 12.4 m-85 -101.38 20.93 14.99 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.485 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.57 63.56 1.57 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.391 0.615 . . . . 0.0 109.377 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.615 ' OD1' HG13 ' A' ' 7' ' ' ILE . 20.7 t-20 . . . . . 0 C--O 1.249 1.053 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.686 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.441 ' HB ' HG13 ' A' ' 35' ' ' ILE . 31.0 m . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 120.784 0.326 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.1 t -72.43 142.47 48.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.286 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.53 ' HB3' HG13 ' A' ' 33' ' ' ILE . 30.3 t -144.49 79.08 1.6 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 82.3 m -103.53 112.37 65.6 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.805 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.723 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 3.0 Cg_exo -77.25 14.29 1.39 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.171 2.581 . . . . 0.0 114.896 -173.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.0 p -160.36 156.18 25.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 118.753 0.706 . . . . 0.0 111.213 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.6 mt -62.67 -34.34 64.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.666 173.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.61 -49.66 82.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.602 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.58 -48.29 80.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.682 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 10' ' ' ARG . 23.5 tpp180 -55.05 -38.83 68.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.767 176.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.493 ' O ' HG21 ' A' ' 15' ' ' VAL . 14.3 t -66.9 -50.05 63.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -55.19 -39.41 69.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.105 0.478 . . . . 0.0 110.702 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -49.7 75.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.957 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -73.52 -23.72 60.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.902 0.382 . . . . 0.0 111.202 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 11' ' ' SER . 79.4 t -66.37 -43.58 91.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.213 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.631 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 85.1 m -69.2 -16.71 63.68 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.755 HH11 ' HG3' ' A' ' 23' ' ' GLU . 21.0 mmm180 -71.05 -27.2 63.48 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.827 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.599 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 93.6 mt -66.98 -52.69 30.16 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 1.2 Cg_endo -85.41 17.24 1.8 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.525 2.15 . . . . 0.0 112.68 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.68 30.13 68.84 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.863 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.631 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 2.1 m -85.67 128.56 58.3 Favored Pre-proline 0 N--CA 1.438 -1.057 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.862 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.4 Cg_endo -58.74 122.29 11.38 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.552 2.168 . . . . 0.0 110.672 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.755 ' HG3' HH11 ' A' ' 17' ' ' ARG . 49.3 mt-10 -48.52 -32.8 8.47 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.111 172.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.68 -51.4 69.7 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.272 173.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.862 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 4.2 tt -57.64 -50.23 73.84 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.032 0.444 . . . . 0.0 110.262 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.6 m -72.71 -21.54 61.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.256 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -66.87 -42.21 85.98 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.944 0.878 . . . . 0.0 110.067 175.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.6 m -66.99 -18.74 65.52 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.776 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -98.63 -48.2 5.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.835 0.826 . . . . 0.0 110.115 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.9 m -68.09 -38.08 81.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.339 -1.3 . . . . 0.0 112.498 -174.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.57 -12.94 32.93 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.523 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.468 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 38.9 t -73.13 143.26 47.39 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.53 HG13 ' HB3' ' A' ' 3' ' ' CYS . 22.1 pt -110.13 144.61 17.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.123 0.487 . . . . 0.0 111.472 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.5 mt -109.17 104.12 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.359 174.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.441 HG13 ' HB ' ' A' ' 1' ' ' THR . 26.1 pt -93.62 138.95 22.69 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.766 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.67 -40.71 44.16 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.055 2.504 . . . . 0.0 112.096 175.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.99 -139.52 5.86 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.454 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.53 21.16 2.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.585 0.231 . . . . 0.0 111.329 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -81.64 73.97 8.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.869 0.842 . . . . 0.0 110.682 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 44' ' ' TYR . 52.9 t -140.38 107.53 6.65 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.267 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 48.5 Cg_endo -71.1 171.41 15.98 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.622 2.214 . . . . 0.0 112.643 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.59 -3.98 23.08 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.85 -0.613 . . . . 0.0 114.353 -174.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -88.67 -19.9 25.58 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 117.614 0.707 . . . . 0.0 109.289 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.723 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 13.0 m-85 -112.22 -6.55 14.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.776 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.97 37.69 1.49 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.959 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.93 -177.665 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.515 ' HB ' HG13 ' A' ' 35' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 120.881 0.372 . . . . 0.0 110.344 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.6 m -95.99 109.52 21.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.958 0.408 . . . . 0.0 109.929 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 64.3 m -123.49 168.33 12.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -173.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.6 t -160.24 136.74 6.44 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.1 11.71 3.24 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.506 2.137 . . . . 0.0 114.847 -170.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 p -164.34 149.58 10.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.218 0.463 . . . . 0.0 110.639 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.682 ' H ' HD12 ' A' ' 7' ' ' ILE . 4.1 mp -66.95 -34.5 70.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.05 -46.71 95.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.265 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.431 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -66.85 -52.37 44.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.21 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.41 ' HA ' ' HD3' ' A' ' 10' ' ' ARG . 6.7 tpp180 -46.28 -44.47 16.56 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.969 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 15' ' ' VAL . 63.3 m -60.27 -58.2 9.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.454 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 9.4 p30 -70.51 -23.56 62.68 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.681 -175.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.592 ' HB2' HG21 ' A' ' 30' ' ' THR . 44.6 t80 -60.48 -52.17 66.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.551 173.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -68.58 -28.34 66.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.336 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 11' ' ' SER . 77.6 t -67.12 -25.85 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.564 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 28.5 t -80.9 -12.78 59.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 110.26 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.756 ' HD3' ' HG3' ' A' ' 23' ' ' GLU . 38.1 mmm-85 -74.85 -44.14 50.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.092 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.812 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -53.83 -39.39 72.87 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -175.353 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.812 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 13.7 Cg_exo -72.18 4.39 3.34 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 121.925 1.75 . . . . 0.0 113.145 176.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.23 37.13 12.91 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.22 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -103.29 138.32 19.51 Favored Pre-proline 0 N--CA 1.436 -1.168 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HD2' HG22 ' A' ' 21' ' ' THR . 30.1 Cg_endo -66.72 129.72 21.68 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.887 2.392 . . . . 0.0 110.441 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.756 ' HG3' ' HD3' ' A' ' 17' ' ' ARG . 1.5 mp0 -42.55 -35.38 1.06 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.614 172.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.74 -47.4 64.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.15 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.1 tt -70.73 -46.72 62.51 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.948 0.404 . . . . 0.0 110.145 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.459 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 11.6 m -66.06 -43.95 85.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.502 -174.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.71 89.75 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.421 0.629 . . . . 0.0 111.661 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.3 m -68.39 -24.77 64.81 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.604 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -100.04 -46.48 5.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.502 0.668 . . . . 0.0 109.792 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.592 HG21 ' HB2' ' A' ' 13' ' ' PHE . 48.8 m -60.91 -44.91 96.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.552 -1.203 . . . . 0.0 112.124 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.53 -16.12 7.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.169 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 37.7 m -66.09 164.94 14.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.5 pt -130.06 143.55 40.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 121.937 -0.477 . . . . 0.0 111.857 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.3 mt -117.15 101.8 12.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.862 HD12 ' HB3' ' A' ' 38' ' ' ALA . 6.6 pt -114.45 136.79 22.39 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.949 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.6 -39.43 88.33 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.155 2.57 . . . . 0.0 112.534 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.92 -138.14 4.33 Favored Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.862 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . 65.45 88.75 0.1 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.456 0.646 . . . . 0.0 111.086 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.79 95.8 0.12 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.538 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 35' ' ' ILE . 60.2 m -56.02 131.17 73.98 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.999 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 32.3 Cg_endo -67.25 178.32 3.14 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 123.012 2.475 . . . . 0.0 112.539 173.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.15 4.51 11.07 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -113.82 -5.69 13.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.666 0.733 . . . . 0.0 110.266 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.538 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 21.4 m-85 -115.88 -14.27 11.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.891 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.4 30.56 3.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.787 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.3 -177.485 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.823 0.344 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 m -103.24 129.68 50.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.182 -175.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.2 m -122.2 98.47 5.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.854 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.0 m -106.03 113.64 63.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 28.2 Cg_exo -64.37 10.44 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.518 2.812 . . . . 0.0 115.068 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.4 p -165.37 148.39 8.02 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.66 0.664 . . . . 0.0 111.131 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.862 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 53.1 mt -64.11 -30.16 49.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.55 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.99 -55.37 19.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.251 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.1 67.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.487 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.862 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -68.05 -31.63 71.41 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.505 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 27.4 m -69.79 -47.76 61.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.957 175.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -51.52 -44.45 62.61 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.262 0.553 . . . . 0.0 110.631 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 75.8 t80 -54.91 -59.02 5.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.381 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -63.65 -31.18 72.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.544 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 11' ' ' SER . 54.0 t -67.86 -37.53 78.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.223 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.524 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 8.5 t -76.34 -33.95 58.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.284 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -83.31 2.0 38.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.933 0.397 . . . . 0.0 111.376 -178.318 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.4 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.5 mt -76.12 -49.47 3.23 Favored Pre-proline 0 N--CA 1.444 -0.74 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 74.1 Cg_endo -75.59 19.08 0.56 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.146 1.897 . . . . 0.0 113.368 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.17 35.22 7.67 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.966 177.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 m -105.0 134.74 19.48 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.804 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 11.5 Cg_endo -59.16 121.11 9.38 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.703 2.269 . . . . 0.0 110.877 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.475 ' HG2' ' HD2' ' A' ' 17' ' ' ARG . 36.7 mt-10 -40.11 -38.94 0.81 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.125 170.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.97 -48.74 75.27 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.873 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.804 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.5 tt -64.68 -42.9 95.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 110.035 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.7 m -68.96 -30.96 69.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.937 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.61 -33.79 76.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.949 0.88 . . . . 0.0 110.503 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 m -74.68 -17.01 60.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.765 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -101.16 -42.91 6.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.735 0.779 . . . . 0.0 109.924 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.8 m -71.88 -47.91 49.47 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.852 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.15 -18.66 15.86 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 41.2 t -66.42 143.37 57.16 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.7 pt -103.34 149.8 7.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 111.871 -173.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.413 HD11 ' CE1' ' A' ' 13' ' ' PHE . 65.6 mt -125.59 124.98 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.037 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.5 pt -122.25 158.55 55.34 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.926 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.0 23.03 0.86 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.229 2.619 . . . . 0.0 112.584 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.03 -154.33 6.85 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.32 60.43 1.7 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.414 0.626 . . . . 0.0 110.218 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 m -85.36 -6.64 59.21 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.87 0.843 . . . . 0.0 110.917 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.9 m -85.22 122.22 73.87 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.504 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.533 ' HD2' ' CZ ' ' A' ' 44' ' ' TYR . 55.9 Cg_endo -72.03 172.31 14.95 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.602 2.202 . . . . 0.0 110.905 169.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.69 38.1 3.26 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.185 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.515 ' OD1' ' HG2' ' A' ' 41' ' ' PRO . 12.6 p-10 -111.84 -31.63 6.88 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.533 ' CZ ' ' HD2' ' A' ' 41' ' ' PRO . 2.4 p90 -122.77 18.6 10.26 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.7 0.762 . . . . 0.0 110.23 175.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.0 24.31 13.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.559 170.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.7 t30 . . . . . 0 C--O 1.245 0.838 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.305 -172.755 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.5 HG22 HD11 ' A' ' 35' ' ' ILE . 10.2 m . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.799 0.333 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.661 HG22 ' SG ' ' A' ' 32' ' ' CYS . 80.8 m -132.71 136.49 46.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.701 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.625 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 26.9 m -127.49 138.33 52.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.498 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 52.6 m -106.16 160.31 26.62 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.19 -171.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.412 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 92.8 Cg_endo -89.78 24.99 0.6 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.613 2.209 . . . . 0.0 113.009 174.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.5 t -172.49 136.05 0.75 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -64.0 -29.27 46.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.563 0.697 . . . . 0.0 109.833 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -71.02 -33.82 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.43 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.468 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -71.7 -45.35 62.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.057 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' NH2' ' HA ' ' A' ' 3' ' ' CYS . 8.0 tpp180 -53.96 -39.14 65.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.135 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' HG23 ' A' ' 15' ' ' VAL . 36.6 t -63.04 -52.7 61.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.408 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 10.7 p30 -74.72 -23.83 58.65 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.551 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.576 ' CZ ' ' HB ' ' A' ' 2' ' ' THR . 25.9 t80 -55.1 -50.5 69.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.2 170.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.54 -38.53 81.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.424 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 11' ' ' SER . 87.2 t -63.29 -39.33 84.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.532 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.574 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 11.5 t -76.73 -31.59 57.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.956 0.408 . . . . 0.0 110.485 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -78.49 -13.67 59.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.189 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.567 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 13.6 mt -63.6 -54.49 42.44 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 7.5 Cg_exo -74.56 18.36 0.5 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.684 2.256 . . . . 0.0 113.282 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.89 33.71 12.11 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.082 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.7 m -99.53 133.36 21.94 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.78 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -57.69 122.71 12.22 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.562 2.175 . . . . 0.0 110.695 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -43.67 -33.27 1.17 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.764 170.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.633 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -56.17 -53.23 59.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 173.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.78 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.6 tt -61.47 -46.68 89.03 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.881 0.372 . . . . 0.0 110.227 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.6 m -65.6 -38.32 89.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.325 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 32' ' ' CYS . . . -61.77 -33.67 74.5 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.627 0.727 . . . . 0.0 111.133 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.9 m -74.35 -18.96 60.61 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.947 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -100.64 -40.11 7.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.768 0.794 . . . . 0.0 109.634 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.6 m -74.74 -31.37 61.8 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.196 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.64 14.66 42.94 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -172.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.661 ' SG ' HG22 ' A' ' 2' ' ' THR . 6.1 t -87.97 167.6 13.57 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.4 pt -133.48 138.03 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 118.559 0.618 . . . . 0.0 112.272 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.633 HD11 ' HA ' ' A' ' 24' ' ' ALA . 4.3 mp -81.76 142.57 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.678 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.5 HD11 HG22 ' A' ' 1' ' ' THR . 0.2 OUTLIER -122.93 148.15 53.21 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 176.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.8 -40.12 47.41 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.959 2.439 . . . . 0.0 112.79 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -113.61 -138.78 7.08 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.076 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.68 9.92 15.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.29 0.567 . . . . 0.0 110.034 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -96.29 107.61 19.99 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.95 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.4 m -104.16 134.15 19.85 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.953 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.664 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 10.0 Cg_endo -52.99 145.88 39.5 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.873 2.382 . . . . 0.0 111.495 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.2 -34.94 63.38 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 114.347 0.499 . . . . 0.0 114.347 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.71 -20.25 39.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.43 0.633 . . . . 0.0 109.901 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.664 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 9.6 m-85 -119.21 26.18 9.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.892 -173.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.91 22.07 6.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.247 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.57 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 45.9 m-80 . . . . . 0 C--O 1.243 0.729 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.56 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.902 0.382 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.447 ' OG1' HG12 ' A' ' 34' ' ' ILE . 44.1 m -86.49 97.29 10.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.308 0.575 . . . . 0.0 110.742 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 84.2 m -89.86 100.09 12.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.575 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 20.5 t -105.75 135.63 19.37 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.879 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 72.7 Cg_endo -76.83 23.49 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.711 2.274 . . . . 0.0 114.004 -174.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.634 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 31.2 t -162.47 145.83 11.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.492 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 58.2 mt -76.11 -26.39 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.65 -46.3 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.722 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 6' ' ' SER . . . -62.11 -41.51 98.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.816 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.61 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 7.1 ptp180 -72.47 -24.3 61.17 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.254 0.55 . . . . 0.0 110.182 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.491 ' O ' HG23 ' A' ' 15' ' ' VAL . 32.7 t -68.41 -47.3 67.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.725 173.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.37 -33.03 71.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.066 0.46 . . . . 0.0 110.163 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.548 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 38.9 t80 -54.99 -53.19 58.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.37 172.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -61.65 -39.99 93.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.029 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 11' ' ' SER . 90.1 t -59.72 -42.22 87.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.209 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.553 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.1 t -74.35 -34.44 63.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.292 0.567 . . . . 0.0 110.577 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.509 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 16.2 tpt180 -60.35 -44.44 95.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.982 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.587 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 60.8 mt -52.94 -53.53 54.02 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 33.5 Cg_exo -60.78 -16.83 46.56 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.582 2.188 . . . . 0.0 113.808 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.32 30.66 2.61 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.285 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.549 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.5 OUTLIER -97.85 139.17 21.15 Favored Pre-proline 0 N--CA 1.431 -1.39 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.717 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -56.89 118.05 4.84 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.045 2.497 . . . . 0.0 111.113 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.509 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 15.1 pt-20 -44.79 -32.55 1.58 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.951 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.8 -48.3 82.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.925 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.717 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -64.96 -47.4 77.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.003 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.431 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 20.8 m -60.93 -39.62 90.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.108 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.15 -55.46 28.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.817 0.817 . . . . 0.0 110.832 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 m -62.56 -25.72 68.21 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.843 -1.526 . . . . 0.0 112.57 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -90.84 -20.03 22.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.844 0.83 . . . . 0.0 109.816 -172.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 m -102.76 -27.77 12.49 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.463 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.18 2.1 13.84 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.132 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.5 m -88.12 154.39 20.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.7 pt -128.62 144.36 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.986 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.447 HG12 ' OG1' ' A' ' 2' ' ' THR . 63.3 mt -106.38 121.57 59.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.571 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.861 HG22 ' H ' ' A' ' 37' ' ' GLY . 5.0 mp -106.42 131.28 21.85 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.645 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.97 -15.88 52.66 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.82 2.346 . . . . 0.0 112.248 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.861 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -99.37 -142.57 13.38 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.96 15.27 1.53 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.051 0.453 . . . . 0.0 110.803 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -103.13 106.53 17.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.391 0.615 . . . . 0.0 110.781 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.2 p -143.96 146.0 32.51 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.389 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.86 166.7 13.45 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.743 2.295 . . . . 0.0 112.56 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.97 2.96 39.78 Favored Glycine 0 CA--C 1.518 0.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.257 -170.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -97.69 -12.67 22.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.631 0.715 . . . . 0.0 109.334 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.485 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 21.0 m-85 -105.82 -14.07 15.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.078 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.11 19.75 5.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.278 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.526 -178.589 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.976 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 17.7 m . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.811 0.338 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.2 m -126.34 126.67 44.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.57 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 73.8 m -128.05 130.44 48.26 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -171.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.666 ' HB2' ' HB2' ' A' ' 10' ' ' ARG . 63.3 m -136.0 140.88 34.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 171.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 10.6 Cg_exo -72.0 15.36 0.39 Allowed 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.087 2.525 . . . . 0.0 114.398 -173.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.2 m -159.27 145.16 16.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.776 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.8 mp -58.11 -38.75 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.54 0.686 . . . . 0.0 109.688 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.34 -42.24 65.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.223 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.38 -33.75 76.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.799 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.666 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -76.38 -27.85 56.52 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.395 0.617 . . . . 0.0 110.003 -179.367 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 15' ' ' VAL . 36.2 m -72.78 -38.01 67.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.958 172.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -59.21 -30.11 67.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.965 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.42 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 65.7 t80 -53.41 -53.88 44.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.343 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -65.57 -29.2 69.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.949 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 11' ' ' SER . 76.8 t -65.46 -31.19 52.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.829 0.347 . . . . 0.0 110.524 177.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 42.8 t -92.2 -0.95 57.4 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.066 0.936 . . . . 0.0 109.822 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -92.43 -29.63 16.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.885 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.522 ' HG ' ' CD ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -61.08 -47.31 95.47 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.661 178.53 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.522 ' CD ' ' HG ' ' A' ' 18' ' ' LEU . 14.5 Cg_exo -70.73 -3.11 11.99 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.15 1.9 . . . . 0.0 112.807 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.05 33.51 14.82 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.955 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.576 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 1.7 m -95.37 143.78 26.69 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.677 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 12.4 Cg_endo -61.9 121.29 9.29 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.786 2.324 . . . . 0.0 110.96 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 1.7 mp0 -39.5 -36.93 0.42 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.068 171.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.87 -49.18 76.28 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.399 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.677 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.2 tt -68.08 -38.84 82.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.354 0.597 . . . . 0.0 109.737 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.537 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 13.0 m -76.14 4.01 9.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.326 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.615 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -101.33 -21.47 14.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.592 0.711 . . . . 0.0 110.315 173.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 m -76.98 -42.3 39.48 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.921 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -86.55 -23.15 25.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.746 0.784 . . . . 0.0 110.535 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.583 ' HB ' ' SG ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -99.9 1.8 43.14 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.798 -174.368 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.48 33.6 86.86 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.126 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.615 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 75.0 m -102.13 165.13 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.95 0.405 . . . . 0.0 110.744 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' A' ' 3' ' ' CYS . 12.6 pt -139.12 147.98 24.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.396 177.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.77 127.37 56.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.582 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.976 ' HB ' ' HB ' ' A' ' 1' ' ' THR . 8.6 mm -115.69 113.16 42.64 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.627 -175.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -71.17 -16.73 31.72 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.176 2.584 . . . . 0.0 111.541 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.488 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -124.35 -139.8 5.4 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.114 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -124.04 25.47 7.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.4 0.619 . . . . 0.0 110.329 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 m -81.81 42.0 0.68 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.877 0.846 . . . . 0.0 110.866 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.543 ' HB2' HG13 ' A' ' 35' ' ' ILE . 53.3 t -134.56 120.09 14.39 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.203 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.4 169.97 20.22 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.741 2.294 . . . . 0.0 112.168 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.66 16.32 4.18 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.078 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -100.31 -17.08 17.46 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.57 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 15.9 m-85 -113.96 -14.18 12.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.45 176.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.73 29.09 5.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.37 0.605 . . . . 0.0 110.047 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.41 ' C ' HH21 ' A' ' 10' ' ' ARG . 2.4 t-20 . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.109 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.472 ' OG1' ' HA ' ' A' ' 38' ' ' ALA . 23.6 m . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.047 0.451 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.736 HG23 HG12 ' A' ' 34' ' ' ILE . 9.8 m -89.35 110.22 21.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.423 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 87.5 m -127.72 167.53 16.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.042 -177.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.699 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 9.8 t -138.93 149.42 61.63 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 6.1 Cg_exo -41.06 -37.91 2.84 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.23 3.287 . . . . 0.0 115.31 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 p -169.36 173.02 6.82 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.309 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.721 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 60.3 mt -61.63 -40.15 85.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.53 177.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.89 -53.2 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.434 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.02 88.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.471 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.721 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -69.7 -25.91 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 0.0 110.949 -177.046 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.5 m -75.13 -12.78 60.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.013 0.435 . . . . 0.0 110.914 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -94.1 -8.2 40.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.8 0.81 . . . . 0.0 109.452 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 65.0 t80 -88.34 -58.06 2.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.625 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -61.22 -37.99 85.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.179 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.92 -18.85 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.062 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.0 t -78.72 -26.14 44.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.876 -0.515 . . . . 0.0 110.19 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.573 ' CD ' ' HB3' ' A' ' 23' ' ' GLU . 51.5 mtm180 -74.18 -29.12 61.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.974 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.4 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 94.8 mt -51.15 -53.07 52.63 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -175.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 37.8 Cg_endo -67.87 -6.27 16.53 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.974 1.783 . . . . 0.0 113.719 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.03 30.93 3.49 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.475 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -101.8 133.26 20.86 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.367 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.865 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.5 Cg_endo -63.58 127.72 20.52 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.576 2.184 . . . . 0.0 110.282 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.659 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 9.8 pt-20 -51.6 -27.54 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.422 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.3 85.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.953 0.406 . . . . 0.0 110.137 172.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.865 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -66.07 -42.64 89.15 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.169 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.484 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 37.5 m -69.24 -31.74 70.49 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.663 -176.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.27 -36.31 83.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.127 0.965 . . . . 0.0 110.123 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 m -77.75 -18.41 56.52 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.207 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -104.33 -54.82 2.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.636 0.731 . . . . 0.0 109.765 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.2 m -63.01 -52.88 61.23 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.608 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.51 1.43 4.27 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.968 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 13' ' ' PHE . 27.1 m -74.36 164.31 26.75 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 3' ' ' CYS . 2.8 pp -124.58 149.14 28.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.372 0.606 . . . . 0.0 112.412 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.736 HG12 HG23 ' A' ' 2' ' ' THR . 74.2 mt -127.13 112.16 27.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.113 174.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.53 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.5 pp -122.14 135.44 25.42 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 10.1 Cg_exo -68.7 79.43 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.436 2.757 . . . . 0.0 111.659 174.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.46 -149.59 6.23 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.472 ' HA ' ' OG1' ' A' ' 1' ' ' THR . . . -142.98 10.34 1.75 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.94 0.4 . . . . 0.0 111.4 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.8 m -146.85 103.61 3.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.614 0.721 . . . . 0.0 110.412 176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 5.8 p -78.77 152.57 77.67 Favored Pre-proline 0 C--N 1.308 -1.227 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.337 175.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.658 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 18.6 Cg_endo -60.26 153.12 61.66 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.142 2.561 . . . . 0.0 112.7 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.45 6.2 39.46 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 114.514 0.566 . . . . 0.0 114.514 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -113.05 -3.06 14.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.761 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 15.7 m-30 -134.25 21.85 3.74 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.097 -1.411 . . . . 0.0 109.773 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.7 20.96 5.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -170.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.417 ' C ' HH21 ' A' ' 10' ' ' ARG . 20.4 m120 . . . . . 0 C--O 1.253 1.245 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.55 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.2 t -105.12 124.53 49.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.459 0.647 . . . . 0.0 110.357 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.1 m -112.87 117.49 32.26 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 5.8 t -146.9 105.27 3.91 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.693 ' HG3' ' HA ' ' A' ' 44' ' ' TYR . 44.9 Cg_endo -92.3 38.57 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.985 2.456 . . . . 0.0 114.259 -171.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.754 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 3.6 m -142.28 119.42 11.42 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.923 -174.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.7 mt -50.63 -37.88 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 123.815 0.697 . . . . 0.0 110.885 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.57 -42.71 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.198 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' A' ' 6' ' ' SER . . . -61.12 -48.62 80.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.287 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.754 ' HG3' ' O ' ' A' ' 6' ' ' SER . 28.5 mtt180 -55.96 -32.73 64.12 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.271 0.558 . . . . 0.0 110.134 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 15' ' ' VAL . 50.5 m -72.69 -57.87 3.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.523 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.416 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 9.4 p30 -73.59 -20.75 60.53 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.328 -173.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -51.94 -57.16 10.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.498 173.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 92.0 m-20 -61.87 -37.36 84.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.525 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 11' ' ' SER . 82.0 t -64.74 -26.01 39.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.265 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.6 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 3.6 t -82.68 -36.31 26.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.1 0.476 . . . . 0.0 110.163 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 21' ' ' THR . 62.3 ttt180 -68.95 -45.26 71.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.69 -174.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.534 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 84.6 mt -53.36 -47.82 94.8 Favored Pre-proline 0 N--CA 1.444 -0.734 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.6 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 13.2 Cg_exo -71.04 21.59 0.22 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.488 2.125 . . . . 0.0 113.752 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.16 35.52 8.07 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.089 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 1.7 m -114.14 134.69 22.16 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.765 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.6 Cg_endo -60.74 124.7 15.54 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.452 2.102 . . . . 0.0 110.817 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -44.31 -32.06 1.2 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.867 170.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.67 -50.47 73.74 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.811 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.765 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.9 tt -62.41 -47.1 85.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.4 m -64.63 -34.09 77.46 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.309 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.0 94.65 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.92 0.867 . . . . 0.0 110.528 176.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -72.81 -20.67 61.11 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.121 -1.4 . . . . 0.0 111.147 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -101.38 -37.45 8.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.785 0.802 . . . . 0.0 109.875 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.5 m -80.85 -42.87 20.86 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.987 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.74 -6.67 9.63 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.8 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 4' ' ' CYS . 3.9 m -74.96 157.94 34.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.3 pt -120.39 138.7 50.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.727 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -111.65 112.91 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.178 0.513 . . . . 0.0 110.594 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.5 pt -115.96 150.76 45.59 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.732 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.18 -51.0 8.48 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.297 2.664 . . . . 0.0 112.488 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.63 -139.77 10.52 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.337 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.74 70.8 1.25 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.543 0.687 . . . . 0.0 109.449 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 m -130.63 43.84 3.05 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.595 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 7.4 p -96.12 127.57 40.15 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.478 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 11.7 Cg_endo -53.61 157.37 9.81 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.476 2.784 . . . . 0.0 113.186 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.61 -23.86 55.72 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.446 -0.797 . . . . 0.0 114.682 -172.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -93.09 0.01 57.17 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 117.852 0.826 . . . . 0.0 109.514 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.693 ' HA ' ' HG3' ' A' ' 5' ' ' PRO . 21.0 m-85 -121.57 0.55 9.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.552 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -126.66 54.64 1.58 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.575 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.68 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 10.0 t30 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.022 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 38.1 m . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.013 0.435 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.445 HG21 ' CD2' ' A' ' 13' ' ' PHE . 10.4 t -133.86 158.65 42.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.203 -176.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 93.3 m -137.84 138.97 39.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.214 174.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -134.62 153.29 78.9 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.598 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.25 3.86 3.76 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.903 2.402 . . . . 0.0 114.324 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.468 ' HA ' ' OD1' ' A' ' 46' ' ' ASN . 33.1 p -164.17 142.66 7.31 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.358 0.526 . . . . 0.0 111.218 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.582 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 61.8 mt -57.27 -32.3 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.32 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.71 -54.19 30.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.182 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.489 ' HB1' HG22 ' A' ' 30' ' ' THR . . . -68.51 -36.8 79.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.475 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.582 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 13.1 ptm180 -69.11 -24.02 64.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.219 0.533 . . . . 0.0 110.636 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' VAL . 49.2 m -76.86 -40.63 46.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.923 172.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -55.87 -34.31 65.38 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.826 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 23' ' ' GLU . 79.6 t80 -53.57 -57.87 9.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.728 0.775 . . . . 0.0 110.546 174.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -62.04 -34.47 76.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.376 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.646 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 92.7 t -63.51 -34.47 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.355 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.722 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 48.4 t -62.56 -31.78 72.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.293 0.568 . . . . 0.0 111.734 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.967 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 12.0 mmm180 -80.11 -10.97 59.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.13 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.572 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 54.6 mt -71.24 -56.87 5.05 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 15' ' ' VAL . 10.4 Cg_endo -90.01 24.17 0.64 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.474 2.116 . . . . 0.0 113.135 -173.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.81 45.75 26.33 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.781 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.722 ' HB ' ' SG ' ' A' ' 16' ' ' CYS . 1.3 m -114.96 132.85 22.79 Favored Pre-proline 0 N--CA 1.44 -0.934 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.895 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 19.0 Cg_endo -61.05 120.9 8.85 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.132 2.555 . . . . 0.0 111.598 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.967 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -52.38 -29.49 24.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.978 170.642 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.27 -45.53 87.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.571 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.895 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 2.2 tt -62.55 -51.18 68.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.187 0.517 . . . . 0.0 109.832 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 96.1 m -71.58 -16.06 62.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.79 -15.72 61.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.981 0.896 . . . . 0.0 110.037 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.3 m -101.69 -20.4 15.01 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.189 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.553 ' HB3' ' HA ' ' A' ' 26' ' ' CYS . 26.2 t80 -101.53 -41.96 6.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.885 0.85 . . . . 0.0 110.001 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.489 HG22 ' HB1' ' A' ' 9' ' ' ALA . 21.8 m -89.76 -37.96 14.16 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.557 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.98 12.75 26.95 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.308 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 55.7 m -81.38 153.45 26.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.837 0.318 . . . . 0.0 110.268 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 pt -117.22 139.79 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.681 0.276 . . . . 0.0 110.838 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.9 mp -96.54 131.9 42.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.136 176.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.425 ' O ' ' HB ' ' A' ' 1' ' ' THR . 2.3 pp -141.5 155.44 67.15 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.513 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.54 -51.83 8.32 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.937 2.425 . . . . 0.0 112.384 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.05 141.56 3.36 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.733 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 59.25 17.0 5.36 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 172.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -108.92 54.24 0.66 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.83 0.824 . . . . 0.0 110.535 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.1 m -130.96 123.03 19.68 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.2 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.03 168.33 25.06 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.573 2.182 . . . . 0.0 111.787 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.67 9.5 10.75 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.382 -0.437 . . . . 0.0 113.683 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -101.13 -16.48 17.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.576 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 20.9 m-85 -122.99 14.62 9.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.145 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.12 21.32 17.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.004 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 6' ' ' SER . 22.3 t-20 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.318 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.542 HG21 ' HA ' ' A' ' 38' ' ' ALA . 19.9 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.653 0.263 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 m -112.91 125.93 54.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.321 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 73.6 m -127.97 151.57 48.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.396 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.526 ' HB2' ' HD3' ' A' ' 10' ' ' ARG . 60.1 m -125.39 142.95 43.12 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.32 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.659 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 2.3 Cg_endo -83.99 5.56 6.27 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.081 2.521 . . . . 0.0 114.535 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 56.6 p -158.13 151.03 22.68 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.799 -0.563 . . . . 0.0 110.605 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.7 mt -67.84 -30.77 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.96 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.51 -46.87 74.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.011 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.447 ' HA ' HD21 ' A' ' 12' ' ' ASN . . . -64.08 -49.71 71.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.093 176.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.526 ' HD3' ' HB2' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -49.19 -40.45 33.4 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.462 176.714 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.421 ' O ' HG23 ' A' ' 15' ' ' VAL . 13.6 t -65.79 -58.43 5.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.459 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.447 HD21 ' HA ' ' A' ' 9' ' ' ALA . 9.9 p30 -69.74 -23.07 63.33 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.541 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.433 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 45.0 t80 -60.13 -58.63 7.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.326 174.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -65.25 -30.7 71.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.401 . . . . 0.0 110.286 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 11' ' ' SER . 61.6 t -74.42 -14.9 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.805 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.693 ' O ' ' HB ' ' A' ' 21' ' ' THR . 49.2 t -91.36 -11.37 38.06 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.861 -0.524 . . . . 0.0 110.562 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.593 ' HD2' ' HB3' ' A' ' 23' ' ' GLU . 4.6 ptm180 -112.32 -22.09 11.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.782 0.801 . . . . 0.0 109.816 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -45.26 95.89 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 114.198 -1.364 . . . . 0.0 112.121 174.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.21 -12.8 30.52 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.923 1.748 . . . . 0.0 112.814 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.53 7.78 23.76 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.803 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.693 ' HB ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -77.81 138.96 61.83 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.039 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.642 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.7 Cg_endo -58.52 115.66 2.7 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 122.859 2.373 . . . . 0.0 111.565 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.593 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 10.5 pt-20 -55.16 -22.62 17.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.643 171.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.449 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -59.74 -49.45 77.66 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.256 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.642 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.2 tt -67.72 -43.48 79.9 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 110.304 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.0 m -68.18 -25.9 65.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.823 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.24 -30.37 70.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.655 0.741 . . . . 0.0 110.731 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.7 m -74.65 -26.16 59.68 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.985 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -102.13 -50.23 3.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.532 0.682 . . . . 0.0 109.905 -173.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.3 m -63.36 -42.81 98.91 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.597 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.62 8.91 17.92 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.526 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 58.6 m -81.98 163.47 22.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.3 pt -127.26 143.48 40.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.684 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 24' ' ' ALA . 55.1 mt -106.41 118.44 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.313 177.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.585 HD11 ' SG ' ' A' ' 40' ' ' CYS . 21.3 pt -128.89 148.17 67.68 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.947 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.66 67.07 8.51 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.83 2.353 . . . . 0.0 112.46 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.68 149.12 5.18 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.542 ' HA ' HG21 ' A' ' 1' ' ' THR . . . -81.94 30.19 0.39 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.144 0.497 . . . . 0.0 110.906 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 m -85.13 30.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.617 0.722 . . . . 0.0 111.192 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.585 ' SG ' HD11 ' A' ' 35' ' ' ILE . 66.7 m -69.16 119.34 69.52 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.346 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.543 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 11.6 Cg_endo -57.66 156.33 27.82 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.668 2.245 . . . . 0.0 111.805 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.98 -8.45 35.31 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 114.344 0.498 . . . . 0.0 114.344 -170.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -100.74 -21.27 15.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.562 0.681 . . . . 0.0 109.696 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.659 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 20.7 m-85 -108.37 8.28 27.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.045 -177.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.33 24.66 12.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.028 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.8 t30 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.191 -176.633 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.473 0.679 0 CA-C-O 120.84 0.352 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t -104.9 130.56 53.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.008 0.432 . . . . 0.0 110.017 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 25.1 m -118.02 132.43 56.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.984 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 5.9 t -152.43 120.16 3.18 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 84.7 Cg_endo -90.04 35.4 0.34 Allowed 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.078 2.519 . . . . 0.0 114.209 -170.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 t -162.47 139.98 8.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.1 mt -74.72 -23.99 18.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.6 t -73.11 -44.24 56.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.086 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -44.21 74.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.227 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -55.13 -38.15 67.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.159 175.529 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 15' ' ' VAL . 22.7 t -61.04 -53.93 51.05 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.961 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -53.28 -35.55 60.2 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.31 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -62.97 -59.06 5.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.224 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.27 -34.12 74.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.17 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 11' ' ' SER . 77.2 t -62.83 -28.57 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.161 0.505 . . . . 0.0 110.829 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.571 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 32.2 t -89.71 -32.08 17.18 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.85 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.704 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 36.8 tpt85 -70.25 -36.2 74.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.725 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.546 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 27.7 mt -60.23 -49.37 91.03 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -175.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 20.4 Cg_exo -68.34 11.93 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.554 2.17 . . . . 0.0 113.428 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.27 40.03 11.88 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.429 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.494 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 1.1 m -104.94 140.0 20.65 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.716 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.0 Cg_endo -56.56 118.57 5.43 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.881 2.388 . . . . 0.0 111.021 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.704 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 8.8 pt-20 -51.36 -29.4 15.26 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.104 171.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.22 -43.56 87.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.686 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.716 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -70.95 -52.41 20.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.916 0.389 . . . . 0.0 110.061 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.428 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 10.9 m -60.52 -38.12 83.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.783 -173.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.06 -58.83 5.51 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.685 0.755 . . . . 0.0 111.218 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -64.55 -21.21 66.63 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.543 -172.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -84.61 -38.34 20.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 122.14 0.971 . . . . 0.0 109.25 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.9 m -81.02 -44.08 18.62 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.881 -1.508 . . . . 0.0 111.722 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.07 -13.16 4.12 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.704 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 4' ' ' CYS . 3.3 m -75.69 157.81 33.14 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.6 pt -125.43 161.54 29.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.188 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.0 mt -128.11 125.04 63.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.273 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.907 HD12 ' HB3' ' A' ' 38' ' ' ALA . 2.7 pt -136.03 146.56 57.12 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.624 -177.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 31.5 Cg_exo -57.69 -55.78 2.17 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.082 2.521 . . . . 0.0 111.91 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.36 -138.79 6.63 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.907 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . 62.55 81.06 0.21 Allowed 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.677 0.751 . . . . 0.0 110.754 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 m -68.1 97.24 0.68 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.722 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.793 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . 72.2 m -62.73 135.43 95.81 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.795 176.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 19.6 Cg_endo -60.64 178.24 0.5 Allowed 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.985 2.457 . . . . 0.0 112.972 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.81 -0.91 28.74 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 114.816 0.686 . . . . 0.0 114.816 -171.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -99.69 -11.15 21.14 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 118.171 0.985 . . . . 0.0 109.306 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.793 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 18.6 m-85 -106.13 -20.69 13.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.545 173.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.53 36.11 1.18 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.783 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.4 t30 . . . . . 0 C--O 1.244 0.792 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.143 -175.995 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 94.3 m . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 121.096 0.474 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.4 HG21 ' CE2' ' A' ' 13' ' ' PHE . 26.2 m -108.6 124.71 50.91 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.82 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 65.4 m -125.7 120.56 31.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.163 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.4 m -104.93 162.82 18.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.731 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.17 -0.56 10.0 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.275 1.983 . . . . 0.0 115.526 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t -170.59 148.7 3.09 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.547 1.067 . . . . 0.0 111.948 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.77 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 29.3 mm -59.84 -35.71 62.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.466 0.65 . . . . 0.0 109.965 172.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -71.97 -42.83 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.767 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.809 ' HB1' HG23 ' A' ' 30' ' ' THR . . . -71.48 -41.15 69.7 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.901 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.77 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.6 OUTLIER -66.73 -28.98 68.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.179 0.514 . . . . 0.0 109.845 178.551 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.501 ' O ' HG23 ' A' ' 15' ' ' VAL . 37.8 t -64.29 -53.28 51.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.547 172.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -52.9 -41.01 63.99 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.555 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.649 ' HA ' ' SG ' ' A' ' 26' ' ' CYS . 58.8 t80 -54.93 -55.76 27.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.945 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -70.28 -25.78 63.5 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.439 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.6 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 47.4 t -65.09 -37.89 81.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.676 174.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.599 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 86.1 m -61.2 -26.84 68.0 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.261 0.553 . . . . 0.0 111.654 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 17' ' ' ARG . 26.0 mmm180 -76.34 -29.65 57.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.622 -176.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.884 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -61.97 -44.58 90.38 Favored Pre-proline 0 CA--C 1.549 0.916 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.298 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.884 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 4.1 Cg_exo -78.5 -30.13 3.36 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 122.101 1.868 . . . . 0.0 112.279 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.5 13.97 2.23 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.1 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 7.0 m -72.34 126.92 90.83 Favored Pre-proline 0 N--CA 1.443 -0.8 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.898 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -57.96 126.42 21.6 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 122.133 1.889 . . . . 0.0 109.932 175.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.72 -37.99 1.34 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.038 171.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.74 -46.63 88.55 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.388 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.898 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 2.3 tt -61.46 -46.52 89.69 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.94 0.4 . . . . 0.0 110.142 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.649 ' SG ' ' HA ' ' A' ' 13' ' ' PHE . 10.9 t -70.14 -26.67 64.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.948 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.06 -19.47 64.88 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.751 0.786 . . . . 0.0 110.731 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.3 m -88.16 -23.82 23.52 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.691 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -96.41 -49.41 5.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.718 0.771 . . . . 0.0 109.84 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.809 HG23 ' HB1' ' A' ' 9' ' ' ALA . 12.8 m -69.8 -29.45 66.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.721 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.77 20.47 65.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.576 -177.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.1 t -90.65 145.9 24.46 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.7 pt -111.73 135.7 50.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.598 . . . . 0.0 112.216 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.7 mt -108.88 104.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.041 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.586 HD11 ' SG ' ' A' ' 40' ' ' CYS . 27.8 pt -123.42 149.56 58.5 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.244 -173.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.0 20.18 1.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.719 2.28 . . . . 0.0 112.466 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.4 -153.05 6.0 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.706 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.9 23.22 6.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.911 0.386 . . . . 0.0 111.062 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 m -77.11 57.03 1.33 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.68 0.753 . . . . 0.0 111.032 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.586 ' SG ' HD11 ' A' ' 35' ' ' ILE . 28.4 m -110.96 104.69 56.51 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.328 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 40' ' ' CYS . 29.3 Cg_endo -64.17 166.87 15.65 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.498 2.132 . . . . 0.0 111.847 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.45 -30.69 65.33 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.38 -0.438 . . . . 0.0 114.049 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.18 -26.56 30.75 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.337 0.589 . . . . 0.0 109.855 -176.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.511 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 14.1 m-85 -113.14 21.99 14.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.765 -171.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 3' ' ' CYS . . . -112.75 30.07 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.526 0.679 . . . . 0.0 109.47 175.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 . . . . . 0 C--O 1.247 0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.263 -176.972 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.439 HG23 HG13 ' A' ' 35' ' ' ILE . 3.6 t . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.436 0.636 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.557 ' HB ' ' CZ ' ' A' ' 13' ' ' PHE . 78.2 m -134.52 141.61 46.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.006 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 65.8 m -116.15 126.78 54.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.811 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 10' ' ' ARG . 63.7 m -118.6 117.35 34.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.904 176.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.39 25.97 0.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.727 2.284 . . . . 0.0 112.802 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -153.04 134.8 14.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.565 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 33.3 mt -60.66 -37.12 74.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.048 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.0 t -72.65 -49.05 43.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.193 0.52 . . . . 0.0 110.127 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.72 -46.23 77.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.988 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -68.11 -29.75 68.74 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 -175.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 15' ' ' VAL . 58.6 m -62.38 -59.06 5.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.946 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -69.7 -25.71 64.0 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.523 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.557 ' CZ ' ' HB ' ' A' ' 2' ' ' THR . 3.9 t80 -58.96 -48.5 81.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.015 172.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.85 -39.49 90.81 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.071 0.463 . . . . 0.0 110.207 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 11' ' ' SER . 43.1 t -69.89 -20.52 23.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.977 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.811 ' O ' ' HB ' ' A' ' 21' ' ' THR . 25.4 t -91.44 -2.93 57.11 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.799 0.809 . . . . 0.0 109.693 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -109.42 -29.5 8.4 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.819 0.818 . . . . 0.0 109.281 -172.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -48.43 92.72 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.855 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.78 -18.65 58.58 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 122.225 1.95 . . . . 0.0 113.282 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.99 12.69 7.57 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.495 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.811 ' HB ' ' O ' ' A' ' 16' ' ' CYS . 3.6 m -85.64 136.31 37.21 Favored Pre-proline 0 N--CA 1.433 -1.31 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.746 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.3 Cg_endo -58.63 118.67 5.6 Favored 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 122.816 2.344 . . . . 0.0 111.389 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HB2' ' HE1' ' A' ' 13' ' ' PHE . 10.2 pt-20 -42.36 -31.63 0.43 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.912 168.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.6 -51.49 69.59 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.847 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.746 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 3.0 tt -59.41 -44.96 92.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.223 0.535 . . . . 0.0 109.951 177.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.7 m -66.92 -42.09 85.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.897 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -57.8 -47.25 83.12 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.396 0.617 . . . . 0.0 111.823 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 m -63.0 -29.21 70.65 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.318 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -95.11 -48.11 6.09 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.614 0.721 . . . . 0.0 109.52 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.7 m -61.84 -38.33 87.81 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.751 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.66 -4.05 11.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.094 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 58.8 m -73.1 168.79 18.36 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.853 0.359 . . . . 0.0 110.196 176.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 40.0 pt -122.53 132.48 71.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.009 0.433 . . . . 0.0 110.762 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 16.5 tt -95.92 139.0 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.403 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.657 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 20.0 pt -121.56 173.01 4.33 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.657 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 73.6 Cg_endo -80.41 -24.09 5.63 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.638 1.558 . . . . 0.0 113.719 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -153.01 -138.15 2.65 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.971 -1.109 . . . . 0.0 113.856 -171.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.38 13.69 33.12 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -83.24 77.2 9.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.732 0.777 . . . . 0.0 110.319 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.554 ' HB2' HD13 ' A' ' 35' ' ' ILE . 30.7 t -155.84 129.28 4.48 Favored Pre-proline 0 C--N 1.311 -1.074 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.087 -178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.05 163.16 31.14 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.61 2.207 . . . . 0.0 112.451 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.539 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -73.81 8.82 9.96 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.537 -176.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.31 -27.79 21.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.404 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 9.9 m-85 -105.61 -7.14 18.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.658 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.539 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -94.1 40.05 1.08 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.926 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--O 1.251 1.14 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.604 178.263 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 6.4 m . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 121.621 0.724 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.4 m -111.44 132.12 54.7 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.682 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.435 ' HB2' HG13 ' A' ' 33' ' ' ILE . 63.6 m -138.71 153.95 48.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.015 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 9' ' ' ALA . 14.7 t -150.06 133.24 8.5 Favored Pre-proline 0 N--CA 1.447 -0.589 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.568 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 9.9 Cg_exo -73.1 -6.12 18.38 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.927 2.418 . . . . 0.0 114.797 -174.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.9 p -163.75 153.54 14.85 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.679 0.672 . . . . 0.0 110.836 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.3 mt -66.41 -30.47 49.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.308 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.49 -46.81 91.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.116 0.484 . . . . 0.0 110.135 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.464 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . . . -63.24 -47.42 82.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.728 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -50.48 -41.21 52.83 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.288 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 15' ' ' VAL . 75.7 m -59.96 -56.47 21.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.458 0.17 . . . . 0.0 111.458 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.437 HD21 ' HA ' ' A' ' 9' ' ' ALA . 9.3 p30 -75.55 -20.52 58.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.755 -175.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.577 ' HB2' HG21 ' A' ' 30' ' ' THR . 65.0 t80 -57.12 -55.42 34.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.592 170.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.567 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 1.7 t-20 -56.32 -41.62 76.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.634 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 11' ' ' SER . 89.8 t -56.86 -30.26 32.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.619 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.504 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.1 t -81.17 -34.14 32.58 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.973 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.691 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 73.5 ttt180 -71.25 -30.65 66.57 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 14' ' ' ASN . 83.2 mt -48.22 -52.45 41.83 Favored Pre-proline 0 N--CA 1.444 -0.736 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -175.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 54.7 Cg_endo -71.0 3.19 3.52 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.007 1.805 . . . . 0.0 113.617 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.06 27.45 6.24 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.34 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.575 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 1.2 m -94.44 137.12 22.76 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.815 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.1 Cg_endo -62.36 126.4 18.42 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.905 2.404 . . . . 0.0 110.478 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.691 ' HG2' ' HD2' ' A' ' 17' ' ' ARG . 37.8 mt-10 -41.5 -38.41 1.29 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.342 173.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.38 82.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.578 0.228 . . . . 0.0 111.2 177.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.815 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.3 tt -64.55 -43.22 94.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.575 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 58.1 m -69.06 -26.2 64.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.593 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.19 -28.95 68.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.224 1.011 . . . . 0.0 110.328 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.4 m -82.39 -19.91 38.19 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.241 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -98.2 -46.09 5.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.02 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.577 HG21 ' HB2' ' A' ' 13' ' ' PHE . 15.7 m -76.16 -61.88 1.79 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.282 -1.327 . . . . 0.0 112.552 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.83 -16.55 3.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.348 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.568 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 32.7 m -65.17 152.88 42.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 3' ' ' CYS . 32.8 pt -113.78 136.71 49.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.077 -174.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 mm -98.44 135.13 34.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.459 HD13 ' SG ' ' A' ' 40' ' ' CYS . 45.3 pt -124.4 150.33 63.99 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.477 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.48 56.99 5.3 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.411 2.074 . . . . 0.0 111.639 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 1' ' ' THR . . . 172.38 -141.05 6.05 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.19 14.75 0.52 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 m -94.67 102.03 13.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.152 0.501 . . . . 0.0 111.433 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.459 ' SG ' HD13 ' A' ' 35' ' ' ILE . 67.9 m -142.18 124.05 8.92 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.654 175.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 59.0 Cg_endo -71.92 -173.94 1.2 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.886 2.39 . . . . 0.0 112.395 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.29 -19.59 66.52 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -168.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -88.23 -15.35 36.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.607 0.704 . . . . 0.0 109.677 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.41 ' HD2' ' HD2' ' A' ' 41' ' ' PRO . 17.3 m-85 -116.42 -1.6 12.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.897 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.22 32.55 4.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.049 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.718 178.045 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.637 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 33.1 m . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 120.894 0.378 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.6 m -126.77 139.97 52.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.107 0.479 . . . . 0.0 111.262 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 32' ' ' CYS . 55.8 m -111.99 96.51 6.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.066 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.592 ' HA ' ' CB ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -106.2 126.08 31.43 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.64 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 65.5 Cg_endo -88.03 31.69 0.42 Allowed 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.105 2.537 . . . . 0.0 114.8 -167.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.435 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 23.9 t -163.93 143.39 7.98 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 122.075 -0.391 . . . . 0.0 110.567 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.77 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.8 mp -60.8 -36.07 68.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -73.68 -52.6 20.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.634 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.442 ' HA ' HD21 ' A' ' 12' ' ' ASN . . . -57.1 -48.05 79.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.582 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -66.38 -24.43 66.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.227 -176.684 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 15' ' ' VAL . 69.9 m -70.69 -55.27 9.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.756 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.442 HD21 ' HA ' ' A' ' 9' ' ' ALA . 10.0 p30 -67.47 -23.13 65.47 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.289 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.406 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 43.2 t80 -60.94 -60.8 3.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.006 172.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -69.16 -32.7 72.21 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.776 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 11' ' ' SER . 68.8 t -67.01 -24.49 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.408 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.507 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -72.76 -33.67 66.49 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.836 0.351 . . . . 0.0 110.384 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 21' ' ' THR . 77.6 ttt180 -72.84 -27.53 61.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.348 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.42 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 82.0 mt -54.62 -52.41 70.16 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -175.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 72.1 Cg_endo -75.85 17.35 0.7 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.062 1.841 . . . . 0.0 113.716 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.03 28.59 7.65 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.475 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 1.3 m -103.39 138.96 19.69 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.529 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 24.8 Cg_endo -66.28 128.89 20.29 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.734 2.29 . . . . 0.0 110.532 173.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -46.09 -30.72 2.0 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.876 173.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -53.06 -54.18 39.28 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 174.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.529 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.1 tm? -61.01 -41.53 96.72 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 120.86 0.362 . . . . 0.0 110.847 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.2 m -68.57 -39.66 80.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.369 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.91 73.22 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.765 0.793 . . . . 0.0 110.608 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.8 m -76.51 -21.87 55.18 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.694 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -94.87 -52.53 4.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.103 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 90.5 m -61.2 -41.55 97.02 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.215 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.54 -8.83 13.25 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.223 175.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.592 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 6.3 p -89.42 179.95 5.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.156 0.478 . . . . 0.0 111.671 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.472 ' H ' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -120.93 153.09 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -168.704 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 24' ' ' ALA . 71.2 mt -109.82 131.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.949 175.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.637 ' O ' ' HB ' ' A' ' 1' ' ' THR . 12.9 pt -135.97 161.35 63.12 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.528 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 73.5 Cg_endo -75.57 1.65 7.77 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.53 2.153 . . . . 0.0 113.623 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.32 -123.47 1.17 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.368 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.535 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . 71.32 -5.8 1.5 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.734 0.814 . . . . 0.0 112.802 173.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 39' ' ' THR . 85.7 m 63.16 10.14 4.38 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.72 0.771 . . . . 0.0 111.823 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.3 m 67.02 141.98 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.642 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 39.8 Cg_endo -70.24 159.1 54.22 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.511 2.14 . . . . 0.0 111.397 171.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.65 85.92 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 114.199 0.44 . . . . 0.0 114.199 -170.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -82.51 -14.15 55.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.325 0.563 . . . . 0.0 110.58 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.64 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 13.5 m-85 -119.34 19.69 12.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.604 -174.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.15 56.56 1.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.185 0.517 . . . . 0.0 110.173 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.705 179.055 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.684 HG21 ' HA2' ' A' ' 37' ' ' GLY . 21.1 m . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 120.897 0.379 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.703 HG22 ' SG ' ' A' ' 32' ' ' CYS . 4.0 m -134.48 132.14 38.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.996 -173.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.0 m -127.03 121.08 30.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.874 0.369 . . . . 0.0 110.532 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 13' ' ' PHE . 57.9 m -109.07 121.29 43.28 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.693 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.779 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 87.7 Cg_endo -88.47 30.92 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.817 2.344 . . . . 0.0 114.779 -171.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.597 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 77.9 p -165.78 147.82 7.29 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.387 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -55.74 -37.69 47.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.679 0.612 . . . . 0.0 112.343 -170.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.67 -39.44 22.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.012 0.434 . . . . 0.0 110.029 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.428 ' HA ' ' CG2' ' A' ' 30' ' ' THR . . . -63.64 -45.67 89.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.55 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -55.67 -42.45 75.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 177.263 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 15' ' ' VAL . 49.1 m -64.43 -49.8 70.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.113 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -58.33 -41.41 84.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 110.644 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.567 ' CE1' ' HB ' ' A' ' 2' ' ' THR . 15.0 t80 -50.17 -46.92 54.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.213 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -71.4 -41.3 69.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.832 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 11' ' ' SER . 87.1 t -63.59 -37.36 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.719 -176.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.582 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 92.5 m -69.86 -28.09 65.37 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.498 ' HD2' ' CE1' ' A' ' 13' ' ' PHE . 81.1 mtp180 -84.69 -20.81 30.62 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 121.662 -0.649 . . . . 0.0 111.811 -170.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.921 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -66.49 -44.41 55.83 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.541 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.921 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 89.3 Cg_endo -85.15 -3.8 9.56 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.626 1.55 . . . . 0.0 113.183 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.22 16.8 15.35 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.397 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 3.6 m -78.82 125.32 84.31 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.568 ' HG2' ' HB3' ' A' ' 25' ' ' LEU . 10.2 Cg_endo -55.64 121.63 10.29 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.688 2.259 . . . . 0.0 111.035 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -41.8 -36.46 1.03 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.277 169.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.523 ' HA ' HG13 ' A' ' 34' ' ' ILE . . . -62.09 -45.18 94.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.876 177.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.568 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 35.9 tp -73.52 -41.3 63.21 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 120.905 0.383 . . . . 0.0 110.613 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.3 t -67.43 -35.73 79.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.484 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.595 ' HA ' ' HB3' ' A' ' 32' ' ' CYS . . . -56.28 -53.72 53.94 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.786 0.803 . . . . 0.0 111.124 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.7 m -61.36 -24.8 66.73 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.143 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.16 -41.96 11.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.448 1.118 . . . . 0.0 109.002 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.428 ' CG2' ' HA ' ' A' ' 9' ' ' ALA . 90.2 m -76.7 -32.33 57.8 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.26 -174.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.68 -5.76 24.38 Favored Glycine 0 C--O 1.229 -0.196 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -174.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.703 ' SG ' HG22 ' A' ' 2' ' ' THR . 6.4 t -73.86 164.95 25.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.609 -0.796 . . . . 0.0 109.379 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.438 HD13 ' HD2' ' A' ' 44' ' ' TYR . 14.4 pt -122.64 152.23 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.887 -175.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.523 HG13 ' HA ' ' A' ' 24' ' ' ALA . 34.5 mm -104.87 134.28 46.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.777 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.64 ' O ' ' HB ' ' A' ' 1' ' ' THR . 42.0 pt -144.88 162.68 37.13 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.51 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.536 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 14.6 Cg_endo -60.14 -43.46 35.53 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.503 2.135 . . . . 0.0 111.703 174.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.684 ' HA2' HG21 ' A' ' 1' ' ' THR . . . 131.76 136.78 3.91 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.854 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.74 -85.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.4 m -141.77 -3.69 1.12 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.939 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.558 ' SG ' HD11 ' A' ' 35' ' ' ILE . 64.8 m 66.09 139.7 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.676 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HG2' ' HD2' ' A' ' 44' ' ' TYR . 9.3 Cg_endo -53.36 149.55 29.27 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.044 2.496 . . . . 0.0 112.551 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.43 -26.25 64.03 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 114.793 0.677 . . . . 0.0 114.793 -169.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -88.35 -14.36 38.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.658 0.729 . . . . 0.0 110.093 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.705 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 16.6 m-85 -117.97 10.98 13.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.914 -175.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.14 50.89 0.86 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.232 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.779 ' HB3' ' HA ' ' A' ' 5' ' ' PRO . 39.7 t30 . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.587 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 120.977 0.418 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.1 m -106.49 114.01 27.87 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.601 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.459 ' HB2' HD12 ' A' ' 35' ' ' ILE . 81.0 m -128.15 106.43 9.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.566 0.698 . . . . 0.0 111.106 -176.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.719 ' SG ' ' HA ' ' A' ' 10' ' ' ARG . 4.1 m -117.15 157.27 47.25 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.547 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.28 -12.22 33.3 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.815 2.343 . . . . 0.0 114.495 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.2 m -143.96 153.44 42.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.923 -0.486 . . . . 0.0 110.57 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.4 -38.9 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 110.567 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.0 t -80.78 -33.75 13.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.949 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.425 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . . . -63.42 -37.67 88.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.104 176.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.719 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 18.5 ttm-85 -69.89 -27.65 64.98 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.606 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 15' ' ' VAL . 22.8 t -77.8 -46.07 22.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.52 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.425 ' OD1' ' HA ' ' A' ' 9' ' ' ALA . 1.5 p-10 -68.29 -21.62 64.78 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.704 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 31.2 t80 -54.37 -54.29 42.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.734 172.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.2 -34.32 77.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.781 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.563 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 73.3 t -60.65 -37.82 76.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.098 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.518 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 23.3 m -62.08 -38.47 88.95 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.899 0.381 . . . . 0.0 112.016 177.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 mtp85 -75.9 -2.59 30.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.663 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.635 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 18.2 mt -76.33 -59.83 1.01 Allowed Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.899 176.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 6.8 Cg_exo -75.45 -24.17 12.38 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.142 1.895 . . . . 0.0 112.64 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 126.83 16.06 2.51 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.874 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 1.1 m -81.39 127.56 73.11 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.845 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 11.6 Cg_endo -59.42 120.26 7.99 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 122.431 2.087 . . . . 0.0 110.685 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -53.4 -28.09 27.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.225 172.596 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.81 -48.92 76.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.089 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.845 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -68.92 -41.31 78.32 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.015 0.436 . . . . 0.0 110.424 -179.441 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.51 -28.23 63.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.841 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.65 -37.9 83.06 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.858 0.837 . . . . 0.0 110.42 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 m -69.68 -23.59 63.47 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.417 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -101.22 -49.11 4.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.728 0.775 . . . . 0.0 110.127 -174.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 83.7 m -66.52 -27.46 67.79 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.798 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.82 24.41 42.0 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.622 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.8 t -103.54 150.77 23.61 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.0 pt -124.29 139.76 49.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.348 0.594 . . . . 0.0 111.464 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.0 mt -93.88 115.76 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.935 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.488 HD12 ' SG ' ' A' ' 40' ' ' CYS . 39.0 mt -124.38 139.29 32.61 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.442 -171.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.52 -45.52 22.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.937 2.425 . . . . 0.0 112.405 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' H ' HG22 ' A' ' 35' ' ' ILE . . . 149.79 148.09 4.68 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.955 174.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 76.46 -19.47 0.42 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.77 0.828 . . . . 0.0 112.747 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 39' ' ' THR . 18.0 m -88.24 5.67 40.53 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.006 0.908 . . . . 0.0 110.984 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.788 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 67.6 m -75.04 115.63 46.56 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.09 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 30.3 Cg_endo -65.14 150.59 87.53 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.606 2.204 . . . . 0.0 111.48 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.23 -15.27 60.72 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 114.406 0.522 . . . . 0.0 114.406 -171.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.1 -19.15 18.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.586 0.693 . . . . 0.0 109.61 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.79 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 19.8 m-85 -114.71 19.39 16.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.304 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.788 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . . . -137.95 31.18 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.245 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.44 ' C ' HH21 ' A' ' 10' ' ' ARG . 57.4 t30 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.235 -0.888 . . . . 0.0 109.933 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 6.8 m . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.826 0.346 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.8 m -120.64 108.09 13.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.282 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 78.1 m -98.17 124.83 42.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.297 -177.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 4.1 t -110.91 126.15 29.29 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.732 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 4.3 Cg_endo -85.42 22.95 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.783 2.322 . . . . 0.0 114.222 -170.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 50.8 m -154.83 136.66 14.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 122.07 -0.394 . . . . 0.0 110.072 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.43 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 60.4 mt -65.06 -31.05 52.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.926 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.61 -41.29 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 6' ' ' SER . . . -59.28 -50.31 74.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.815 175.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -63.19 -26.2 68.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.142 0.496 . . . . 0.0 110.485 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 15' ' ' VAL . 19.8 t -68.74 -54.7 14.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.619 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.411 HD21 ' HA ' ' A' ' 9' ' ' ALA . 9.0 p30 -75.09 -24.62 58.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.007 0.432 . . . . 0.0 110.275 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.4 ' HB2' HG21 ' A' ' 30' ' ' THR . 35.0 t80 -54.8 -57.22 12.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.478 174.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.33 -27.71 67.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 110.428 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 11' ' ' SER . 93.6 t -71.41 -18.7 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.567 176.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 4.8 t -83.76 -26.92 29.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.261 0.553 . . . . 0.0 109.669 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.62 ' HG3' ' HB3' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -89.67 -37.97 14.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.557 -171.561 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.539 ' HG ' ' CD ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -49.64 -45.53 78.8 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 115.007 -0.997 . . . . 0.0 113.538 -179.333 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.539 ' CD ' ' HG ' ' A' ' 18' ' ' LEU . 9.8 Cg_exo -73.06 9.15 1.46 Allowed 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 122.389 2.059 . . . . 0.0 113.961 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.29 34.48 4.2 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.642 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.505 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 1.6 m -115.7 137.37 23.18 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 14.9 Cg_endo -60.55 123.5 13.17 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.484 2.123 . . . . 0.0 110.651 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.62 ' HB3' ' HG3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -47.54 -31.19 4.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.366 172.255 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -54.14 -50.94 65.81 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.475 172.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.6 tp -70.14 -38.5 75.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.826 0.346 . . . . 0.0 110.398 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -68.78 -34.43 75.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.4 89.91 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.929 0.871 . . . . 0.0 110.453 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 m -65.04 -24.78 67.58 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.625 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -100.94 -40.84 7.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.586 0.707 . . . . 0.0 110.184 -173.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.4 HG21 ' HB2' ' A' ' 13' ' ' PHE . 39.0 m -74.49 -39.05 62.7 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.579 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.49 -7.5 11.33 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.949 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.51 154.58 41.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 pt -118.75 155.9 20.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.684 -175.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.628 HD11 ' HA ' ' A' ' 24' ' ' ALA . 81.7 mt -113.51 125.12 70.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.679 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.501 ' O ' ' HB ' ' A' ' 1' ' ' THR . 13.0 pt -128.14 106.01 19.9 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.546 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.35 80.13 0.78 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 123.061 2.507 . . . . 0.0 111.687 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.92 -137.05 2.15 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.798 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.77 -37.22 0.54 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.71 100.77 6.35 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.178 0.513 . . . . 0.0 111.984 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 53.7 t -119.67 119.13 31.61 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.44 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 43' ' ' ASP . 43.9 Cg_endo -67.53 148.78 79.28 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.555 2.17 . . . . 0.0 112.104 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -73.5 21.28 1.18 Allowed Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.22 -0.445 . . . . 0.0 113.295 -175.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 41' ' ' PRO . 6.9 m-20 -102.96 -22.65 13.79 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.732 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 8.0 m-85 -121.74 -2.73 9.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.784 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.57 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -90.32 42.29 1.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.373 -169.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.471 175.721 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 8.7 m . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 t -138.14 161.29 37.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.718 0.294 . . . . 0.0 110.604 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.0 p -143.96 149.96 37.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 3.3 t -140.6 136.08 16.25 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 26.4 Cg_exo -64.33 -19.53 65.66 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.288 2.659 . . . . 0.0 114.915 -173.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.5 p -137.55 156.29 48.27 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.867 -0.521 . . . . 0.0 111.486 -176.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.799 ' HA ' ' HD2' ' A' ' 10' ' ' ARG . 54.2 mt -69.1 -32.92 56.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.338 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.7 t -67.29 -51.49 52.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.035 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.49 ' HB1' HG22 ' A' ' 30' ' ' THR . . . -62.63 -36.49 82.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.738 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.799 ' HD2' ' HA ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -65.02 -39.66 93.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.196 0.522 . . . . 0.0 110.654 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 15' ' ' VAL . 27.9 m -65.92 -44.51 84.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.023 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -61.76 -45.17 95.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.781 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.666 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 1.3 p90 -71.58 -31.23 66.72 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.987 -176.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.45 -51.16 68.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.96 0.409 . . . . 0.0 110.685 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 11' ' ' SER . 39.8 t -68.44 -10.75 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.737 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.605 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.6 t -81.47 -26.26 35.38 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.807 -0.558 . . . . 0.0 109.874 176.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 1.103 ' HD3' ' HG3' ' A' ' 23' ' ' GLU . 40.4 mtm180 -75.35 -24.13 57.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.487 0.661 . . . . 0.0 109.992 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.566 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 64.2 tp -56.4 -52.21 74.97 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.077 -177.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 13.9 Cg_exo -71.03 -3.09 12.14 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.339 2.026 . . . . 0.0 113.397 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.54 30.09 5.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.691 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.466 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -96.07 139.33 21.74 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.545 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.466 ' HD2' HG22 ' A' ' 21' ' ' THR . 26.0 Cg_endo -66.29 132.27 29.05 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.93 2.42 . . . . 0.0 111.099 175.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 1.103 ' HG3' ' HD3' ' A' ' 17' ' ' ARG . 28.8 mp0 -39.38 -39.65 0.7 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.508 170.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.69 -52.95 20.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.216 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.09 -45.92 75.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.739 0.304 . . . . 0.0 110.203 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.423 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 21.8 m -64.68 -40.11 94.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.618 -174.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.76 -47.34 72.52 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.585 0.707 . . . . 0.0 111.173 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.4 m -65.93 -24.98 66.93 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.124 -175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -92.13 -45.48 8.25 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.009 0.909 . . . . 0.0 109.257 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.49 HG22 ' HB1' ' A' ' 9' ' ' ALA . 61.6 m -70.16 -40.04 74.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.122 -176.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.56 4.18 21.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.15 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -84.45 155.7 22.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.5 pt -118.71 153.41 20.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.321 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.41 135.99 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.01 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.599 HD13 ' HB2' ' A' ' 40' ' ' CYS . 13.0 pt -131.67 129.53 22.09 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.084 0.468 . . . . 0.0 110.88 -173.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.1 -29.01 65.45 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.866 2.378 . . . . 0.0 111.783 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.97 -135.6 3.13 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.011 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.61 41.01 1.09 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.361 0.6 . . . . 0.0 110.284 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -80.59 22.93 0.54 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.182 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.599 ' HB2' HD13 ' A' ' 35' ' ' ILE . 31.6 t -135.94 124.25 15.33 Favored Pre-proline 0 C--N 1.313 -1.022 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.196 -175.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.76 164.63 33.81 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.668 2.246 . . . . 0.0 112.514 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.89 -2.33 45.24 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.29 -172.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -90.03 -25.22 20.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 117.796 0.798 . . . . 0.0 109.253 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 13.3 m-85 -101.3 8.53 42.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.309 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.61 48.24 0.93 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.256 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.619 -178.415 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.513 HG21 ' HA ' ' A' ' 39' ' ' THR . 3.1 m . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -138.79 143.47 38.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.843 0.354 . . . . 0.0 111.126 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 5.9 m -152.62 160.4 43.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.451 178.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 10' ' ' ARG . 8.9 t -140.01 143.81 35.65 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 14.2 Cg_exo -70.5 0.87 5.55 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.087 2.525 . . . . 0.0 113.493 -178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.0 m -152.8 139.73 19.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.624 HG13 ' OD1' ' A' ' 46' ' ' ASN . 72.0 mt -61.29 -36.37 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.142 0.496 . . . . 0.0 110.276 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.47 -29.98 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.759 -174.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.2 -28.68 27.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.167 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -70.2 -35.62 74.04 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.596 -177.961 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 15' ' ' VAL . 2.9 p -68.13 -46.91 69.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.491 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.88 -30.99 71.95 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.906 0.384 . . . . 0.0 111.029 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.505 ' HZ ' ' HB2' ' A' ' 23' ' ' GLU . 36.5 t80 -54.27 -50.95 66.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.488 174.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 28.9 m-80 -65.85 -32.7 74.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.224 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 11' ' ' SER . 93.1 t -61.53 -32.85 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.306 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.425 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 6.4 t -78.06 -26.41 48.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.132 0.491 . . . . 0.0 110.426 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -79.28 -18.92 51.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.509 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.8 mt -55.25 -53.57 60.38 Favored Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.142 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 59.8 Cg_endo -72.97 17.03 0.4 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.081 1.854 . . . . 0.0 113.11 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.88 15.5 61.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.46 173.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.594 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 1.3 m -77.85 138.08 61.91 Favored Pre-proline 0 N--CA 1.433 -1.3 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.494 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 15.6 Cg_endo -61.88 121.89 10.18 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.726 2.284 . . . . 0.0 110.861 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.505 ' HB2' ' HZ ' ' A' ' 13' ' ' PHE . 10.3 pt-20 -40.64 -37.43 0.73 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.939 170.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.68 77.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.317 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.482 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 32.2 tp -72.99 -39.81 65.75 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 120.609 0.242 . . . . 0.0 110.43 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.594 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 61.2 m -65.44 -34.03 77.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.467 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -65.55 -39.41 91.69 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.702 0.763 . . . . 0.0 110.496 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.4 m -71.28 -18.88 62.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.841 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -92.84 -21.43 19.88 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.235 1.017 . . . . 0.0 109.525 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 m -107.78 -49.91 3.15 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.029 -172.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.92 -17.74 5.15 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.452 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 11.5 m -67.8 167.41 13.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.077 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.9 pt -131.65 137.11 55.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.388 0.613 . . . . 0.0 112.46 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.75 128.77 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 167.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.486 ' O ' ' HB ' ' A' ' 1' ' ' THR . 4.8 tt -130.35 97.62 22.02 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-O 121.654 0.74 . . . . 0.0 110.153 -173.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.0 42.76 1.38 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.641 2.894 . . . . 0.0 113.073 -174.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 38' ' ' ALA . . . 155.8 145.72 4.26 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.638 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . 76.41 30.64 0.65 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.397 0.679 . . . . 0.0 111.006 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.513 ' HA ' HG21 ' A' ' 1' ' ' THR . 58.2 m 46.91 -95.48 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.93 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 63.0 m -151.75 152.66 30.65 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-O 120.941 0.4 . . . . 0.0 110.961 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 6.2 Cg_exo -74.82 -172.02 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.217 2.611 . . . . 0.0 111.233 171.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.63 -44.35 2.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.621 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.5 -22.06 35.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.69 0.757 . . . . 0.0 109.74 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.611 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 12.4 m-85 -101.38 20.93 14.99 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.485 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.57 63.56 1.57 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.391 0.615 . . . . 0.0 109.377 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.624 ' OD1' HG13 ' A' ' 7' ' ' ILE . 20.7 t-20 . . . . . 0 C--O 1.249 1.053 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.686 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' THR . . . . . 0.468 ' HB ' HG13 ' A' ' 35' ' ' ILE . 31.0 m . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 120.784 0.326 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.1 t -72.43 142.47 48.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.286 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.555 ' HB3' HG13 ' A' ' 33' ' ' ILE . 30.3 t -144.49 79.08 1.6 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 82.3 m -103.53 112.37 65.6 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.805 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.695 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 3.0 Cg_exo -77.25 14.29 1.39 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.171 2.581 . . . . 0.0 114.896 -173.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.0 p -160.36 156.18 25.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 118.753 0.706 . . . . 0.0 111.213 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.6 mt -62.67 -34.34 64.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.666 173.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.61 -49.66 82.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.602 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.58 -48.29 80.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.682 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' A' ' 10' ' ' ARG . 23.5 tpp180 -55.05 -38.83 68.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.767 176.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.5 ' O ' HG23 ' A' ' 15' ' ' VAL . 14.3 t -66.9 -50.05 63.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -55.19 -39.41 69.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.105 0.478 . . . . 0.0 110.702 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -49.7 75.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.957 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -73.52 -23.72 60.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.902 0.382 . . . . 0.0 111.202 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 11' ' ' SER . 79.4 t -66.37 -43.58 91.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.213 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.663 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 85.1 m -69.2 -16.71 63.68 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.784 HH11 ' HG3' ' A' ' 23' ' ' GLU . 21.0 mmm180 -71.05 -27.2 63.48 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.827 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.605 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 93.6 mt -66.98 -52.69 30.16 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 1.2 Cg_endo -85.41 17.24 1.8 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.525 2.15 . . . . 0.0 112.68 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.68 30.13 68.84 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.863 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 2.1 m -85.67 128.56 58.3 Favored Pre-proline 0 N--CA 1.438 -1.057 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.884 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.4 Cg_endo -58.74 122.29 11.38 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.552 2.168 . . . . 0.0 110.672 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.784 ' HG3' HH11 ' A' ' 17' ' ' ARG . 49.3 mt-10 -48.52 -32.8 8.47 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.111 172.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.68 -51.4 69.7 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.272 173.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.884 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 4.2 tt -57.64 -50.23 73.84 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.032 0.444 . . . . 0.0 110.262 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.6 m -72.71 -21.54 61.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.256 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -66.87 -42.21 85.98 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.944 0.878 . . . . 0.0 110.067 175.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.6 m -66.99 -18.74 65.52 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.776 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -98.63 -48.2 5.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.835 0.826 . . . . 0.0 110.115 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.9 m -68.09 -38.08 81.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.339 -1.3 . . . . 0.0 112.498 -174.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.57 -12.94 32.93 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.523 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.47 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 38.9 t -73.13 143.26 47.39 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.555 HG13 ' HB3' ' A' ' 3' ' ' CYS . 22.1 pt -110.13 144.61 17.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.123 0.487 . . . . 0.0 111.472 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.5 mt -109.17 104.12 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.359 174.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.468 HG13 ' HB ' ' A' ' 1' ' ' THR . 26.1 pt -93.62 138.95 22.69 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.766 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 24.7 Cg_exo -61.67 -40.71 44.16 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.055 2.504 . . . . 0.0 112.096 175.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.99 -139.52 5.86 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.454 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.53 21.16 2.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.585 0.231 . . . . 0.0 111.329 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -81.64 73.97 8.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.869 0.842 . . . . 0.0 110.682 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 44' ' ' TYR . 52.9 t -140.38 107.53 6.65 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.267 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 48.5 Cg_endo -71.1 171.41 15.98 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.622 2.214 . . . . 0.0 112.643 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.59 -3.98 23.08 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.85 -0.613 . . . . 0.0 114.353 -174.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -88.67 -19.9 25.58 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 117.614 0.707 . . . . 0.0 109.289 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.695 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 13.0 m-85 -112.22 -6.55 14.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.776 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.97 37.69 1.49 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.959 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.93 -177.665 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.515 ' HB ' HG13 ' A' ' 35' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 120.881 0.372 . . . . 0.0 110.344 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.6 m -95.99 109.52 21.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.958 0.408 . . . . 0.0 109.929 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 64.3 m -123.49 168.33 12.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -173.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.6 t -160.24 136.74 6.44 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.1 11.71 3.24 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.506 2.137 . . . . 0.0 114.847 -170.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 p -164.34 149.58 10.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.218 0.463 . . . . 0.0 110.639 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.682 ' H ' HD12 ' A' ' 7' ' ' ILE . 4.1 mp -66.95 -34.5 70.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.05 -46.71 95.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.265 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.431 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -66.85 -52.37 44.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.21 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.41 ' HA ' ' HD3' ' A' ' 10' ' ' ARG . 6.7 tpp180 -46.28 -44.47 16.56 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.969 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 15' ' ' VAL . 63.3 m -60.27 -58.2 9.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.454 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 9.4 p30 -70.51 -23.56 62.68 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.681 -175.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.592 ' HB2' HG21 ' A' ' 30' ' ' THR . 44.6 t80 -60.48 -52.17 66.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.551 173.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -68.58 -28.34 66.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.336 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 11' ' ' SER . 77.6 t -67.12 -25.85 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.564 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 28.5 t -80.9 -12.78 59.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 110.26 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.756 ' HD3' ' HG3' ' A' ' 23' ' ' GLU . 38.1 mmm-85 -74.85 -44.14 50.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.092 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.812 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -53.83 -39.39 72.87 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -175.353 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.812 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 13.7 Cg_exo -72.18 4.39 3.34 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 121.925 1.75 . . . . 0.0 113.145 176.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.23 37.13 12.91 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.22 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -103.29 138.32 19.51 Favored Pre-proline 0 N--CA 1.436 -1.168 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HD2' HG22 ' A' ' 21' ' ' THR . 30.1 Cg_endo -66.72 129.72 21.68 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.887 2.392 . . . . 0.0 110.441 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.756 ' HG3' ' HD3' ' A' ' 17' ' ' ARG . 1.5 mp0 -42.55 -35.38 1.06 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.614 172.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.74 -47.4 64.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.15 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.1 tt -70.73 -46.72 62.51 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.948 0.404 . . . . 0.0 110.145 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.459 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 11.6 m -66.06 -43.95 85.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.502 -174.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.71 89.75 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.421 0.629 . . . . 0.0 111.661 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.3 m -68.39 -24.77 64.81 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.604 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -100.04 -46.48 5.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.502 0.668 . . . . 0.0 109.792 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.592 HG21 ' HB2' ' A' ' 13' ' ' PHE . 48.8 m -60.91 -44.91 96.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.552 -1.203 . . . . 0.0 112.124 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.53 -16.12 7.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.169 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 37.7 m -66.09 164.94 14.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.5 pt -130.06 143.55 40.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 121.937 -0.477 . . . . 0.0 111.857 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.3 mt -117.15 101.8 12.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.862 HD12 ' HB3' ' A' ' 38' ' ' ALA . 6.6 pt -114.45 136.79 22.39 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.949 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.6 -39.43 88.33 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.155 2.57 . . . . 0.0 112.534 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.92 -138.14 4.33 Favored Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.862 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . 65.45 88.75 0.1 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.456 0.646 . . . . 0.0 111.086 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.79 95.8 0.12 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.538 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 35' ' ' ILE . 60.2 m -56.02 131.17 73.98 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.999 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 32.3 Cg_endo -67.25 178.32 3.14 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 123.012 2.475 . . . . 0.0 112.539 173.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.15 4.51 11.07 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -113.82 -5.69 13.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.666 0.733 . . . . 0.0 110.266 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.538 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 21.4 m-85 -115.88 -14.27 11.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.891 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.4 30.56 3.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.787 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.3 -177.485 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.823 0.344 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 m -103.24 129.68 50.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.182 -175.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.2 m -122.2 98.47 5.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.854 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.0 m -106.03 113.64 63.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 28.2 Cg_exo -64.37 10.44 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.518 2.812 . . . . 0.0 115.068 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.4 p -165.37 148.39 8.02 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.66 0.664 . . . . 0.0 111.131 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.862 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 53.1 mt -64.11 -30.16 49.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.55 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.99 -55.37 19.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.251 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.1 67.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.487 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.862 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -68.05 -31.63 71.41 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.505 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 27.4 m -69.79 -47.76 61.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.957 175.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -51.52 -44.45 62.61 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.262 0.553 . . . . 0.0 110.631 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 75.8 t80 -54.91 -59.02 5.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.381 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -63.65 -31.18 72.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.544 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 11' ' ' SER . 54.0 t -67.86 -37.53 78.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.223 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.524 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 8.5 t -76.34 -33.95 58.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.284 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -83.31 2.0 38.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.933 0.397 . . . . 0.0 111.376 -178.318 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.4 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.5 mt -76.12 -49.47 3.23 Favored Pre-proline 0 N--CA 1.444 -0.74 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 74.1 Cg_endo -75.59 19.08 0.56 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.146 1.897 . . . . 0.0 113.368 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.17 35.22 7.67 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.966 177.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 m -105.0 134.74 19.48 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.804 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 11.5 Cg_endo -59.16 121.11 9.38 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.703 2.269 . . . . 0.0 110.877 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.475 ' HG2' ' HD2' ' A' ' 17' ' ' ARG . 36.7 mt-10 -40.11 -38.94 0.81 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.125 170.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.97 -48.74 75.27 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.873 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.804 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.5 tt -64.68 -42.9 95.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 110.035 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.7 m -68.96 -30.96 69.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.937 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.61 -33.79 76.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.949 0.88 . . . . 0.0 110.503 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 m -74.68 -17.01 60.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.765 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -101.16 -42.91 6.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.735 0.779 . . . . 0.0 109.924 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.8 m -71.88 -47.91 49.47 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.852 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.15 -18.66 15.86 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 41.2 t -66.42 143.37 57.16 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.7 pt -103.34 149.8 7.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 111.871 -173.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.413 HD11 ' CE1' ' A' ' 13' ' ' PHE . 65.6 mt -125.59 124.98 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.037 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.5 pt -122.25 158.55 55.34 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.926 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.0 23.03 0.86 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.229 2.619 . . . . 0.0 112.584 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.03 -154.33 6.85 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.32 60.43 1.7 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.414 0.626 . . . . 0.0 110.218 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 m -85.36 -6.64 59.21 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.87 0.843 . . . . 0.0 110.917 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.9 m -85.22 122.22 73.87 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.504 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.533 ' HD2' ' CZ ' ' A' ' 44' ' ' TYR . 55.9 Cg_endo -72.03 172.31 14.95 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.602 2.202 . . . . 0.0 110.905 169.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.69 38.1 3.26 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.185 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.515 ' OD1' ' HG2' ' A' ' 41' ' ' PRO . 12.6 p-10 -111.84 -31.63 6.88 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.533 ' CZ ' ' HD2' ' A' ' 41' ' ' PRO . 2.4 p90 -122.77 18.6 10.26 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.7 0.762 . . . . 0.0 110.23 175.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.0 24.31 13.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.559 170.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.7 t30 . . . . . 0 C--O 1.245 0.838 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.305 -172.755 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.5 HG22 HD11 ' A' ' 35' ' ' ILE . 10.2 m . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.799 0.333 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.661 HG22 ' SG ' ' A' ' 32' ' ' CYS . 80.8 m -132.71 136.49 46.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.701 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.625 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 26.9 m -127.49 138.33 52.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.498 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 52.6 m -106.16 160.31 26.62 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.19 -171.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.412 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 92.8 Cg_endo -89.78 24.99 0.6 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.613 2.209 . . . . 0.0 113.009 174.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.5 t -172.49 136.05 0.75 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -64.0 -29.27 46.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.563 0.697 . . . . 0.0 109.833 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -71.02 -33.82 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.43 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.468 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -71.7 -45.35 62.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.057 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' NH2' ' HA ' ' A' ' 3' ' ' CYS . 8.0 tpp180 -53.96 -39.14 65.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.135 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' HG23 ' A' ' 15' ' ' VAL . 36.6 t -63.04 -52.7 61.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.408 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 10.7 p30 -74.72 -23.83 58.65 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.551 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.576 ' CZ ' ' HB ' ' A' ' 2' ' ' THR . 25.9 t80 -55.1 -50.5 69.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.2 170.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.54 -38.53 81.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.424 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 11' ' ' SER . 87.2 t -63.29 -39.33 84.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.532 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.574 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 11.5 t -76.73 -31.59 57.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.956 0.408 . . . . 0.0 110.485 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -78.49 -13.67 59.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.189 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.567 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 13.6 mt -63.6 -54.49 42.44 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 7.5 Cg_exo -74.56 18.36 0.5 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.684 2.256 . . . . 0.0 113.282 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.89 33.71 12.11 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.082 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.7 m -99.53 133.36 21.94 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.78 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -57.69 122.71 12.22 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.562 2.175 . . . . 0.0 110.695 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -43.67 -33.27 1.17 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.764 170.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.633 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -56.17 -53.23 59.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 173.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.78 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.6 tt -61.47 -46.68 89.03 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.881 0.372 . . . . 0.0 110.227 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.6 m -65.6 -38.32 89.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.325 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 32' ' ' CYS . . . -61.77 -33.67 74.5 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.627 0.727 . . . . 0.0 111.133 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.9 m -74.35 -18.96 60.61 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.947 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -100.64 -40.11 7.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.768 0.794 . . . . 0.0 109.634 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.6 m -74.74 -31.37 61.8 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.196 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.64 14.66 42.94 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -172.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.661 ' SG ' HG22 ' A' ' 2' ' ' THR . 6.1 t -87.97 167.6 13.57 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.4 pt -133.48 138.03 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 118.559 0.618 . . . . 0.0 112.272 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.633 HD11 ' HA ' ' A' ' 24' ' ' ALA . 4.3 mp -81.76 142.57 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.678 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.5 HD11 HG22 ' A' ' 1' ' ' THR . 0.2 OUTLIER -122.93 148.15 53.21 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 176.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.8 -40.12 47.41 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.959 2.439 . . . . 0.0 112.79 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -113.61 -138.78 7.08 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.076 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.68 9.92 15.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.29 0.567 . . . . 0.0 110.034 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -96.29 107.61 19.99 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.95 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.4 m -104.16 134.15 19.85 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.953 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.664 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 10.0 Cg_endo -52.99 145.88 39.5 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.873 2.382 . . . . 0.0 111.495 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.2 -34.94 63.38 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 114.347 0.499 . . . . 0.0 114.347 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.71 -20.25 39.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.43 0.633 . . . . 0.0 109.901 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.664 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 9.6 m-85 -119.21 26.18 9.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.892 -173.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.91 22.07 6.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.247 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.57 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 45.9 m-80 . . . . . 0 C--O 1.243 0.729 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.56 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.902 0.382 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.447 ' OG1' HG12 ' A' ' 34' ' ' ILE . 44.1 m -86.49 97.29 10.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.308 0.575 . . . . 0.0 110.742 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 84.2 m -89.86 100.09 12.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.575 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 20.5 t -105.75 135.63 19.37 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.879 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 72.7 Cg_endo -76.83 23.49 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.711 2.274 . . . . 0.0 114.004 -174.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.634 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 31.2 t -162.47 145.83 11.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.492 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 58.2 mt -76.11 -26.39 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.65 -46.3 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.722 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 6' ' ' SER . . . -62.11 -41.51 98.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.816 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.61 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 7.1 ptp180 -72.47 -24.3 61.17 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.254 0.55 . . . . 0.0 110.182 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.491 ' O ' HG23 ' A' ' 15' ' ' VAL . 32.7 t -68.41 -47.3 67.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.725 173.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.37 -33.03 71.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.066 0.46 . . . . 0.0 110.163 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.548 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 38.9 t80 -54.99 -53.19 58.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.37 172.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -61.65 -39.99 93.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.029 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 11' ' ' SER . 90.1 t -59.72 -42.22 87.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.209 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.553 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.1 t -74.35 -34.44 63.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.292 0.567 . . . . 0.0 110.577 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.509 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 16.2 tpt180 -60.35 -44.44 95.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.982 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.587 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 60.8 mt -52.94 -53.53 54.02 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 33.5 Cg_exo -60.78 -16.83 46.56 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.582 2.188 . . . . 0.0 113.808 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.32 30.66 2.61 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.285 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.549 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.5 OUTLIER -97.85 139.17 21.15 Favored Pre-proline 0 N--CA 1.431 -1.39 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.717 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -56.89 118.05 4.84 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.045 2.497 . . . . 0.0 111.113 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.509 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 15.1 pt-20 -44.79 -32.55 1.58 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.951 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.8 -48.3 82.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.925 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.717 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -64.96 -47.4 77.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.003 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.431 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 20.8 m -60.93 -39.62 90.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.108 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.15 -55.46 28.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.817 0.817 . . . . 0.0 110.832 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 m -62.56 -25.72 68.21 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.843 -1.526 . . . . 0.0 112.57 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -90.84 -20.03 22.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.844 0.83 . . . . 0.0 109.816 -172.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 m -102.76 -27.77 12.49 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.463 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.18 2.1 13.84 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.132 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.5 m -88.12 154.39 20.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.7 pt -128.62 144.36 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.986 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.447 HG12 ' OG1' ' A' ' 2' ' ' THR . 63.3 mt -106.38 121.57 59.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.571 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.861 HG22 ' H ' ' A' ' 37' ' ' GLY . 5.0 mp -106.42 131.28 21.85 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.645 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.97 -15.88 52.66 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.82 2.346 . . . . 0.0 112.248 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.861 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -99.37 -142.57 13.38 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.96 15.27 1.53 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.051 0.453 . . . . 0.0 110.803 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -103.13 106.53 17.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.391 0.615 . . . . 0.0 110.781 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.2 p -143.96 146.0 32.51 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.389 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.86 166.7 13.45 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.743 2.295 . . . . 0.0 112.56 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.97 2.96 39.78 Favored Glycine 0 CA--C 1.518 0.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.257 -170.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -97.69 -12.67 22.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.631 0.715 . . . . 0.0 109.334 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.485 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 21.0 m-85 -105.82 -14.07 15.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.078 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.11 19.75 5.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.278 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.526 -178.589 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.976 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 17.7 m . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.811 0.338 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.2 m -126.34 126.67 44.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.57 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 73.8 m -128.05 130.44 48.26 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -171.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.666 ' HB2' ' HB2' ' A' ' 10' ' ' ARG . 63.3 m -136.0 140.88 34.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 171.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 10.6 Cg_exo -72.0 15.36 0.39 Allowed 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.087 2.525 . . . . 0.0 114.398 -173.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.2 m -159.27 145.16 16.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.776 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.8 mp -58.11 -38.75 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.54 0.686 . . . . 0.0 109.688 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.34 -42.24 65.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.223 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.38 -33.75 76.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.799 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.666 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -76.38 -27.85 56.52 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.395 0.617 . . . . 0.0 110.003 -179.367 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 15' ' ' VAL . 36.2 m -72.78 -38.01 67.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.958 172.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -59.21 -30.11 67.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.965 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.42 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 65.7 t80 -53.41 -53.88 44.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.343 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -65.57 -29.2 69.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.949 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 11' ' ' SER . 76.8 t -65.46 -31.19 52.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.829 0.347 . . . . 0.0 110.524 177.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 42.8 t -92.2 -0.95 57.4 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.066 0.936 . . . . 0.0 109.822 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -92.43 -29.63 16.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.885 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.522 ' HG ' ' CD ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -61.08 -47.31 95.47 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.661 178.53 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' CD ' ' HG ' ' A' ' 18' ' ' LEU . 14.5 Cg_exo -70.73 -3.11 11.99 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.15 1.9 . . . . 0.0 112.807 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.05 33.51 14.82 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.955 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.576 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 1.7 m -95.37 143.78 26.69 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.677 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 12.4 Cg_endo -61.9 121.29 9.29 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.786 2.324 . . . . 0.0 110.96 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 1.7 mp0 -39.5 -36.93 0.42 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.068 171.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.87 -49.18 76.28 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.399 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.677 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.2 tt -68.08 -38.84 82.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.354 0.597 . . . . 0.0 109.737 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.537 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 13.0 m -76.14 4.01 9.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.326 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.615 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -101.33 -21.47 14.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.592 0.711 . . . . 0.0 110.315 173.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 m -76.98 -42.3 39.48 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.921 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -86.55 -23.15 25.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.746 0.784 . . . . 0.0 110.535 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.583 ' HB ' ' SG ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -99.9 1.8 43.14 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.798 -174.368 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.48 33.6 86.86 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.126 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.615 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 75.0 m -102.13 165.13 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.95 0.405 . . . . 0.0 110.744 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' A' ' 3' ' ' CYS . 12.6 pt -139.12 147.98 24.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.396 177.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.77 127.37 56.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.582 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.976 ' HB ' ' HB ' ' A' ' 1' ' ' THR . 8.6 mm -115.69 113.16 42.64 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.627 -175.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -71.17 -16.73 31.72 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.176 2.584 . . . . 0.0 111.541 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.488 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -124.35 -139.8 5.4 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.114 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -124.04 25.47 7.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.4 0.619 . . . . 0.0 110.329 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 m -81.81 42.0 0.68 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.877 0.846 . . . . 0.0 110.866 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.543 ' HB2' HG13 ' A' ' 35' ' ' ILE . 53.3 t -134.56 120.09 14.39 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.203 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.4 169.97 20.22 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.741 2.294 . . . . 0.0 112.168 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.66 16.32 4.18 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.078 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -100.31 -17.08 17.46 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.57 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 15.9 m-85 -113.96 -14.18 12.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.45 176.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.73 29.09 5.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.37 0.605 . . . . 0.0 110.047 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.41 ' C ' HH21 ' A' ' 10' ' ' ARG . 2.4 t-20 . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.109 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.472 ' OG1' ' HA ' ' A' ' 38' ' ' ALA . 23.6 m . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.047 0.451 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.736 HG23 HG12 ' A' ' 34' ' ' ILE . 9.8 m -89.35 110.22 21.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.423 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 87.5 m -127.72 167.53 16.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.042 -177.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.699 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 9.8 t -138.93 149.42 61.63 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 6.1 Cg_exo -41.06 -37.91 2.84 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.23 3.287 . . . . 0.0 115.31 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 p -169.36 173.02 6.82 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.309 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.721 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 60.3 mt -61.63 -40.15 85.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.53 177.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.89 -53.2 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.434 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.02 88.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.471 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.721 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -69.7 -25.91 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 0.0 110.949 -177.046 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.5 m -75.13 -12.78 60.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.013 0.435 . . . . 0.0 110.914 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -94.1 -8.2 40.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.8 0.81 . . . . 0.0 109.452 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 65.0 t80 -88.34 -58.06 2.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.625 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -61.22 -37.99 85.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.179 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.92 -18.85 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.062 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.0 t -78.72 -26.14 44.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.876 -0.515 . . . . 0.0 110.19 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.573 ' CD ' ' HB3' ' A' ' 23' ' ' GLU . 51.5 mtm180 -74.18 -29.12 61.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.974 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.4 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 94.8 mt -51.15 -53.07 52.63 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -175.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 37.8 Cg_endo -67.87 -6.27 16.53 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.974 1.783 . . . . 0.0 113.719 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.03 30.93 3.49 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.475 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -101.8 133.26 20.86 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.367 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.865 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.5 Cg_endo -63.58 127.72 20.52 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.576 2.184 . . . . 0.0 110.282 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.659 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 9.8 pt-20 -51.6 -27.54 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.422 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.3 85.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.953 0.406 . . . . 0.0 110.137 172.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.865 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -66.07 -42.64 89.15 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.169 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.484 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 37.5 m -69.24 -31.74 70.49 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.663 -176.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.27 -36.31 83.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.127 0.965 . . . . 0.0 110.123 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 m -77.75 -18.41 56.52 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.207 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -104.33 -54.82 2.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.636 0.731 . . . . 0.0 109.765 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.2 m -63.01 -52.88 61.23 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.608 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.51 1.43 4.27 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.968 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 13' ' ' PHE . 27.1 m -74.36 164.31 26.75 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 3' ' ' CYS . 2.8 pp -124.58 149.14 28.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.372 0.606 . . . . 0.0 112.412 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.736 HG12 HG23 ' A' ' 2' ' ' THR . 74.2 mt -127.13 112.16 27.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.113 174.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.53 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.5 pp -122.14 135.44 25.42 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 10.1 Cg_exo -68.7 79.43 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.436 2.757 . . . . 0.0 111.659 174.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.46 -149.59 6.23 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.472 ' HA ' ' OG1' ' A' ' 1' ' ' THR . . . -142.98 10.34 1.75 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.94 0.4 . . . . 0.0 111.4 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.8 m -146.85 103.61 3.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.614 0.721 . . . . 0.0 110.412 176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 5.8 p -78.77 152.57 77.67 Favored Pre-proline 0 C--N 1.308 -1.227 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.337 175.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.658 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 18.6 Cg_endo -60.26 153.12 61.66 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.142 2.561 . . . . 0.0 112.7 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.45 6.2 39.46 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 114.514 0.566 . . . . 0.0 114.514 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -113.05 -3.06 14.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.761 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 15.7 m-30 -134.25 21.85 3.74 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.097 -1.411 . . . . 0.0 109.773 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.7 20.96 5.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -170.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.417 ' C ' HH21 ' A' ' 10' ' ' ARG . 20.4 m120 . . . . . 0 C--O 1.253 1.245 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.55 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.2 t -105.12 124.53 49.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.459 0.647 . . . . 0.0 110.357 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.1 m -112.87 117.49 32.26 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 5.8 t -146.9 105.27 3.91 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.693 ' HG3' ' HA ' ' A' ' 44' ' ' TYR . 44.9 Cg_endo -92.3 38.57 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.985 2.456 . . . . 0.0 114.259 -171.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.754 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 3.6 m -142.28 119.42 11.42 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.923 -174.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.7 mt -50.63 -37.88 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 123.815 0.697 . . . . 0.0 110.885 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.57 -42.71 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.198 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' A' ' 6' ' ' SER . . . -61.12 -48.62 80.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.287 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.754 ' HG3' ' O ' ' A' ' 6' ' ' SER . 28.5 mtt180 -55.96 -32.73 64.12 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.271 0.558 . . . . 0.0 110.134 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 15' ' ' VAL . 50.5 m -72.69 -57.87 3.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.523 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.416 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 9.4 p30 -73.59 -20.75 60.53 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.328 -173.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -51.94 -57.16 10.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.498 173.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 92.0 m-20 -61.87 -37.36 84.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.525 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 11' ' ' SER . 82.0 t -64.74 -26.01 39.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.265 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.6 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 3.6 t -82.68 -36.31 26.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.1 0.476 . . . . 0.0 110.163 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 21' ' ' THR . 62.3 ttt180 -68.95 -45.26 71.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.69 -174.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.534 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 84.6 mt -53.36 -47.82 94.8 Favored Pre-proline 0 N--CA 1.444 -0.734 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.6 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 13.2 Cg_exo -71.04 21.59 0.22 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.488 2.125 . . . . 0.0 113.752 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.16 35.52 8.07 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.089 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 1.7 m -114.14 134.69 22.16 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.765 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.6 Cg_endo -60.74 124.7 15.54 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.452 2.102 . . . . 0.0 110.817 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -44.31 -32.06 1.2 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.867 170.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.67 -50.47 73.74 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.811 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.765 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.9 tt -62.41 -47.1 85.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.4 m -64.63 -34.09 77.46 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.309 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.0 94.65 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.92 0.867 . . . . 0.0 110.528 176.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -72.81 -20.67 61.11 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.121 -1.4 . . . . 0.0 111.147 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -101.38 -37.45 8.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.785 0.802 . . . . 0.0 109.875 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.5 m -80.85 -42.87 20.86 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.987 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.74 -6.67 9.63 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.8 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 4' ' ' CYS . 3.9 m -74.96 157.94 34.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.3 pt -120.39 138.7 50.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.727 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -111.65 112.91 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.178 0.513 . . . . 0.0 110.594 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.5 pt -115.96 150.76 45.59 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.732 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.18 -51.0 8.48 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.297 2.664 . . . . 0.0 112.488 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.63 -139.77 10.52 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.337 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.74 70.8 1.25 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.543 0.687 . . . . 0.0 109.449 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 m -130.63 43.84 3.05 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.595 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 7.4 p -96.12 127.57 40.15 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.478 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 11.7 Cg_endo -53.61 157.37 9.81 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.476 2.784 . . . . 0.0 113.186 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.61 -23.86 55.72 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.446 -0.797 . . . . 0.0 114.682 -172.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -93.09 0.01 57.17 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 117.852 0.826 . . . . 0.0 109.514 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.693 ' HA ' ' HG3' ' A' ' 5' ' ' PRO . 21.0 m-85 -121.57 0.55 9.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.552 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -126.66 54.64 1.58 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.575 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.68 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 10.0 t30 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.022 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 38.1 m . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.013 0.435 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.445 HG21 ' CD2' ' A' ' 13' ' ' PHE . 10.4 t -133.86 158.65 42.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.203 -176.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 93.3 m -137.84 138.97 39.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.214 174.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -134.62 153.29 78.9 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.25 3.86 3.76 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.903 2.402 . . . . 0.0 114.324 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.468 ' HA ' ' OD1' ' A' ' 46' ' ' ASN . 33.1 p -164.17 142.66 7.31 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.358 0.526 . . . . 0.0 111.218 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.582 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 61.8 mt -57.27 -32.3 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.32 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.71 -54.19 30.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.182 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.489 ' HB1' HG22 ' A' ' 30' ' ' THR . . . -68.51 -36.8 79.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.475 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.582 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 13.1 ptm180 -69.11 -24.02 64.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.219 0.533 . . . . 0.0 110.636 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' VAL . 49.2 m -76.86 -40.63 46.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.923 172.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -55.87 -34.31 65.38 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.826 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 23' ' ' GLU . 79.6 t80 -53.57 -57.87 9.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.728 0.775 . . . . 0.0 110.546 174.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -62.04 -34.47 76.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.376 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.646 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 92.7 t -63.51 -34.47 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.355 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.722 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 48.4 t -62.56 -31.78 72.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.293 0.568 . . . . 0.0 111.734 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.967 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 12.0 mmm180 -80.11 -10.97 59.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.13 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.572 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 54.6 mt -71.24 -56.87 5.05 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 15' ' ' VAL . 10.4 Cg_endo -90.01 24.17 0.64 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.474 2.116 . . . . 0.0 113.135 -173.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.81 45.75 26.33 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.781 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.722 ' HB ' ' SG ' ' A' ' 16' ' ' CYS . 1.3 m -114.96 132.85 22.79 Favored Pre-proline 0 N--CA 1.44 -0.934 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.895 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 19.0 Cg_endo -61.05 120.9 8.85 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.132 2.555 . . . . 0.0 111.598 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.967 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -52.38 -29.49 24.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.978 170.642 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.27 -45.53 87.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.571 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.895 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 2.2 tt -62.55 -51.18 68.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.187 0.517 . . . . 0.0 109.832 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 96.1 m -71.58 -16.06 62.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.79 -15.72 61.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.981 0.896 . . . . 0.0 110.037 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.3 m -101.69 -20.4 15.01 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.189 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.553 ' HB3' ' HA ' ' A' ' 26' ' ' CYS . 26.2 t80 -101.53 -41.96 6.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.885 0.85 . . . . 0.0 110.001 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.489 HG22 ' HB1' ' A' ' 9' ' ' ALA . 21.8 m -89.76 -37.96 14.16 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.557 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.98 12.75 26.95 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.308 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 55.7 m -81.38 153.45 26.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.837 0.318 . . . . 0.0 110.268 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 pt -117.22 139.79 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.681 0.276 . . . . 0.0 110.838 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.9 mp -96.54 131.9 42.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.136 176.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.425 ' O ' ' HB ' ' A' ' 1' ' ' THR . 2.3 pp -141.5 155.44 67.15 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.513 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.54 -51.83 8.32 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.937 2.425 . . . . 0.0 112.384 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.05 141.56 3.36 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.733 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 59.25 17.0 5.36 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 172.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -108.92 54.24 0.66 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.83 0.824 . . . . 0.0 110.535 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.1 m -130.96 123.03 19.68 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.2 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.03 168.33 25.06 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.573 2.182 . . . . 0.0 111.787 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.67 9.5 10.75 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.382 -0.437 . . . . 0.0 113.683 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -101.13 -16.48 17.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.576 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 20.9 m-85 -122.99 14.62 9.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.145 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.12 21.32 17.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.004 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 6' ' ' SER . 22.3 t-20 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.318 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.542 HG21 ' HA ' ' A' ' 38' ' ' ALA . 19.9 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.653 0.263 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 m -112.91 125.93 54.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.321 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 73.6 m -127.97 151.57 48.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.396 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.526 ' HB2' ' HD3' ' A' ' 10' ' ' ARG . 60.1 m -125.39 142.95 43.12 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.32 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.659 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 2.3 Cg_endo -83.99 5.56 6.27 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.081 2.521 . . . . 0.0 114.535 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 56.6 p -158.13 151.03 22.68 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.799 -0.563 . . . . 0.0 110.605 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.7 mt -67.84 -30.77 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.96 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.51 -46.87 74.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.011 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.447 ' HA ' HD21 ' A' ' 12' ' ' ASN . . . -64.08 -49.71 71.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.093 176.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.526 ' HD3' ' HB2' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -49.19 -40.45 33.4 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.462 176.714 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.421 ' O ' HG23 ' A' ' 15' ' ' VAL . 13.6 t -65.79 -58.43 5.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.459 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.447 HD21 ' HA ' ' A' ' 9' ' ' ALA . 9.9 p30 -69.74 -23.07 63.33 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.541 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.433 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 45.0 t80 -60.13 -58.63 7.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.326 174.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -65.25 -30.7 71.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.401 . . . . 0.0 110.286 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 11' ' ' SER . 61.6 t -74.42 -14.9 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.805 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.693 ' O ' ' HB ' ' A' ' 21' ' ' THR . 49.2 t -91.36 -11.37 38.06 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.861 -0.524 . . . . 0.0 110.562 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.593 ' HD2' ' HB3' ' A' ' 23' ' ' GLU . 4.6 ptm180 -112.32 -22.09 11.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.782 0.801 . . . . 0.0 109.816 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -45.26 95.89 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 114.198 -1.364 . . . . 0.0 112.121 174.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.21 -12.8 30.52 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.923 1.748 . . . . 0.0 112.814 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.53 7.78 23.76 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.803 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.693 ' HB ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -77.81 138.96 61.83 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.039 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.642 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.7 Cg_endo -58.52 115.66 2.7 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 122.859 2.373 . . . . 0.0 111.565 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.593 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 10.5 pt-20 -55.16 -22.62 17.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.643 171.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.449 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -59.74 -49.45 77.66 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.256 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.642 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.2 tt -67.72 -43.48 79.9 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 110.304 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.0 m -68.18 -25.9 65.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.823 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.24 -30.37 70.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.655 0.741 . . . . 0.0 110.731 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.7 m -74.65 -26.16 59.68 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.985 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -102.13 -50.23 3.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.532 0.682 . . . . 0.0 109.905 -173.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.3 m -63.36 -42.81 98.91 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.597 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.62 8.91 17.92 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.526 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 58.6 m -81.98 163.47 22.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.3 pt -127.26 143.48 40.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.684 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 24' ' ' ALA . 55.1 mt -106.41 118.44 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.313 177.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.585 HD11 ' SG ' ' A' ' 40' ' ' CYS . 21.3 pt -128.89 148.17 67.68 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.947 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.66 67.07 8.51 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.83 2.353 . . . . 0.0 112.46 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.68 149.12 5.18 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.542 ' HA ' HG21 ' A' ' 1' ' ' THR . . . -81.94 30.19 0.39 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.144 0.497 . . . . 0.0 110.906 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 m -85.13 30.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.617 0.722 . . . . 0.0 111.192 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.585 ' SG ' HD11 ' A' ' 35' ' ' ILE . 66.7 m -69.16 119.34 69.52 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.346 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.543 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 11.6 Cg_endo -57.66 156.33 27.82 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.668 2.245 . . . . 0.0 111.805 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.98 -8.45 35.31 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 114.344 0.498 . . . . 0.0 114.344 -170.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -100.74 -21.27 15.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.562 0.681 . . . . 0.0 109.696 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.659 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 20.7 m-85 -108.37 8.28 27.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.045 -177.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.33 24.66 12.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.028 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.8 t30 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.191 -176.633 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.473 0.679 0 CA-C-O 120.84 0.352 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t -104.9 130.56 53.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.008 0.432 . . . . 0.0 110.017 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 25.1 m -118.02 132.43 56.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.984 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 5.9 t -152.43 120.16 3.18 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 84.7 Cg_endo -90.04 35.4 0.34 Allowed 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.078 2.519 . . . . 0.0 114.209 -170.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 t -162.47 139.98 8.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.1 mt -74.72 -23.99 18.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.6 t -73.11 -44.24 56.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.086 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -44.21 74.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.227 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -55.13 -38.15 67.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.159 175.529 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 15' ' ' VAL . 22.7 t -61.04 -53.93 51.05 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.961 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -53.28 -35.55 60.2 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.31 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -62.97 -59.06 5.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.224 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.27 -34.12 74.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.17 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 11' ' ' SER . 77.2 t -62.83 -28.57 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.161 0.505 . . . . 0.0 110.829 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.571 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 32.2 t -89.71 -32.08 17.18 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.85 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.704 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 36.8 tpt85 -70.25 -36.2 74.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.725 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.546 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 27.7 mt -60.23 -49.37 91.03 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -175.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 20.4 Cg_exo -68.34 11.93 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.554 2.17 . . . . 0.0 113.428 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.27 40.03 11.88 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.429 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.494 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 1.1 m -104.94 140.0 20.65 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.716 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.0 Cg_endo -56.56 118.57 5.43 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.881 2.388 . . . . 0.0 111.021 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.704 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 8.8 pt-20 -51.36 -29.4 15.26 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.104 171.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.22 -43.56 87.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.686 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.716 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -70.95 -52.41 20.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.916 0.389 . . . . 0.0 110.061 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 10.9 m -60.52 -38.12 83.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.783 -173.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.06 -58.83 5.51 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.685 0.755 . . . . 0.0 111.218 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -64.55 -21.21 66.63 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.543 -172.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -84.61 -38.34 20.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 122.14 0.971 . . . . 0.0 109.25 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.9 m -81.02 -44.08 18.62 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.881 -1.508 . . . . 0.0 111.722 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.07 -13.16 4.12 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.704 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 4' ' ' CYS . 3.3 m -75.69 157.81 33.14 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.6 pt -125.43 161.54 29.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.188 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.0 mt -128.11 125.04 63.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.273 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.907 HD12 ' HB3' ' A' ' 38' ' ' ALA . 2.7 pt -136.03 146.56 57.12 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.624 -177.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 31.5 Cg_exo -57.69 -55.78 2.17 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.082 2.521 . . . . 0.0 111.91 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.36 -138.79 6.63 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.907 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . 62.55 81.06 0.21 Allowed 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.677 0.751 . . . . 0.0 110.754 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 m -68.1 97.24 0.68 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.722 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.793 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . 72.2 m -62.73 135.43 95.81 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.795 176.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 19.6 Cg_endo -60.64 178.24 0.5 Allowed 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.985 2.457 . . . . 0.0 112.972 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.81 -0.91 28.74 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 114.816 0.686 . . . . 0.0 114.816 -171.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -99.69 -11.15 21.14 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 118.171 0.985 . . . . 0.0 109.306 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.793 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 18.6 m-85 -106.13 -20.69 13.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.545 173.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.53 36.11 1.18 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.783 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.4 t30 . . . . . 0 C--O 1.244 0.792 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.143 -175.995 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 94.3 m . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 121.096 0.474 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.4 HG21 ' CE2' ' A' ' 13' ' ' PHE . 26.2 m -108.6 124.71 50.91 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.82 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 65.4 m -125.7 120.56 31.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.163 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.4 m -104.93 162.82 18.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.731 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.17 -0.56 10.0 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.275 1.983 . . . . 0.0 115.526 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t -170.59 148.7 3.09 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.547 1.067 . . . . 0.0 111.948 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.77 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 29.3 mm -59.84 -35.71 62.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.466 0.65 . . . . 0.0 109.965 172.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -71.97 -42.83 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.767 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.809 ' HB1' HG23 ' A' ' 30' ' ' THR . . . -71.48 -41.15 69.7 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.901 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.77 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.6 OUTLIER -66.73 -28.98 68.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.179 0.514 . . . . 0.0 109.845 178.551 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.501 ' O ' HG23 ' A' ' 15' ' ' VAL . 37.8 t -64.29 -53.28 51.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.547 172.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -52.9 -41.01 63.99 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.555 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.649 ' HA ' ' SG ' ' A' ' 26' ' ' CYS . 58.8 t80 -54.93 -55.76 27.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.945 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -70.28 -25.78 63.5 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.439 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.6 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 47.4 t -65.09 -37.89 81.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.676 174.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.599 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 86.1 m -61.2 -26.84 68.0 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.261 0.553 . . . . 0.0 111.654 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 17' ' ' ARG . 26.0 mmm180 -76.34 -29.65 57.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.622 -176.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.884 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -61.97 -44.58 90.38 Favored Pre-proline 0 CA--C 1.549 0.916 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.298 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.884 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 4.1 Cg_exo -78.5 -30.13 3.36 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 122.101 1.868 . . . . 0.0 112.279 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.5 13.97 2.23 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.1 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 7.0 m -72.34 126.92 90.83 Favored Pre-proline 0 N--CA 1.443 -0.8 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.898 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -57.96 126.42 21.6 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 122.133 1.889 . . . . 0.0 109.932 175.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.72 -37.99 1.34 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.038 171.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.74 -46.63 88.55 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.388 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.898 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 2.3 tt -61.46 -46.52 89.69 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.94 0.4 . . . . 0.0 110.142 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.649 ' SG ' ' HA ' ' A' ' 13' ' ' PHE . 10.9 t -70.14 -26.67 64.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.948 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.06 -19.47 64.88 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.751 0.786 . . . . 0.0 110.731 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.3 m -88.16 -23.82 23.52 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.691 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -96.41 -49.41 5.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.718 0.771 . . . . 0.0 109.84 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.809 HG23 ' HB1' ' A' ' 9' ' ' ALA . 12.8 m -69.8 -29.45 66.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.721 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.77 20.47 65.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.576 -177.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.1 t -90.65 145.9 24.46 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.7 pt -111.73 135.7 50.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.598 . . . . 0.0 112.216 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.7 mt -108.88 104.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.041 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.586 HD11 ' SG ' ' A' ' 40' ' ' CYS . 27.8 pt -123.42 149.56 58.5 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.244 -173.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.0 20.18 1.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.719 2.28 . . . . 0.0 112.466 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.4 -153.05 6.0 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.706 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.9 23.22 6.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.911 0.386 . . . . 0.0 111.062 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 m -77.11 57.03 1.33 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.68 0.753 . . . . 0.0 111.032 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.586 ' SG ' HD11 ' A' ' 35' ' ' ILE . 28.4 m -110.96 104.69 56.51 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.328 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 40' ' ' CYS . 29.3 Cg_endo -64.17 166.87 15.65 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.498 2.132 . . . . 0.0 111.847 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.45 -30.69 65.33 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.38 -0.438 . . . . 0.0 114.049 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.18 -26.56 30.75 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.337 0.589 . . . . 0.0 109.855 -176.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.511 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 14.1 m-85 -113.14 21.99 14.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.765 -171.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 3' ' ' CYS . . . -112.75 30.07 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.526 0.679 . . . . 0.0 109.47 175.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 . . . . . 0 C--O 1.247 0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.263 -176.972 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.439 HG23 HG13 ' A' ' 35' ' ' ILE . 3.6 t . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.436 0.636 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.557 ' HB ' ' CZ ' ' A' ' 13' ' ' PHE . 78.2 m -134.52 141.61 46.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.006 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 65.8 m -116.15 126.78 54.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.811 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 10' ' ' ARG . 63.7 m -118.6 117.35 34.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.904 176.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.39 25.97 0.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.727 2.284 . . . . 0.0 112.802 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -153.04 134.8 14.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.565 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 33.3 mt -60.66 -37.12 74.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.048 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.0 t -72.65 -49.05 43.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.193 0.52 . . . . 0.0 110.127 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.72 -46.23 77.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.988 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -68.11 -29.75 68.74 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 -175.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 15' ' ' VAL . 58.6 m -62.38 -59.06 5.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.946 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -69.7 -25.71 64.0 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.523 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.557 ' CZ ' ' HB ' ' A' ' 2' ' ' THR . 3.9 t80 -58.96 -48.5 81.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.015 172.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.85 -39.49 90.81 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.071 0.463 . . . . 0.0 110.207 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 11' ' ' SER . 43.1 t -69.89 -20.52 23.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.977 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.811 ' O ' ' HB ' ' A' ' 21' ' ' THR . 25.4 t -91.44 -2.93 57.11 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.799 0.809 . . . . 0.0 109.693 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -109.42 -29.5 8.4 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.819 0.818 . . . . 0.0 109.281 -172.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -48.43 92.72 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.855 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.78 -18.65 58.58 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 122.225 1.95 . . . . 0.0 113.282 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.99 12.69 7.57 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.495 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.811 ' HB ' ' O ' ' A' ' 16' ' ' CYS . 3.6 m -85.64 136.31 37.21 Favored Pre-proline 0 N--CA 1.433 -1.31 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.746 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.3 Cg_endo -58.63 118.67 5.6 Favored 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 122.816 2.344 . . . . 0.0 111.389 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HB2' ' HE1' ' A' ' 13' ' ' PHE . 10.2 pt-20 -42.36 -31.63 0.43 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.912 168.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.6 -51.49 69.59 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.847 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.746 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 3.0 tt -59.41 -44.96 92.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.223 0.535 . . . . 0.0 109.951 177.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.7 m -66.92 -42.09 85.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.897 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -57.8 -47.25 83.12 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.396 0.617 . . . . 0.0 111.823 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 m -63.0 -29.21 70.65 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.318 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -95.11 -48.11 6.09 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.614 0.721 . . . . 0.0 109.52 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.7 m -61.84 -38.33 87.81 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.751 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.66 -4.05 11.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.094 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 58.8 m -73.1 168.79 18.36 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.853 0.359 . . . . 0.0 110.196 176.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 40.0 pt -122.53 132.48 71.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.009 0.433 . . . . 0.0 110.762 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 16.5 tt -95.92 139.0 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.403 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.657 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 20.0 pt -121.56 173.01 4.33 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.657 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 73.6 Cg_endo -80.41 -24.09 5.63 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.638 1.558 . . . . 0.0 113.719 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -153.01 -138.15 2.65 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.971 -1.109 . . . . 0.0 113.856 -171.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.38 13.69 33.12 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -83.24 77.2 9.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.732 0.777 . . . . 0.0 110.319 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.554 ' HB2' HD13 ' A' ' 35' ' ' ILE . 30.7 t -155.84 129.28 4.48 Favored Pre-proline 0 C--N 1.311 -1.074 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.087 -178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.05 163.16 31.14 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.61 2.207 . . . . 0.0 112.451 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.539 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -73.81 8.82 9.96 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.537 -176.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.31 -27.79 21.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.404 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 9.9 m-85 -105.61 -7.14 18.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.658 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.539 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -94.1 40.05 1.08 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.926 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--O 1.251 1.14 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.604 178.263 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 6.4 m . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 121.621 0.724 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.4 m -111.44 132.12 54.7 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.682 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.435 ' HB2' HG13 ' A' ' 33' ' ' ILE . 63.6 m -138.71 153.95 48.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.015 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 9' ' ' ALA . 14.7 t -150.06 133.24 8.5 Favored Pre-proline 0 N--CA 1.447 -0.589 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.568 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 9.9 Cg_exo -73.1 -6.12 18.38 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.927 2.418 . . . . 0.0 114.797 -174.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.9 p -163.75 153.54 14.85 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.679 0.672 . . . . 0.0 110.836 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.3 mt -66.41 -30.47 49.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.308 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.49 -46.81 91.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.116 0.484 . . . . 0.0 110.135 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.464 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . . . -63.24 -47.42 82.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.728 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -50.48 -41.21 52.83 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.288 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 15' ' ' VAL . 75.7 m -59.96 -56.47 21.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.458 0.17 . . . . 0.0 111.458 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.437 HD21 ' HA ' ' A' ' 9' ' ' ALA . 9.3 p30 -75.55 -20.52 58.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.755 -175.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.577 ' HB2' HG21 ' A' ' 30' ' ' THR . 65.0 t80 -57.12 -55.42 34.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.592 170.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.567 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 1.7 t-20 -56.32 -41.62 76.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.634 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 11' ' ' SER . 89.8 t -56.86 -30.26 32.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.619 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.504 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.1 t -81.17 -34.14 32.58 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.973 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.691 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 73.5 ttt180 -71.25 -30.65 66.57 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 14' ' ' ASN . 83.2 mt -48.22 -52.45 41.83 Favored Pre-proline 0 N--CA 1.444 -0.736 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -175.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 54.7 Cg_endo -71.0 3.19 3.52 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.007 1.805 . . . . 0.0 113.617 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.06 27.45 6.24 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.34 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.575 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 1.2 m -94.44 137.12 22.76 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.815 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.1 Cg_endo -62.36 126.4 18.42 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.905 2.404 . . . . 0.0 110.478 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.691 ' HG2' ' HD2' ' A' ' 17' ' ' ARG . 37.8 mt-10 -41.5 -38.41 1.29 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.342 173.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.38 82.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.578 0.228 . . . . 0.0 111.2 177.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.815 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.3 tt -64.55 -43.22 94.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.575 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 58.1 m -69.06 -26.2 64.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.593 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.19 -28.95 68.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.224 1.011 . . . . 0.0 110.328 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.4 m -82.39 -19.91 38.19 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.241 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -98.2 -46.09 5.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.02 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.577 HG21 ' HB2' ' A' ' 13' ' ' PHE . 15.7 m -76.16 -61.88 1.79 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.282 -1.327 . . . . 0.0 112.552 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.83 -16.55 3.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.348 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.568 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 32.7 m -65.17 152.88 42.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 3' ' ' CYS . 32.8 pt -113.78 136.71 49.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.077 -174.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 mm -98.44 135.13 34.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.459 HD13 ' SG ' ' A' ' 40' ' ' CYS . 45.3 pt -124.4 150.33 63.99 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.477 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.48 56.99 5.3 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.411 2.074 . . . . 0.0 111.639 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 1' ' ' THR . . . 172.38 -141.05 6.05 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.19 14.75 0.52 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 m -94.67 102.03 13.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.152 0.501 . . . . 0.0 111.433 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.459 ' SG ' HD13 ' A' ' 35' ' ' ILE . 67.9 m -142.18 124.05 8.92 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.654 175.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 59.0 Cg_endo -71.92 -173.94 1.2 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.886 2.39 . . . . 0.0 112.395 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.29 -19.59 66.52 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -168.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -88.23 -15.35 36.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.607 0.704 . . . . 0.0 109.677 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.41 ' HD2' ' HD2' ' A' ' 41' ' ' PRO . 17.3 m-85 -116.42 -1.6 12.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.897 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.22 32.55 4.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.049 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.718 178.045 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.637 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 33.1 m . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 120.894 0.378 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.6 m -126.77 139.97 52.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.107 0.479 . . . . 0.0 111.262 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 32' ' ' CYS . 55.8 m -111.99 96.51 6.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.066 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.592 ' HA ' ' CB ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -106.2 126.08 31.43 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.64 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 65.5 Cg_endo -88.03 31.69 0.42 Allowed 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.105 2.537 . . . . 0.0 114.8 -167.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.435 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 23.9 t -163.93 143.39 7.98 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 122.075 -0.391 . . . . 0.0 110.567 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.77 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.8 mp -60.8 -36.07 68.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -73.68 -52.6 20.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.634 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.442 ' HA ' HD21 ' A' ' 12' ' ' ASN . . . -57.1 -48.05 79.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.582 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -66.38 -24.43 66.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.227 -176.684 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 15' ' ' VAL . 69.9 m -70.69 -55.27 9.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.756 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.442 HD21 ' HA ' ' A' ' 9' ' ' ALA . 10.0 p30 -67.47 -23.13 65.47 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.289 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.406 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 43.2 t80 -60.94 -60.8 3.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.006 172.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -69.16 -32.7 72.21 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.776 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 11' ' ' SER . 68.8 t -67.01 -24.49 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.408 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.507 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -72.76 -33.67 66.49 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.836 0.351 . . . . 0.0 110.384 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 21' ' ' THR . 77.6 ttt180 -72.84 -27.53 61.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.348 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.42 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 82.0 mt -54.62 -52.41 70.16 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -175.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 72.1 Cg_endo -75.85 17.35 0.7 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.062 1.841 . . . . 0.0 113.716 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.03 28.59 7.65 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.475 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 1.3 m -103.39 138.96 19.69 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.529 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 24.8 Cg_endo -66.28 128.89 20.29 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.734 2.29 . . . . 0.0 110.532 173.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -46.09 -30.72 2.0 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.876 173.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -53.06 -54.18 39.28 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 174.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.529 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.1 tm? -61.01 -41.53 96.72 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 120.86 0.362 . . . . 0.0 110.847 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.2 m -68.57 -39.66 80.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.369 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.91 73.22 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.765 0.793 . . . . 0.0 110.608 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.8 m -76.51 -21.87 55.18 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.694 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -94.87 -52.53 4.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.103 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 90.5 m -61.2 -41.55 97.02 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.215 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.54 -8.83 13.25 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.223 175.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.592 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 6.3 p -89.42 179.95 5.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.156 0.478 . . . . 0.0 111.671 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.472 ' H ' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -120.93 153.09 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -168.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 24' ' ' ALA . 71.2 mt -109.82 131.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.949 175.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.637 ' O ' ' HB ' ' A' ' 1' ' ' THR . 12.9 pt -135.97 161.35 63.12 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.528 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 73.5 Cg_endo -75.57 1.65 7.77 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.53 2.153 . . . . 0.0 113.623 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.32 -123.47 1.17 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.368 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.535 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . 71.32 -5.8 1.5 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.734 0.814 . . . . 0.0 112.802 173.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 39' ' ' THR . 85.7 m 63.16 10.14 4.38 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.72 0.771 . . . . 0.0 111.823 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.3 m 67.02 141.98 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.642 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 39.8 Cg_endo -70.24 159.1 54.22 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.511 2.14 . . . . 0.0 111.397 171.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.65 85.92 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 114.199 0.44 . . . . 0.0 114.199 -170.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -82.51 -14.15 55.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.325 0.563 . . . . 0.0 110.58 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.64 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 13.5 m-85 -119.34 19.69 12.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.604 -174.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.15 56.56 1.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.185 0.517 . . . . 0.0 110.173 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.705 179.055 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.684 HG21 ' HA2' ' A' ' 37' ' ' GLY . 21.1 m . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 120.897 0.379 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.703 HG22 ' SG ' ' A' ' 32' ' ' CYS . 4.0 m -134.48 132.14 38.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.996 -173.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.0 m -127.03 121.08 30.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.874 0.369 . . . . 0.0 110.532 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 13' ' ' PHE . 57.9 m -109.07 121.29 43.28 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.693 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.779 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 87.7 Cg_endo -88.47 30.92 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.817 2.344 . . . . 0.0 114.779 -171.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.597 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 77.9 p -165.78 147.82 7.29 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.387 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -55.74 -37.69 47.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.679 0.612 . . . . 0.0 112.343 -170.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.67 -39.44 22.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.012 0.434 . . . . 0.0 110.029 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.428 ' HA ' ' CG2' ' A' ' 30' ' ' THR . . . -63.64 -45.67 89.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.55 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -55.67 -42.45 75.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 177.263 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 15' ' ' VAL . 49.1 m -64.43 -49.8 70.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.113 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -58.33 -41.41 84.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 110.644 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.567 ' CE1' ' HB ' ' A' ' 2' ' ' THR . 15.0 t80 -50.17 -46.92 54.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.213 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -71.4 -41.3 69.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.832 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 11' ' ' SER . 87.1 t -63.59 -37.36 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.719 -176.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.582 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 92.5 m -69.86 -28.09 65.37 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.498 ' HD2' ' CE1' ' A' ' 13' ' ' PHE . 81.1 mtp180 -84.69 -20.81 30.62 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 121.662 -0.649 . . . . 0.0 111.811 -170.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.921 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -66.49 -44.41 55.83 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.541 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.921 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 89.3 Cg_endo -85.15 -3.8 9.56 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.626 1.55 . . . . 0.0 113.183 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.22 16.8 15.35 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.397 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 3.6 m -78.82 125.32 84.31 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.568 ' HG2' ' HB3' ' A' ' 25' ' ' LEU . 10.2 Cg_endo -55.64 121.63 10.29 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.688 2.259 . . . . 0.0 111.035 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -41.8 -36.46 1.03 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.277 169.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.523 ' HA ' HG13 ' A' ' 34' ' ' ILE . . . -62.09 -45.18 94.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.876 177.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.568 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 35.9 tp -73.52 -41.3 63.21 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 120.905 0.383 . . . . 0.0 110.613 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.3 t -67.43 -35.73 79.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.484 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.595 ' HA ' ' HB3' ' A' ' 32' ' ' CYS . . . -56.28 -53.72 53.94 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.786 0.803 . . . . 0.0 111.124 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.7 m -61.36 -24.8 66.73 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.143 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.16 -41.96 11.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.448 1.118 . . . . 0.0 109.002 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.428 ' CG2' ' HA ' ' A' ' 9' ' ' ALA . 90.2 m -76.7 -32.33 57.8 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.26 -174.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.68 -5.76 24.38 Favored Glycine 0 C--O 1.229 -0.196 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -174.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.703 ' SG ' HG22 ' A' ' 2' ' ' THR . 6.4 t -73.86 164.95 25.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.609 -0.796 . . . . 0.0 109.379 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.438 HD13 ' HD2' ' A' ' 44' ' ' TYR . 14.4 pt -122.64 152.23 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.887 -175.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.523 HG13 ' HA ' ' A' ' 24' ' ' ALA . 34.5 mm -104.87 134.28 46.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.777 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.64 ' O ' ' HB ' ' A' ' 1' ' ' THR . 42.0 pt -144.88 162.68 37.13 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.51 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.536 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 14.6 Cg_endo -60.14 -43.46 35.53 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.503 2.135 . . . . 0.0 111.703 174.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.684 ' HA2' HG21 ' A' ' 1' ' ' THR . . . 131.76 136.78 3.91 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.854 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.74 -85.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.4 m -141.77 -3.69 1.12 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.939 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.558 ' SG ' HD11 ' A' ' 35' ' ' ILE . 64.8 m 66.09 139.7 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.676 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HG2' ' HD2' ' A' ' 44' ' ' TYR . 9.3 Cg_endo -53.36 149.55 29.27 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.044 2.496 . . . . 0.0 112.551 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.43 -26.25 64.03 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 114.793 0.677 . . . . 0.0 114.793 -169.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -88.35 -14.36 38.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.658 0.729 . . . . 0.0 110.093 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.705 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 16.6 m-85 -117.97 10.98 13.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.914 -175.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.14 50.89 0.86 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.232 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.779 ' HB3' ' HA ' ' A' ' 5' ' ' PRO . 39.7 t30 . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.587 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 120.977 0.418 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.1 m -106.49 114.01 27.87 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.601 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.459 ' HB2' HD12 ' A' ' 35' ' ' ILE . 81.0 m -128.15 106.43 9.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.566 0.698 . . . . 0.0 111.106 -176.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.719 ' SG ' ' HA ' ' A' ' 10' ' ' ARG . 4.1 m -117.15 157.27 47.25 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.547 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.28 -12.22 33.3 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.815 2.343 . . . . 0.0 114.495 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.2 m -143.96 153.44 42.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.923 -0.486 . . . . 0.0 110.57 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.4 -38.9 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 110.567 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.0 t -80.78 -33.75 13.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.949 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.425 ' HA ' ' OD1' ' A' ' 12' ' ' ASN . . . -63.42 -37.67 88.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.104 176.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.719 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 18.5 ttm-85 -69.89 -27.65 64.98 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.606 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 15' ' ' VAL . 22.8 t -77.8 -46.07 22.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.52 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.425 ' OD1' ' HA ' ' A' ' 9' ' ' ALA . 1.5 p-10 -68.29 -21.62 64.78 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.704 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 31.2 t80 -54.37 -54.29 42.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.734 172.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.2 -34.32 77.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.781 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.563 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 73.3 t -60.65 -37.82 76.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.098 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.518 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 23.3 m -62.08 -38.47 88.95 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.899 0.381 . . . . 0.0 112.016 177.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 mtp85 -75.9 -2.59 30.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.663 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.635 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 18.2 mt -76.33 -59.83 1.01 Allowed Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.899 176.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 6.8 Cg_exo -75.45 -24.17 12.38 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.142 1.895 . . . . 0.0 112.64 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 126.83 16.06 2.51 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.874 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 1.1 m -81.39 127.56 73.11 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.845 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 11.6 Cg_endo -59.42 120.26 7.99 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 122.431 2.087 . . . . 0.0 110.685 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -53.4 -28.09 27.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.225 172.596 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.81 -48.92 76.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.089 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.845 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -68.92 -41.31 78.32 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.015 0.436 . . . . 0.0 110.424 -179.441 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.51 -28.23 63.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.841 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.65 -37.9 83.06 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.858 0.837 . . . . 0.0 110.42 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 m -69.68 -23.59 63.47 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.417 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -101.22 -49.11 4.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.728 0.775 . . . . 0.0 110.127 -174.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 83.7 m -66.52 -27.46 67.79 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.798 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.82 24.41 42.0 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.622 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.8 t -103.54 150.77 23.61 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.0 pt -124.29 139.76 49.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.348 0.594 . . . . 0.0 111.464 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.0 mt -93.88 115.76 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.935 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.488 HD12 ' SG ' ' A' ' 40' ' ' CYS . 39.0 mt -124.38 139.29 32.61 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.442 -171.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.52 -45.52 22.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.937 2.425 . . . . 0.0 112.405 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' H ' HG22 ' A' ' 35' ' ' ILE . . . 149.79 148.09 4.68 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.955 174.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 76.46 -19.47 0.42 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.77 0.828 . . . . 0.0 112.747 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 39' ' ' THR . 18.0 m -88.24 5.67 40.53 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.006 0.908 . . . . 0.0 110.984 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.788 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 67.6 m -75.04 115.63 46.56 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.09 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 30.3 Cg_endo -65.14 150.59 87.53 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.606 2.204 . . . . 0.0 111.48 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.23 -15.27 60.72 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 114.406 0.522 . . . . 0.0 114.406 -171.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.1 -19.15 18.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.586 0.693 . . . . 0.0 109.61 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.79 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 19.8 m-85 -114.71 19.39 16.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.304 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.788 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . . . -137.95 31.18 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.245 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.44 ' C ' HH21 ' A' ' 10' ' ' ARG . 57.4 t30 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.235 -0.888 . . . . 0.0 109.933 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 6.8 m . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.826 0.346 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.8 m -120.64 108.09 13.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.282 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 78.1 m -98.17 124.83 42.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.297 -177.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 4.1 t -110.91 126.15 29.29 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.732 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 4.3 Cg_endo -85.42 22.95 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.783 2.322 . . . . 0.0 114.222 -170.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 50.8 m -154.83 136.66 14.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 122.07 -0.394 . . . . 0.0 110.072 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.43 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 60.4 mt -65.06 -31.05 52.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.926 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.61 -41.29 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 6' ' ' SER . . . -59.28 -50.31 74.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.815 175.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -63.19 -26.2 68.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.142 0.496 . . . . 0.0 110.485 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 15' ' ' VAL . 19.8 t -68.74 -54.7 14.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.619 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.411 HD21 ' HA ' ' A' ' 9' ' ' ALA . 9.0 p30 -75.09 -24.62 58.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.007 0.432 . . . . 0.0 110.275 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.4 ' HB2' HG21 ' A' ' 30' ' ' THR . 35.0 t80 -54.8 -57.22 12.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.478 174.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.33 -27.71 67.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 110.428 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 11' ' ' SER . 93.6 t -71.41 -18.7 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.567 176.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 4.8 t -83.76 -26.92 29.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.261 0.553 . . . . 0.0 109.669 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.62 ' HG3' ' HB3' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -89.67 -37.97 14.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.557 -171.561 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.539 ' HG ' ' CD ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -49.64 -45.53 78.8 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 115.007 -0.997 . . . . 0.0 113.538 -179.333 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.539 ' CD ' ' HG ' ' A' ' 18' ' ' LEU . 9.8 Cg_exo -73.06 9.15 1.46 Allowed 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 122.389 2.059 . . . . 0.0 113.961 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.29 34.48 4.2 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.642 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.505 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 1.6 m -115.7 137.37 23.18 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 14.9 Cg_endo -60.55 123.5 13.17 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.484 2.123 . . . . 0.0 110.651 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.62 ' HB3' ' HG3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -47.54 -31.19 4.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.366 172.255 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -54.14 -50.94 65.81 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.475 172.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.6 tp -70.14 -38.5 75.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.826 0.346 . . . . 0.0 110.398 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -68.78 -34.43 75.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.4 89.91 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.929 0.871 . . . . 0.0 110.453 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 m -65.04 -24.78 67.58 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.625 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -100.94 -40.84 7.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.586 0.707 . . . . 0.0 110.184 -173.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.4 HG21 ' HB2' ' A' ' 13' ' ' PHE . 39.0 m -74.49 -39.05 62.7 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.579 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.49 -7.5 11.33 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.949 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.51 154.58 41.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 pt -118.75 155.9 20.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.684 -175.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.628 HD11 ' HA ' ' A' ' 24' ' ' ALA . 81.7 mt -113.51 125.12 70.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.679 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.501 ' O ' ' HB ' ' A' ' 1' ' ' THR . 13.0 pt -128.14 106.01 19.9 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.546 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.35 80.13 0.78 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 123.061 2.507 . . . . 0.0 111.687 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.92 -137.05 2.15 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.798 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.77 -37.22 0.54 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.71 100.77 6.35 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.178 0.513 . . . . 0.0 111.984 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 53.7 t -119.67 119.13 31.61 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.44 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 43' ' ' ASP . 43.9 Cg_endo -67.53 148.78 79.28 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.555 2.17 . . . . 0.0 112.104 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -73.5 21.28 1.18 Allowed Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.22 -0.445 . . . . 0.0 113.295 -175.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 41' ' ' PRO . 6.9 m-20 -102.96 -22.65 13.79 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.732 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 8.0 m-85 -121.74 -2.73 9.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.784 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.57 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -90.32 42.29 1.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.373 -169.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.471 175.721 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 8.7 m . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 t -138.14 161.29 37.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.718 0.294 . . . . 0.0 110.604 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.0 p -143.96 149.96 37.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 3.3 t -140.6 136.08 16.25 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 26.4 Cg_exo -64.33 -19.53 65.66 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.288 2.659 . . . . 0.0 114.915 -173.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.5 p -137.55 156.29 48.27 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.867 -0.521 . . . . 0.0 111.486 -176.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.799 ' HA ' ' HD2' ' A' ' 10' ' ' ARG . 54.2 mt -69.1 -32.92 56.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.338 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.7 t -67.29 -51.49 52.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.035 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.49 ' HB1' HG22 ' A' ' 30' ' ' THR . . . -62.63 -36.49 82.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.738 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.799 ' HD2' ' HA ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -65.02 -39.66 93.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.196 0.522 . . . . 0.0 110.654 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 15' ' ' VAL . 27.9 m -65.92 -44.51 84.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.023 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -61.76 -45.17 95.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.781 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.666 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 1.3 p90 -71.58 -31.23 66.72 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.987 -176.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.45 -51.16 68.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.96 0.409 . . . . 0.0 110.685 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 11' ' ' SER . 39.8 t -68.44 -10.75 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.737 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.605 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.6 t -81.47 -26.26 35.38 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.807 -0.558 . . . . 0.0 109.874 176.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 1.103 ' HD3' ' HG3' ' A' ' 23' ' ' GLU . 40.4 mtm180 -75.35 -24.13 57.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.487 0.661 . . . . 0.0 109.992 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.566 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 64.2 tp -56.4 -52.21 74.97 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.077 -177.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 13.9 Cg_exo -71.03 -3.09 12.14 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.339 2.026 . . . . 0.0 113.397 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.54 30.09 5.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.691 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.466 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -96.07 139.33 21.74 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.545 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.466 ' HD2' HG22 ' A' ' 21' ' ' THR . 26.0 Cg_endo -66.29 132.27 29.05 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.93 2.42 . . . . 0.0 111.099 175.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 1.103 ' HG3' ' HD3' ' A' ' 17' ' ' ARG . 28.8 mp0 -39.38 -39.65 0.7 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.508 170.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.69 -52.95 20.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.216 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.09 -45.92 75.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.739 0.304 . . . . 0.0 110.203 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.423 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 21.8 m -64.68 -40.11 94.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.618 -174.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.76 -47.34 72.52 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.585 0.707 . . . . 0.0 111.173 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.4 m -65.93 -24.98 66.93 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.124 -175.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -92.13 -45.48 8.25 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.009 0.909 . . . . 0.0 109.257 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.49 HG22 ' HB1' ' A' ' 9' ' ' ALA . 61.6 m -70.16 -40.04 74.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.122 -176.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.56 4.18 21.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.15 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -84.45 155.7 22.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.5 pt -118.71 153.41 20.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.321 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.41 135.99 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.01 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.599 HD13 ' HB2' ' A' ' 40' ' ' CYS . 13.0 pt -131.67 129.53 22.09 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.084 0.468 . . . . 0.0 110.88 -173.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.1 -29.01 65.45 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.866 2.378 . . . . 0.0 111.783 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.97 -135.6 3.13 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.011 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.61 41.01 1.09 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.361 0.6 . . . . 0.0 110.284 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -80.59 22.93 0.54 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.182 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.599 ' HB2' HD13 ' A' ' 35' ' ' ILE . 31.6 t -135.94 124.25 15.33 Favored Pre-proline 0 C--N 1.313 -1.022 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.196 -175.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.76 164.63 33.81 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.668 2.246 . . . . 0.0 112.514 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.89 -2.33 45.24 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.29 -172.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -90.03 -25.22 20.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 117.796 0.798 . . . . 0.0 109.253 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 13.3 m-85 -101.3 8.53 42.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.309 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.61 48.24 0.93 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.256 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.619 -178.415 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.513 HG21 ' HA ' ' A' ' 39' ' ' THR . 3.1 m . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -138.79 143.47 38.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.843 0.354 . . . . 0.0 111.126 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 5.9 m -152.62 160.4 43.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.451 178.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 10' ' ' ARG . 8.9 t -140.01 143.81 35.65 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 14.2 Cg_exo -70.5 0.87 5.55 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.087 2.525 . . . . 0.0 113.493 -178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.0 m -152.8 139.73 19.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.624 HG13 ' OD1' ' A' ' 46' ' ' ASN . 72.0 mt -61.29 -36.37 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.142 0.496 . . . . 0.0 110.276 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.47 -29.98 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.759 -174.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.2 -28.68 27.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.167 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -70.2 -35.62 74.04 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.596 -177.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 15' ' ' VAL . 2.9 p -68.13 -46.91 69.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.491 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.88 -30.99 71.95 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.906 0.384 . . . . 0.0 111.029 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.505 ' HZ ' ' HB2' ' A' ' 23' ' ' GLU . 36.5 t80 -54.27 -50.95 66.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.488 174.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 28.9 m-80 -65.85 -32.7 74.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.224 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 11' ' ' SER . 93.1 t -61.53 -32.85 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.306 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.425 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 6.4 t -78.06 -26.41 48.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.132 0.491 . . . . 0.0 110.426 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -79.28 -18.92 51.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.509 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.8 mt -55.25 -53.57 60.38 Favored Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.142 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 59.8 Cg_endo -72.97 17.03 0.4 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.081 1.854 . . . . 0.0 113.11 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.88 15.5 61.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.46 173.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.594 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 1.3 m -77.85 138.08 61.91 Favored Pre-proline 0 N--CA 1.433 -1.3 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.494 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 15.6 Cg_endo -61.88 121.89 10.18 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.726 2.284 . . . . 0.0 110.861 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.505 ' HB2' ' HZ ' ' A' ' 13' ' ' PHE . 10.3 pt-20 -40.64 -37.43 0.73 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.939 170.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.68 77.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.317 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.482 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 32.2 tp -72.99 -39.81 65.75 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 120.609 0.242 . . . . 0.0 110.43 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.594 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 61.2 m -65.44 -34.03 77.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.467 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -65.55 -39.41 91.69 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.702 0.763 . . . . 0.0 110.496 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.4 m -71.28 -18.88 62.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.841 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -92.84 -21.43 19.88 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.235 1.017 . . . . 0.0 109.525 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 m -107.78 -49.91 3.15 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.029 -172.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.92 -17.74 5.15 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.452 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 11.5 m -67.8 167.41 13.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.077 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.9 pt -131.65 137.11 55.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.388 0.613 . . . . 0.0 112.46 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.75 128.77 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 167.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.486 ' O ' ' HB ' ' A' ' 1' ' ' THR . 4.8 tt -130.35 97.62 22.02 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-O 121.654 0.74 . . . . 0.0 110.153 -173.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.0 42.76 1.38 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.641 2.894 . . . . 0.0 113.073 -174.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 38' ' ' ALA . . . 155.8 145.72 4.26 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.638 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . 76.41 30.64 0.65 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.397 0.679 . . . . 0.0 111.006 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.513 ' HA ' HG21 ' A' ' 1' ' ' THR . 58.2 m 46.91 -95.48 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.93 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 63.0 m -151.75 152.66 30.65 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-O 120.941 0.4 . . . . 0.0 110.961 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 6.2 Cg_exo -74.82 -172.02 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.217 2.611 . . . . 0.0 111.233 171.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.63 -44.35 2.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.621 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.5 -22.06 35.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.69 0.757 . . . . 0.0 109.74 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.611 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 12.4 m-85 -101.38 20.93 14.99 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.485 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.57 63.56 1.57 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.391 0.615 . . . . 0.0 109.377 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.624 ' OD1' HG13 ' A' ' 7' ' ' ILE . 20.7 t-20 . . . . . 0 C--O 1.249 1.053 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.686 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.468 ' HB ' HG13 ' A' ' 35' ' ' ILE . 31.0 m . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 120.784 0.326 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.1 t -72.43 142.47 48.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.286 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.555 ' HB3' HG13 ' A' ' 33' ' ' ILE . 30.3 t -144.49 79.08 1.6 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 82.3 m -103.53 112.37 65.6 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.805 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.695 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 3.0 Cg_exo -77.25 14.29 1.39 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.171 2.581 . . . . 0.0 114.896 -173.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.0 p -160.36 156.18 25.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 118.753 0.706 . . . . 0.0 111.213 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.6 mt -62.67 -34.34 64.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.666 173.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.61 -49.66 82.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.602 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.58 -48.29 80.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.682 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' A' ' 10' ' ' ARG . 23.5 tpp180 -55.05 -38.83 68.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.767 176.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.5 ' O ' HG23 ' A' ' 15' ' ' VAL . 14.3 t -66.9 -50.05 63.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -55.19 -39.41 69.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.105 0.478 . . . . 0.0 110.702 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -49.7 75.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.957 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -73.52 -23.72 60.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.902 0.382 . . . . 0.0 111.202 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 11' ' ' SER . 79.4 t -66.37 -43.58 91.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.213 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.663 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 85.1 m -69.2 -16.71 63.68 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.784 HH11 ' HG3' ' A' ' 23' ' ' GLU . 21.0 mmm180 -71.05 -27.2 63.48 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.827 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.605 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 93.6 mt -66.98 -52.69 30.16 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 1.2 Cg_endo -85.41 17.24 1.8 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.525 2.15 . . . . 0.0 112.68 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.68 30.13 68.84 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.863 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 2.1 m -85.67 128.56 58.3 Favored Pre-proline 0 N--CA 1.438 -1.057 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.884 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.4 Cg_endo -58.74 122.29 11.38 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.552 2.168 . . . . 0.0 110.672 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.784 ' HG3' HH11 ' A' ' 17' ' ' ARG . 49.3 mt-10 -48.52 -32.8 8.47 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.111 172.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.68 -51.4 69.7 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.272 173.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.884 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 4.2 tt -57.64 -50.23 73.84 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.032 0.444 . . . . 0.0 110.262 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.6 m -72.71 -21.54 61.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.256 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -66.87 -42.21 85.98 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.944 0.878 . . . . 0.0 110.067 175.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.6 m -66.99 -18.74 65.52 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.776 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -98.63 -48.2 5.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.835 0.826 . . . . 0.0 110.115 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 92.9 m -68.09 -38.08 81.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.339 -1.3 . . . . 0.0 112.498 -174.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.57 -12.94 32.93 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.523 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.47 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 38.9 t -73.13 143.26 47.39 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.555 HG13 ' HB3' ' A' ' 3' ' ' CYS . 22.1 pt -110.13 144.61 17.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.123 0.487 . . . . 0.0 111.472 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.5 mt -109.17 104.12 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.359 174.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.468 HG13 ' HB ' ' A' ' 1' ' ' THR . 26.1 pt -93.62 138.95 22.69 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.766 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 24.7 Cg_exo -61.67 -40.71 44.16 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.055 2.504 . . . . 0.0 112.096 175.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.99 -139.52 5.86 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.454 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.53 21.16 2.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.585 0.231 . . . . 0.0 111.329 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -81.64 73.97 8.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.869 0.842 . . . . 0.0 110.682 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 44' ' ' TYR . 52.9 t -140.38 107.53 6.65 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.267 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 48.5 Cg_endo -71.1 171.41 15.98 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.622 2.214 . . . . 0.0 112.643 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.59 -3.98 23.08 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.85 -0.613 . . . . 0.0 114.353 -174.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -88.67 -19.9 25.58 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 117.614 0.707 . . . . 0.0 109.289 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.695 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 13.0 m-85 -112.22 -6.55 14.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.776 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.97 37.69 1.49 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.959 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.93 -177.665 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.515 ' HB ' HG13 ' A' ' 35' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 120.881 0.372 . . . . 0.0 110.344 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.6 m -95.99 109.52 21.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.958 0.408 . . . . 0.0 109.929 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 64.3 m -123.49 168.33 12.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -173.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.6 t -160.24 136.74 6.44 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.1 11.71 3.24 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.506 2.137 . . . . 0.0 114.847 -170.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 p -164.34 149.58 10.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.218 0.463 . . . . 0.0 110.639 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.682 ' H ' HD12 ' A' ' 7' ' ' ILE . 4.1 mp -66.95 -34.5 70.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.05 -46.71 95.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.265 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.431 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -66.85 -52.37 44.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.21 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.41 ' HA ' ' HD3' ' A' ' 10' ' ' ARG . 6.7 tpp180 -46.28 -44.47 16.56 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.969 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 15' ' ' VAL . 63.3 m -60.27 -58.2 9.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.454 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 9.4 p30 -70.51 -23.56 62.68 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.681 -175.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.592 ' HB2' HG21 ' A' ' 30' ' ' THR . 44.6 t80 -60.48 -52.17 66.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.551 173.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -68.58 -28.34 66.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.336 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 11' ' ' SER . 77.6 t -67.12 -25.85 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.564 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 28.5 t -80.9 -12.78 59.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 110.26 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.756 ' HD3' ' HG3' ' A' ' 23' ' ' GLU . 38.1 mmm-85 -74.85 -44.14 50.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.092 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.812 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -53.83 -39.39 72.87 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -175.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.812 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 13.7 Cg_exo -72.18 4.39 3.34 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 121.925 1.75 . . . . 0.0 113.145 176.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.23 37.13 12.91 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.22 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -103.29 138.32 19.51 Favored Pre-proline 0 N--CA 1.436 -1.168 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HD2' HG22 ' A' ' 21' ' ' THR . 30.1 Cg_endo -66.72 129.72 21.68 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.887 2.392 . . . . 0.0 110.441 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.756 ' HG3' ' HD3' ' A' ' 17' ' ' ARG . 1.5 mp0 -42.55 -35.38 1.06 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.614 172.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.74 -47.4 64.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.15 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.1 tt -70.73 -46.72 62.51 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.948 0.404 . . . . 0.0 110.145 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.459 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 11.6 m -66.06 -43.95 85.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.502 -174.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.71 89.75 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.421 0.629 . . . . 0.0 111.661 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.3 m -68.39 -24.77 64.81 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.604 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -100.04 -46.48 5.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.502 0.668 . . . . 0.0 109.792 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.592 HG21 ' HB2' ' A' ' 13' ' ' PHE . 48.8 m -60.91 -44.91 96.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.552 -1.203 . . . . 0.0 112.124 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.53 -16.12 7.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.169 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 37.7 m -66.09 164.94 14.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.5 pt -130.06 143.55 40.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 121.937 -0.477 . . . . 0.0 111.857 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.3 mt -117.15 101.8 12.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.862 HD12 ' HB3' ' A' ' 38' ' ' ALA . 6.6 pt -114.45 136.79 22.39 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.949 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.6 -39.43 88.33 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.155 2.57 . . . . 0.0 112.534 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.92 -138.14 4.33 Favored Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.862 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . 65.45 88.75 0.1 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.456 0.646 . . . . 0.0 111.086 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.79 95.8 0.12 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.538 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 35' ' ' ILE . 60.2 m -56.02 131.17 73.98 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.999 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 32.3 Cg_endo -67.25 178.32 3.14 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 123.012 2.475 . . . . 0.0 112.539 173.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.15 4.51 11.07 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -113.82 -5.69 13.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.666 0.733 . . . . 0.0 110.266 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.538 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 21.4 m-85 -115.88 -14.27 11.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.891 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.4 30.56 3.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.787 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.42 HD22 ' C ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.3 -177.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.823 0.344 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 m -103.24 129.68 50.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.182 -175.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.2 m -122.2 98.47 5.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.854 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.0 m -106.03 113.64 63.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 28.2 Cg_exo -64.37 10.44 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.518 2.812 . . . . 0.0 115.068 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.4 p -165.37 148.39 8.02 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.66 0.664 . . . . 0.0 111.131 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.862 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 53.1 mt -64.11 -30.16 49.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.55 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.99 -55.37 19.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.251 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.1 67.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.487 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.862 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -68.05 -31.63 71.41 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.505 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 27.4 m -69.79 -47.76 61.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.957 175.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -51.52 -44.45 62.61 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.262 0.553 . . . . 0.0 110.631 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 75.8 t80 -54.91 -59.02 5.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.381 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -63.65 -31.18 72.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.544 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 11' ' ' SER . 54.0 t -67.86 -37.53 78.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.223 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.524 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 8.5 t -76.34 -33.95 58.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.284 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -83.31 2.0 38.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.933 0.397 . . . . 0.0 111.376 -178.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.4 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.5 mt -76.12 -49.47 3.23 Favored Pre-proline 0 N--CA 1.444 -0.74 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 74.1 Cg_endo -75.59 19.08 0.56 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.146 1.897 . . . . 0.0 113.368 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.17 35.22 7.67 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.966 177.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 m -105.0 134.74 19.48 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.804 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 11.5 Cg_endo -59.16 121.11 9.38 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.703 2.269 . . . . 0.0 110.877 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.475 ' HG2' ' HD2' ' A' ' 17' ' ' ARG . 36.7 mt-10 -40.11 -38.94 0.81 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.125 170.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.97 -48.74 75.27 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.873 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.804 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.5 tt -64.68 -42.9 95.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 110.035 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.7 m -68.96 -30.96 69.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.937 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.61 -33.79 76.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.949 0.88 . . . . 0.0 110.503 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 m -74.68 -17.01 60.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.765 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -101.16 -42.91 6.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.735 0.779 . . . . 0.0 109.924 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.8 m -71.88 -47.91 49.47 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.852 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.15 -18.66 15.86 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 41.2 t -66.42 143.37 57.16 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.7 pt -103.34 149.8 7.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 111.871 -173.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.413 HD11 ' CE1' ' A' ' 13' ' ' PHE . 65.6 mt -125.59 124.98 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.037 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.5 pt -122.25 158.55 55.34 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.926 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.0 23.03 0.86 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.229 2.619 . . . . 0.0 112.584 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.03 -154.33 6.85 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.32 60.43 1.7 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.414 0.626 . . . . 0.0 110.218 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 m -85.36 -6.64 59.21 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.87 0.843 . . . . 0.0 110.917 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.9 m -85.22 122.22 73.87 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.504 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.533 ' HD2' ' CZ ' ' A' ' 44' ' ' TYR . 55.9 Cg_endo -72.03 172.31 14.95 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.602 2.202 . . . . 0.0 110.905 169.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.69 38.1 3.26 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.185 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.515 ' OD1' ' HG2' ' A' ' 41' ' ' PRO . 12.6 p-10 -111.84 -31.63 6.88 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.533 ' CZ ' ' HD2' ' A' ' 41' ' ' PRO . 2.4 p90 -122.77 18.6 10.26 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.7 0.762 . . . . 0.0 110.23 175.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.0 24.31 13.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.559 170.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.7 t30 . . . . . 0 C--O 1.245 0.838 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.305 -172.755 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.5 HG22 HD11 ' A' ' 35' ' ' ILE . 10.2 m . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.799 0.333 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.661 HG22 ' SG ' ' A' ' 32' ' ' CYS . 80.8 m -132.71 136.49 46.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.701 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.625 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 26.9 m -127.49 138.33 52.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.498 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 52.6 m -106.16 160.31 26.62 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.19 -171.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.412 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 92.8 Cg_endo -89.78 24.99 0.6 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.613 2.209 . . . . 0.0 113.009 174.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.5 t -172.49 136.05 0.75 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -64.0 -29.27 46.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.563 0.697 . . . . 0.0 109.833 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -71.02 -33.82 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.43 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.468 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -71.7 -45.35 62.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.057 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' NH2' ' HA ' ' A' ' 3' ' ' CYS . 8.0 tpp180 -53.96 -39.14 65.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.135 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' HG23 ' A' ' 15' ' ' VAL . 36.6 t -63.04 -52.7 61.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.408 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 10.7 p30 -74.72 -23.83 58.65 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.551 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.576 ' CZ ' ' HB ' ' A' ' 2' ' ' THR . 25.9 t80 -55.1 -50.5 69.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.2 170.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -59.54 -38.53 81.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.424 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 11' ' ' SER . 87.2 t -63.29 -39.33 84.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.532 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.574 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 11.5 t -76.73 -31.59 57.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.956 0.408 . . . . 0.0 110.485 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -78.49 -13.67 59.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.189 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.567 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 13.6 mt -63.6 -54.49 42.44 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 7.5 Cg_exo -74.56 18.36 0.5 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.684 2.256 . . . . 0.0 113.282 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.89 33.71 12.11 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.082 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.7 m -99.53 133.36 21.94 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.78 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -57.69 122.71 12.22 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.562 2.175 . . . . 0.0 110.695 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -43.67 -33.27 1.17 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.764 170.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.633 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -56.17 -53.23 59.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 173.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.78 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.6 tt -61.47 -46.68 89.03 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.881 0.372 . . . . 0.0 110.227 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.6 m -65.6 -38.32 89.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.325 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 32' ' ' CYS . . . -61.77 -33.67 74.5 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.627 0.727 . . . . 0.0 111.133 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.9 m -74.35 -18.96 60.61 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.947 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -100.64 -40.11 7.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.768 0.794 . . . . 0.0 109.634 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.6 m -74.74 -31.37 61.8 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.196 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.64 14.66 42.94 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -172.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.661 ' SG ' HG22 ' A' ' 2' ' ' THR . 6.1 t -87.97 167.6 13.57 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.4 pt -133.48 138.03 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 118.559 0.618 . . . . 0.0 112.272 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.633 HD11 ' HA ' ' A' ' 24' ' ' ALA . 4.3 mp -81.76 142.57 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.678 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.5 HD11 HG22 ' A' ' 1' ' ' THR . 0.2 OUTLIER -122.93 148.15 53.21 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 176.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.8 -40.12 47.41 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.959 2.439 . . . . 0.0 112.79 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -113.61 -138.78 7.08 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.076 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.68 9.92 15.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.29 0.567 . . . . 0.0 110.034 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -96.29 107.61 19.99 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.95 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.4 m -104.16 134.15 19.85 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.953 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.664 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 10.0 Cg_endo -52.99 145.88 39.5 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.873 2.382 . . . . 0.0 111.495 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.2 -34.94 63.38 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 114.347 0.499 . . . . 0.0 114.347 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.71 -20.25 39.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.43 0.633 . . . . 0.0 109.901 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.664 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 9.6 m-85 -119.21 26.18 9.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.892 -173.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.91 22.07 6.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.247 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.57 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 45.9 m-80 . . . . . 0 C--O 1.243 0.729 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.56 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.902 0.382 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.447 ' OG1' HG12 ' A' ' 34' ' ' ILE . 44.1 m -86.49 97.29 10.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.308 0.575 . . . . 0.0 110.742 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 84.2 m -89.86 100.09 12.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.575 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 20.5 t -105.75 135.63 19.37 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.879 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 72.7 Cg_endo -76.83 23.49 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.711 2.274 . . . . 0.0 114.004 -174.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.634 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 31.2 t -162.47 145.83 11.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.492 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 58.2 mt -76.11 -26.39 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.65 -46.3 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.722 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 6' ' ' SER . . . -62.11 -41.51 98.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.816 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.61 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 7.1 ptp180 -72.47 -24.3 61.17 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.254 0.55 . . . . 0.0 110.182 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.491 ' O ' HG23 ' A' ' 15' ' ' VAL . 32.7 t -68.41 -47.3 67.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.725 173.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.37 -33.03 71.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.066 0.46 . . . . 0.0 110.163 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.548 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 38.9 t80 -54.99 -53.19 58.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.37 172.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -61.65 -39.99 93.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.029 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 11' ' ' SER . 90.1 t -59.72 -42.22 87.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.209 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.553 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.1 t -74.35 -34.44 63.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.292 0.567 . . . . 0.0 110.577 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.509 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 16.2 tpt180 -60.35 -44.44 95.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.982 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.587 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 60.8 mt -52.94 -53.53 54.02 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 33.5 Cg_exo -60.78 -16.83 46.56 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.582 2.188 . . . . 0.0 113.808 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.32 30.66 2.61 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.285 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.549 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.5 OUTLIER -97.85 139.17 21.15 Favored Pre-proline 0 N--CA 1.431 -1.39 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.717 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -56.89 118.05 4.84 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.045 2.497 . . . . 0.0 111.113 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.509 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 15.1 pt-20 -44.79 -32.55 1.58 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.951 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.8 -48.3 82.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.925 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.717 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -64.96 -47.4 77.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.003 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.431 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 20.8 m -60.93 -39.62 90.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.108 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.15 -55.46 28.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.817 0.817 . . . . 0.0 110.832 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 m -62.56 -25.72 68.21 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.843 -1.526 . . . . 0.0 112.57 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -90.84 -20.03 22.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.844 0.83 . . . . 0.0 109.816 -172.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 m -102.76 -27.77 12.49 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.463 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.18 2.1 13.84 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.132 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.5 m -88.12 154.39 20.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.7 pt -128.62 144.36 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.986 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.447 HG12 ' OG1' ' A' ' 2' ' ' THR . 63.3 mt -106.38 121.57 59.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.571 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.861 HG22 ' H ' ' A' ' 37' ' ' GLY . 5.0 mp -106.42 131.28 21.85 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.645 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.97 -15.88 52.66 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.82 2.346 . . . . 0.0 112.248 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.861 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -99.37 -142.57 13.38 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.96 15.27 1.53 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.051 0.453 . . . . 0.0 110.803 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -103.13 106.53 17.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.391 0.615 . . . . 0.0 110.781 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.2 p -143.96 146.0 32.51 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.389 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.86 166.7 13.45 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.743 2.295 . . . . 0.0 112.56 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.97 2.96 39.78 Favored Glycine 0 CA--C 1.518 0.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.257 -170.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -97.69 -12.67 22.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.631 0.715 . . . . 0.0 109.334 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.485 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 21.0 m-85 -105.82 -14.07 15.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.078 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.11 19.75 5.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.278 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.526 -178.589 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.976 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 17.7 m . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.811 0.338 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.2 m -126.34 126.67 44.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.57 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 73.8 m -128.05 130.44 48.26 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -171.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.666 ' HB2' ' HB2' ' A' ' 10' ' ' ARG . 63.3 m -136.0 140.88 34.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 171.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 10.6 Cg_exo -72.0 15.36 0.39 Allowed 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.087 2.525 . . . . 0.0 114.398 -173.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.2 m -159.27 145.16 16.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.776 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.8 mp -58.11 -38.75 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.54 0.686 . . . . 0.0 109.688 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.34 -42.24 65.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.223 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.38 -33.75 76.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.799 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.666 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -76.38 -27.85 56.52 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.395 0.617 . . . . 0.0 110.003 -179.367 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 15' ' ' VAL . 36.2 m -72.78 -38.01 67.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.958 172.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -59.21 -30.11 67.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.965 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.42 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 65.7 t80 -53.41 -53.88 44.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.343 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -65.57 -29.2 69.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.949 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 11' ' ' SER . 76.8 t -65.46 -31.19 52.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.829 0.347 . . . . 0.0 110.524 177.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 42.8 t -92.2 -0.95 57.4 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.066 0.936 . . . . 0.0 109.822 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -92.43 -29.63 16.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.885 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.522 ' HG ' ' CD ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -61.08 -47.31 95.47 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.661 178.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.522 ' CD ' ' HG ' ' A' ' 18' ' ' LEU . 14.5 Cg_exo -70.73 -3.11 11.99 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.15 1.9 . . . . 0.0 112.807 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.05 33.51 14.82 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.955 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.576 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 1.7 m -95.37 143.78 26.69 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.677 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 12.4 Cg_endo -61.9 121.29 9.29 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.786 2.324 . . . . 0.0 110.96 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 1.7 mp0 -39.5 -36.93 0.42 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.068 171.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.87 -49.18 76.28 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.399 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.677 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.2 tt -68.08 -38.84 82.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.354 0.597 . . . . 0.0 109.737 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.537 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 13.0 m -76.14 4.01 9.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.326 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.615 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -101.33 -21.47 14.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.592 0.711 . . . . 0.0 110.315 173.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 m -76.98 -42.3 39.48 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.921 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -86.55 -23.15 25.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.746 0.784 . . . . 0.0 110.535 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.583 ' HB ' ' SG ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -99.9 1.8 43.14 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.798 -174.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.48 33.6 86.86 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.126 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.615 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 75.0 m -102.13 165.13 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.95 0.405 . . . . 0.0 110.744 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' A' ' 3' ' ' CYS . 12.6 pt -139.12 147.98 24.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.396 177.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.77 127.37 56.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.582 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.976 ' HB ' ' HB ' ' A' ' 1' ' ' THR . 8.6 mm -115.69 113.16 42.64 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.627 -175.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -71.17 -16.73 31.72 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.176 2.584 . . . . 0.0 111.541 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.488 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -124.35 -139.8 5.4 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.114 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -124.04 25.47 7.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.4 0.619 . . . . 0.0 110.329 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 m -81.81 42.0 0.68 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.877 0.846 . . . . 0.0 110.866 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.543 ' HB2' HG13 ' A' ' 35' ' ' ILE . 53.3 t -134.56 120.09 14.39 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.203 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.4 169.97 20.22 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.741 2.294 . . . . 0.0 112.168 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.66 16.32 4.18 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.078 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -100.31 -17.08 17.46 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.57 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 15.9 m-85 -113.96 -14.18 12.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.45 176.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.73 29.09 5.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.37 0.605 . . . . 0.0 110.047 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.41 ' C ' HH21 ' A' ' 10' ' ' ARG . 2.4 t-20 . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.109 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.472 ' OG1' ' HA ' ' A' ' 38' ' ' ALA . 23.6 m . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.047 0.451 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.736 HG23 HG12 ' A' ' 34' ' ' ILE . 9.8 m -89.35 110.22 21.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.423 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 87.5 m -127.72 167.53 16.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.042 -177.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.699 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 9.8 t -138.93 149.42 61.63 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 6.1 Cg_exo -41.06 -37.91 2.84 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.23 3.287 . . . . 0.0 115.31 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 p -169.36 173.02 6.82 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.309 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.721 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 60.3 mt -61.63 -40.15 85.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.53 177.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.89 -53.2 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.434 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.02 88.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.471 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.721 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -69.7 -25.91 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 0.0 110.949 -177.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.5 m -75.13 -12.78 60.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.013 0.435 . . . . 0.0 110.914 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -94.1 -8.2 40.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.8 0.81 . . . . 0.0 109.452 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 65.0 t80 -88.34 -58.06 2.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.625 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -61.22 -37.99 85.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.179 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.92 -18.85 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.062 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.0 t -78.72 -26.14 44.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.876 -0.515 . . . . 0.0 110.19 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.573 ' CD ' ' HB3' ' A' ' 23' ' ' GLU . 51.5 mtm180 -74.18 -29.12 61.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.974 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.4 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 94.8 mt -51.15 -53.07 52.63 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -175.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 37.8 Cg_endo -67.87 -6.27 16.53 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.974 1.783 . . . . 0.0 113.719 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.03 30.93 3.49 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.475 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -101.8 133.26 20.86 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.865 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.5 Cg_endo -63.58 127.72 20.52 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.576 2.184 . . . . 0.0 110.282 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.659 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 9.8 pt-20 -51.6 -27.54 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.422 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.3 85.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.953 0.406 . . . . 0.0 110.137 172.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.865 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -66.07 -42.64 89.15 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.169 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.484 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 37.5 m -69.24 -31.74 70.49 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.663 -176.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.27 -36.31 83.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.127 0.965 . . . . 0.0 110.123 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 m -77.75 -18.41 56.52 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.207 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -104.33 -54.82 2.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.636 0.731 . . . . 0.0 109.765 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.2 m -63.01 -52.88 61.23 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.608 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.51 1.43 4.27 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.968 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 13' ' ' PHE . 27.1 m -74.36 164.31 26.75 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 3' ' ' CYS . 2.8 pp -124.58 149.14 28.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.372 0.606 . . . . 0.0 112.412 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.736 HG12 HG23 ' A' ' 2' ' ' THR . 74.2 mt -127.13 112.16 27.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.113 174.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.53 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.5 pp -122.14 135.44 25.42 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 10.1 Cg_exo -68.7 79.43 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.436 2.757 . . . . 0.0 111.659 174.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.46 -149.59 6.23 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.472 ' HA ' ' OG1' ' A' ' 1' ' ' THR . . . -142.98 10.34 1.75 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.94 0.4 . . . . 0.0 111.4 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.8 m -146.85 103.61 3.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.614 0.721 . . . . 0.0 110.412 176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 5.8 p -78.77 152.57 77.67 Favored Pre-proline 0 C--N 1.308 -1.227 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.337 175.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.658 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 18.6 Cg_endo -60.26 153.12 61.66 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.142 2.561 . . . . 0.0 112.7 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.45 6.2 39.46 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 114.514 0.566 . . . . 0.0 114.514 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -113.05 -3.06 14.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.761 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 15.7 m-30 -134.25 21.85 3.74 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.097 -1.411 . . . . 0.0 109.773 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.7 20.96 5.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -170.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.417 ' C ' HH21 ' A' ' 10' ' ' ARG . 20.4 m120 . . . . . 0 C--O 1.253 1.245 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.55 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.2 t -105.12 124.53 49.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.459 0.647 . . . . 0.0 110.357 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.1 m -112.87 117.49 32.26 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 5.8 t -146.9 105.27 3.91 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.693 ' HG3' ' HA ' ' A' ' 44' ' ' TYR . 44.9 Cg_endo -92.3 38.57 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.985 2.456 . . . . 0.0 114.259 -171.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.754 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 3.6 m -142.28 119.42 11.42 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.923 -174.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.7 mt -50.63 -37.88 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 123.815 0.697 . . . . 0.0 110.885 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.57 -42.71 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.198 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' A' ' 6' ' ' SER . . . -61.12 -48.62 80.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.287 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.754 ' HG3' ' O ' ' A' ' 6' ' ' SER . 28.5 mtt180 -55.96 -32.73 64.12 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.271 0.558 . . . . 0.0 110.134 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 15' ' ' VAL . 50.5 m -72.69 -57.87 3.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.523 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.416 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 9.4 p30 -73.59 -20.75 60.53 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.328 -173.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -51.94 -57.16 10.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.498 173.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 92.0 m-20 -61.87 -37.36 84.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.525 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 11' ' ' SER . 82.0 t -64.74 -26.01 39.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.265 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.6 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 3.6 t -82.68 -36.31 26.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.1 0.476 . . . . 0.0 110.163 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 21' ' ' THR . 62.3 ttt180 -68.95 -45.26 71.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.69 -174.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.534 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 84.6 mt -53.36 -47.82 94.8 Favored Pre-proline 0 N--CA 1.444 -0.734 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.6 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 13.2 Cg_exo -71.04 21.59 0.22 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.488 2.125 . . . . 0.0 113.752 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.16 35.52 8.07 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.089 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 1.7 m -114.14 134.69 22.16 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.765 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.6 Cg_endo -60.74 124.7 15.54 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.452 2.102 . . . . 0.0 110.817 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -44.31 -32.06 1.2 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.867 170.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.67 -50.47 73.74 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.811 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.765 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.9 tt -62.41 -47.1 85.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.4 m -64.63 -34.09 77.46 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.309 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.0 94.65 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.92 0.867 . . . . 0.0 110.528 176.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -72.81 -20.67 61.11 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.121 -1.4 . . . . 0.0 111.147 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -101.38 -37.45 8.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.785 0.802 . . . . 0.0 109.875 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.5 m -80.85 -42.87 20.86 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.987 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.74 -6.67 9.63 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.8 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 4' ' ' CYS . 3.9 m -74.96 157.94 34.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.3 pt -120.39 138.7 50.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.727 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -111.65 112.91 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.178 0.513 . . . . 0.0 110.594 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.5 pt -115.96 150.76 45.59 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.732 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.18 -51.0 8.48 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.297 2.664 . . . . 0.0 112.488 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.63 -139.77 10.52 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.337 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.74 70.8 1.25 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.543 0.687 . . . . 0.0 109.449 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 m -130.63 43.84 3.05 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.595 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 7.4 p -96.12 127.57 40.15 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.478 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 11.7 Cg_endo -53.61 157.37 9.81 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.476 2.784 . . . . 0.0 113.186 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.61 -23.86 55.72 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.446 -0.797 . . . . 0.0 114.682 -172.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -93.09 0.01 57.17 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 117.852 0.826 . . . . 0.0 109.514 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.693 ' HA ' ' HG3' ' A' ' 5' ' ' PRO . 21.0 m-85 -121.57 0.55 9.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.552 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -126.66 54.64 1.58 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.575 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.68 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 10.0 t30 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.022 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 38.1 m . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.013 0.435 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.445 HG21 ' CD2' ' A' ' 13' ' ' PHE . 10.4 t -133.86 158.65 42.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.203 -176.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 93.3 m -137.84 138.97 39.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.214 174.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -134.62 153.29 78.9 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.25 3.86 3.76 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.903 2.402 . . . . 0.0 114.324 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.468 ' HA ' ' OD1' ' A' ' 46' ' ' ASN . 33.1 p -164.17 142.66 7.31 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.358 0.526 . . . . 0.0 111.218 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.582 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 61.8 mt -57.27 -32.3 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.32 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.71 -54.19 30.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.182 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.489 ' HB1' HG22 ' A' ' 30' ' ' THR . . . -68.51 -36.8 79.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.475 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.582 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 13.1 ptm180 -69.11 -24.02 64.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.219 0.533 . . . . 0.0 110.636 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' VAL . 49.2 m -76.86 -40.63 46.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.923 172.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -55.87 -34.31 65.38 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.826 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 23' ' ' GLU . 79.6 t80 -53.57 -57.87 9.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.728 0.775 . . . . 0.0 110.546 174.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -62.04 -34.47 76.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.376 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.646 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 92.7 t -63.51 -34.47 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.355 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.722 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 48.4 t -62.56 -31.78 72.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.293 0.568 . . . . 0.0 111.734 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.967 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 12.0 mmm180 -80.11 -10.97 59.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.13 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.572 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 54.6 mt -71.24 -56.87 5.05 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 15' ' ' VAL . 10.4 Cg_endo -90.01 24.17 0.64 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.474 2.116 . . . . 0.0 113.135 -173.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.81 45.75 26.33 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.781 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.722 ' HB ' ' SG ' ' A' ' 16' ' ' CYS . 1.3 m -114.96 132.85 22.79 Favored Pre-proline 0 N--CA 1.44 -0.934 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.895 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 19.0 Cg_endo -61.05 120.9 8.85 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.132 2.555 . . . . 0.0 111.598 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.967 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -52.38 -29.49 24.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.978 170.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.27 -45.53 87.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.571 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.895 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 2.2 tt -62.55 -51.18 68.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.187 0.517 . . . . 0.0 109.832 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 96.1 m -71.58 -16.06 62.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.79 -15.72 61.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.981 0.896 . . . . 0.0 110.037 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.3 m -101.69 -20.4 15.01 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.189 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.553 ' HB3' ' HA ' ' A' ' 26' ' ' CYS . 26.2 t80 -101.53 -41.96 6.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.885 0.85 . . . . 0.0 110.001 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.489 HG22 ' HB1' ' A' ' 9' ' ' ALA . 21.8 m -89.76 -37.96 14.16 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.557 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.98 12.75 26.95 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.308 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 55.7 m -81.38 153.45 26.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.837 0.318 . . . . 0.0 110.268 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 pt -117.22 139.79 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.681 0.276 . . . . 0.0 110.838 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.9 mp -96.54 131.9 42.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.136 176.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.425 ' O ' ' HB ' ' A' ' 1' ' ' THR . 2.3 pp -141.5 155.44 67.15 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.513 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.54 -51.83 8.32 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.937 2.425 . . . . 0.0 112.384 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.05 141.56 3.36 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.733 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 59.25 17.0 5.36 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 172.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -108.92 54.24 0.66 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.83 0.824 . . . . 0.0 110.535 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.1 m -130.96 123.03 19.68 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.2 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.03 168.33 25.06 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.573 2.182 . . . . 0.0 111.787 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.67 9.5 10.75 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.382 -0.437 . . . . 0.0 113.683 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -101.13 -16.48 17.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.576 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 20.9 m-85 -122.99 14.62 9.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.145 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.12 21.32 17.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.004 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 6' ' ' SER . 22.3 t-20 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.318 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.542 HG21 ' HA ' ' A' ' 38' ' ' ALA . 19.9 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.653 0.263 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 m -112.91 125.93 54.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.321 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 73.6 m -127.97 151.57 48.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.396 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.526 ' HB2' ' HD3' ' A' ' 10' ' ' ARG . 60.1 m -125.39 142.95 43.12 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.32 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.659 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 2.3 Cg_endo -83.99 5.56 6.27 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.081 2.521 . . . . 0.0 114.535 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 56.6 p -158.13 151.03 22.68 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.799 -0.563 . . . . 0.0 110.605 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.7 mt -67.84 -30.77 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.96 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.51 -46.87 74.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.011 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.447 ' HA ' HD21 ' A' ' 12' ' ' ASN . . . -64.08 -49.71 71.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.093 176.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.526 ' HD3' ' HB2' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -49.19 -40.45 33.4 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.462 176.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.421 ' O ' HG23 ' A' ' 15' ' ' VAL . 13.6 t -65.79 -58.43 5.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.459 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.447 HD21 ' HA ' ' A' ' 9' ' ' ALA . 9.9 p30 -69.74 -23.07 63.33 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.541 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.433 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 45.0 t80 -60.13 -58.63 7.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.326 174.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -65.25 -30.7 71.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.401 . . . . 0.0 110.286 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 11' ' ' SER . 61.6 t -74.42 -14.9 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.805 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.693 ' O ' ' HB ' ' A' ' 21' ' ' THR . 49.2 t -91.36 -11.37 38.06 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.861 -0.524 . . . . 0.0 110.562 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.593 ' HD2' ' HB3' ' A' ' 23' ' ' GLU . 4.6 ptm180 -112.32 -22.09 11.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.782 0.801 . . . . 0.0 109.816 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -45.26 95.89 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 114.198 -1.364 . . . . 0.0 112.121 174.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.21 -12.8 30.52 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.923 1.748 . . . . 0.0 112.814 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.53 7.78 23.76 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.803 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.693 ' HB ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -77.81 138.96 61.83 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.039 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.642 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.7 Cg_endo -58.52 115.66 2.7 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 122.859 2.373 . . . . 0.0 111.565 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.593 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 10.5 pt-20 -55.16 -22.62 17.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.643 171.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.449 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -59.74 -49.45 77.66 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.256 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.642 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.2 tt -67.72 -43.48 79.9 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 110.304 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.0 m -68.18 -25.9 65.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.823 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.24 -30.37 70.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.655 0.741 . . . . 0.0 110.731 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.7 m -74.65 -26.16 59.68 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.985 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -102.13 -50.23 3.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.532 0.682 . . . . 0.0 109.905 -173.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.3 m -63.36 -42.81 98.91 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.597 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.62 8.91 17.92 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.526 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 58.6 m -81.98 163.47 22.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.3 pt -127.26 143.48 40.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.684 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 24' ' ' ALA . 55.1 mt -106.41 118.44 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.313 177.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.585 HD11 ' SG ' ' A' ' 40' ' ' CYS . 21.3 pt -128.89 148.17 67.68 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.947 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.66 67.07 8.51 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.83 2.353 . . . . 0.0 112.46 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.68 149.12 5.18 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.542 ' HA ' HG21 ' A' ' 1' ' ' THR . . . -81.94 30.19 0.39 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.144 0.497 . . . . 0.0 110.906 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 m -85.13 30.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.617 0.722 . . . . 0.0 111.192 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.585 ' SG ' HD11 ' A' ' 35' ' ' ILE . 66.7 m -69.16 119.34 69.52 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.346 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.543 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 11.6 Cg_endo -57.66 156.33 27.82 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.668 2.245 . . . . 0.0 111.805 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.98 -8.45 35.31 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 114.344 0.498 . . . . 0.0 114.344 -170.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -100.74 -21.27 15.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.562 0.681 . . . . 0.0 109.696 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.659 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 20.7 m-85 -108.37 8.28 27.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.045 -177.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.33 24.66 12.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.028 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.8 t30 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.191 -176.633 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.473 0.679 0 CA-C-O 120.84 0.352 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t -104.9 130.56 53.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.008 0.432 . . . . 0.0 110.017 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 25.1 m -118.02 132.43 56.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.984 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 5.9 t -152.43 120.16 3.18 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 84.7 Cg_endo -90.04 35.4 0.34 Allowed 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.078 2.519 . . . . 0.0 114.209 -170.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 t -162.47 139.98 8.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.1 mt -74.72 -23.99 18.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.6 t -73.11 -44.24 56.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.086 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -44.21 74.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.227 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -55.13 -38.15 67.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.159 175.529 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 15' ' ' VAL . 22.7 t -61.04 -53.93 51.05 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.961 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -53.28 -35.55 60.2 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.31 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -62.97 -59.06 5.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.224 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.27 -34.12 74.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.17 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 11' ' ' SER . 77.2 t -62.83 -28.57 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.161 0.505 . . . . 0.0 110.829 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.571 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 32.2 t -89.71 -32.08 17.18 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.85 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.704 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 36.8 tpt85 -70.25 -36.2 74.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.725 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.546 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 27.7 mt -60.23 -49.37 91.03 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -175.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 20.4 Cg_exo -68.34 11.93 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.554 2.17 . . . . 0.0 113.428 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.27 40.03 11.88 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.429 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.494 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 1.1 m -104.94 140.0 20.65 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.716 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.0 Cg_endo -56.56 118.57 5.43 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.881 2.388 . . . . 0.0 111.021 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.704 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 8.8 pt-20 -51.36 -29.4 15.26 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.104 171.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.22 -43.56 87.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.686 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.716 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -70.95 -52.41 20.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.916 0.389 . . . . 0.0 110.061 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.428 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 10.9 m -60.52 -38.12 83.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.783 -173.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.06 -58.83 5.51 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.685 0.755 . . . . 0.0 111.218 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -64.55 -21.21 66.63 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.543 -172.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -84.61 -38.34 20.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 122.14 0.971 . . . . 0.0 109.25 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.9 m -81.02 -44.08 18.62 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.881 -1.508 . . . . 0.0 111.722 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.07 -13.16 4.12 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.704 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 4' ' ' CYS . 3.3 m -75.69 157.81 33.14 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.6 pt -125.43 161.54 29.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.188 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.0 mt -128.11 125.04 63.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.273 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.907 HD12 ' HB3' ' A' ' 38' ' ' ALA . 2.7 pt -136.03 146.56 57.12 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.624 -177.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 31.5 Cg_exo -57.69 -55.78 2.17 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.082 2.521 . . . . 0.0 111.91 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.36 -138.79 6.63 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.907 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . 62.55 81.06 0.21 Allowed 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.677 0.751 . . . . 0.0 110.754 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 m -68.1 97.24 0.68 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.722 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.793 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . 72.2 m -62.73 135.43 95.81 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.795 176.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 19.6 Cg_endo -60.64 178.24 0.5 Allowed 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.985 2.457 . . . . 0.0 112.972 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.81 -0.91 28.74 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 114.816 0.686 . . . . 0.0 114.816 -171.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -99.69 -11.15 21.14 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 118.171 0.985 . . . . 0.0 109.306 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.793 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 18.6 m-85 -106.13 -20.69 13.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.545 173.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.53 36.11 1.18 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.783 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.4 t30 . . . . . 0 C--O 1.244 0.792 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.143 -175.995 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 94.3 m . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 121.096 0.474 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.4 HG21 ' CE2' ' A' ' 13' ' ' PHE . 26.2 m -108.6 124.71 50.91 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.82 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 65.4 m -125.7 120.56 31.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.163 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.4 m -104.93 162.82 18.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.731 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.17 -0.56 10.0 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.275 1.983 . . . . 0.0 115.526 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t -170.59 148.7 3.09 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.547 1.067 . . . . 0.0 111.948 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.77 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 29.3 mm -59.84 -35.71 62.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.466 0.65 . . . . 0.0 109.965 172.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -71.97 -42.83 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.767 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.809 ' HB1' HG23 ' A' ' 30' ' ' THR . . . -71.48 -41.15 69.7 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.901 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.77 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.6 OUTLIER -66.73 -28.98 68.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.179 0.514 . . . . 0.0 109.845 178.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.501 ' O ' HG23 ' A' ' 15' ' ' VAL . 37.8 t -64.29 -53.28 51.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.547 172.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -52.9 -41.01 63.99 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.555 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.649 ' HA ' ' SG ' ' A' ' 26' ' ' CYS . 58.8 t80 -54.93 -55.76 27.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.945 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 11' ' ' SER . 10.9 p30 -70.28 -25.78 63.5 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.439 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.6 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 47.4 t -65.09 -37.89 81.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.676 174.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.599 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 86.1 m -61.2 -26.84 68.0 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.261 0.553 . . . . 0.0 111.654 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 17' ' ' ARG . 26.0 mmm180 -76.34 -29.65 57.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.622 -176.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.884 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -61.97 -44.58 90.38 Favored Pre-proline 0 CA--C 1.549 0.916 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.298 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.884 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 4.1 Cg_exo -78.5 -30.13 3.36 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 122.101 1.868 . . . . 0.0 112.279 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.5 13.97 2.23 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.1 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 7.0 m -72.34 126.92 90.83 Favored Pre-proline 0 N--CA 1.443 -0.8 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.898 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -57.96 126.42 21.6 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 122.133 1.889 . . . . 0.0 109.932 175.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.72 -37.99 1.34 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.038 171.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.74 -46.63 88.55 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.388 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.898 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 2.3 tt -61.46 -46.52 89.69 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.94 0.4 . . . . 0.0 110.142 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.649 ' SG ' ' HA ' ' A' ' 13' ' ' PHE . 10.9 t -70.14 -26.67 64.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.948 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.06 -19.47 64.88 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.751 0.786 . . . . 0.0 110.731 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.3 m -88.16 -23.82 23.52 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.691 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -96.41 -49.41 5.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.718 0.771 . . . . 0.0 109.84 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.809 HG23 ' HB1' ' A' ' 9' ' ' ALA . 12.8 m -69.8 -29.45 66.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.721 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.77 20.47 65.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.576 -177.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.1 t -90.65 145.9 24.46 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.7 pt -111.73 135.7 50.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.598 . . . . 0.0 112.216 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.7 mt -108.88 104.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.041 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.586 HD11 ' SG ' ' A' ' 40' ' ' CYS . 27.8 pt -123.42 149.56 58.5 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.244 -173.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.0 20.18 1.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.719 2.28 . . . . 0.0 112.466 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.4 -153.05 6.0 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.706 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.9 23.22 6.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.911 0.386 . . . . 0.0 111.062 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 m -77.11 57.03 1.33 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.68 0.753 . . . . 0.0 111.032 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.586 ' SG ' HD11 ' A' ' 35' ' ' ILE . 28.4 m -110.96 104.69 56.51 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.328 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 40' ' ' CYS . 29.3 Cg_endo -64.17 166.87 15.65 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.498 2.132 . . . . 0.0 111.847 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.45 -30.69 65.33 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.38 -0.438 . . . . 0.0 114.049 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.18 -26.56 30.75 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.337 0.589 . . . . 0.0 109.855 -176.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.511 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 14.1 m-85 -113.14 21.99 14.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.765 -171.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 3' ' ' CYS . . . -112.75 30.07 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.526 0.679 . . . . 0.0 109.47 175.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 . . . . . 0 C--O 1.247 0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.263 -176.972 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.439 HG23 HG13 ' A' ' 35' ' ' ILE . 3.6 t . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.436 0.636 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.557 ' HB ' ' CZ ' ' A' ' 13' ' ' PHE . 78.2 m -134.52 141.61 46.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.006 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 65.8 m -116.15 126.78 54.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.811 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 10' ' ' ARG . 63.7 m -118.6 117.35 34.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.904 176.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.39 25.97 0.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.727 2.284 . . . . 0.0 112.802 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -153.04 134.8 14.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.565 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 33.3 mt -60.66 -37.12 74.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.048 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.0 t -72.65 -49.05 43.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.193 0.52 . . . . 0.0 110.127 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.72 -46.23 77.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.988 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -68.11 -29.75 68.74 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 -175.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 15' ' ' VAL . 58.6 m -62.38 -59.06 5.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.946 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -69.7 -25.71 64.0 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.523 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.557 ' CZ ' ' HB ' ' A' ' 2' ' ' THR . 3.9 t80 -58.96 -48.5 81.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.015 172.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.85 -39.49 90.81 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.071 0.463 . . . . 0.0 110.207 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 11' ' ' SER . 43.1 t -69.89 -20.52 23.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.977 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.811 ' O ' ' HB ' ' A' ' 21' ' ' THR . 25.4 t -91.44 -2.93 57.11 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.799 0.809 . . . . 0.0 109.693 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -109.42 -29.5 8.4 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.819 0.818 . . . . 0.0 109.281 -172.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -48.43 92.72 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.855 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.78 -18.65 58.58 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 122.225 1.95 . . . . 0.0 113.282 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.99 12.69 7.57 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.495 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.811 ' HB ' ' O ' ' A' ' 16' ' ' CYS . 3.6 m -85.64 136.31 37.21 Favored Pre-proline 0 N--CA 1.433 -1.31 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.746 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.3 Cg_endo -58.63 118.67 5.6 Favored 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 122.816 2.344 . . . . 0.0 111.389 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HB2' ' HE1' ' A' ' 13' ' ' PHE . 10.2 pt-20 -42.36 -31.63 0.43 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.912 168.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.6 -51.49 69.59 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.847 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.746 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 3.0 tt -59.41 -44.96 92.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.223 0.535 . . . . 0.0 109.951 177.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.7 m -66.92 -42.09 85.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.897 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -57.8 -47.25 83.12 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.396 0.617 . . . . 0.0 111.823 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 m -63.0 -29.21 70.65 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.318 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -95.11 -48.11 6.09 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.614 0.721 . . . . 0.0 109.52 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.7 m -61.84 -38.33 87.81 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.751 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.66 -4.05 11.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.094 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 58.8 m -73.1 168.79 18.36 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.853 0.359 . . . . 0.0 110.196 176.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 40.0 pt -122.53 132.48 71.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.009 0.433 . . . . 0.0 110.762 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 16.5 tt -95.92 139.0 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.403 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.657 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 20.0 pt -121.56 173.01 4.33 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.657 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 73.6 Cg_endo -80.41 -24.09 5.63 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.638 1.558 . . . . 0.0 113.719 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -153.01 -138.15 2.65 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.971 -1.109 . . . . 0.0 113.856 -171.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.38 13.69 33.12 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -83.24 77.2 9.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.732 0.777 . . . . 0.0 110.319 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.554 ' HB2' HD13 ' A' ' 35' ' ' ILE . 30.7 t -155.84 129.28 4.48 Favored Pre-proline 0 C--N 1.311 -1.074 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.087 -178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.05 163.16 31.14 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.61 2.207 . . . . 0.0 112.451 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.539 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -73.81 8.82 9.96 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.537 -176.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.31 -27.79 21.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.404 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 9.9 m-85 -105.61 -7.14 18.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.658 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.539 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -94.1 40.05 1.08 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.926 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--O 1.251 1.14 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.604 178.263 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 6.4 m . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 121.621 0.724 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.4 m -111.44 132.12 54.7 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.682 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.435 ' HB2' HG13 ' A' ' 33' ' ' ILE . 63.6 m -138.71 153.95 48.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.015 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 9' ' ' ALA . 14.7 t -150.06 133.24 8.5 Favored Pre-proline 0 N--CA 1.447 -0.589 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.568 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 9.9 Cg_exo -73.1 -6.12 18.38 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.927 2.418 . . . . 0.0 114.797 -174.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.9 p -163.75 153.54 14.85 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.679 0.672 . . . . 0.0 110.836 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.3 mt -66.41 -30.47 49.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.308 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.49 -46.81 91.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.116 0.484 . . . . 0.0 110.135 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.464 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . . . -63.24 -47.42 82.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.728 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -50.48 -41.21 52.83 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.288 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 15' ' ' VAL . 75.7 m -59.96 -56.47 21.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.458 0.17 . . . . 0.0 111.458 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.437 HD21 ' HA ' ' A' ' 9' ' ' ALA . 9.3 p30 -75.55 -20.52 58.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.755 -175.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.577 ' HB2' HG21 ' A' ' 30' ' ' THR . 65.0 t80 -57.12 -55.42 34.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.592 170.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.567 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 1.7 t-20 -56.32 -41.62 76.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.634 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 11' ' ' SER . 89.8 t -56.86 -30.26 32.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.619 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.504 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.1 t -81.17 -34.14 32.58 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.973 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.691 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 73.5 ttt180 -71.25 -30.65 66.57 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 14' ' ' ASN . 83.2 mt -48.22 -52.45 41.83 Favored Pre-proline 0 N--CA 1.444 -0.736 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -175.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 54.7 Cg_endo -71.0 3.19 3.52 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.007 1.805 . . . . 0.0 113.617 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.06 27.45 6.24 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.34 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.575 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 1.2 m -94.44 137.12 22.76 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.815 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.1 Cg_endo -62.36 126.4 18.42 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.905 2.404 . . . . 0.0 110.478 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.691 ' HG2' ' HD2' ' A' ' 17' ' ' ARG . 37.8 mt-10 -41.5 -38.41 1.29 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.342 173.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.38 82.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.578 0.228 . . . . 0.0 111.2 177.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.815 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.3 tt -64.55 -43.22 94.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.575 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 58.1 m -69.06 -26.2 64.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.593 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.19 -28.95 68.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.224 1.011 . . . . 0.0 110.328 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.4 m -82.39 -19.91 38.19 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.241 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -98.2 -46.09 5.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.02 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.577 HG21 ' HB2' ' A' ' 13' ' ' PHE . 15.7 m -76.16 -61.88 1.79 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.282 -1.327 . . . . 0.0 112.552 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.83 -16.55 3.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.348 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.568 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 32.7 m -65.17 152.88 42.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 3' ' ' CYS . 32.8 pt -113.78 136.71 49.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.077 -174.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 mm -98.44 135.13 34.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.459 HD13 ' SG ' ' A' ' 40' ' ' CYS . 45.3 pt -124.4 150.33 63.99 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.477 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.48 56.99 5.3 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.411 2.074 . . . . 0.0 111.639 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 1' ' ' THR . . . 172.38 -141.05 6.05 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.19 14.75 0.52 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 m -94.67 102.03 13.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.152 0.501 . . . . 0.0 111.433 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.459 ' SG ' HD13 ' A' ' 35' ' ' ILE . 67.9 m -142.18 124.05 8.92 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.654 175.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 59.0 Cg_endo -71.92 -173.94 1.2 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.886 2.39 . . . . 0.0 112.395 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.29 -19.59 66.52 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -168.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -88.23 -15.35 36.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.607 0.704 . . . . 0.0 109.677 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.41 ' HD2' ' HD2' ' A' ' 41' ' ' PRO . 17.3 m-85 -116.42 -1.6 12.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.897 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.22 32.55 4.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.049 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.718 178.045 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.637 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 33.1 m . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 120.894 0.378 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.6 m -126.77 139.97 52.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.107 0.479 . . . . 0.0 111.262 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 32' ' ' CYS . 55.8 m -111.99 96.51 6.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.066 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.592 ' HA ' ' CB ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -106.2 126.08 31.43 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.64 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 65.5 Cg_endo -88.03 31.69 0.42 Allowed 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.105 2.537 . . . . 0.0 114.8 -167.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.435 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 23.9 t -163.93 143.39 7.98 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 122.075 -0.391 . . . . 0.0 110.567 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.77 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.8 mp -60.8 -36.07 68.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -73.68 -52.6 20.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.634 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.442 ' HA ' HD21 ' A' ' 12' ' ' ASN . . . -57.1 -48.05 79.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.582 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -66.38 -24.43 66.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.227 -176.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 15' ' ' VAL . 69.9 m -70.69 -55.27 9.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.756 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.442 HD21 ' HA ' ' A' ' 9' ' ' ALA . 10.0 p30 -67.47 -23.13 65.47 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.289 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.406 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 43.2 t80 -60.94 -60.8 3.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.006 172.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -69.16 -32.7 72.21 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.776 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 11' ' ' SER . 68.8 t -67.01 -24.49 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.408 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.507 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -72.76 -33.67 66.49 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.836 0.351 . . . . 0.0 110.384 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 21' ' ' THR . 77.6 ttt180 -72.84 -27.53 61.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.348 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.42 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 82.0 mt -54.62 -52.41 70.16 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -175.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 72.1 Cg_endo -75.85 17.35 0.7 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.062 1.841 . . . . 0.0 113.716 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.03 28.59 7.65 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.475 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 1.3 m -103.39 138.96 19.69 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.529 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 24.8 Cg_endo -66.28 128.89 20.29 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.734 2.29 . . . . 0.0 110.532 173.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -46.09 -30.72 2.0 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.876 173.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -53.06 -54.18 39.28 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 174.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.529 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.1 tm? -61.01 -41.53 96.72 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 120.86 0.362 . . . . 0.0 110.847 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.2 m -68.57 -39.66 80.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.369 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.91 73.22 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.765 0.793 . . . . 0.0 110.608 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.8 m -76.51 -21.87 55.18 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.694 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -94.87 -52.53 4.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.103 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 90.5 m -61.2 -41.55 97.02 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.215 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.54 -8.83 13.25 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.223 175.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.592 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 6.3 p -89.42 179.95 5.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.156 0.478 . . . . 0.0 111.671 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -120.93 153.09 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -168.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 24' ' ' ALA . 71.2 mt -109.82 131.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.949 175.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.637 ' O ' ' HB ' ' A' ' 1' ' ' THR . 12.9 pt -135.97 161.35 63.12 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.528 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 73.5 Cg_endo -75.57 1.65 7.77 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.53 2.153 . . . . 0.0 113.623 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.32 -123.47 1.17 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.368 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.535 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . 71.32 -5.8 1.5 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.734 0.814 . . . . 0.0 112.802 173.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 39' ' ' THR . 85.7 m 63.16 10.14 4.38 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.72 0.771 . . . . 0.0 111.823 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.3 m 67.02 141.98 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.642 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 39.8 Cg_endo -70.24 159.1 54.22 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.511 2.14 . . . . 0.0 111.397 171.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.65 85.92 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 114.199 0.44 . . . . 0.0 114.199 -170.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -82.51 -14.15 55.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.325 0.563 . . . . 0.0 110.58 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.64 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 13.5 m-85 -119.34 19.69 12.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.604 -174.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.15 56.56 1.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.185 0.517 . . . . 0.0 110.173 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.425 HD22 ' C ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.705 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.684 HG21 ' HA2' ' A' ' 37' ' ' GLY . 21.1 m . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 120.897 0.379 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.703 HG22 ' SG ' ' A' ' 32' ' ' CYS . 4.0 m -134.48 132.14 38.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.996 -173.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.0 m -127.03 121.08 30.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.874 0.369 . . . . 0.0 110.532 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 13' ' ' PHE . 57.9 m -109.07 121.29 43.28 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.693 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.779 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 87.7 Cg_endo -88.47 30.92 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.817 2.344 . . . . 0.0 114.779 -171.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.597 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 77.9 p -165.78 147.82 7.29 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.387 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -55.74 -37.69 47.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.679 0.612 . . . . 0.0 112.343 -170.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.67 -39.44 22.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.012 0.434 . . . . 0.0 110.029 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.428 ' HA ' ' CG2' ' A' ' 30' ' ' THR . . . -63.64 -45.67 89.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.55 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -55.67 -42.45 75.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 177.263 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 15' ' ' VAL . 49.1 m -64.43 -49.8 70.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.113 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.459 HD22 HG23 ' A' ' 30' ' ' THR . 93.2 m-20 -58.33 -41.41 84.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 110.644 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.567 ' CE1' ' HB ' ' A' ' 2' ' ' THR . 15.0 t80 -50.17 -46.92 54.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.213 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -71.4 -41.3 69.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.832 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 11' ' ' SER . 87.1 t -63.59 -37.36 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.719 -176.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.582 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 92.5 m -69.86 -28.09 65.37 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.498 ' HD2' ' CE1' ' A' ' 13' ' ' PHE . 81.1 mtp180 -84.69 -20.81 30.62 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 121.662 -0.649 . . . . 0.0 111.811 -170.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.921 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -66.49 -44.41 55.83 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.541 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.921 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 89.3 Cg_endo -85.15 -3.8 9.56 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.626 1.55 . . . . 0.0 113.183 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.22 16.8 15.35 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.397 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 3.6 m -78.82 125.32 84.31 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.568 ' HG2' ' HB3' ' A' ' 25' ' ' LEU . 10.2 Cg_endo -55.64 121.63 10.29 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.688 2.259 . . . . 0.0 111.035 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -41.8 -36.46 1.03 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.277 169.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.523 ' HA ' HG13 ' A' ' 34' ' ' ILE . . . -62.09 -45.18 94.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.876 177.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.568 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 35.9 tp -73.52 -41.3 63.21 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 120.905 0.383 . . . . 0.0 110.613 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.3 t -67.43 -35.73 79.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.484 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.595 ' HA ' ' HB3' ' A' ' 32' ' ' CYS . . . -56.28 -53.72 53.94 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.786 0.803 . . . . 0.0 111.124 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.7 m -61.36 -24.8 66.73 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.143 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.16 -41.96 11.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.448 1.118 . . . . 0.0 109.002 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.459 HG23 HD22 ' A' ' 12' ' ' ASN . 90.2 m -76.7 -32.33 57.8 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.26 -174.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.68 -5.76 24.38 Favored Glycine 0 C--O 1.229 -0.196 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -174.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.703 ' SG ' HG22 ' A' ' 2' ' ' THR . 6.4 t -73.86 164.95 25.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.609 -0.796 . . . . 0.0 109.379 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.438 HD13 ' HD2' ' A' ' 44' ' ' TYR . 14.4 pt -122.64 152.23 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.887 -175.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.523 HG13 ' HA ' ' A' ' 24' ' ' ALA . 34.5 mm -104.87 134.28 46.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.777 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.64 ' O ' ' HB ' ' A' ' 1' ' ' THR . 42.0 pt -144.88 162.68 37.13 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.51 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.536 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 14.6 Cg_endo -60.14 -43.46 35.53 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.503 2.135 . . . . 0.0 111.703 174.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.684 ' HA2' HG21 ' A' ' 1' ' ' THR . . . 131.76 136.78 3.91 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.854 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.74 -85.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.4 m -141.77 -3.69 1.12 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.939 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.558 ' SG ' HD11 ' A' ' 35' ' ' ILE . 64.8 m 66.09 139.7 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.676 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HG2' ' HD2' ' A' ' 44' ' ' TYR . 9.3 Cg_endo -53.36 149.55 29.27 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.044 2.496 . . . . 0.0 112.551 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.43 -26.25 64.03 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 114.793 0.677 . . . . 0.0 114.793 -169.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -88.35 -14.36 38.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.658 0.729 . . . . 0.0 110.093 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.705 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 16.6 m-85 -117.97 10.98 13.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.914 -175.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.14 50.89 0.86 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.232 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.779 ' HB3' ' HA ' ' A' ' 5' ' ' PRO . 39.7 t30 . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.587 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 120.977 0.418 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.1 m -106.49 114.01 27.87 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.601 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.459 ' HB2' HD12 ' A' ' 35' ' ' ILE . 81.0 m -128.15 106.43 9.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.566 0.698 . . . . 0.0 111.106 -176.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.719 ' SG ' ' HA ' ' A' ' 10' ' ' ARG . 4.1 m -117.15 157.27 47.25 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.547 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.28 -12.22 33.3 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.815 2.343 . . . . 0.0 114.495 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.2 m -143.96 153.44 42.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.923 -0.486 . . . . 0.0 110.57 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.4 -38.9 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 110.567 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.0 t -80.78 -33.75 13.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.949 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.575 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -63.42 -37.67 88.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.104 176.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.719 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 18.5 ttm-85 -69.89 -27.65 64.98 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.606 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 15' ' ' VAL . 22.8 t -77.8 -46.07 22.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.52 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 11.4 p30 -68.29 -21.62 64.78 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.704 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 31.2 t80 -54.37 -54.29 42.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.734 172.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.2 -34.32 77.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.781 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.563 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 73.3 t -60.65 -37.82 76.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.098 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.518 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 23.3 m -62.08 -38.47 88.95 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.899 0.381 . . . . 0.0 112.016 177.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 mtp85 -75.9 -2.59 30.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.663 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.635 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 18.2 mt -76.33 -59.83 1.01 Allowed Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.899 176.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 6.8 Cg_exo -75.45 -24.17 12.38 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.142 1.895 . . . . 0.0 112.64 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 126.83 16.06 2.51 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.874 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 1.1 m -81.39 127.56 73.11 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.845 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 11.6 Cg_endo -59.42 120.26 7.99 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 122.431 2.087 . . . . 0.0 110.685 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -53.4 -28.09 27.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.225 172.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.81 -48.92 76.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.089 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.845 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -68.92 -41.31 78.32 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.015 0.436 . . . . 0.0 110.424 -179.441 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.51 -28.23 63.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.841 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.65 -37.9 83.06 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.858 0.837 . . . . 0.0 110.42 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 m -69.68 -23.59 63.47 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.417 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -101.22 -49.11 4.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.728 0.775 . . . . 0.0 110.127 -174.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 83.7 m -66.52 -27.46 67.79 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.798 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.82 24.41 42.0 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.622 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.8 t -103.54 150.77 23.61 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.0 pt -124.29 139.76 49.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.348 0.594 . . . . 0.0 111.464 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.0 mt -93.88 115.76 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.935 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.488 HD12 ' SG ' ' A' ' 40' ' ' CYS . 39.0 mt -124.38 139.29 32.61 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.442 -171.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.52 -45.52 22.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.937 2.425 . . . . 0.0 112.405 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' H ' HG22 ' A' ' 35' ' ' ILE . . . 149.79 148.09 4.68 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.955 174.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 76.46 -19.47 0.42 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.77 0.828 . . . . 0.0 112.747 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 39' ' ' THR . 18.0 m -88.24 5.67 40.53 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.006 0.908 . . . . 0.0 110.984 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.788 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 67.6 m -75.04 115.63 46.56 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.09 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 30.3 Cg_endo -65.14 150.59 87.53 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.606 2.204 . . . . 0.0 111.48 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.23 -15.27 60.72 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 114.406 0.522 . . . . 0.0 114.406 -171.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.1 -19.15 18.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.586 0.693 . . . . 0.0 109.61 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.79 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 19.8 m-85 -114.71 19.39 16.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.304 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.788 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . . . -137.95 31.18 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.245 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.44 ' C ' HH21 ' A' ' 10' ' ' ARG . 57.4 t30 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.235 -0.888 . . . . 0.0 109.933 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 6.8 m . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.826 0.346 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.8 m -120.64 108.09 13.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.282 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 78.1 m -98.17 124.83 42.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.297 -177.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 4.1 t -110.91 126.15 29.29 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.732 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 4.3 Cg_endo -85.42 22.95 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.783 2.322 . . . . 0.0 114.222 -170.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 50.8 m -154.83 136.66 14.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 122.07 -0.394 . . . . 0.0 110.072 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.43 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 60.4 mt -65.06 -31.05 52.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.926 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.61 -41.29 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 6' ' ' SER . . . -59.28 -50.31 74.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.815 175.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -63.19 -26.2 68.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.142 0.496 . . . . 0.0 110.485 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 15' ' ' VAL . 19.8 t -68.74 -54.7 14.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.619 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.411 HD21 ' HA ' ' A' ' 9' ' ' ALA . 9.0 p30 -75.09 -24.62 58.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.007 0.432 . . . . 0.0 110.275 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.4 ' HB2' HG21 ' A' ' 30' ' ' THR . 35.0 t80 -54.8 -57.22 12.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.478 174.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.33 -27.71 67.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 110.428 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 11' ' ' SER . 93.6 t -71.41 -18.7 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.567 176.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 4.8 t -83.76 -26.92 29.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.261 0.553 . . . . 0.0 109.669 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.62 ' HG3' ' HB3' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -89.67 -37.97 14.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.557 -171.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.539 ' HG ' ' CD ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -49.64 -45.53 78.8 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 115.007 -0.997 . . . . 0.0 113.538 -179.333 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.539 ' CD ' ' HG ' ' A' ' 18' ' ' LEU . 9.8 Cg_exo -73.06 9.15 1.46 Allowed 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 122.389 2.059 . . . . 0.0 113.961 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.29 34.48 4.2 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.642 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.505 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 1.6 m -115.7 137.37 23.18 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 14.9 Cg_endo -60.55 123.5 13.17 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.484 2.123 . . . . 0.0 110.651 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.62 ' HB3' ' HG3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -47.54 -31.19 4.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.366 172.255 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -54.14 -50.94 65.81 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.475 172.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.6 tp -70.14 -38.5 75.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.826 0.346 . . . . 0.0 110.398 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -68.78 -34.43 75.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.4 89.91 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.929 0.871 . . . . 0.0 110.453 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 m -65.04 -24.78 67.58 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.625 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -100.94 -40.84 7.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.586 0.707 . . . . 0.0 110.184 -173.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.4 HG21 ' HB2' ' A' ' 13' ' ' PHE . 39.0 m -74.49 -39.05 62.7 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.579 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.49 -7.5 11.33 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.949 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.51 154.58 41.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 pt -118.75 155.9 20.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.684 -175.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.628 HD11 ' HA ' ' A' ' 24' ' ' ALA . 81.7 mt -113.51 125.12 70.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.679 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.501 ' O ' ' HB ' ' A' ' 1' ' ' THR . 13.0 pt -128.14 106.01 19.9 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.546 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.35 80.13 0.78 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 123.061 2.507 . . . . 0.0 111.687 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.92 -137.05 2.15 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.798 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.77 -37.22 0.54 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.71 100.77 6.35 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.178 0.513 . . . . 0.0 111.984 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 53.7 t -119.67 119.13 31.61 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.44 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 43' ' ' ASP . 43.9 Cg_endo -67.53 148.78 79.28 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.555 2.17 . . . . 0.0 112.104 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -73.5 21.28 1.18 Allowed Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.22 -0.445 . . . . 0.0 113.295 -175.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 41' ' ' PRO . 6.9 m-20 -102.96 -22.65 13.79 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.732 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 8.0 m-85 -121.74 -2.73 9.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.784 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.57 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -90.32 42.29 1.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.373 -169.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.0 m120 . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.471 175.721 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 8.7 m . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 t -138.14 161.29 37.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.718 0.294 . . . . 0.0 110.604 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.0 p -143.96 149.96 37.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 3.3 t -140.6 136.08 16.25 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 26.4 Cg_exo -64.33 -19.53 65.66 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.288 2.659 . . . . 0.0 114.915 -173.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.5 p -137.55 156.29 48.27 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.867 -0.521 . . . . 0.0 111.486 -176.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.799 ' HA ' ' HD2' ' A' ' 10' ' ' ARG . 54.2 mt -69.1 -32.92 56.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.338 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.7 t -67.29 -51.49 52.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.035 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.49 ' HB1' HG22 ' A' ' 30' ' ' THR . . . -62.63 -36.49 82.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.738 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.799 ' HD2' ' HA ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -65.02 -39.66 93.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.196 0.522 . . . . 0.0 110.654 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 15' ' ' VAL . 27.9 m -65.92 -44.51 84.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.023 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -61.76 -45.17 95.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.781 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.666 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 1.3 p90 -71.58 -31.23 66.72 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.987 -176.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.45 -51.16 68.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.96 0.409 . . . . 0.0 110.685 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 11' ' ' SER . 39.8 t -68.44 -10.75 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.737 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.605 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.6 t -81.47 -26.26 35.38 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.807 -0.558 . . . . 0.0 109.874 176.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 1.103 ' HD3' ' HG3' ' A' ' 23' ' ' GLU . 40.4 mtm180 -75.35 -24.13 57.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.487 0.661 . . . . 0.0 109.992 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.566 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 64.2 tp -56.4 -52.21 74.97 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.077 -177.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 13.9 Cg_exo -71.03 -3.09 12.14 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.339 2.026 . . . . 0.0 113.397 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.54 30.09 5.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.691 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.466 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -96.07 139.33 21.74 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.545 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.466 ' HD2' HG22 ' A' ' 21' ' ' THR . 26.0 Cg_endo -66.29 132.27 29.05 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.93 2.42 . . . . 0.0 111.099 175.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 1.103 ' HG3' ' HD3' ' A' ' 17' ' ' ARG . 28.8 mp0 -39.38 -39.65 0.7 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.508 170.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.69 -52.95 20.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.216 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.09 -45.92 75.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.739 0.304 . . . . 0.0 110.203 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.423 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 21.8 m -64.68 -40.11 94.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.618 -174.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.76 -47.34 72.52 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.585 0.707 . . . . 0.0 111.173 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.4 m -65.93 -24.98 66.93 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.124 -175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -92.13 -45.48 8.25 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.009 0.909 . . . . 0.0 109.257 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.49 HG22 ' HB1' ' A' ' 9' ' ' ALA . 61.6 m -70.16 -40.04 74.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.122 -176.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.56 4.18 21.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.15 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -84.45 155.7 22.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.5 pt -118.71 153.41 20.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.321 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.41 135.99 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.01 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.599 HD13 ' HB2' ' A' ' 40' ' ' CYS . 13.0 pt -131.67 129.53 22.09 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.084 0.468 . . . . 0.0 110.88 -173.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.1 -29.01 65.45 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.866 2.378 . . . . 0.0 111.783 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.97 -135.6 3.13 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.011 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.61 41.01 1.09 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.361 0.6 . . . . 0.0 110.284 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -80.59 22.93 0.54 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.182 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.599 ' HB2' HD13 ' A' ' 35' ' ' ILE . 31.6 t -135.94 124.25 15.33 Favored Pre-proline 0 C--N 1.313 -1.022 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.196 -175.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.76 164.63 33.81 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.668 2.246 . . . . 0.0 112.514 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.89 -2.33 45.24 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.29 -172.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -90.03 -25.22 20.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 117.796 0.798 . . . . 0.0 109.253 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 13.3 m-85 -101.3 8.53 42.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.309 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.61 48.24 0.93 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.256 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.619 -178.415 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.513 HG21 ' HA ' ' A' ' 39' ' ' THR . 3.1 m . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -138.79 143.47 38.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.843 0.354 . . . . 0.0 111.126 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 5.9 m -152.62 160.4 43.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.451 178.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 10' ' ' ARG . 8.9 t -140.01 143.81 35.65 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 14.2 Cg_exo -70.5 0.87 5.55 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.087 2.525 . . . . 0.0 113.493 -178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.0 m -152.8 139.73 19.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.624 HG13 ' OD1' ' A' ' 46' ' ' ASN . 72.0 mt -61.29 -36.37 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.142 0.496 . . . . 0.0 110.276 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.47 -29.98 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.759 -174.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.2 -28.68 27.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.167 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -70.2 -35.62 74.04 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.596 -177.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 15' ' ' VAL . 2.9 p -68.13 -46.91 69.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.491 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.88 -30.99 71.95 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.906 0.384 . . . . 0.0 111.029 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.505 ' HZ ' ' HB2' ' A' ' 23' ' ' GLU . 36.5 t80 -54.27 -50.95 66.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.488 174.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 28.9 m-80 -65.85 -32.7 74.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.224 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 11' ' ' SER . 93.1 t -61.53 -32.85 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.306 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.425 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 6.4 t -78.06 -26.41 48.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.132 0.491 . . . . 0.0 110.426 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -79.28 -18.92 51.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.509 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.8 mt -55.25 -53.57 60.38 Favored Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.142 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 59.8 Cg_endo -72.97 17.03 0.4 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.081 1.854 . . . . 0.0 113.11 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.88 15.5 61.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.46 173.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.594 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 1.3 m -77.85 138.08 61.91 Favored Pre-proline 0 N--CA 1.433 -1.3 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.494 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 15.6 Cg_endo -61.88 121.89 10.18 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.726 2.284 . . . . 0.0 110.861 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.505 ' HB2' ' HZ ' ' A' ' 13' ' ' PHE . 10.3 pt-20 -40.64 -37.43 0.73 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.939 170.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.68 77.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.317 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.482 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 32.2 tp -72.99 -39.81 65.75 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 120.609 0.242 . . . . 0.0 110.43 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.594 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 61.2 m -65.44 -34.03 77.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.467 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -65.55 -39.41 91.69 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.702 0.763 . . . . 0.0 110.496 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.4 m -71.28 -18.88 62.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.841 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -92.84 -21.43 19.88 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.235 1.017 . . . . 0.0 109.525 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 m -107.78 -49.91 3.15 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.029 -172.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.92 -17.74 5.15 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.452 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 11.5 m -67.8 167.41 13.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.077 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.9 pt -131.65 137.11 55.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.388 0.613 . . . . 0.0 112.46 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.75 128.77 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 167.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.486 ' O ' ' HB ' ' A' ' 1' ' ' THR . 4.8 tt -130.35 97.62 22.02 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-O 121.654 0.74 . . . . 0.0 110.153 -173.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.0 42.76 1.38 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.641 2.894 . . . . 0.0 113.073 -174.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 38' ' ' ALA . . . 155.8 145.72 4.26 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.638 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . 76.41 30.64 0.65 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.397 0.679 . . . . 0.0 111.006 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.513 ' HA ' HG21 ' A' ' 1' ' ' THR . 58.2 m 46.91 -95.48 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.93 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 63.0 m -151.75 152.66 30.65 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-O 120.941 0.4 . . . . 0.0 110.961 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 6.2 Cg_exo -74.82 -172.02 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.217 2.611 . . . . 0.0 111.233 171.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.63 -44.35 2.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.621 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.5 -22.06 35.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.69 0.757 . . . . 0.0 109.74 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.611 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 12.4 m-85 -101.38 20.93 14.99 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.485 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.57 63.56 1.57 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.391 0.615 . . . . 0.0 109.377 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.624 ' OD1' HG13 ' A' ' 7' ' ' ILE . 20.7 t-20 . . . . . 0 C--O 1.249 1.053 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.686 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' THR . . . . . 0.468 ' HB ' HG13 ' A' ' 35' ' ' ILE . 31.0 m . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 120.784 0.326 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.1 t -72.43 142.47 48.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.286 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.555 ' HB3' HG13 ' A' ' 33' ' ' ILE . 30.3 t -144.49 79.08 1.6 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 82.3 m -103.53 112.37 65.6 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.805 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.695 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 3.0 Cg_exo -77.25 14.29 1.39 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.171 2.581 . . . . 0.0 114.896 -173.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.0 p -160.36 156.18 25.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 118.753 0.706 . . . . 0.0 111.213 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.6 mt -62.67 -34.34 64.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.666 173.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.61 -49.66 82.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.602 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.58 -48.29 80.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.682 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 10' ' ' ARG . 23.5 tpp180 -55.05 -38.83 68.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.767 176.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.5 ' O ' HG23 ' A' ' 15' ' ' VAL . 14.3 t -66.9 -50.05 63.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.471 HD22 HG23 ' A' ' 30' ' ' THR . 93.4 m-20 -55.19 -39.41 69.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.105 0.478 . . . . 0.0 110.702 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -49.7 75.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.957 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -73.52 -23.72 60.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.902 0.382 . . . . 0.0 111.202 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 11' ' ' SER . 79.4 t -66.37 -43.58 91.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.213 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.663 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 85.1 m -69.2 -16.71 63.68 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.784 HH11 ' HG3' ' A' ' 23' ' ' GLU . 21.0 mmm180 -71.05 -27.2 63.48 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.827 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.605 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 93.6 mt -66.98 -52.69 30.16 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 1.2 Cg_endo -85.41 17.24 1.8 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.525 2.15 . . . . 0.0 112.68 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.68 30.13 68.84 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.863 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 2.1 m -85.67 128.56 58.3 Favored Pre-proline 0 N--CA 1.438 -1.057 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.884 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.4 Cg_endo -58.74 122.29 11.38 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.552 2.168 . . . . 0.0 110.672 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.784 ' HG3' HH11 ' A' ' 17' ' ' ARG . 49.3 mt-10 -48.52 -32.8 8.47 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.111 172.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.68 -51.4 69.7 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.272 173.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.884 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 4.2 tt -57.64 -50.23 73.84 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.032 0.444 . . . . 0.0 110.262 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.6 m -72.71 -21.54 61.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.256 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -66.87 -42.21 85.98 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.944 0.878 . . . . 0.0 110.067 175.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.6 m -66.99 -18.74 65.52 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.776 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -98.63 -48.2 5.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.835 0.826 . . . . 0.0 110.115 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.471 HG23 HD22 ' A' ' 12' ' ' ASN . 92.9 m -68.09 -38.08 81.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.339 -1.3 . . . . 0.0 112.498 -174.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.57 -12.94 32.93 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.523 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.47 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 38.9 t -73.13 143.26 47.39 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.555 HG13 ' HB3' ' A' ' 3' ' ' CYS . 22.1 pt -110.13 144.61 17.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.123 0.487 . . . . 0.0 111.472 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.5 mt -109.17 104.12 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.359 174.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.468 HG13 ' HB ' ' A' ' 1' ' ' THR . 26.1 pt -93.62 138.95 22.69 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.766 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 24.7 Cg_exo -61.67 -40.71 44.16 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.055 2.504 . . . . 0.0 112.096 175.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.99 -139.52 5.86 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.454 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.53 21.16 2.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.585 0.231 . . . . 0.0 111.329 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -81.64 73.97 8.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.869 0.842 . . . . 0.0 110.682 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 44' ' ' TYR . 52.9 t -140.38 107.53 6.65 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.267 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 48.5 Cg_endo -71.1 171.41 15.98 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.622 2.214 . . . . 0.0 112.643 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.59 -3.98 23.08 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.85 -0.613 . . . . 0.0 114.353 -174.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -88.67 -19.9 25.58 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 117.614 0.707 . . . . 0.0 109.289 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.695 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 13.0 m-85 -112.22 -6.55 14.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.776 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.97 37.69 1.49 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.959 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.93 -177.665 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.515 ' HB ' HG13 ' A' ' 35' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 120.881 0.372 . . . . 0.0 110.344 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.6 m -95.99 109.52 21.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.958 0.408 . . . . 0.0 109.929 176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 64.3 m -123.49 168.33 12.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -173.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.6 t -160.24 136.74 6.44 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.1 11.71 3.24 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.506 2.137 . . . . 0.0 114.847 -170.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.1 p -164.34 149.58 10.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.218 0.463 . . . . 0.0 110.639 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.682 ' H ' HD12 ' A' ' 7' ' ' ILE . 4.1 mp -66.95 -34.5 70.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.2 t -62.05 -46.71 95.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.265 -178.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.431 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -66.85 -52.37 44.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.21 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.41 ' HA ' ' HD3' ' A' ' 10' ' ' ARG . 6.7 tpp180 -46.28 -44.47 16.56 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.969 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 15' ' ' VAL . 63.3 m -60.27 -58.2 9.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.454 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 9.4 p30 -70.51 -23.56 62.68 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.681 -175.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.592 ' HB2' HG21 ' A' ' 30' ' ' THR . 44.6 t80 -60.48 -52.17 66.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.551 173.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -68.58 -28.34 66.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.336 178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 11' ' ' SER . 77.6 t -67.12 -25.85 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.536 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.564 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 28.5 t -80.9 -12.78 59.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.293 0.568 . . . . 0.0 110.26 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.756 ' HD3' ' HG3' ' A' ' 23' ' ' GLU . 38.1 mmm-85 -74.85 -44.14 50.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.092 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.812 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -53.83 -39.39 72.87 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -175.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.812 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 13.7 Cg_exo -72.18 4.39 3.34 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 121.925 1.75 . . . . 0.0 113.145 176.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.23 37.13 12.91 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.22 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.459 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -103.29 138.32 19.51 Favored Pre-proline 0 N--CA 1.436 -1.168 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HD2' HG22 ' A' ' 21' ' ' THR . 30.1 Cg_endo -66.72 129.72 21.68 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.887 2.392 . . . . 0.0 110.441 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.756 ' HG3' ' HD3' ' A' ' 17' ' ' ARG . 1.5 mp0 -42.55 -35.38 1.06 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.614 172.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.74 -47.4 64.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.15 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.411 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.1 tt -70.73 -46.72 62.51 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 120.948 0.404 . . . . 0.0 110.145 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.459 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 11.6 m -66.06 -43.95 85.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.502 -174.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.71 89.75 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.421 0.629 . . . . 0.0 111.661 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.3 m -68.39 -24.77 64.81 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 114.527 -1.215 . . . . 0.0 111.604 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -100.04 -46.48 5.32 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.502 0.668 . . . . 0.0 109.792 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.592 HG21 ' HB2' ' A' ' 13' ' ' PHE . 48.8 m -60.91 -44.91 96.52 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.552 -1.203 . . . . 0.0 112.124 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.53 -16.12 7.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.464 -0.874 . . . . 0.0 112.169 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 37.7 m -66.09 164.94 14.43 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.5 pt -130.06 143.55 40.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 121.937 -0.477 . . . . 0.0 111.857 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.3 mt -117.15 101.8 12.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.862 HD12 ' HB3' ' A' ' 38' ' ' ALA . 6.6 pt -114.45 136.79 22.39 Favored Pre-proline 0 C--N 1.313 -0.995 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.949 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -57.6 -39.43 88.33 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.155 2.57 . . . . 0.0 112.534 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -129.92 -138.14 4.33 Favored Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.862 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . 65.45 88.75 0.1 Allowed 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.456 0.646 . . . . 0.0 111.086 173.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.79 95.8 0.12 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.538 177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 35' ' ' ILE . 60.2 m -56.02 131.17 73.98 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.999 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 32.3 Cg_endo -67.25 178.32 3.14 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 123.012 2.475 . . . . 0.0 112.539 173.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -71.15 4.51 11.07 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 114.425 0.53 . . . . 0.0 114.425 -173.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -113.82 -5.69 13.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.666 0.733 . . . . 0.0 110.266 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.538 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 21.4 m-85 -115.88 -14.27 11.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.891 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -100.4 30.56 3.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.787 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.42 HD22 ' C ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.878 0 CA-C-O 118.319 -0.848 . . . . 0.0 109.3 -177.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.823 0.344 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 m -103.24 129.68 50.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.182 -175.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.2 m -122.2 98.47 5.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.854 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 80.0 m -106.03 113.64 63.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 28.2 Cg_exo -64.37 10.44 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 123.518 2.812 . . . . 0.0 115.068 -176.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.4 p -165.37 148.39 8.02 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.66 0.664 . . . . 0.0 111.131 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.862 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 53.1 mt -64.11 -30.16 49.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.55 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.99 -55.37 19.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.251 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.1 67.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.487 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.862 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.4 OUTLIER -68.05 -31.63 71.41 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.505 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 27.4 m -69.79 -47.76 61.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.957 175.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -51.52 -44.45 62.61 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.262 0.553 . . . . 0.0 110.631 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 75.8 t80 -54.91 -59.02 5.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.381 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -63.65 -31.18 72.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.544 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 11' ' ' SER . 54.0 t -67.86 -37.53 78.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.223 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.524 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 8.5 t -76.34 -33.95 58.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.284 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -83.31 2.0 38.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.933 0.397 . . . . 0.0 111.376 -178.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.4 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.5 mt -76.12 -49.47 3.23 Favored Pre-proline 0 N--CA 1.444 -0.74 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.524 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 74.1 Cg_endo -75.59 19.08 0.56 Allowed 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.146 1.897 . . . . 0.0 113.368 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.17 35.22 7.67 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.966 177.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 m -105.0 134.74 19.48 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.804 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 11.5 Cg_endo -59.16 121.11 9.38 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.703 2.269 . . . . 0.0 110.877 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.475 ' HG2' ' HD2' ' A' ' 17' ' ' ARG . 36.7 mt-10 -40.11 -38.94 0.81 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.125 170.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.97 -48.74 75.27 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.873 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.804 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.5 tt -64.68 -42.9 95.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 110.035 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.7 m -68.96 -30.96 69.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.937 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.61 -33.79 76.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.949 0.88 . . . . 0.0 110.503 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.3 m -74.68 -17.01 60.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.765 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -101.16 -42.91 6.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.735 0.779 . . . . 0.0 109.924 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.8 m -71.88 -47.91 49.47 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.852 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.15 -18.66 15.86 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 -174.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 41.2 t -66.42 143.37 57.16 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.7 pt -103.34 149.8 7.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 111.871 -173.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.413 HD11 ' CE1' ' A' ' 13' ' ' PHE . 65.6 mt -125.59 124.98 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.037 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.5 pt -122.25 158.55 55.34 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.926 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -86.0 23.03 0.86 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.229 2.619 . . . . 0.0 112.584 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -155.03 -154.33 6.85 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.32 60.43 1.7 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.414 0.626 . . . . 0.0 110.218 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 m -85.36 -6.64 59.21 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.87 0.843 . . . . 0.0 110.917 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.9 m -85.22 122.22 73.87 Favored Pre-proline 0 C--N 1.309 -1.175 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.504 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.533 ' HD2' ' CZ ' ' A' ' 44' ' ' TYR . 55.9 Cg_endo -72.03 172.31 14.95 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.602 2.202 . . . . 0.0 110.905 169.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.69 38.1 3.26 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.185 -172.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.515 ' OD1' ' HG2' ' A' ' 41' ' ' PRO . 12.6 p-10 -111.84 -31.63 6.88 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.533 ' CZ ' ' HD2' ' A' ' 41' ' ' PRO . 2.4 p90 -122.77 18.6 10.26 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.7 0.762 . . . . 0.0 110.23 175.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -109.0 24.31 13.31 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.559 170.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.7 t30 . . . . . 0 C--O 1.245 0.838 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.305 -172.755 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.5 HG22 HD11 ' A' ' 35' ' ' ILE . 10.2 m . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.799 0.333 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.661 HG22 ' SG ' ' A' ' 32' ' ' CYS . 80.8 m -132.71 136.49 46.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.701 -176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.625 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 26.9 m -127.49 138.33 52.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.498 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.57 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 52.6 m -106.16 160.31 26.62 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.19 -171.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.412 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 92.8 Cg_endo -89.78 24.99 0.6 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.613 2.209 . . . . 0.0 113.009 174.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.5 t -172.49 136.05 0.75 Allowed 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.9 mt -64.0 -29.27 46.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.563 0.697 . . . . 0.0 109.833 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -71.02 -33.82 53.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.43 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.468 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -71.7 -45.35 62.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.057 177.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' NH2' ' HA ' ' A' ' 3' ' ' CYS . 8.0 tpp180 -53.96 -39.14 65.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.135 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.457 ' O ' HG23 ' A' ' 15' ' ' VAL . 36.6 t -63.04 -52.7 61.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.408 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.468 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 10.7 p30 -74.72 -23.83 58.65 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.551 -177.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.576 ' CZ ' ' HB ' ' A' ' 2' ' ' THR . 25.9 t80 -55.1 -50.5 69.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.2 170.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -59.54 -38.53 81.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.424 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 11' ' ' SER . 87.2 t -63.29 -39.33 84.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.532 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.574 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 11.5 t -76.73 -31.59 57.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.956 0.408 . . . . 0.0 110.485 -176.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -78.49 -13.67 59.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.189 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.567 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 13.6 mt -63.6 -54.49 42.44 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 7.5 Cg_exo -74.56 18.36 0.5 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.684 2.256 . . . . 0.0 113.282 -178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.89 33.71 12.11 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.376 -0.916 . . . . 0.0 113.082 176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.7 m -99.53 133.36 21.94 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.78 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -57.69 122.71 12.22 Favored 'Trans proline' 0 N--CA 1.441 -1.591 0 C-N-CA 122.562 2.175 . . . . 0.0 110.695 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -43.67 -33.27 1.17 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.764 170.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.633 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -56.17 -53.23 59.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.135 173.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.78 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.6 tt -61.47 -46.68 89.03 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.881 0.372 . . . . 0.0 110.227 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.6 m -65.6 -38.32 89.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.325 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 32' ' ' CYS . . . -61.77 -33.67 74.5 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.627 0.727 . . . . 0.0 111.133 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.9 m -74.35 -18.96 60.61 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.519 -1.219 . . . . 0.0 110.947 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -100.64 -40.11 7.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.768 0.794 . . . . 0.0 109.634 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.6 m -74.74 -31.37 61.8 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.497 -1.229 . . . . 0.0 112.196 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.64 14.66 42.94 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -172.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.661 ' SG ' HG22 ' A' ' 2' ' ' THR . 6.1 t -87.97 167.6 13.57 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.4 pt -133.48 138.03 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 118.559 0.618 . . . . 0.0 112.272 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.633 HD11 ' HA ' ' A' ' 24' ' ' ALA . 4.3 mp -81.76 142.57 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.678 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.5 HD11 HG22 ' A' ' 1' ' ' THR . 0.2 OUTLIER -122.93 148.15 53.21 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 176.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.8 -40.12 47.41 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.959 2.439 . . . . 0.0 112.79 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -113.61 -138.78 7.08 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.076 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.68 9.92 15.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.29 0.567 . . . . 0.0 110.034 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -96.29 107.61 19.99 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.95 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 55.4 m -104.16 134.15 19.85 Favored Pre-proline 0 C--N 1.312 -1.027 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.953 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.664 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 10.0 Cg_endo -52.99 145.88 39.5 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.873 2.382 . . . . 0.0 111.495 177.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -56.2 -34.94 63.38 Favored Glycine 0 CA--C 1.52 0.346 0 N-CA-C 114.347 0.499 . . . . 0.0 114.347 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -81.71 -20.25 39.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.43 0.633 . . . . 0.0 109.901 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.664 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 9.6 m-85 -119.21 26.18 9.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.318 -0.855 . . . . 0.0 109.892 -173.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.91 22.07 6.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.247 -178.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.57 ' O ' ' HB2' ' A' ' 4' ' ' CYS . 45.9 m-80 . . . . . 0 C--O 1.243 0.729 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.56 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 89.5 m . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.902 0.382 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.447 ' OG1' HG12 ' A' ' 34' ' ' ILE . 44.1 m -86.49 97.29 10.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.308 0.575 . . . . 0.0 110.742 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 84.2 m -89.86 100.09 12.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.575 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 20.5 t -105.75 135.63 19.37 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.879 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 72.7 Cg_endo -76.83 23.49 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.711 2.274 . . . . 0.0 114.004 -174.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.634 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 31.2 t -162.47 145.83 11.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.492 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 58.2 mt -76.11 -26.39 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.2 t -81.65 -46.3 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.722 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 6' ' ' SER . . . -62.11 -41.51 98.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.816 177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.61 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 7.1 ptp180 -72.47 -24.3 61.17 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.254 0.55 . . . . 0.0 110.182 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.491 ' O ' HG23 ' A' ' 15' ' ' VAL . 32.7 t -68.41 -47.3 67.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.725 173.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.37 -33.03 71.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.066 0.46 . . . . 0.0 110.163 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.548 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 38.9 t80 -54.99 -53.19 58.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.37 172.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -61.65 -39.99 93.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.029 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 11' ' ' SER . 90.1 t -59.72 -42.22 87.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.209 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.553 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.1 t -74.35 -34.44 63.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.292 0.567 . . . . 0.0 110.577 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.509 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 16.2 tpt180 -60.35 -44.44 95.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.982 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.587 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 60.8 mt -52.94 -53.53 54.02 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -171.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 33.5 Cg_exo -60.78 -16.83 46.56 Favored 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.582 2.188 . . . . 0.0 113.808 -177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 113.32 30.66 2.61 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.285 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.549 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.5 OUTLIER -97.85 139.17 21.15 Favored Pre-proline 0 N--CA 1.431 -1.39 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.717 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -56.89 118.05 4.84 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.045 2.497 . . . . 0.0 111.113 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.509 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 15.1 pt-20 -44.79 -32.55 1.58 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.951 172.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.8 -48.3 82.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.925 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.717 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -64.96 -47.4 77.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.967 0.413 . . . . 0.0 110.003 178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.431 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 20.8 m -60.93 -39.62 90.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.108 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.15 -55.46 28.54 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.817 0.817 . . . . 0.0 110.832 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 m -62.56 -25.72 68.21 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.843 -1.526 . . . . 0.0 112.57 -173.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -90.84 -20.03 22.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.844 0.83 . . . . 0.0 109.816 -172.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 m -102.76 -27.77 12.49 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.463 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.18 2.1 13.84 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.132 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.5 m -88.12 154.39 20.49 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.7 pt -128.62 144.36 38.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.986 176.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.447 HG12 ' OG1' ' A' ' 2' ' ' THR . 63.3 mt -106.38 121.57 59.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.571 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.861 HG22 ' H ' ' A' ' 37' ' ' GLY . 5.0 mp -106.42 131.28 21.85 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.645 177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.97 -15.88 52.66 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.82 2.346 . . . . 0.0 112.248 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.861 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -99.37 -142.57 13.38 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 174.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.96 15.27 1.53 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.051 0.453 . . . . 0.0 110.803 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -103.13 106.53 17.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.391 0.615 . . . . 0.0 110.781 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.2 p -143.96 146.0 32.51 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.389 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.86 166.7 13.45 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.743 2.295 . . . . 0.0 112.56 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -73.97 2.96 39.78 Favored Glycine 0 CA--C 1.518 0.248 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.257 -170.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -97.69 -12.67 22.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 117.631 0.715 . . . . 0.0 109.334 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.485 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 21.0 m-85 -105.82 -14.07 15.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.078 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -91.11 19.75 5.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.278 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.338 -0.839 . . . . 0.0 110.526 -178.589 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.976 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 17.7 m . . . . . 0 N--CA 1.476 0.827 0 CA-C-O 120.811 0.338 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.2 m -126.34 126.67 44.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.57 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 73.8 m -128.05 130.44 48.26 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -171.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.666 ' HB2' ' HB2' ' A' ' 10' ' ' ARG . 63.3 m -136.0 140.88 34.54 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 171.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 10.6 Cg_exo -72.0 15.36 0.39 Allowed 'Trans proline' 0 CA--C 1.534 0.479 0 C-N-CA 123.087 2.525 . . . . 0.0 114.398 -173.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 60.2 m -159.27 145.16 16.27 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.776 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.8 mp -58.11 -38.75 69.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.54 0.686 . . . . 0.0 109.688 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.5 t -72.34 -42.24 65.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.223 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.38 -33.75 76.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.799 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.666 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 0.2 OUTLIER -76.38 -27.85 56.52 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.395 0.617 . . . . 0.0 110.003 -179.367 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 15' ' ' VAL . 36.2 m -72.78 -38.01 67.41 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.958 172.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -59.21 -30.11 67.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.965 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.42 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 65.7 t80 -53.41 -53.88 44.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.343 174.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -65.57 -29.2 69.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.949 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 11' ' ' SER . 76.8 t -65.46 -31.19 52.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.829 0.347 . . . . 0.0 110.524 177.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 26' ' ' CYS . 42.8 t -92.2 -0.95 57.4 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 122.066 0.936 . . . . 0.0 109.822 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -92.43 -29.63 16.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.885 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.522 ' HG ' ' CD ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -61.08 -47.31 95.47 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 114.636 -1.165 . . . . 0.0 112.661 178.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' CD ' ' HG ' ' A' ' 18' ' ' LEU . 14.5 Cg_exo -70.73 -3.11 11.99 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.15 1.9 . . . . 0.0 112.807 -178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.05 33.51 14.82 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.955 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.576 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 1.7 m -95.37 143.78 26.69 Favored Pre-proline 0 N--CA 1.43 -1.43 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.677 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 12.4 Cg_endo -61.9 121.29 9.29 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.786 2.324 . . . . 0.0 110.96 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 1.7 mp0 -39.5 -36.93 0.42 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.068 171.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.87 -49.18 76.28 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.399 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.677 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.2 tt -68.08 -38.84 82.84 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.354 0.597 . . . . 0.0 109.737 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.537 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 13.0 m -76.14 4.01 9.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.326 -178.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.615 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -101.33 -21.47 14.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.592 0.711 . . . . 0.0 110.315 173.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 m -76.98 -42.3 39.48 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.921 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -86.55 -23.15 25.94 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.746 0.784 . . . . 0.0 110.535 -171.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.583 ' HB ' ' SG ' ' A' ' 32' ' ' CYS . 0.2 OUTLIER -99.9 1.8 43.14 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.798 -174.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.48 33.6 86.86 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.126 -178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.615 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 75.0 m -102.13 165.13 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.95 0.405 . . . . 0.0 110.744 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.464 HG13 ' HB2' ' A' ' 3' ' ' CYS . 12.6 pt -139.12 147.98 24.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.396 177.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.3 mt -102.77 127.37 56.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.582 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.976 ' HB ' ' HB ' ' A' ' 1' ' ' THR . 8.6 mm -115.69 113.16 42.64 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.627 -175.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -71.17 -16.73 31.72 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.176 2.584 . . . . 0.0 111.541 173.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.488 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -124.35 -139.8 5.4 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.114 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -124.04 25.47 7.88 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.4 0.619 . . . . 0.0 110.329 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 m -81.81 42.0 0.68 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.877 0.846 . . . . 0.0 110.866 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.543 ' HB2' HG13 ' A' ' 35' ' ' ILE . 53.3 t -134.56 120.09 14.39 Favored Pre-proline 0 C--N 1.312 -1.062 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.203 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.4 169.97 20.22 Favored 'Trans proline' 0 C--O 1.237 0.426 0 C-N-CA 122.741 2.294 . . . . 0.0 112.168 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.66 16.32 4.18 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.078 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -100.31 -17.08 17.46 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.57 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 15.9 m-85 -113.96 -14.18 12.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.45 176.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -102.73 29.09 5.57 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.37 0.605 . . . . 0.0 110.047 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.41 ' C ' HH21 ' A' ' 10' ' ' ARG . 2.4 t-20 . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.109 -174.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.472 ' OG1' ' HA ' ' A' ' 38' ' ' ALA . 23.6 m . . . . . 0 N--CA 1.471 0.583 0 CA-C-O 121.047 0.451 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.736 HG23 HG12 ' A' ' 34' ' ' ILE . 9.8 m -89.35 110.22 21.04 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.423 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.549 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 87.5 m -127.72 167.53 16.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.042 -177.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.699 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 9.8 t -138.93 149.42 61.63 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 44' ' ' TYR . 6.1 Cg_exo -41.06 -37.91 2.84 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.23 3.287 . . . . 0.0 115.31 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.0 p -169.36 173.02 6.82 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.309 -172.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.721 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 60.3 mt -61.63 -40.15 85.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.53 177.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.8 t -60.89 -53.2 52.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.434 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.68 -40.02 88.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.471 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.721 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -69.7 -25.91 64.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.359 . . . . 0.0 110.949 -177.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.5 m -75.13 -12.78 60.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.013 0.435 . . . . 0.0 110.914 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -94.1 -8.2 40.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.8 0.81 . . . . 0.0 109.452 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.659 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 65.0 t80 -88.34 -58.06 2.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.625 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -61.22 -37.99 85.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.179 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 86.7 t -70.92 -18.85 21.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.062 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.0 t -78.72 -26.14 44.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 121.876 -0.515 . . . . 0.0 110.19 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.573 ' CD ' ' HB3' ' A' ' 23' ' ' GLU . 51.5 mtm180 -74.18 -29.12 61.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.974 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.4 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 94.8 mt -51.15 -53.07 52.63 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -175.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 37.8 Cg_endo -67.87 -6.27 16.53 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.974 1.783 . . . . 0.0 113.719 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.03 30.93 3.49 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.475 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -101.8 133.26 20.86 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.865 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.5 Cg_endo -63.58 127.72 20.52 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.576 2.184 . . . . 0.0 110.282 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.659 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 9.8 pt-20 -51.6 -27.54 11.52 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.422 174.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.3 85.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.953 0.406 . . . . 0.0 110.137 172.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.865 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -66.07 -42.64 89.15 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.169 177.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.484 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 37.5 m -69.24 -31.74 70.49 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.663 -176.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.27 -36.31 83.25 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.127 0.965 . . . . 0.0 110.123 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.3 m -77.75 -18.41 56.52 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.207 -177.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -104.33 -54.82 2.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.636 0.731 . . . . 0.0 109.765 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.2 m -63.01 -52.88 61.23 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.608 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.51 1.43 4.27 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.968 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 13' ' ' PHE . 27.1 m -74.36 164.31 26.75 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 3' ' ' CYS . 2.8 pp -124.58 149.14 28.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.372 0.606 . . . . 0.0 112.412 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.736 HG12 HG23 ' A' ' 2' ' ' THR . 74.2 mt -127.13 112.16 27.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.113 174.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.53 ' O ' HD12 ' A' ' 35' ' ' ILE . 2.5 pp -122.14 135.44 25.42 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-O 121.093 0.473 . . . . 0.0 111.647 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 10.1 Cg_exo -68.7 79.43 0.66 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 123.436 2.757 . . . . 0.0 111.659 174.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.46 -149.59 6.23 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.472 ' HA ' ' OG1' ' A' ' 1' ' ' THR . . . -142.98 10.34 1.75 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.94 0.4 . . . . 0.0 111.4 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.8 m -146.85 103.61 3.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.614 0.721 . . . . 0.0 110.412 176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 5.8 p -78.77 152.57 77.67 Favored Pre-proline 0 C--N 1.308 -1.227 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.337 175.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.658 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 18.6 Cg_endo -60.26 153.12 61.66 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.142 2.561 . . . . 0.0 112.7 -176.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.45 6.2 39.46 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 114.514 0.566 . . . . 0.0 114.514 -171.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -113.05 -3.06 14.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.761 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 15.7 m-30 -134.25 21.85 3.74 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.097 -1.411 . . . . 0.0 109.773 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -92.7 20.96 5.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -170.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.417 ' C ' HH21 ' A' ' 10' ' ' ARG . 20.4 m120 . . . . . 0 C--O 1.253 1.245 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.55 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.2 t -105.12 124.53 49.69 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.459 0.647 . . . . 0.0 110.357 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.1 m -112.87 117.49 32.26 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 5.8 t -146.9 105.27 3.91 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -174.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.693 ' HG3' ' HA ' ' A' ' 44' ' ' TYR . 44.9 Cg_endo -92.3 38.57 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.985 2.456 . . . . 0.0 114.259 -171.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.754 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 3.6 m -142.28 119.42 11.42 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.923 -174.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.7 mt -50.63 -37.88 16.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 O-C-N 123.815 0.697 . . . . 0.0 110.885 -178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.3 t -79.57 -42.71 23.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.198 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.683 ' HB3' ' HB2' ' A' ' 6' ' ' SER . . . -61.12 -48.62 80.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.287 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.754 ' HG3' ' O ' ' A' ' 6' ' ' SER . 28.5 mtt180 -55.96 -32.73 64.12 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.271 0.558 . . . . 0.0 110.134 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 15' ' ' VAL . 50.5 m -72.69 -57.87 3.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.523 -176.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.416 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 9.4 p30 -73.59 -20.75 60.53 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.328 -173.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -51.94 -57.16 10.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.498 173.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 92.0 m-20 -61.87 -37.36 84.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.525 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 11' ' ' SER . 82.0 t -64.74 -26.01 39.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.265 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.6 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 3.6 t -82.68 -36.31 26.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.1 0.476 . . . . 0.0 110.163 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 21' ' ' THR . 62.3 ttt180 -68.95 -45.26 71.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.69 -174.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.534 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 84.6 mt -53.36 -47.82 94.8 Favored Pre-proline 0 N--CA 1.444 -0.734 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -174.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.6 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 13.2 Cg_exo -71.04 21.59 0.22 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.488 2.125 . . . . 0.0 113.752 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.16 35.52 8.07 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.089 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 1.7 m -114.14 134.69 22.16 Favored Pre-proline 0 N--CA 1.436 -1.171 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.765 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.6 Cg_endo -60.74 124.7 15.54 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.452 2.102 . . . . 0.0 110.817 177.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pm0 -44.31 -32.06 1.2 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.867 170.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.67 -50.47 73.74 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.811 174.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.765 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.9 tt -62.41 -47.1 85.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.4 m -64.63 -34.09 77.46 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.309 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.22 -40.0 94.65 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.92 0.867 . . . . 0.0 110.528 176.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.2 m -72.81 -20.67 61.11 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.121 -1.4 . . . . 0.0 111.147 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -101.38 -37.45 8.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.785 0.802 . . . . 0.0 109.875 -174.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.5 m -80.85 -42.87 20.86 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.415 -1.266 . . . . 0.0 111.987 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 122.74 -6.67 9.63 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.8 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 4' ' ' CYS . 3.9 m -74.96 157.94 34.12 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 176.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.3 pt -120.39 138.7 50.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.727 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.8 mt -111.65 112.91 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.178 0.513 . . . . 0.0 110.594 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 30.5 pt -115.96 150.76 45.59 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.732 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.18 -51.0 8.48 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 123.297 2.664 . . . . 0.0 112.488 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -95.63 -139.77 10.52 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.337 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.74 70.8 1.25 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.543 0.687 . . . . 0.0 109.449 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 m -130.63 43.84 3.05 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.595 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 45' ' ' ALA . 7.4 p -96.12 127.57 40.15 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.478 175.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 11.7 Cg_endo -53.61 157.37 9.81 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.476 2.784 . . . . 0.0 113.186 -175.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.61 -23.86 55.72 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.446 -0.797 . . . . 0.0 114.682 -172.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -93.09 0.01 57.17 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 117.852 0.826 . . . . 0.0 109.514 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.693 ' HA ' ' HG3' ' A' ' 5' ' ' PRO . 21.0 m-85 -121.57 0.55 9.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.552 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -126.66 54.64 1.58 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.575 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.68 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 10.0 t30 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.022 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 38.1 m . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.013 0.435 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.445 HG21 ' CD2' ' A' ' 13' ' ' PHE . 10.4 t -133.86 158.65 42.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.203 -176.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 93.3 m -137.84 138.97 39.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.214 174.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 0.5 OUTLIER -134.62 153.29 78.9 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -175.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -72.25 3.86 3.76 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.903 2.402 . . . . 0.0 114.324 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.468 ' HA ' ' OD1' ' A' ' 46' ' ' ASN . 33.1 p -164.17 142.66 7.31 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.358 0.526 . . . . 0.0 111.218 -178.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.582 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 61.8 mt -57.27 -32.3 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.32 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.71 -54.19 30.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.182 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.489 ' HB1' HG22 ' A' ' 30' ' ' THR . . . -68.51 -36.8 79.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.475 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.582 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 13.1 ptm180 -69.11 -24.02 64.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.219 0.533 . . . . 0.0 110.636 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' VAL . 49.2 m -76.86 -40.63 46.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.923 172.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -55.87 -34.31 65.38 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.826 176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 23' ' ' GLU . 79.6 t80 -53.57 -57.87 9.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.728 0.775 . . . . 0.0 110.546 174.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -62.04 -34.47 76.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.376 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.646 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 92.7 t -63.51 -34.47 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.355 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.722 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 48.4 t -62.56 -31.78 72.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.293 0.568 . . . . 0.0 111.734 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.967 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 12.0 mmm180 -80.11 -10.97 59.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.13 -176.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.572 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 54.6 mt -71.24 -56.87 5.05 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.646 ' HD3' ' O ' ' A' ' 15' ' ' VAL . 10.4 Cg_endo -90.01 24.17 0.64 Allowed 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.474 2.116 . . . . 0.0 113.135 -173.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.81 45.75 26.33 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.781 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.722 ' HB ' ' SG ' ' A' ' 16' ' ' CYS . 1.3 m -114.96 132.85 22.79 Favored Pre-proline 0 N--CA 1.44 -0.934 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 176.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.895 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 19.0 Cg_endo -61.05 120.9 8.85 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.132 2.555 . . . . 0.0 111.598 178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.967 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -52.38 -29.49 24.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.978 170.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.27 -45.53 87.7 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.571 173.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.895 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 2.2 tt -62.55 -51.18 68.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.187 0.517 . . . . 0.0 109.832 176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 29' ' ' TYR . 96.1 m -71.58 -16.06 62.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.79 -15.72 61.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.981 0.896 . . . . 0.0 110.037 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.3 m -101.69 -20.4 15.01 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.189 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.553 ' HB3' ' HA ' ' A' ' 26' ' ' CYS . 26.2 t80 -101.53 -41.96 6.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.885 0.85 . . . . 0.0 110.001 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.489 HG22 ' HB1' ' A' ' 9' ' ' ALA . 21.8 m -89.76 -37.96 14.16 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.557 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.98 12.75 26.95 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.308 176.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 55.7 m -81.38 153.45 26.96 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.837 0.318 . . . . 0.0 110.268 176.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 pt -117.22 139.79 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.681 0.276 . . . . 0.0 110.838 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.9 mp -96.54 131.9 42.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.136 176.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.425 ' O ' ' HB ' ' A' ' 1' ' ' THR . 2.3 pp -141.5 155.44 67.15 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.513 -178.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.54 -51.83 8.32 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.937 2.425 . . . . 0.0 112.384 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.05 141.56 3.36 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.733 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 59.25 17.0 5.36 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 172.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -108.92 54.24 0.66 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.83 0.824 . . . . 0.0 110.535 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 60.1 m -130.96 123.03 19.68 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.2 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.03 168.33 25.06 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.573 2.182 . . . . 0.0 111.787 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.67 9.5 10.75 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.382 -0.437 . . . . 0.0 113.683 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -101.13 -16.48 17.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.576 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 20.9 m-85 -122.99 14.62 9.9 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.145 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.12 21.32 17.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.004 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.468 ' OD1' ' HA ' ' A' ' 6' ' ' SER . 22.3 t-20 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.318 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.542 HG21 ' HA ' ' A' ' 38' ' ' ALA . 19.9 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.653 0.263 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 m -112.91 125.93 54.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.321 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 73.6 m -127.97 151.57 48.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.396 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.526 ' HB2' ' HD3' ' A' ' 10' ' ' ARG . 60.1 m -125.39 142.95 43.12 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.32 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.659 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 2.3 Cg_endo -83.99 5.56 6.27 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.081 2.521 . . . . 0.0 114.535 -176.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 56.6 p -158.13 151.03 22.68 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.799 -0.563 . . . . 0.0 110.605 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.7 mt -67.84 -30.77 49.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.96 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.51 -46.87 74.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.011 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.447 ' HA ' HD21 ' A' ' 12' ' ' ASN . . . -64.08 -49.71 71.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.093 176.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.526 ' HD3' ' HB2' ' A' ' 4' ' ' CYS . 0.5 OUTLIER -49.19 -40.45 33.4 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.462 176.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.421 ' O ' HG23 ' A' ' 15' ' ' VAL . 13.6 t -65.79 -58.43 5.67 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.459 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.447 HD21 ' HA ' ' A' ' 9' ' ' ALA . 9.9 p30 -69.74 -23.07 63.33 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.541 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.433 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 45.0 t80 -60.13 -58.63 7.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.326 174.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -65.25 -30.7 71.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.401 . . . . 0.0 110.286 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 11' ' ' SER . 61.6 t -74.42 -14.9 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.805 176.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.693 ' O ' ' HB ' ' A' ' 21' ' ' THR . 49.2 t -91.36 -11.37 38.06 Favored 'General case' 0 C--O 1.217 -0.631 0 O-C-N 121.861 -0.524 . . . . 0.0 110.562 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.593 ' HD2' ' HB3' ' A' ' 23' ' ' GLU . 4.6 ptm180 -112.32 -22.09 11.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.782 0.801 . . . . 0.0 109.816 -177.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -45.26 95.89 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 114.198 -1.364 . . . . 0.0 112.121 174.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -71.21 -12.8 30.52 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 121.923 1.748 . . . . 0.0 112.814 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 111.53 7.78 23.76 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.803 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.693 ' HB ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -77.81 138.96 61.83 Favored Pre-proline 0 N--CA 1.435 -1.2 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.039 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.642 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.7 Cg_endo -58.52 115.66 2.7 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 122.859 2.373 . . . . 0.0 111.565 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.593 ' HB3' ' HD2' ' A' ' 17' ' ' ARG . 10.5 pt-20 -55.16 -22.62 17.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.643 171.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.449 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -59.74 -49.45 77.66 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.256 170.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.642 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.2 tt -67.72 -43.48 79.9 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.057 0.456 . . . . 0.0 110.304 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.0 m -68.18 -25.9 65.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.823 -177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.24 -30.37 70.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.655 0.741 . . . . 0.0 110.731 175.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 28.7 m -74.65 -26.16 59.68 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.985 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -102.13 -50.23 3.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.532 0.682 . . . . 0.0 109.905 -173.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.3 m -63.36 -42.81 98.91 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.597 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.62 8.91 17.92 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.526 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 58.6 m -81.98 163.47 22.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.3 pt -127.26 143.48 40.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.684 -177.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 24' ' ' ALA . 55.1 mt -106.41 118.44 54.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.313 177.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.585 HD11 ' SG ' ' A' ' 40' ' ' CYS . 21.3 pt -128.89 148.17 67.68 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.947 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.66 67.07 8.51 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.83 2.353 . . . . 0.0 112.46 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 154.68 149.12 5.18 Favored Glycine 0 N--CA 1.44 -1.086 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.542 ' HA ' HG21 ' A' ' 1' ' ' THR . . . -81.94 30.19 0.39 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.144 0.497 . . . . 0.0 110.906 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 m -85.13 30.69 0.58 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.617 0.722 . . . . 0.0 111.192 -176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.585 ' SG ' HD11 ' A' ' 35' ' ' ILE . 66.7 m -69.16 119.34 69.52 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.346 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.543 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 11.6 Cg_endo -57.66 156.33 27.82 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.668 2.245 . . . . 0.0 111.805 177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.98 -8.45 35.31 Favored Glycine 0 CA--C 1.52 0.356 0 N-CA-C 114.344 0.498 . . . . 0.0 114.344 -170.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -100.74 -21.27 15.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.562 0.681 . . . . 0.0 109.696 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.659 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 20.7 m-85 -108.37 8.28 27.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.045 -177.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.33 24.66 12.04 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.028 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.8 t30 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.191 -176.633 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.473 0.679 0 CA-C-O 120.84 0.352 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t -104.9 130.56 53.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.008 0.432 . . . . 0.0 110.017 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 25.1 m -118.02 132.43 56.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.984 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 5.9 t -152.43 120.16 3.18 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 84.7 Cg_endo -90.04 35.4 0.34 Allowed 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.078 2.519 . . . . 0.0 114.209 -170.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.8 t -162.47 139.98 8.27 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 59.1 mt -74.72 -23.99 18.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.6 t -73.11 -44.24 56.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.086 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -44.21 74.55 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.227 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 10' ' ' ARG . 0.1 OUTLIER -55.13 -38.15 67.83 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.159 175.529 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 15' ' ' VAL . 22.7 t -61.04 -53.93 51.05 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.961 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -53.28 -35.55 60.2 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.31 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -62.97 -59.06 5.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.224 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.27 -34.12 74.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.17 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 11' ' ' SER . 77.2 t -62.83 -28.57 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.161 0.505 . . . . 0.0 110.829 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.571 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 32.2 t -89.71 -32.08 17.18 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.85 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.704 ' HD3' ' HB3' ' A' ' 23' ' ' GLU . 36.8 tpt85 -70.25 -36.2 74.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.725 -176.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.546 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 27.7 mt -60.23 -49.37 91.03 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -175.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 20.4 Cg_exo -68.34 11.93 0.25 Allowed 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 122.554 2.17 . . . . 0.0 113.428 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.27 40.03 11.88 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.429 177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.494 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 1.1 m -104.94 140.0 20.65 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.716 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.0 Cg_endo -56.56 118.57 5.43 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.881 2.388 . . . . 0.0 111.021 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.704 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 8.8 pt-20 -51.36 -29.4 15.26 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.104 171.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.22 -43.56 87.74 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.686 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.716 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.4 tt -70.95 -52.41 20.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.916 0.389 . . . . 0.0 110.061 176.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 10.9 m -60.52 -38.12 83.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.783 -173.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.06 -58.83 5.51 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.685 0.755 . . . . 0.0 111.218 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.6 m -64.55 -21.21 66.63 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.543 -172.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -84.61 -38.34 20.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 122.14 0.971 . . . . 0.0 109.25 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.9 m -81.02 -44.08 18.62 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 113.881 -1.508 . . . . 0.0 111.722 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.07 -13.16 4.12 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.76 -0.734 . . . . 0.0 111.704 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 4' ' ' CYS . 3.3 m -75.69 157.81 33.14 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.6 pt -125.43 161.54 29.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.188 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 68.0 mt -128.11 125.04 63.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.273 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.907 HD12 ' HB3' ' A' ' 38' ' ' ALA . 2.7 pt -136.03 146.56 57.12 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.624 -177.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 31.5 Cg_exo -57.69 -55.78 2.17 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.082 2.521 . . . . 0.0 111.91 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.36 -138.79 6.63 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.907 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . 62.55 81.06 0.21 Allowed 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.677 0.751 . . . . 0.0 110.754 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 m -68.1 97.24 0.68 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.722 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.793 ' HB3' ' HB2' ' A' ' 44' ' ' TYR . 72.2 m -62.73 135.43 95.81 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.795 176.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.416 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 19.6 Cg_endo -60.64 178.24 0.5 Allowed 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.985 2.457 . . . . 0.0 112.972 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -69.81 -0.91 28.74 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 114.816 0.686 . . . . 0.0 114.816 -171.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -99.69 -11.15 21.14 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 118.171 0.985 . . . . 0.0 109.306 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.793 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . 18.6 m-85 -106.13 -20.69 13.33 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.545 173.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.53 36.11 1.18 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.783 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 57.4 t30 . . . . . 0 C--O 1.244 0.792 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.143 -175.995 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 94.3 m . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 121.096 0.474 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.4 HG21 ' CE2' ' A' ' 13' ' ' PHE . 26.2 m -108.6 124.71 50.91 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.82 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 65.4 m -125.7 120.56 31.0 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.163 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 77.4 m -104.93 162.82 18.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.731 -175.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -83.17 -0.56 10.0 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.275 1.983 . . . . 0.0 115.526 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t -170.59 148.7 3.09 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 119.547 1.067 . . . . 0.0 111.948 -172.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.77 ' HA ' ' HG2' ' A' ' 10' ' ' ARG . 29.3 mm -59.84 -35.71 62.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.466 0.65 . . . . 0.0 109.965 172.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.6 t -71.97 -42.83 68.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.767 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.809 ' HB1' HG23 ' A' ' 30' ' ' THR . . . -71.48 -41.15 69.7 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.901 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.77 ' HG2' ' HA ' ' A' ' 7' ' ' ILE . 0.6 OUTLIER -66.73 -28.98 68.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.179 0.514 . . . . 0.0 109.845 178.551 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.501 ' O ' HG23 ' A' ' 15' ' ' VAL . 37.8 t -64.29 -53.28 51.41 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.547 172.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -52.9 -41.01 63.99 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.555 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.649 ' HA ' ' SG ' ' A' ' 26' ' ' CYS . 58.8 t80 -54.93 -55.76 27.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.945 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.454 ' ND2' ' HA ' ' A' ' 11' ' ' SER . 10.9 p30 -70.28 -25.78 63.5 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.439 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.6 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 47.4 t -65.09 -37.89 81.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.676 174.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.599 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 86.1 m -61.2 -26.84 68.0 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.261 0.553 . . . . 0.0 111.654 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 17' ' ' ARG . 26.0 mmm180 -76.34 -29.65 57.34 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.622 -176.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.884 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -61.97 -44.58 90.38 Favored Pre-proline 0 CA--C 1.549 0.916 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.298 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.884 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 4.1 Cg_exo -78.5 -30.13 3.36 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 122.101 1.868 . . . . 0.0 112.279 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.5 13.97 2.23 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.1 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 7.0 m -72.34 126.92 90.83 Favored Pre-proline 0 N--CA 1.443 -0.8 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.898 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -57.96 126.42 21.6 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 122.133 1.889 . . . . 0.0 109.932 175.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.72 -37.99 1.34 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.038 171.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.74 -46.63 88.55 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 111.388 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.898 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 2.3 tt -61.46 -46.52 89.69 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.94 0.4 . . . . 0.0 110.142 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.649 ' SG ' ' HA ' ' A' ' 13' ' ' PHE . 10.9 t -70.14 -26.67 64.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.948 -177.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.06 -19.47 64.88 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.751 0.786 . . . . 0.0 110.731 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.3 m -88.16 -23.82 23.52 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.691 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -96.41 -49.41 5.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.718 0.771 . . . . 0.0 109.84 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.809 HG23 ' HB1' ' A' ' 9' ' ' ALA . 12.8 m -69.8 -29.45 66.76 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.721 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.77 20.47 65.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.576 -177.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.1 t -90.65 145.9 24.46 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.7 pt -111.73 135.7 50.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.355 0.598 . . . . 0.0 112.216 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 59.7 mt -108.88 104.8 17.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.041 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.586 HD11 ' SG ' ' A' ' 40' ' ' CYS . 27.8 pt -123.42 149.56 58.5 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.244 -173.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -84.0 20.18 1.24 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.719 2.28 . . . . 0.0 112.466 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.4 -153.05 6.0 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.706 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.9 23.22 6.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.911 0.386 . . . . 0.0 111.062 -176.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 m -77.11 57.03 1.33 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.68 0.753 . . . . 0.0 111.032 -179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.586 ' SG ' HD11 ' A' ' 35' ' ' ILE . 28.4 m -110.96 104.69 56.51 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.328 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 40' ' ' CYS . 29.3 Cg_endo -64.17 166.87 15.65 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.498 2.132 . . . . 0.0 111.847 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -58.45 -30.69 65.33 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.38 -0.438 . . . . 0.0 114.049 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.18 -26.56 30.75 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 121.337 0.589 . . . . 0.0 109.855 -176.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.511 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 14.1 m-85 -113.14 21.99 14.77 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.765 -171.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' A' ' 3' ' ' CYS . . . -112.75 30.07 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.526 0.679 . . . . 0.0 109.47 175.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 . . . . . 0 C--O 1.247 0.956 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.263 -176.972 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.439 HG23 HG13 ' A' ' 35' ' ' ILE . 3.6 t . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.436 0.636 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.557 ' HB ' ' CZ ' ' A' ' 13' ' ' PHE . 78.2 m -134.52 141.61 46.77 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.006 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.404 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 65.8 m -116.15 126.78 54.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.811 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 10' ' ' ARG . 63.7 m -118.6 117.35 34.36 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.904 176.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.39 25.97 0.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.727 2.284 . . . . 0.0 112.802 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -153.04 134.8 14.57 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.565 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 33.3 mt -60.66 -37.12 74.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.048 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.0 t -72.65 -49.05 43.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.193 0.52 . . . . 0.0 110.127 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.72 -46.23 77.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.988 177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -68.11 -29.75 68.74 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 -175.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 15' ' ' VAL . 58.6 m -62.38 -59.06 5.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.946 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -69.7 -25.71 64.0 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.523 -177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.557 ' CZ ' ' HB ' ' A' ' 2' ' ' THR . 3.9 t80 -58.96 -48.5 81.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.015 172.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.85 -39.49 90.81 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.071 0.463 . . . . 0.0 110.207 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 11' ' ' SER . 43.1 t -69.89 -20.52 23.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.977 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.811 ' O ' ' HB ' ' A' ' 21' ' ' THR . 25.4 t -91.44 -2.93 57.11 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 121.799 0.809 . . . . 0.0 109.693 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -109.42 -29.5 8.4 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.819 0.818 . . . . 0.0 109.281 -172.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -48.43 92.72 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.855 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.78 -18.65 58.58 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 122.225 1.95 . . . . 0.0 113.282 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.99 12.69 7.57 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.495 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.811 ' HB ' ' O ' ' A' ' 16' ' ' CYS . 3.6 m -85.64 136.31 37.21 Favored Pre-proline 0 N--CA 1.433 -1.31 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.746 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.3 Cg_endo -58.63 118.67 5.6 Favored 'Trans proline' 0 N--CA 1.443 -1.457 0 C-N-CA 122.816 2.344 . . . . 0.0 111.389 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HB2' ' HE1' ' A' ' 13' ' ' PHE . 10.2 pt-20 -42.36 -31.63 0.43 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.912 168.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.6 -51.49 69.59 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.847 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.746 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 3.0 tt -59.41 -44.96 92.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.223 0.535 . . . . 0.0 109.951 177.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.7 m -66.92 -42.09 85.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.897 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -57.8 -47.25 83.12 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.396 0.617 . . . . 0.0 111.823 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 m -63.0 -29.21 70.65 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.318 -172.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -95.11 -48.11 6.09 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.614 0.721 . . . . 0.0 109.52 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 91.7 m -61.84 -38.33 87.81 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.751 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.66 -4.05 11.94 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.094 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 58.8 m -73.1 168.79 18.36 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.853 0.359 . . . . 0.0 110.196 176.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 40.0 pt -122.53 132.48 71.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.009 0.433 . . . . 0.0 110.762 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 2' ' ' THR . 16.5 tt -95.92 139.0 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.403 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.657 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 20.0 pt -121.56 173.01 4.33 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -175.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.657 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 73.6 Cg_endo -80.41 -24.09 5.63 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.638 1.558 . . . . 0.0 113.719 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -153.01 -138.15 2.65 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.971 -1.109 . . . . 0.0 113.856 -171.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.38 13.69 33.12 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -83.24 77.2 9.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.732 0.777 . . . . 0.0 110.319 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.554 ' HB2' HD13 ' A' ' 35' ' ' ILE . 30.7 t -155.84 129.28 4.48 Favored Pre-proline 0 C--N 1.311 -1.074 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.087 -178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.05 163.16 31.14 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.61 2.207 . . . . 0.0 112.451 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.539 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -73.81 8.82 9.96 Favored Glycine 0 N--CA 1.451 -0.321 0 CA-C-N 115.921 -0.581 . . . . 0.0 113.537 -176.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.31 -27.79 21.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.404 ' HB3' ' HB3' ' A' ' 3' ' ' CYS . 9.9 m-85 -105.61 -7.14 18.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.658 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.539 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -94.1 40.05 1.08 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.926 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 C--O 1.251 1.14 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.604 178.263 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 37' ' ' GLY . 6.4 m . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 121.621 0.724 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.4 m -111.44 132.12 54.7 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.682 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.435 ' HB2' HG13 ' A' ' 33' ' ' ILE . 63.6 m -138.71 153.95 48.54 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.015 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 9' ' ' ALA . 14.7 t -150.06 133.24 8.5 Favored Pre-proline 0 N--CA 1.447 -0.589 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.568 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 9.9 Cg_exo -73.1 -6.12 18.38 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.927 2.418 . . . . 0.0 114.797 -174.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.9 p -163.75 153.54 14.85 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.679 0.672 . . . . 0.0 110.836 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.3 mt -66.41 -30.47 49.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.308 177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.49 -46.81 91.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.116 0.484 . . . . 0.0 110.135 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.464 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . . . -63.24 -47.42 82.53 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.728 175.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -50.48 -41.21 52.83 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.288 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 15' ' ' VAL . 75.7 m -59.96 -56.47 21.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.458 0.17 . . . . 0.0 111.458 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.437 HD21 ' HA ' ' A' ' 9' ' ' ALA . 9.3 p30 -75.55 -20.52 58.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.755 -175.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.577 ' HB2' HG21 ' A' ' 30' ' ' THR . 65.0 t80 -57.12 -55.42 34.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.592 170.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.567 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 1.7 t-20 -56.32 -41.62 76.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.634 176.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 11' ' ' SER . 89.8 t -56.86 -30.26 32.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.619 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.504 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.1 t -81.17 -34.14 32.58 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.973 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.691 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 73.5 ttt180 -71.25 -30.65 66.57 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 14' ' ' ASN . 83.2 mt -48.22 -52.45 41.83 Favored Pre-proline 0 N--CA 1.444 -0.736 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -175.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 54.7 Cg_endo -71.0 3.19 3.52 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.007 1.805 . . . . 0.0 113.617 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.06 27.45 6.24 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.34 176.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.575 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 1.2 m -94.44 137.12 22.76 Favored Pre-proline 0 N--CA 1.435 -1.194 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.815 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 18.1 Cg_endo -62.36 126.4 18.42 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 122.905 2.404 . . . . 0.0 110.478 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.691 ' HG2' ' HD2' ' A' ' 17' ' ' ARG . 37.8 mt-10 -41.5 -38.41 1.29 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.342 173.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.38 82.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.578 0.228 . . . . 0.0 111.2 177.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.815 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.3 tt -64.55 -43.22 94.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.575 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 58.1 m -69.06 -26.2 64.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.593 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.19 -28.95 68.52 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 122.224 1.011 . . . . 0.0 110.328 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.4 m -82.39 -19.91 38.19 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.241 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -98.2 -46.09 5.97 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.02 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.577 HG21 ' HB2' ' A' ' 13' ' ' PHE . 15.7 m -76.16 -61.88 1.79 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.282 -1.327 . . . . 0.0 112.552 -177.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.83 -16.55 3.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.348 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.568 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 32.7 m -65.17 152.88 42.51 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 3' ' ' CYS . 32.8 pt -113.78 136.71 49.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 C-N-CA 120.271 -0.572 . . . . 0.0 112.077 -174.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.4 mm -98.44 135.13 34.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 173.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.459 HD13 ' SG ' ' A' ' 40' ' ' CYS . 45.3 pt -124.4 150.33 63.99 Favored Pre-proline 0 C--N 1.314 -0.944 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.477 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -76.48 56.99 5.3 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.411 2.074 . . . . 0.0 111.639 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.624 ' O ' ' HA ' ' A' ' 1' ' ' THR . . . 172.38 -141.05 6.05 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.19 14.75 0.52 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.2 m -94.67 102.03 13.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.152 0.501 . . . . 0.0 111.433 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.459 ' SG ' HD13 ' A' ' 35' ' ' ILE . 67.9 m -142.18 124.05 8.92 Favored Pre-proline 0 C--N 1.312 -1.053 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.654 175.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 59.0 Cg_endo -71.92 -173.94 1.2 Allowed 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.886 2.39 . . . . 0.0 112.395 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.29 -19.59 66.52 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 114.961 0.744 . . . . 0.0 114.961 -168.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -88.23 -15.35 36.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 117.607 0.704 . . . . 0.0 109.677 -177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.41 ' HD2' ' HD2' ' A' ' 41' ' ' PRO . 17.3 m-85 -116.42 -1.6 12.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.897 -176.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.22 32.55 4.55 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.049 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.488 -0.768 . . . . 0.0 109.718 178.045 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.637 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 33.1 m . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 120.894 0.378 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.6 m -126.77 139.97 52.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.107 0.479 . . . . 0.0 111.262 -174.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 32' ' ' CYS . 55.8 m -111.99 96.51 6.09 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.066 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.592 ' HA ' ' CB ' ' A' ' 32' ' ' CYS . 0.1 OUTLIER -106.2 126.08 31.43 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.64 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 65.5 Cg_endo -88.03 31.69 0.42 Allowed 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.105 2.537 . . . . 0.0 114.8 -167.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.435 ' O ' ' HG2' ' A' ' 10' ' ' ARG . 23.9 t -163.93 143.39 7.98 Favored 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 122.075 -0.391 . . . . 0.0 110.567 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.77 ' H ' HD12 ' A' ' 7' ' ' ILE . 3.8 mp -60.8 -36.07 68.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 175.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -73.68 -52.6 20.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.634 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.442 ' HA ' HD21 ' A' ' 12' ' ' ASN . . . -57.1 -48.05 79.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.582 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -66.38 -24.43 66.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.227 -176.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 15' ' ' VAL . 69.9 m -70.69 -55.27 9.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.756 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.442 HD21 ' HA ' ' A' ' 9' ' ' ALA . 10.0 p30 -67.47 -23.13 65.47 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.289 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.406 ' O ' ' HB3' ' A' ' 16' ' ' CYS . 43.2 t80 -60.94 -60.8 3.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.006 172.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -69.16 -32.7 72.21 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.866 -0.333 . . . . 0.0 110.776 -175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 11' ' ' SER . 68.8 t -67.01 -24.49 32.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.408 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.507 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 1.0 OUTLIER -72.76 -33.67 66.49 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.836 0.351 . . . . 0.0 110.384 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 21' ' ' THR . 77.6 ttt180 -72.84 -27.53 61.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.348 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.42 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 82.0 mt -54.62 -52.41 70.16 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 -175.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 72.1 Cg_endo -75.85 17.35 0.7 Allowed 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.062 1.841 . . . . 0.0 113.716 -177.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.03 28.59 7.65 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.475 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 17' ' ' ARG . 1.3 m -103.39 138.96 19.69 Favored Pre-proline 0 N--CA 1.438 -1.072 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.529 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 24.8 Cg_endo -66.28 128.89 20.29 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.734 2.29 . . . . 0.0 110.532 173.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -46.09 -30.72 2.0 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.876 173.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -53.06 -54.18 39.28 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 174.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.529 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 1.1 tm? -61.01 -41.53 96.72 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 120.86 0.362 . . . . 0.0 110.847 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.2 m -68.57 -39.66 80.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.369 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.58 -31.91 73.22 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.765 0.793 . . . . 0.0 110.608 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 39.8 m -76.51 -21.87 55.18 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.694 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -94.87 -52.53 4.21 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.103 -176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 90.5 m -61.2 -41.55 97.02 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.215 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.54 -8.83 13.25 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.223 175.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.592 ' CB ' ' HA ' ' A' ' 4' ' ' CYS . 6.3 p -89.42 179.95 5.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.156 0.478 . . . . 0.0 111.671 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -120.93 153.09 24.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -168.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 24' ' ' ALA . 71.2 mt -109.82 131.56 60.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.949 175.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.637 ' O ' ' HB ' ' A' ' 1' ' ' THR . 12.9 pt -135.97 161.35 63.12 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.528 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 73.5 Cg_endo -75.57 1.65 7.77 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.53 2.153 . . . . 0.0 113.623 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.32 -123.47 1.17 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.368 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.535 ' HB3' HD12 ' A' ' 35' ' ' ILE . . . 71.32 -5.8 1.5 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.734 0.814 . . . . 0.0 112.802 173.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 39' ' ' THR . 85.7 m 63.16 10.14 4.38 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.72 0.771 . . . . 0.0 111.823 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 84.3 m 67.02 141.98 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.642 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HG2' ' CD2' ' A' ' 44' ' ' TYR . 39.8 Cg_endo -70.24 159.1 54.22 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.511 2.14 . . . . 0.0 111.397 171.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.75 -33.65 85.92 Favored Glycine 0 CA--C 1.519 0.32 0 N-CA-C 114.199 0.44 . . . . 0.0 114.199 -170.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -82.51 -14.15 55.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.325 0.563 . . . . 0.0 110.58 -174.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.64 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 13.5 m-85 -119.34 19.69 12.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.604 -174.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.15 56.56 1.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.185 0.517 . . . . 0.0 110.173 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.425 HD22 ' C ' ' A' ' 46' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.705 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.684 HG21 ' HA2' ' A' ' 37' ' ' GLY . 21.1 m . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 120.897 0.379 . . . . 0.0 110.355 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.703 HG22 ' SG ' ' A' ' 32' ' ' CYS . 4.0 m -134.48 132.14 38.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.996 -173.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.0 m -127.03 121.08 30.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.874 0.369 . . . . 0.0 110.532 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.483 ' SG ' ' HB2' ' A' ' 13' ' ' PHE . 57.9 m -109.07 121.29 43.28 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.693 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.779 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 87.7 Cg_endo -88.47 30.92 0.42 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.817 2.344 . . . . 0.0 114.779 -171.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.597 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 77.9 p -165.78 147.82 7.29 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.132 -0.627 . . . . 0.0 110.387 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.1 mt -55.74 -37.69 47.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.679 0.612 . . . . 0.0 112.343 -170.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.67 -39.44 22.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.012 0.434 . . . . 0.0 110.029 -176.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.428 ' HA ' ' CG2' ' A' ' 30' ' ' THR . . . -63.64 -45.67 89.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.55 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -55.67 -42.45 75.13 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 177.263 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 15' ' ' VAL . 49.1 m -64.43 -49.8 70.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.113 -178.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.459 HD22 HG23 ' A' ' 30' ' ' THR . 93.2 m-20 -58.33 -41.41 84.49 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 110.644 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.567 ' CE1' ' HB ' ' A' ' 2' ' ' THR . 15.0 t80 -50.17 -46.92 54.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.213 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -71.4 -41.3 69.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.832 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 11' ' ' SER . 87.1 t -63.59 -37.36 79.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.719 -176.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.582 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 92.5 m -69.86 -28.09 65.37 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.498 ' HD2' ' CE1' ' A' ' 13' ' ' PHE . 81.1 mtp180 -84.69 -20.81 30.62 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 121.662 -0.649 . . . . 0.0 111.811 -170.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.921 ' HG ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -66.49 -44.41 55.83 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.541 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.921 ' HD3' ' HG ' ' A' ' 18' ' ' LEU . 89.3 Cg_endo -85.15 -3.8 9.56 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.626 1.55 . . . . 0.0 113.183 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.22 16.8 15.35 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.397 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 3.6 m -78.82 125.32 84.31 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 175.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.568 ' HG2' ' HB3' ' A' ' 25' ' ' LEU . 10.2 Cg_endo -55.64 121.63 10.29 Favored 'Trans proline' 0 N--CA 1.445 -1.34 0 C-N-CA 122.688 2.259 . . . . 0.0 111.035 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -41.8 -36.46 1.03 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.277 169.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.523 ' HA ' HG13 ' A' ' 34' ' ' ILE . . . -62.09 -45.18 94.66 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.876 177.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.568 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 35.9 tp -73.52 -41.3 63.21 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 120.905 0.383 . . . . 0.0 110.613 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.3 t -67.43 -35.73 79.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.484 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.595 ' HA ' ' HB3' ' A' ' 32' ' ' CYS . . . -56.28 -53.72 53.94 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.786 0.803 . . . . 0.0 111.124 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.7 m -61.36 -24.8 66.73 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 113.956 -1.475 . . . . 0.0 112.143 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.16 -41.96 11.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 122.448 1.118 . . . . 0.0 109.002 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.459 HG23 HD22 ' A' ' 12' ' ' ASN . 90.2 m -76.7 -32.33 57.8 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.26 -174.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.68 -5.76 24.38 Favored Glycine 0 C--O 1.229 -0.196 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -174.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.703 ' SG ' HG22 ' A' ' 2' ' ' THR . 6.4 t -73.86 164.95 25.97 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.609 -0.796 . . . . 0.0 109.379 176.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.438 HD13 ' HD2' ' A' ' 44' ' ' TYR . 14.4 pt -122.64 152.23 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 119.863 -0.735 . . . . 0.0 112.887 -175.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.523 HG13 ' HA ' ' A' ' 24' ' ' ALA . 34.5 mm -104.87 134.28 46.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.777 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.64 ' O ' ' HB ' ' A' ' 1' ' ' THR . 42.0 pt -144.88 162.68 37.13 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.51 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.536 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 14.6 Cg_endo -60.14 -43.46 35.53 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.503 2.135 . . . . 0.0 111.703 174.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.684 ' HA2' HG21 ' A' ' 1' ' ' THR . . . 131.76 136.78 3.91 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.854 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.74 -85.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 176.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.4 m -141.77 -3.69 1.12 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.939 174.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.558 ' SG ' HD11 ' A' ' 35' ' ' ILE . 64.8 m 66.09 139.7 0.06 OUTLIER Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.676 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HG2' ' HD2' ' A' ' 44' ' ' TYR . 9.3 Cg_endo -53.36 149.55 29.27 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.044 2.496 . . . . 0.0 112.551 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.43 -26.25 64.03 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 114.793 0.677 . . . . 0.0 114.793 -169.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -88.35 -14.36 38.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 117.658 0.729 . . . . 0.0 110.093 -177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.705 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . 16.6 m-85 -117.97 10.98 13.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.914 -175.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.14 50.89 0.86 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.232 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.779 ' HB3' ' HA ' ' A' ' 5' ' ' PRO . 39.7 t30 . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.407 -0.806 . . . . 0.0 109.587 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 120.977 0.418 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 42.1 m -106.49 114.01 27.87 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.601 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.459 ' HB2' HD12 ' A' ' 35' ' ' ILE . 81.0 m -128.15 106.43 9.05 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.566 0.698 . . . . 0.0 111.106 -176.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.719 ' SG ' ' HA ' ' A' ' 10' ' ' ARG . 4.1 m -117.15 157.27 47.25 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.547 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.28 -12.22 33.3 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.815 2.343 . . . . 0.0 114.495 -176.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.2 m -143.96 153.44 42.26 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.923 -0.486 . . . . 0.0 110.57 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.2 mm -61.4 -38.9 81.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.328 0.585 . . . . 0.0 110.567 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 67.0 t -80.78 -33.75 13.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.949 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.575 ' HA ' ' ND2' ' A' ' 12' ' ' ASN . . . -63.42 -37.67 88.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.104 176.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.719 ' HA ' ' SG ' ' A' ' 4' ' ' CYS . 18.5 ttm-85 -69.89 -27.65 64.98 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.606 177.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 15' ' ' VAL . 22.8 t -77.8 -46.07 22.66 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.52 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.575 ' ND2' ' HA ' ' A' ' 9' ' ' ALA . 11.4 p30 -68.29 -21.62 64.78 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.704 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 31.2 t80 -54.37 -54.29 42.55 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.734 172.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -63.2 -34.32 77.38 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.781 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.563 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 73.3 t -60.65 -37.82 76.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.098 179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.518 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 23.3 m -62.08 -38.47 88.95 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.899 0.381 . . . . 0.0 112.016 177.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 mtp85 -75.9 -2.59 30.96 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.663 -177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.635 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 18.2 mt -76.33 -59.83 1.01 Allowed Pre-proline 0 N--CA 1.439 -0.998 0 CA-C-O 119.289 -0.386 . . . . 0.0 111.899 176.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 6.8 Cg_exo -75.45 -24.17 12.38 Favored 'Trans proline' 0 C--N 1.359 1.114 0 C-N-CA 122.142 1.895 . . . . 0.0 112.64 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 126.83 16.06 2.51 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.874 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 1.1 m -81.39 127.56 73.11 Favored Pre-proline 0 N--CA 1.44 -0.972 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.845 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 11.6 Cg_endo -59.42 120.26 7.99 Favored 'Trans proline' 0 N--CA 1.444 -1.41 0 C-N-CA 122.431 2.087 . . . . 0.0 110.685 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -53.4 -28.09 27.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.225 172.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.81 -48.92 76.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.089 172.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.845 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -68.92 -41.31 78.32 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.015 0.436 . . . . 0.0 110.424 -179.441 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 94.5 m -71.51 -28.23 63.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.841 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.65 -37.9 83.06 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.858 0.837 . . . . 0.0 110.42 176.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.6 m -69.68 -23.59 63.47 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 113.902 -1.499 . . . . 0.0 111.417 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -101.22 -49.11 4.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.728 0.775 . . . . 0.0 110.127 -174.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 83.7 m -66.52 -27.46 67.79 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.798 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.82 24.41 42.0 Favored Glycine 0 C--O 1.228 -0.272 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.622 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.8 t -103.54 150.77 23.61 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.0 pt -124.29 139.76 49.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.348 0.594 . . . . 0.0 111.464 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.0 mt -93.88 115.76 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.935 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.488 HD12 ' SG ' ' A' ' 40' ' ' CYS . 39.0 mt -124.38 139.29 32.61 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.442 -171.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.52 -45.52 22.92 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.937 2.425 . . . . 0.0 112.405 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' H ' HG22 ' A' ' 35' ' ' ILE . . . 149.79 148.09 4.68 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.955 174.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 76.46 -19.47 0.42 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.77 0.828 . . . . 0.0 112.747 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 39' ' ' THR . 18.0 m -88.24 5.67 40.53 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 122.006 0.908 . . . . 0.0 110.984 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.788 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 67.6 m -75.04 115.63 46.56 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.09 -178.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 30.3 Cg_endo -65.14 150.59 87.53 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.606 2.204 . . . . 0.0 111.48 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.23 -15.27 60.72 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 114.406 0.522 . . . . 0.0 114.406 -171.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.1 -19.15 18.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.586 0.693 . . . . 0.0 109.61 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.79 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 19.8 m-85 -114.71 19.39 16.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.304 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.788 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . . . -137.95 31.18 2.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.245 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.44 ' C ' HH21 ' A' ' 10' ' ' ARG . 57.4 t30 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.235 -0.888 . . . . 0.0 109.933 -178.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 6.8 m . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.826 0.346 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.8 m -120.64 108.09 13.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.282 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 78.1 m -98.17 124.83 42.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.297 -177.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 4.1 t -110.91 126.15 29.29 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.732 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 4.3 Cg_endo -85.42 22.95 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.783 2.322 . . . . 0.0 114.222 -170.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 50.8 m -154.83 136.66 14.49 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 122.07 -0.394 . . . . 0.0 110.072 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.43 ' O ' ' HG3' ' A' ' 10' ' ' ARG . 60.4 mt -65.06 -31.05 52.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.926 -175.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.61 -41.29 16.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 6' ' ' SER . . . -59.28 -50.31 74.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.815 175.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -63.19 -26.2 68.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.142 0.496 . . . . 0.0 110.485 -178.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 15' ' ' VAL . 19.8 t -68.74 -54.7 14.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.619 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.411 HD21 ' HA ' ' A' ' 9' ' ' ALA . 9.0 p30 -75.09 -24.62 58.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.007 0.432 . . . . 0.0 110.275 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.4 ' HB2' HG21 ' A' ' 30' ' ' THR . 35.0 t80 -54.8 -57.22 12.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.478 174.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.33 -27.71 67.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 110.428 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 11' ' ' SER . 93.6 t -71.41 -18.7 20.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.567 176.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.407 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 4.8 t -83.76 -26.92 29.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.261 0.553 . . . . 0.0 109.669 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.62 ' HG3' ' HB3' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -89.67 -37.97 14.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.557 -171.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.539 ' HG ' ' CD ' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -49.64 -45.53 78.8 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 115.007 -0.997 . . . . 0.0 113.538 -179.333 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.539 ' CD ' ' HG ' ' A' ' 18' ' ' LEU . 9.8 Cg_exo -73.06 9.15 1.46 Allowed 'Trans proline' 0 C--N 1.362 1.255 0 C-N-CA 122.389 2.059 . . . . 0.0 113.961 -176.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.29 34.48 4.2 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.642 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.505 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 1.6 m -115.7 137.37 23.18 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 14.9 Cg_endo -60.55 123.5 13.17 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.484 2.123 . . . . 0.0 110.651 178.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.62 ' HB3' ' HG3' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -47.54 -31.19 4.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.366 172.255 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.628 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -54.14 -50.94 65.81 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.475 172.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 57.6 tp -70.14 -38.5 75.54 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 120.826 0.346 . . . . 0.0 110.398 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -68.78 -34.43 75.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.107 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.23 -46.4 89.91 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.929 0.871 . . . . 0.0 110.453 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 m -65.04 -24.78 67.58 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.728 -1.578 . . . . 0.0 111.625 -176.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -100.94 -40.84 7.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.586 0.707 . . . . 0.0 110.184 -173.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.4 HG21 ' HB2' ' A' ' 13' ' ' PHE . 39.0 m -74.49 -39.05 62.7 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.579 -177.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.49 -7.5 11.33 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.949 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.51 154.58 41.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.6 pt -118.75 155.9 20.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.684 -175.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.628 HD11 ' HA ' ' A' ' 24' ' ' ALA . 81.7 mt -113.51 125.12 70.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.679 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.501 ' O ' ' HB ' ' A' ' 1' ' ' THR . 13.0 pt -128.14 106.01 19.9 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.546 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.35 80.13 0.78 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 123.061 2.507 . . . . 0.0 111.687 178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -167.92 -137.05 2.15 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.798 178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.77 -37.22 0.54 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.71 100.77 6.35 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.178 0.513 . . . . 0.0 111.984 -175.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 53.7 t -119.67 119.13 31.61 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.44 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' C ' ' H ' ' A' ' 43' ' ' ASP . 43.9 Cg_endo -67.53 148.78 79.28 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.555 2.17 . . . . 0.0 112.104 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -73.5 21.28 1.18 Allowed Glycine 0 CA--C 1.517 0.168 0 CA-C-N 116.22 -0.445 . . . . 0.0 113.295 -175.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 41' ' ' PRO . 6.9 m-20 -102.96 -22.65 13.79 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.732 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 8.0 m-85 -121.74 -2.73 9.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.784 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.57 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -90.32 42.29 1.09 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.373 -169.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.0 m120 . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.471 175.721 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 35' ' ' ILE . 8.7 m . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 t -138.14 161.29 37.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.718 0.294 . . . . 0.0 110.604 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.0 p -143.96 149.96 37.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 3.3 t -140.6 136.08 16.25 Favored Pre-proline 0 N--CA 1.452 -0.359 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 26.4 Cg_exo -64.33 -19.53 65.66 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 123.288 2.659 . . . . 0.0 114.915 -173.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.5 p -137.55 156.29 48.27 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.867 -0.521 . . . . 0.0 111.486 -176.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.799 ' HA ' ' HD2' ' A' ' 10' ' ' ARG . 54.2 mt -69.1 -32.92 56.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.338 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.7 t -67.29 -51.49 52.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.035 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.49 ' HB1' HG22 ' A' ' 30' ' ' THR . . . -62.63 -36.49 82.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.738 179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.799 ' HD2' ' HA ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -65.02 -39.66 93.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.196 0.522 . . . . 0.0 110.654 179.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 15' ' ' VAL . 27.9 m -65.92 -44.51 84.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.023 176.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -61.76 -45.17 95.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.781 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.666 ' CD2' ' HA ' ' A' ' 10' ' ' ARG . 1.3 p90 -71.58 -31.23 66.72 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.987 -176.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.45 -51.16 68.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.96 0.409 . . . . 0.0 110.685 172.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 11' ' ' SER . 39.8 t -68.44 -10.75 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.737 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.605 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 7.6 t -81.47 -26.26 35.38 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.807 -0.558 . . . . 0.0 109.874 176.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 1.103 ' HD3' ' HG3' ' A' ' 23' ' ' GLU . 40.4 mtm180 -75.35 -24.13 57.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.487 0.661 . . . . 0.0 109.992 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.566 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 64.2 tp -56.4 -52.21 74.97 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.077 -177.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 16' ' ' CYS . 13.9 Cg_exo -71.03 -3.09 12.14 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.339 2.026 . . . . 0.0 113.397 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.54 30.09 5.71 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.691 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.466 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -96.07 139.33 21.74 Favored Pre-proline 0 N--CA 1.436 -1.165 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.545 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.466 ' HD2' HG22 ' A' ' 21' ' ' THR . 26.0 Cg_endo -66.29 132.27 29.05 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.93 2.42 . . . . 0.0 111.099 175.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 1.103 ' HG3' ' HD3' ' A' ' 17' ' ' ARG . 28.8 mp0 -39.38 -39.65 0.7 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.508 170.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -48.69 -52.95 20.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.216 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.09 -45.92 75.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.739 0.304 . . . . 0.0 110.203 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.423 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 21.8 m -64.68 -40.11 94.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.618 -174.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.76 -47.34 72.52 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.585 0.707 . . . . 0.0 111.173 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.4 m -65.93 -24.98 66.93 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.124 -175.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -92.13 -45.48 8.25 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 122.009 0.909 . . . . 0.0 109.257 -176.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.49 HG22 ' HB1' ' A' ' 9' ' ' ALA . 61.6 m -70.16 -40.04 74.97 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.916 -1.493 . . . . 0.0 112.122 -176.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.56 4.18 21.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.228 -0.986 . . . . 0.0 112.15 -178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 m -84.45 155.7 22.1 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.5 pt -118.71 153.41 20.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.321 -177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.41 135.99 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.01 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.599 HD13 ' HB2' ' A' ' 40' ' ' CYS . 13.0 pt -131.67 129.53 22.09 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.084 0.468 . . . . 0.0 110.88 -173.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.1 -29.01 65.45 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.866 2.378 . . . . 0.0 111.783 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.97 -135.6 3.13 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.011 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.61 41.01 1.09 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.361 0.6 . . . . 0.0 110.284 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -80.59 22.93 0.54 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.182 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.599 ' HB2' HD13 ' A' ' 35' ' ' ILE . 31.6 t -135.94 124.25 15.33 Favored Pre-proline 0 C--N 1.313 -1.022 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.196 -175.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.76 164.63 33.81 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.668 2.246 . . . . 0.0 112.514 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.89 -2.33 45.24 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.29 -172.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -90.03 -25.22 20.93 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 117.796 0.798 . . . . 0.0 109.253 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 5' ' ' PRO . 13.3 m-85 -101.3 8.53 42.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.309 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.61 48.24 0.93 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.256 175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.619 -178.415 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.513 HG21 ' HA ' ' A' ' 39' ' ' THR . 3.1 m . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -138.79 143.47 38.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.843 0.354 . . . . 0.0 111.126 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 5.9 m -152.62 160.4 43.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.451 178.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 10' ' ' ARG . 8.9 t -140.01 143.81 35.65 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -176.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 14.2 Cg_exo -70.5 0.87 5.55 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.087 2.525 . . . . 0.0 113.493 -178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.0 m -152.8 139.73 19.11 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 176.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.624 HG13 ' OD1' ' A' ' 46' ' ' ASN . 72.0 mt -61.29 -36.37 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.142 0.496 . . . . 0.0 110.276 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.47 -29.98 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.759 -174.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.2 -28.68 27.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.167 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -70.2 -35.62 74.04 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.596 -177.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 15' ' ' VAL . 2.9 p -68.13 -46.91 69.57 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.491 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.88 -30.99 71.95 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.906 0.384 . . . . 0.0 111.029 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.505 ' HZ ' ' HB2' ' A' ' 23' ' ' GLU . 36.5 t80 -54.27 -50.95 66.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.488 174.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 28.9 m-80 -65.85 -32.7 74.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.224 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 11' ' ' SER . 93.1 t -61.53 -32.85 54.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.306 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.425 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 6.4 t -78.06 -26.41 48.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.132 0.491 . . . . 0.0 110.426 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -79.28 -18.92 51.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.11 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.509 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.8 mt -55.25 -53.57 60.38 Favored Pre-proline 0 N--CA 1.442 -0.827 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.142 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 59.8 Cg_endo -72.97 17.03 0.4 Allowed 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.081 1.854 . . . . 0.0 113.11 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.88 15.5 61.16 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.054 -0.593 . . . . 0.0 113.46 173.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.594 ' HB ' ' SG ' ' A' ' 26' ' ' CYS . 1.3 m -77.85 138.08 61.91 Favored Pre-proline 0 N--CA 1.433 -1.3 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.494 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 15.6 Cg_endo -61.88 121.89 10.18 Favored 'Trans proline' 0 N--CA 1.439 -1.679 0 C-N-CA 122.726 2.284 . . . . 0.0 110.861 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.505 ' HB2' ' HZ ' ' A' ' 13' ' ' PHE . 10.3 pt-20 -40.64 -37.43 0.73 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.939 170.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.66 -48.68 77.05 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.317 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.482 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 32.2 tp -72.99 -39.81 65.75 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 120.609 0.242 . . . . 0.0 110.43 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.594 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 61.2 m -65.44 -34.03 77.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.467 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -65.55 -39.41 91.69 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.702 0.763 . . . . 0.0 110.496 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.4 m -71.28 -18.88 62.4 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.841 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -92.84 -21.43 19.88 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 122.235 1.017 . . . . 0.0 109.525 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.5 m -107.78 -49.91 3.15 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 113.949 -1.478 . . . . 0.0 112.029 -172.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.92 -17.74 5.15 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -175.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.452 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 11.5 m -67.8 167.41 13.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.484 -0.358 . . . . 0.0 110.077 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.9 pt -131.65 137.11 55.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.388 0.613 . . . . 0.0 112.46 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.75 128.77 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 167.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.486 ' O ' ' HB ' ' A' ' 1' ' ' THR . 4.8 tt -130.35 97.62 22.02 Favored Pre-proline 0 C--N 1.311 -1.098 0 CA-C-O 121.654 0.74 . . . . 0.0 110.153 -173.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.0 42.76 1.38 Allowed 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.641 2.894 . . . . 0.0 113.073 -174.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 38' ' ' ALA . . . 155.8 145.72 4.26 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.638 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . 76.41 30.64 0.65 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.397 0.679 . . . . 0.0 111.006 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.513 ' HA ' HG21 ' A' ' 1' ' ' THR . 58.2 m 46.91 -95.48 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.93 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 63.0 m -151.75 152.66 30.65 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-O 120.941 0.4 . . . . 0.0 110.961 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 44' ' ' TYR . 6.2 Cg_exo -74.82 -172.02 1.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.217 2.611 . . . . 0.0 111.233 171.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.63 -44.35 2.72 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.621 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -82.5 -22.06 35.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.69 0.757 . . . . 0.0 109.74 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.611 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 12.4 m-85 -101.38 20.93 14.99 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.485 -177.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.57 63.56 1.57 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.391 0.615 . . . . 0.0 109.377 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.624 ' OD1' HG13 ' A' ' 7' ' ' ILE . 20.7 t-20 . . . . . 0 C--O 1.249 1.053 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.686 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.468 ' HB ' HG13 ' A' ' 35' ' ' ILE . 31.0 m . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 120.784 0.326 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.1 t -72.43 142.47 48.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.286 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.555 ' HB3' HG13 ' A' ' 33' ' ' ILE . 30.3 t -144.49 79.08 1.6 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -178.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 82.3 m -103.53 112.37 65.6 Favored Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.805 -175.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.695 ' HB3' ' HD1' ' A' ' 44' ' ' TYR . 3.0 Cg_exo -77.25 14.29 1.39 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.171 2.581 . . . . 0.0 114.896 -173.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 79.0 p -160.36 156.18 25.8 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 118.753 0.706 . . . . 0.0 111.213 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 68.6 mt -62.67 -34.34 64.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.666 173.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.61 -49.66 82.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.602 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.58 -48.29 80.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.682 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HA ' ' HD3' ' A' ' 10' ' ' ARG . 23.5 tpp180 -55.05 -38.83 68.5 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.767 176.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.5 ' O ' HG23 ' A' ' 15' ' ' VAL . 14.3 t -66.9 -50.05 63.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.471 HD22 HG23 ' A' ' 30' ' ' THR . 93.4 m-20 -55.19 -39.41 69.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.105 0.478 . . . . 0.0 110.702 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -57.65 -49.7 75.6 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.957 179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -73.52 -23.72 60.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.902 0.382 . . . . 0.0 111.202 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 11' ' ' SER . 79.4 t -66.37 -43.58 91.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.213 173.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.663 ' HB3' ' HB ' ' A' ' 21' ' ' THR . 85.1 m -69.2 -16.71 63.68 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.784 HH11 ' HG3' ' A' ' 23' ' ' GLU . 21.0 mmm180 -71.05 -27.2 63.48 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.827 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.605 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 93.6 mt -66.98 -52.69 30.16 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -177.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 18' ' ' LEU . 1.2 Cg_endo -85.41 17.24 1.8 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 122.525 2.15 . . . . 0.0 112.68 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.68 30.13 68.84 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.863 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.663 ' HB ' ' HB3' ' A' ' 16' ' ' CYS . 2.1 m -85.67 128.56 58.3 Favored Pre-proline 0 N--CA 1.438 -1.057 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.884 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 10.4 Cg_endo -58.74 122.29 11.38 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.552 2.168 . . . . 0.0 110.672 175.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.784 ' HG3' HH11 ' A' ' 17' ' ' ARG . 49.3 mt-10 -48.52 -32.8 8.47 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.111 172.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.68 -51.4 69.7 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.272 173.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.884 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 4.2 tt -57.64 -50.23 73.84 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.032 0.444 . . . . 0.0 110.262 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.6 m -72.71 -21.54 61.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.256 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 32' ' ' CYS . . . -66.87 -42.21 85.98 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.944 0.878 . . . . 0.0 110.067 175.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.6 m -66.99 -18.74 65.52 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 113.496 -1.684 . . . . 0.0 110.776 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -98.63 -48.2 5.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.835 0.826 . . . . 0.0 110.115 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.471 HG23 HD22 ' A' ' 12' ' ' ASN . 92.9 m -68.09 -38.08 81.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.339 -1.3 . . . . 0.0 112.498 -174.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.57 -12.94 32.93 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.523 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.47 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 38.9 t -73.13 143.26 47.39 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.555 HG13 ' HB3' ' A' ' 3' ' ' CYS . 22.1 pt -110.13 144.61 17.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.123 0.487 . . . . 0.0 111.472 -176.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.5 mt -109.17 104.12 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.359 174.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.468 HG13 ' HB ' ' A' ' 1' ' ' THR . 26.1 pt -93.62 138.95 22.69 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.766 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 35' ' ' ILE . 24.7 Cg_exo -61.67 -40.71 44.16 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.055 2.504 . . . . 0.0 112.096 175.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.99 -139.52 5.86 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.454 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -139.53 21.16 2.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.585 0.231 . . . . 0.0 111.329 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -81.64 73.97 8.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.869 0.842 . . . . 0.0 110.682 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.455 ' SG ' ' HB2' ' A' ' 44' ' ' TYR . 52.9 t -140.38 107.53 6.65 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.267 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HD2' ' HD2' ' A' ' 44' ' ' TYR . 48.5 Cg_endo -71.1 171.41 15.98 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.622 2.214 . . . . 0.0 112.643 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -66.59 -3.98 23.08 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.85 -0.613 . . . . 0.0 114.353 -174.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -88.67 -19.9 25.58 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 117.614 0.707 . . . . 0.0 109.289 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.695 ' HD1' ' HB3' ' A' ' 5' ' ' PRO . 13.0 m-85 -112.22 -6.55 14.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.776 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -98.97 37.69 1.49 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.959 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.93 -177.665 . . . . . . . . 0 0 . 1 stop_ save_